OBO_ID (LABEL):	UBERON_0002107 (liver)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC184457	8/2003	S50-PMC184457	['Liver function tests normalized soon after admission.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC1852384	1/2007	S28-PMC1852384	['all patients were evaluated by an attending anesthesiologist before surgery.routine preoperative studies included: electrocardiogram, Chest x-ray, Gallbladder ultrasonography, Serum electrolytes, glucose, hba1c, calcium, albumin, Lipid profile, Liver function tests, complete Blood count, Platelets, prothrombin time, partial thromboplastin time, inr, and Urinalysis.']	N/A	N/A	[('UBERON_0001443', 'chest', 134, 'chest'), ('UBERON_0002110', 'gall bladder', 147, 'gallbladder'), ('UBERON_0001977', 'blood serum', 176, 'serum'), ('CHEBI_18059', 'lipid', 230, 'lipid'), ('UBERON_0002107', 'liver', 245, 'liver'), ('UBERON_0000178', 'blood', 276, 'blood'), ('CL_0000233', 'platelet', 289, 'platelets'), ('GO_0006281', 'DNA repair', 356, 'urinalysis')]
PMC1852384	1/2007	S48-PMC1852384	['all routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [Serum electrolytes, Glucose, hba1c, calcium, albumin, Lipid profile, Liver function tests, complete Blood count, Platelets, Serum Insulin, iron, ferritin, Vitamin B12, 25-Oh Vitamin D, and Thiamine (Vitamin B1)].']	N/A	N/A	[('UBERON_0001977', 'blood serum', 120, 'serum'), ('CHEBI_17234', 'glucose', 140, 'glucose'), ('CHEBI_18059', 'lipid', 174, 'lipid'), ('UBERON_0002107', 'liver', 189, 'liver'), ('UBERON_0000178', 'blood', 220, 'blood'), ('CL_0000233', 'platelet', 233, 'platelets'), ('UBERON_0001977', 'blood serum', 244, 'serum'), ('PR_000045358', 'insulin family protein', 250, 'insulin'), ('CHEBI_33279', 'vitamin D5', 275, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 283, 'B12'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 288, '25-OH'), ('CHEBI_27300', 'vitamin D', 294, 'vitamin D'), ('CHEBI_26948', 'vitamin B1', 309, 'thiamine'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 319, 'vitamin B1')]
PMC2022638	10/2007	S177-PMC2022638	['in Rats, Endosulfan is converted by the Liver after oral administration to Endosulfan Sulfate and Endosulfan Diol; peak Serum concentrations are reached within hours and elimination achieved within days (agency for Toxic substances and disease registry 2000;chan and mohd 2005;chan et al.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('CHEBI_4791', 'endosulfan', 9, 'endosulfan'), ('UBERON_0002107', 'liver', 40, 'liver'), ('CHEBI_34735', 'edifenphos', 75, 'endosulfan sulfate'), ('CHEBI_23965', 'estradiol', 98, 'endosulfan diol'), ('UBERON_0001977', 'blood serum', 120, 'serum'), ('CHEBI_33348', 'tantalum atom', 215, 'Toxic')]
PMC2022678	10/2007	S165-PMC2022678	['in addition, when As3+exposure was combined with either in utero or Postnatal Estrogen, Liver lesions were enhanced and Bladder lesions also developed (waalkes et al.']	N/A	N/A	[('CHEBI_29108', 'calcium(2+)', 18, 'As3+'), ('GO_0007567', 'parturition', 68, 'postnatal'), ('CHEBI_50114', 'estrogen', 78, 'estrogen'), ('UBERON_0002107', 'liver', 88, 'liver'), ('UBERON_0018707', 'bladder organ', 120, 'bladder')]
PMC2265032	3/2008	S2-PMC2265032	['Rats receiving daily doses of Arsenic equivalent to the levels in groundwater from heavily Arsenic-contaminated areas of the bengal basin retained significantly less of the element in Blood and Liver and Excreted significantly more in Urine when Fed 2 mg/ml Age.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rats'), ('CHEBI_27563', 'arsenic atom', 30, 'arsenic'), ('CHEBI_27563', 'arsenic atom', 91, 'arsenic'), ('UBERON_0000178', 'blood', 184, 'blood'), ('UBERON_0002107', 'liver', 194, 'liver'), ('GO_0007588', 'excretion', 204, 'excreted'), ('UBERON_0001088', 'urine', 235, 'urine'), ('GO_0007631', 'feeding behavior', 246, 'fed'), ('CHEBI_80551', 'APC', 258, 'AGE')]
PMC2672359	2/2009	S99-PMC2672359	['finally, Cocoa beans are some of the principal dietary sources of ochratoxin a, a Mycotoxin that causes adducts in Testicular dna of Rats and is an established cause of Liver and Kidney tumors in rodents and is a Testicular Toxicant [28,29].']	N/A	N/A	[('CHEBI_15346', 'coenzyme A', 9, 'cocoa'), ('CHEBI_25441', 'mycothiols', 82, 'mycotoxin'), ('UBERON_0000473', 'testis', 115, 'testicular'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 133, 'rats'), ('UBERON_0002107', 'liver', 169, 'liver'), ('UBERON_0002113', 'kidney', 179, 'kidney'), ('UBERON_0000473', 'testis', 213, 'testicular'), ('CHEBI_27014', 'tocoquinone-10', 224, 'toxicant')]
PMC2707610	7/2009	S86-PMC2707610	['Body Fat (Brown Adipose Tissue (Bat), Epididymal Fat, Retroperitoneal (Rp) Fat, Mesenteric Fat was dissected and weighed, as well as various Organs (Heart, Liver, and Pancreas).']	N/A	N/A	[('UBERON_0006314', 'bodily fluid', 0, 'Body fat'), ('UBERON_0001348', 'brown adipose tissue', 10, 'brown adipose tissue'), ('UBERON_0001348', 'brown adipose tissue', 32, 'BAT'), ('UBERON_0004359', 'corpus epididymis', 38, 'epididymal fat'), ('UBERON_0013531', 'retrosplenial region', 54, 'retroperitoneal ...'), ('UBERON_0001377', 'quadriceps femoris', 71, 'Rp ... fat'), ('UBERON_0003284', 'mesentery of midgut', 80, 'mesenteric fat'), ('UBERON_0000062', 'organ', 141, 'organs'), ('UBERON_0000948', 'heart', 149, 'heart'), ('UBERON_0002107', 'liver', 156, 'liver'), ('UBERON_0001264', 'pancreas', 167, 'pancreas')]
PMC2707610	7/2009	S139-PMC2707610	['5±0.226.5±0.226.8±0.3‡27.1±0.4‡27.2±0.2‡27.4±0.2‡Tibia (cm)4.63±0.054.67±0.034.71±0.04*4.71±0.02*4.78±0.04‡4.76±0.05‡4.87±0.05*‡4.88±0.05*‡Liver (g)11.5±0.412.1±0.412.3±0.3*13.6±0.3*16.5±0.8‡17.0±1.1‡19.8±1.3*‡20.7±1.0*‡Heart (g)1.16±0.041.36±0.031.26±0.06*1.49±0.05*1.24±0.02‡1.55±0.05‡1.36±0.03*‡1.64±0.06*‡Bat (g)0.34±0.030.37±0.020.35±0.02*0.43±0.03*0.76±0.04‡0.72±0.05‡1.00±0.10*‡1.10±0.10*‡rp fat (g)3.05±0.244.32±0.444.30±0.27*5.50±0.48*11.79±1.20‡12.34±1.41‡20.94±2.18*‡19.77±1.26*‡Epididymal (g)5.15±0.247.15±0.517.25±0.33*8.20±0.38*16.01±1.50‡19.06±1.74‡27.58±2.50*‡26.30±1.59*‡Mesenteric (g)3.59±0.224.91±0.354.78±0.32*5.30±0.32*9.88±1.20‡10.08±1.45‡16.20±1.49*‡17.80±1.33*‡\nresults are expressed as mean±sem.']	N/A	N/A	[('UBERON_0000979', 'tibia', 49, 'Tibia'), ('UBERON_0002107', 'liver', 139, 'Liver'), ('UBERON_0000948', 'heart', 220, 'Heart'), ('UBERON_0001348', 'brown adipose tissue', 309, 'BAT'), ('UBERON_0001301', 'epididymis', 490, 'Epididymal'), ('UBERON_0000956', 'cerebral cortex', 588, 'Mesenteric')]
PMC2707610	7/2009	S191-PMC2707610	['Liver and Heart weights were also greater in Rats Fed hfd compared with Chow-Fed litter mates (p<0.05), with over 40% and 50% increase in Liver weight in offspring from lean and obese dams, respectively (p<0.001 Rats from obese vs. lean dams,table 3).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000948', 'heart', 10, 'heart'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 45, 'rats'), ('GO_0007631', 'feeding behavior', 50, 'fed'), ('CHEBI_33290', 'food', 72, 'chow'), ('GO_0007631', 'feeding behavior', 77, 'fed'), ('UBERON_0002107', 'liver', 138, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 212, 'rats')]
PMC2724426	7/2009	S177-PMC2724426	['since the Liver has a limited capacity to convert Folic Acid to Dihydrofolate, a form utilized by the body, significant amounts of Folic Acid can enter circulation [40].']	N/A	N/A	[('UBERON_0002107', 'liver', 10, 'liver'), ('CHEBI_30751', 'formic acid', 50, 'folic acid'), ('CHEBI_36263', 'hydrogenmolybdate', 64, 'dihydrofolate'), ('CHEBI_30751', 'formic acid', 131, 'folic acid')]
PMC2749934	9/2009	S4-PMC2749934	['Gene Expression profiles of Liver, Retroperitoneal White Adipose Fat, and Biceps Femoris Skeletal Muscle Tissue from young Adult male Rats (55 days old) in which Nutritional status had been manipulated in utero by maternal undernutrition (un) were compared to the profiles of offspring of ad libitum Fed mothers serving as the control group (ad) (8 offspring/group).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Gene expression'), ('SO_0000704', 'gene', 0, 'Gene'), ('UBERON_0002107', 'liver', 28, 'liver'), ('UBERON_0003693', 'retroperitoneal space', 35, 'retroperitoneal'), ('UBERON_0001998', 'sternocostal joint', 51, 'white adipose fat'), ('UBERON_0001374', 'biceps femoris', 74, 'biceps femoris'), ('UBERON_0001134', 'skeletal muscle tissue', 89, 'skeletal muscle'), ('UBERON_0000479', 'tissue', 105, 'tissue'), ('UBERON_0007023', 'adult organism', 123, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 134, 'rats'), ('CHEBI_7495', 'nefazodone hydrochloride', 162, 'nutritional'), ('GO_0007631', 'feeding behavior', 300, 'fed')]
PMC2749934	9/2009	S43-PMC2749934	['Tissues (Liver, Retroperitoneal White Adipose Fat, and Biceps Femoris Skeletal Muscle) were immediately dissected and snap-frozen in liquid nitrogen for molecular analysis.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissues'), ('UBERON_0002107', 'liver', 9, 'liver'), ('UBERON_0003693', 'retroperitoneal space', 16, 'retroperitoneal'), ('UBERON_0001998', 'sternocostal joint', 32, 'white adipose fat'), ('UBERON_0001374', 'biceps femoris', 55, 'biceps femoris'), ('UBERON_0001134', 'skeletal muscle tissue', 70, 'skeletal muscle')]
PMC2749934	9/2009	S57-PMC2749934	['the samples from Liver, Skeletal muscle, and White Adipose Fat Tissue for male offspring (n\u200a=\u200a8) were hybridized to the ratref-12 beadchip available from illumina (sampling 21,290 Genes from the Rat transcriptome).']	N/A	N/A	[('UBERON_0002107', 'liver', 17, 'liver'), ('UBERON_0004288', 'skeleton', 24, 'skeletal'), ('UBERON_0001347', 'white adipose tissue', 45, 'white adipose fat tissue'), ('SO_0000704', 'gene', 180, 'genes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 195, 'rat')]
PMC2749934	9/2009	S94-PMC2749934	['Expression analysis\nExpression profiling was done for Liver, White Adipose Fat, and Skeletal Muscle Tissue from young Adult (55-day-old) male Rats born to either ad or un dams.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('GO_0010467', 'gene expression', 20, 'Expression'), ('UBERON_0002107', 'liver', 54, 'liver'), ('UBERON_0001998', 'sternocostal joint', 61, 'white adipose fat'), ('UBERON_0004833', 'lip skeletal muscle', 84, 'skeletal muscle tissue'), ('UBERON_0007023', 'adult organism', 118, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 142, 'rats')]
PMC2749934	9/2009	S147-PMC2749934	['the Livers of un Animals show changes in the anomalous Expression of rna for several enzymes involved in Glycogenesis, Glycogenolysis and Glycolysis.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'livers'), ('NCBITaxon_33208', 'Metazoa', 17, 'animals'), ('GO_0010467', 'gene expression', 55, 'expression'), ('GO_0006096', 'glycolytic process', 105, 'glycogenesis'), ('GO_0005981', 'regulation of glycogen catabolic process', 119, 'glycogenolysis'), ('GO_0006096', 'glycolytic process', 138, 'glycolysis')]
PMC2749934	9/2009	S166-PMC2749934	['the Livers of un Animals show changes in Expression of Genes whose products are known to attenuate the Pi3 Kinase Signaling Pathway that is common to both receptors.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'livers'), ('NCBITaxon_33208', 'Metazoa', 17, 'animals'), ('GO_0010467', 'gene expression', 41, 'expression'), ('SO_0000704', 'gene', 55, 'genes'), ('GO_0038161', 'prolactin signaling pathway', 103, 'PI3 kinase signaling pathway')]
PMC2749934	9/2009	S179-PMC2749934	['the Liver is the major source of circulating Igf-1.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('PR_000008929', 'interferon-related developmental regulator 1', 45, 'IGF-1')]
PMC2756957	10/2009	S160-PMC2756957	['blunted first pass Insulin Metabolism and Insulin-induced suppression of Hepatic Glucose output).']	N/A	N/A	[('GO_1901142', 'insulin metabolic process', 19, 'insulin metabolism'), ('PR_000045358', 'insulin family protein', 19, 'insulin'), ('PR_000045358', 'insulin family protein', 42, 'insulin'), ('UBERON_0002107', 'liver', 73, 'hepatic'), ('CHEBI_17234', 'glucose', 81, 'glucose')]
PMC2756957	10/2009	S183-PMC2756957	['during hyperglycaemia, clearance is additionally coupled to mass-action passive Glucose Transfer Into Pancreatic and Hepatic Cells (via Glut2, which has a high kmfor Glucose;[36]).']	N/A	N/A	[('CHEBI_17234', 'glucose', 80, 'glucose'), ('GO_0045023', 'G0 to G1 transition', 80, 'glucose transfer into ...'), ('CL_0002351', 'progenitor cell of endocrine pancreas', 102, 'pancreatic ...'), ('UBERON_0001264', 'pancreas', 102, 'pancreatic'), ('CL_0000632', 'hepatic stellate cell', 117, 'hepatic cells'), ('UBERON_0002107', 'liver', 117, 'hepatic'), ('GO_0007567', 'parturition', 125, 'cells'), ('PR_000008011', 'glycerol kinase 2', 136, 'Glut2'), ('CHEBI_17234', 'glucose', 166, 'glucose')]
PMC2780862	12/2009	S57-PMC2780862	['glucokinase is a key enzyme in Hepatic Glucose Utilization, and its activity is decreased in the Liver of diabetic patients (35).']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'hepatic'), ('CHEBI_17234', 'glucose', 39, 'glucose'), ('GO_0006094', 'gluconeogenesis', 39, 'glucose utilization'), ('UBERON_0002107', 'liver', 97, 'liver')]
PMC2780862	12/2009	S59-PMC2780862	['moreover, in aged compared with young Rats, the Liver displays reduced levels of glucokinase Expression and enzyme activity in parallel with increased Dna Methylation of the glucokinase Promoter (37).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 38, 'rats'), ('UBERON_0002107', 'liver', 48, 'liver'), ('GO_0010467', 'gene expression', 93, 'expression'), ('GO_0006306', 'DNA methylation', 151, 'DNA methylation'), ('SO_0000167', 'promoter', 186, 'promoter')]
PMC2825514	1/2010	S41-PMC2825514	['Bone Marrow from the Femur Of the hind Limb (flushed by 0.9%-Nacl-Water using a 25g-needle-seringe), Adipose Tissue, and Liver were collected (about 50 mg) and weighed.']	N/A	N/A	[('UBERON_0002371', 'bone marrow', 0, 'Bone marrow'), ('UBERON_0002421', 'hippocampal formation', 21, 'femur of ... limb'), ('CHEBI_26710', 'sodium chloride', 61, 'NaCl'), ('CHEBI_15377', 'water', 66, 'water'), ('UBERON_0001013', 'adipose tissue', 101, 'adipose tissue'), ('UBERON_0002107', 'liver', 121, 'liver')]
PMC2825514	1/2010	S44-PMC2825514	['Retroperitoneal, Epididymal, Interscapular and Subcutaneous Adipose Tissue, as well as the Liver and the Pancreas were collected and weighed.']	N/A	N/A	[('UBERON_0003693', 'retroperitoneal space', 0, 'Retroperitoneal'), ('UBERON_0004360', 'cauda epididymis', 17, 'epididymal ...'), ('UBERON_4200094', 'inner digits of hand', 29, 'interscapular ...'), ('UBERON_0002023', 'claustrum of brain', 47, 'subcutaneous'), ('UBERON_0001013', 'adipose tissue', 60, 'adipose tissue'), ('UBERON_0002107', 'liver', 91, 'liver'), ('UBERON_0001264', 'pancreas', 105, 'pancreas')]
PMC2825514	1/2010	S85-PMC2825514	['Glycerol kinase in the Liver overestimates the calculation of Fsrtgin the Liver.']	N/A	N/A	[('CHEBI_17754', 'glycerol', 0, 'Glycerol'), ('UBERON_0002107', 'liver', 23, 'liver'), ('PR_000029110', 'glycerol kinase 3', 62, 'FSRTGin'), ('UBERON_0002107', 'liver', 74, 'liver')]
PMC2825514	1/2010	S121-PMC2825514	['the Liver weight as well as the Pancreas weight did not differ between groups at d21 and d136 (data not shown).']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('UBERON_0001264', 'pancreas', 32, 'pancreas')]
PMC2825514	1/2010	S125-PMC2825514	['a higher Hepatic dnl (p < 0.001) was observed at d21 in guinea pigs Fed 0.8%-ala Intake compared to 10%-ala Intake (table 5, additional file5).']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'hepatic'), ('GO_0007631', 'feeding behavior', 68, 'fed'), ('GO_0007631', 'feeding behavior', 81, 'intake'), ('GO_0007631', 'feeding behavior', 108, 'intake')]
PMC2825514	1/2010	S214-PMC2825514	['caption (media)\n\nclick here for file\n\ncaption (supplementary-material)\nadditional file 5\ntable s5 on "de novo Lipogenesis (dnl) and fractional synthesis rate (fsr) of tg in the Liver and Adipose Tissues (at) at d21 and d136" .']	N/A	N/A	[('GO_0008610', 'lipid biosynthetic process', 110, 'lipogenesis'), ('UBERON_0002107', 'liver', 177, 'liver'), ('UBERON_0001013', 'adipose tissue', 187, 'adipose tissues')]
PMC2849017	9/2007	S209-PMC2849017	['dietary sources consumed by women in canada and korea\nfolates are present naturally in a variety of Foods and occur in especially high levels in Liver, dried peas and beans and green leafy vegetables including broccoli.']	N/A	N/A	[('CHEBI_33290', 'food', 100, 'foods'), ('UBERON_0002107', 'liver', 145, 'liver')]
PMC2874518	6/2010	S61-PMC2874518	['caption (table-wrap): table 2\n\naverage daily intakes of Vitamins and Minerals (from diet alone) based on 24-hour dietary recall at 8–12 weeks of Pregnancy, leeds, uk, 2003–06 ( n = 1257)Micronutrientmean (sd)rni*recommended increment to rni during Pregnancy**proportion of women with Intakes above the Pregnancy rni (95% ci)Thiamin (mg/day)2.4 (7.7)0.8+0.185 (83, 87)riboflavin (mg/day)1.7 (0.8)1.1+0.358 (55, 61)niacin (mg/day)20 (10)13–75 (72, 77)Vitamin B6 (mg/day)2.1 (1.0)1.2–85 (82, 86)Vitamin B12 (μg/day)3.9 (3.7)1.5–79 (77, 82)Folate (μg/day)257 (119)200+10032 (29, 35)vitamin c (μg/day)143 (129)40+1075 (73, 78)Vitamin A (μg Retinol equivalent/day)803 (665)600+10045 (42, 48)Vitamin D (μg/day)2.5 (2.7)–102 (1, 3)Vitamin E (mg/day)7.9 (5.4)–****–Calcium (mg/day)938 (471)700***65 (62, 68)Phosphorus (mg/day)1344 (501)550***98 (97, 99)magnesium (mg/day)283 (112)270***49 (46, 52)iron (mg/day)11.5 (5.3)14.8***20 (18, 23)Zinc (mg/day)8.6 (4.3)7***59 (56, 62)copper (mg/day)1.1 (0.6)1.2***32 (29, 35)Selenium (μg/day)58 (37)60***40 (38, 43)Iodine (μg/day)118 (82)140***28 (24, 29)\nreference Nutrient intakes (rni) for women aged 19–50 years in the uk.21\nreference Nutrient intakes for Pregnant women.21\nno increment.21\nsafe intake – above 3 mg/day for women.21\n\ntype of supplements\nwomen reported taking 22 different types of supplements including Folic Acid, iron, combined Folic Acid–iron preparations, multivitamin–Mineral preparations (six brands), evening primrose, cod Liver oil, Omega 3, Vitamin C, Vitamin B, Vitamin D, Vitamin E, Vitamin A, calcium, zinc, magnesium and Selenium preparations (table 3).']	N/A	N/A	[('CHEBI_33277', 'gamma-tocotrienol', 56, 'vitamins'), ('CHEBI_46751', 'quinolizidine', 69, 'minerals'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('CHEBI_6923', 'miconazole', 186, 'MicronutrientMean'), ('GO_0007565', 'female pregnancy', 248, 'pregnancy'), ('GO_0007631', 'feeding behavior', 284, 'intakes'), ('GO_0007565', 'female pregnancy', 302, 'pregnancy'), ('CHEBI_9544', 'thiethylperazine', 324, 'Thiamin'), ('CHEBI_27306', 'vitamin B6', 449, 'Vitamin B6'), ('PR_000017269', 'ventral anterior homeobox 2', 449, 'Vitamin B6'), ('CHEBI_28334', 'malonamoyl-CoA', 492, 'Vitamin B12'), ('PR_000017279', 'testis-specific basic protein Y 1', 492, 'Vitamin B12'), ('CHEBI_81245', 'Vulpecholate', 536, 'Folate'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 621, 'Vitamin A'), ('CHEBI_26536', 'retinoic acid', 635, 'retinol'), ('CHEBI_28384', 'vitamin K', 685, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 723, 'Vitamin E'), ('CHEBI_31341', 'calcium dihydroxide', 756, 'Calcium'), ('CHEBI_30207', 'phosphorus(.)', 798, 'Phosphorus'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 929, 'Zinc'), ('CHEBI_27568', 'selenium atom', 1007, 'Selenium'), ('CHEBI_31719', 'ipriflavone', 1047, 'Iodine'), ('CHEBI_33284', 'nutrient', 1098, 'nutrient'), ('CHEBI_33284', 'nutrient', 1171, 'nutrient'), ('GO_0007565', 'female pregnancy', 1192, 'pregnant'), ('CHEBI_30751', 'formic acid', 1355, 'folic acid'), ('CHEBI_30751', 'formic acid', 1382, 'folic acid'), ('CHEBI_46662', 'mineral', 1425, 'mineral'), ('UBERON_0002107', 'liver', 1482, 'liver'), ('CHEBI_30823', 'oleate', 1493, 'omega'), ('CHEBI_27300', 'vitamin D', 1502, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 1513, 'vitamin B'), ('CHEBI_27300', 'vitamin D', 1524, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1535, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 1546, 'vitamin A'), ('CHEBI_27568', 'selenium atom', 1586, 'selenium')]
PMC2874518	6/2010	S64-PMC2874518	['caption (table-wrap): table 3\n\nnumber of women taking different types of Supplements during Pregnancysupplementfirst trimestersecond trimesterthird trimesterfolic Acid845512Iron82129Folic Acid/iron211multivitamin-mineral29317779evening primrose622cod Liver oil1023omega 3 fish oil11129vitamin c18815vitamin B702Vitamin e131vitamin a001calcium1483zinc711magnesium200selenium200\n\nBirth outcomes\nBirthweight was known for 1259 babies.']	N/A	N/A	[('CHEBI_33341', 'titanium atom', 73, 'supplements'), ('GO_0036367', 'light adaption', 92, 'pregnancySupplementFirst'), ('CHEBI_35673', 'abietane', 163, 'acid845512Iron82129Folic acid'), ('UBERON_0002107', 'liver', 251, 'liver'), ('PR_000001411', 'CD276 molecule', 307, 'B702Vitamin'), ('GO_0007567', 'parturition', 378, 'Birth'), ('GO_0007608', 'sensory perception of smell', 393, 'Birthweight')]
PMC2889879	5/2010	S69-PMC2889879	['aa exists in limited levels in Liver, meat and Eggs, but can be Metabolized in Humans from other Fatty Acids in the Omega-6 Fatty Acid family.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'liver'), ('CL_0000025', 'egg cell', 47, 'eggs'), ('GO_0008152', 'metabolic process', 64, 'metabolized'), ('NCBITaxon_9606', 'Homo sapiens', 79, 'humans'), ('CHEBI_35366', 'fatty acid', 97, 'fatty acids'), ('CHEBI_33809', 'digalacturonic acid', 116, 'omega-6 fatty acid')]
PMC2898025	5/2010	S38-PMC2898025	['insecticides and Herbicides constitute the bulk of farm chemical exposures: two key routes of exposure are dermal and Respiratory [27], bypassing Detoxification in the Liver.']	N/A	N/A	[('CHEBI_35353', 'isocyanide', 17, 'herbicides'), ('UBERON_0001004', 'respiratory system', 118, 'respiratory'), ('GO_0098754', 'detoxification', 146, 'detoxification'), ('UBERON_0002107', 'liver', 168, 'liver')]
PMC2916909	7/2010	S4-PMC2916909	['interventional topics was increased dietary Intake of cod Liver oil and oily fish for women during Pregnancy and for infants during the first 2 years of Life, reduced parental Smoking and reduced indoor dampness.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 44, 'intake'), ('UBERON_0002107', 'liver', 58, 'liver'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('UBERON_0000104', 'life cycle', 153, 'life'), ('GO_0007601', 'visual perception', 176, 'smoking')]
PMC2916909	7/2010	S8-PMC2916909	['results\nIntake of oily fish and cod Liver oil increased statistically significantly among women and infants in the intervention cohort compared to the control cohort.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 8, 'Intake'), ('UBERON_0002107', 'liver', 36, 'liver')]
PMC2916909	7/2010	S34-PMC2916909	['prophylactic measures to induce behavioral changes regarding tobacco smoking, Consumption of cod Liver oil, oily fish, and indoor dampness were developed in collaboration between general practitioners (gps), midwives, public health visitors and parents using a delphi technique[23].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 78, 'consumption'), ('UBERON_0002107', 'liver', 97, 'liver')]
PMC2916909	7/2010	S50-PMC2916909	['Cod Liver oil was to be introduced to the child from 4-6 weeks of age increasing to 5 ml/day, and oily fish at least twice a week from 6 months of age as dinner or sandwich spread.']	N/A	N/A	[('CHEBI_33290', 'food', 0, 'Cod'), ('UBERON_0002107', 'liver', 4, 'liver')]
PMC2916909	7/2010	S70-PMC2916909	['duration of breastfeeding, time for introduction and type of infant formula, Vitamins and cod Liver oil, information on housing conditions, parental smoking at start of pregnancy and 1 year after Birth, indoor smoking, and Pregnancy related complications were collected.']	N/A	N/A	[('CHEBI_33277', 'gamma-tocotrienol', 77, 'vitamins'), ('UBERON_0002107', 'liver', 94, 'liver'), ('GO_0007567', 'parturition', 196, 'birth'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
PMC2916909	7/2010	S71-PMC2916909	['information on Consumption of vegetables, Cod Liver oil, lean fish (Cod and coalfish) and oily fish (redfish, halibut, salmon, trout, herring and mackerel) as dinner and sandwich spread were collected by using validated semi quantitative Food frequency questions with six categories: never, less than once a week, once a week, twice a week, three times a week and four times a week or more, and re-categorized later in the analyses[33,34].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 15, 'consumption'), ('NCBITaxon_10088', 'Mus <genus>', 42, 'cod'), ('UBERON_0002107', 'liver', 46, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 68, 'cod'), ('CHEBI_33290', 'food', 238, 'food')]
PMC2916909	7/2010	S115-PMC2916909	['during the first 2 years of Life the proportion of infants continuing the cod Liver oil supplement was about 10 percentage points higher in the intervention cohort (tables3and4).']	N/A	N/A	[('UBERON_0000104', 'life cycle', 28, 'life'), ('UBERON_0002107', 'liver', 78, 'liver')]
PMC2916909	7/2010	S119-PMC2916909	['caption (table-wrap): table 2\n\ndifferent exposure and risk behaviours assessed at 6 weeks after Birth and the hange in annual prevalence for the intervention cohort and for the control cohort (pact 2009).intervention cohort (n = 1685)control cohort (n = 3142) rate%95% cip trend*rate%95% cip trend*or*95% ci at start Pregnancy\u2003\u2003maternal smoking283/163617.315.5-19.20.001702/296923.622.2-25.20.010.700.60-0.82\u2003\u2003paternal smoking292/159418.316.5-20.30.001652/280323.321.7-24.90.030.800.68-0.94during Pregnancy\u2003\u2003maternal cod Liver oil 4 times a week or more1098/166066.163.8-68.40.591288/305542.240.4-43.90.162.442.15-2.78\u2003\u2003maternal oily Fish Intake once a week or more624/155340.237.8-42.60.61858/281230.528.8-32.20.361.511.32-1.72\u2003\u2003maternal lean Fish intake once a week or more658/166639.537.2-41.90.61807/305526.424.9-28.00.401.801.58-2.06\u2003\u2003maternal vegetable almost daily876/147659.356.8-61.90.251548/270457.255.4-59.10.151.060.93-1.21at 6 weeks after Birth\u2003\u2003maternal smoking87/16345.34.3-6.50.002317/293410.89.7-12.0<0.0010.550.42-0.70\u2003\u2003paternal smoking200/158712.611.1-14.30.04593/276821.419.9-23.00.010.590.49-0.70\u2003\u2003keeping Dog in house142/15669.17.7-10.60.69289/282610.29.16-11.40.950.830.67-1.03\u2003\u2003keeping Cat in house174/156611.19.7-12.80.58251/28268.97.9-10.00.901.321.07-1.64\u2003\u2003indoor dampness index ≥369/16724.13.3-5.20.66129/30624.23.6-5.00.881.080.79-1.46\u2003\u2003Breastfeeding1644/166598.798.1-99.20.393061/311098.497.9-98.80.811.000.59-1.71\u2003\u2003child having cod Liver oil supplement1011/166560.758.4-63.00.571786/310257.655.8-59.30.661.030.93-1.21\ncomparisons of risk behaviour between the intervention cohort and the control cohort are presented as or with 95% ci (based on logistic regression).']	N/A	N/A	[('GO_0007567', 'parturition', 96, 'birth'), ('GO_0007565', 'female pregnancy', 317, 'pregnancy'), ('GO_0007565', 'female pregnancy', 497, 'pregnancy'), ('UBERON_0002107', 'liver', 521, 'liver'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 634, 'fish'), ('GO_0007631', 'feeding behavior', 639, 'intake'), ('CHEBI_83324', 'pent-2-enoyl-CoA(4-)', 744, 'fish'), ('GO_0007567', 'parturition', 952, 'birth'), ('NCBITaxon_33208', 'Metazoa', 1127, 'dog'), ('NCBITaxon_33208', 'Metazoa', 1210, 'cat'), ('UBERON_0013552', 'Brodmann (1909) area 21', 1366, 'Breastfeeding1644'), ('UBERON_0002107', 'liver', 1463, 'liver')]
PMC2916909	7/2010	S122-PMC2916909	["caption (table-wrap): table 3\n\ndifferent exposure and risk behaviours at 1 year after Birth and the change in annual prevalence for the intervention cohort and for the control cohort (pact 2009).intervention cohort (n = 1214)control cohort (n = 3892) rate%95% cip trend*rate%95% cip trend*or*95% ci at 1 year after Birth\u2003\u2003maternal smoking105/11988.87.3-10.50.17720/375519.218.0-20.5<0.0010.470.38-0.59\u2003\u2003paternal smoking148/114412.911.1-15.00.15724/346820.919.6-22.3<0.0010.640.52-0.77\u2003\u2003keeping Dog in house95/11398.36.9-10.10.11318/35608.98.0-9.90.740.900.71-1.16\u2003\u2003keeping Cat in house122/113910.79.0-12.70.87312/35608.87.9-9.70.461.331.06-1.67\u2003\u2003indoor dampness index47/12053.92.9-5.20.44158/38004.23.6-4.80.271.000.72-1.41children's diet at 1 year of age\u2003\u2003exclusively Breastfed 4 months or more957/120679.477.0-81.50.008274/385671.169.6-72.50.141.461.25-1.72\u2003\u2003Cod Liver oil 4 times a week or more568/120947.044.2-49.80.341497/385838.837.3-40.40.771.271.11-1.46\u2003\u2003any kind of fish once a week or more712/121358.755.9-61.40.031879/387248.547.0-50.10.061.531.33-1.74\u2003\u2003oily fish once a week or more445/121336.734.0-39.40.02908/387823.422.1-24.8<0.0011.881.63-2.17\u2003\u2003lean fish once a week or more582/120448.345.5-51.20.291679/385543.642.0-45.10.461.241.08-1.42\u2003\u2003vegetables almost daily889/119874.271.7-76.60.762910/381476.375.0-77.70.790.870.74-1.01\ncomparisons of risk behaviour between the control cohort and the intervention cohort are presented as or with 95% ci (based on logistic regression)."]	N/A	N/A	[('GO_0007567', 'parturition', 86, 'birth'), ('GO_0007567', 'parturition', 315, 'birth'), ('NCBITaxon_33208', 'Metazoa', 494, 'dog'), ('NCBITaxon_33208', 'Metazoa', 573, 'cat'), ('GO_0007567', 'parturition', 769, 'breastfed'), ('CHEBI_33290', 'food', 861, 'Cod'), ('UBERON_0002107', 'liver', 865, 'liver')]
PMC2916909	7/2010	S125-PMC2916909	["caption (table-wrap): table 4\n\ndifferent exposure and risk behaviours at 2 years after Birth and the change in annual prevalence for the intervention cohort and for the control cohort (pact 2009).intervention cohort (n = 1267)control cohort (n = 4826) rate%95% cip trend*rate%95% cip trend*or*95% ci at 2 year after Birth\u2003\u2003maternal smoking123/12449.98.4-11.70.87885/466119.017.9-20.1<0.0010.500.41-0.61\u2003\u2003paternal smoking136/118311.59.8-13.40.11760/421718.016.9-19.2<0.0010.620.51-0.75\u2003\u2003keeping Dog in house96/11988.06.6-9.70.53368/44038.47.6-9.20.230.950.75-1.21\u2003\u2003keeping Cat in house133/119811.19.4-13.00.41398/44039.08.2-9.90.711.311.06-1.62\u2003\u2003indoor dampness index46/12593.72.7-4.90.10170/47403.63.1-4.20.111.030.74-1.45children's diet at 2 year of age\u2003\u2003cod Liver oil 4 times a week or more539/125742.940.2-45.60.431609/476733.832.4-35.10.801.441.27-1.64\u2003\u2003any kind of fish once a week or more926/125873.671.1-76.00.873398/478271.169.8-72.30.961.130.98-1.30\u2003\u2003oily fish once a week or more625/126449.446.7-52.20.041679/480934.933.6-36.3<0.0011.851.63-2.10\u2003\u2003lean fish once a week or more768/125661.158.4-63.80.613086/477664.663.3-66.00.070.850.75-0.97\u2003\u2003vegetables almost daily630/125250.347.6-53.10.252340/473549.448.0-50.8<0.0011.010.89-1.15\ncomparisons of risk behaviour between the control cohort and the intervention cohort are presented as or with 95% ci (based on logistic regression)."]	N/A	N/A	[('GO_0007567', 'parturition', 87, 'birth'), ('GO_0007567', 'parturition', 316, 'birth'), ('NCBITaxon_33208', 'Metazoa', 494, 'dog'), ('NCBITaxon_33208', 'Metazoa', 572, 'cat'), ('UBERON_0002107', 'liver', 760, 'liver')]
PMC2916909	7/2010	S194-PMC2916909	['the dietary intervention to increase the Intake of cod Liver oil and oily fish in Pregnancy and among mothers and children first 2 years was successful.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 41, 'intake'), ('UBERON_0002107', 'liver', 55, 'liver'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy')]
PMC2936567	9/2010	S74-PMC2936567	['(exp 2) real time rt-pcr\ntotal rna was extracted from Livers of ldlr−/− Mice with gen elute™ Mammalian total rna miniprep kit (sigma, st. louis, mo, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 54, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'mice'), ('NCBITaxon_33208', 'Metazoa', 93, 'Mammalian')]
PMC2936567	9/2010	S75-PMC2936567	['the quality of rna extracted from Livers was assessed previous to Reverse Transcription by electrophoresis in 1% Agarose gel and samples were stored at −80°c.']	N/A	N/A	[('UBERON_0002107', 'liver', 34, 'livers'), ('GO_0001171', 'reverse transcription', 66, 'reverse transcription'), ('CHEBI_2511', 'agarose', 113, 'agarose')]
PMC2936567	9/2010	S160-PMC2936567	['atherosclerosis measurements in Aortic Root of Ldlr−/− Mice and Liver mrna analysis with real-time pcr\nfigure 4ashows representative oil red-o stained sections of the Aortic root from male Mice of the 4 experimental groups.']	N/A	N/A	[('UBERON_0010172', 'bulb of aorta', 32, 'aortic root'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 47, 'LDLr'), ('NCBITaxon_10088', 'Mus <genus>', 55, 'mice'), ('UBERON_0002107', 'liver', 64, 'liver'), ('UBERON_0000947', 'aorta', 167, 'aortic'), ('NCBITaxon_10088', 'Mus <genus>', 189, 'mice')]
PMC2994393	8/2010	S11-PMC2994393	['background\nTaurine, 2-Aminoethanesulfonic Acid, is present at a high concentration in many Organs including Liver, Brain, Heart, Kidneys, and Reproductive Organs [1].']	N/A	N/A	[('CHEBI_15884', 'tropine', 11, 'Taurine'), ('CHEBI_15753', '2-oxoadipic acid', 20, '2-aminoethanesulfonic acid'), ('UBERON_0000062', 'organ', 91, 'organs'), ('UBERON_0002107', 'liver', 108, 'liver'), ('UBERON_0000955', 'brain', 115, 'brain'), ('UBERON_0000948', 'heart', 122, 'heart'), ('UBERON_0002113', 'kidney', 129, 'kidneys'), ('GO_0000003', 'reproduction', 142, 'reproductive'), ('UBERON_0003133', 'reproductive organ', 142, 'reproductive organs')]
PMC3001618	1/2011	S0-PMC3001618	["suboptimal maternal nutrition, during early Fetal Liver Development, promotes Lipid accumulation in the Liver of obese offspring\n\nabstract\nmaternal nutrition during the period of early Organ Development can Modulate the offspring's ability to Metabolise excess fat as young Adults when exposed to an obesogenic environment."]	N/A	N/A	[('GO_0007631', 'feeding behavior', 44, 'fetal'), ('GO_0001889', 'liver development', 50, 'liver development'), ('UBERON_0002107', 'liver', 50, 'liver'), ('CHEBI_18059', 'lipid', 78, 'lipid'), ('UBERON_0002107', 'liver', 104, 'liver'), ('GO_0048513', 'animal organ development', 185, 'organ development'), ('UBERON_0000062', 'organ', 185, 'organ'), ('GO_0065007', 'biological regulation', 207, 'modulate'), ('GO_0008152', 'metabolic process', 243, 'metabolise'), ('UBERON_0007023', 'adult organism', 274, 'adults')]
PMC3001618	1/2011	S3-PMC3001618	['at weaning, offspring were made obese, and at ∼1 year of age Livers were sampled.']	N/A	N/A	[('UBERON_0002107', 'liver', 61, 'livers')]
PMC3001618	1/2011	S44-PMC3001618	['de Novo synthesis, Uptake Of Nefa released from Adipose Tissue Lipolysis, Uptake of dietary Tag, reduced Hepatic Fatty Acid Oxidation and reduced release of Tag in the form of very low-density lipoproteins.']	N/A	N/A	[('GO_0007567', 'parturition', 3, 'novo'), ('GO_0043652', 'engulfment of apoptotic cell', 19, 'uptake of NEFA ...'), ('UBERON_0001013', 'adipose tissue', 48, 'adipose tissue'), ('GO_0016042', 'lipid catabolic process', 63, 'lipolysis'), ('GO_0098657', 'import into cell', 74, 'uptake'), ('CHEBI_17855', 'triglyceride', 92, 'TAG'), ('UBERON_0002107', 'liver', 105, 'hepatic'), ('CHEBI_35366', 'fatty acid', 113, 'fatty acid'), ('GO_0019395', 'fatty acid oxidation', 113, 'fatty acid oxidation'), ('CHEBI_17855', 'triglyceride', 157, 'TAG')]
PMC3001618	1/2011	S53-PMC3001618	['l: 2.5±0.3; o: 8.0±0.3; nro: 7.7±0.6\u200ag/kg ( p<0.001)) and had no effect on relative Liver weight (i.e.']	N/A	N/A	[('UBERON_0002107', 'liver', 84, 'liver')]
PMC3001618	1/2011	S63-PMC3001618	['Hepatic Gene Expression\nfollowing obesity, Expression of Genes that determine Hepatic sensitivity to Cortisol (i.e.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010467', 'gene expression', 8, 'gene expression'), ('SO_0000704', 'gene', 8, 'gene'), ('GO_0010467', 'gene expression', 43, 'expression'), ('SO_0000704', 'gene', 57, 'genes'), ('UBERON_0002107', 'liver', 78, 'hepatic'), ('CHEBI_17650', 'cortisol', 101, 'cortisol')]
PMC3001618	1/2011	S67-PMC3001618	['maternal Nutrient restriction followed by juvenile-onset obesity resulted in an upregulation of Pparg , its co-activator ( Pgc1Α ) and Igfbp1 in Adult Livers of 1-year-old obese Sheep.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 9, 'nutrient'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 96, 'PPARG'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 123, 'PGC1α'), ('PR_000008940', 'intraflagellar transport protein 88', 135, 'IGFBP1'), ('UBERON_0007023', 'adult organism', 145, 'adult'), ('UBERON_0002107', 'liver', 151, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 178, 'sheep')]
PMC3001618	1/2011	S68-PMC3001618	['there was no effect of either Prenatal diet or Postnatal obesity on Hepatic mrna abundance for Energy-Sensing Amp-Related Kinase ( ampk ), Insulin-Sensitive Adiponectin or inflammatory markers Tnf and Interleukin 6 ( Il6 ;table 1).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 30, 'prenatal'), ('GO_0007567', 'parturition', 47, 'postnatal'), ('UBERON_0002107', 'liver', 68, 'hepatic'), ('PR_000007208', 'steroid hormone receptor ERR1', 95, 'energy-sensing AMP-related kinase'), ('PR_000008890', 'isocitrate dehydrogenase [NAD] subunit beta, mitochondrial', 139, 'insulin-sensitive adiponectin'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 193, 'TNF'), ('PR_000008988', 'interleukin-1 family member 5', 201, 'interleukin 6'), ('PR_000008989', 'interleukin-1 family member 7', 217, 'IL6')]
PMC3001618	1/2011	S158-PMC3001618	['Adult offspring were humanely killed by electrocortical stunning and exsanguination at 1 year of age to enable Liver Tissue sampling.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('UBERON_0002107', 'liver', 111, 'liver'), ('UBERON_0000479', 'tissue', 117, 'tissue')]
PMC3001618	1/2011	S159-PMC3001618	['after weighing, a representative Liver sample from the right Hepatic Lobe was flash frozen in liquid nitrogen and stored at −80\u200a°c until analysis was undertaken, in duplicate, for each Animal.']	N/A	N/A	[('UBERON_0002107', 'liver', 33, 'liver'), ('UBERON_0001113', 'lobe of liver', 61, 'hepatic lobe'), ('NCBITaxon_33208', 'Metazoa', 185, 'animal')]
PMC3001618	1/2011	S161-PMC3001618	['molecular and biochemical analyses\n\nLipid extraction and Tag assay\nLipids were extracted from frozen Liver Tissue (∼400\u200amg) with a Mixture of Chloroform and Methanol (1:1) and dissolved in Tert-Butyl Alcohol/Triton x-100 Mixture (1/1 by volume) before enzymatic measurement (infinity Triglycerides liquid stable Reagent; thermo Electron, worthing, uk;folch et al .']	N/A	N/A	[('CHEBI_18059', 'lipid', 36, 'Lipid'), ('CHEBI_17855', 'triglyceride', 57, 'TAG'), ('CHEBI_18059', 'lipid', 67, 'Lipids'), ('UBERON_0002107', 'liver', 101, 'liver'), ('UBERON_0000479', 'tissue', 107, 'tissue'), ('CHEBI_60004', 'mixture', 131, 'mixture'), ('CHEBI_35255', 'chloroform', 142, 'chloroform'), ('CHEBI_17790', 'methanol', 157, 'methanol'), ('CHEBI_64555', 'trans-p-coumaryl alcohol', 189, 'tert-butyl alcohol'), ('CHEBI_29236', 'protium atom', 208, 'Triton'), ('CHEBI_60004', 'mixture', 221, 'mixture'), ('CHEBI_17855', 'triglyceride', 284, 'Triglycerides'), ('CHEBI_33893', 'reagent', 312, 'Reagent'), ('CHEBI_10545', 'electron', 328, 'Electron')]
PMC3001618	1/2011	S164-PMC3001618	['histological analyses\napproximately, 1\u200acm3blocks of frozen Liver Tissue were cut from the centre of the right Hepatic Lobe, embedded in optimum cutting temperature Compound (oct; Tissue-tek; miles, naperville, il, usa) and stored at −80\u200a°c until being processed.']	N/A	N/A	[('UBERON_0002107', 'liver', 59, 'liver'), ('UBERON_0000479', 'tissue', 65, 'tissue'), ('UBERON_0001113', 'lobe of liver', 110, 'hepatic lobe'), ('CHEBI_36357', 'polyatomic entity', 164, 'compound'), ('UBERON_0000479', 'tissue', 179, 'Tissue')]
PMC3001618	1/2011	S165-PMC3001618	['frozen oct Liver Tissue was cut into 10\u200aμm serial sections using a cryostat (bright otf model cryostat, specimen temperature set at −21\u200a°c).']	N/A	N/A	[('UBERON_0002107', 'liver', 11, 'liver'), ('UBERON_0000479', 'tissue', 17, 'tissue')]
PMC3001618	1/2011	S166-PMC3001618	['three random Liver sections per Animal were fixed in 3.7% Formaldehyde, stained with Haematoxylin–eosin and imaged with a leica dmrb microscope connected to hamamatsu-open lab imaging system under ×20 and ×40 magnification lenses to assess Liver architecture and density of voids resulting from Lipid infiltration.']	N/A	N/A	[('UBERON_0002107', 'liver', 13, 'liver'), ('NCBITaxon_33208', 'Metazoa', 32, 'animal'), ('CHEBI_16842', 'formaldehyde', 58, 'formaldehyde'), ('CHEBI_51686', 'haematoxylin', 85, 'haematoxylin'), ('UBERON_0002107', 'liver', 240, 'liver'), ('CHEBI_18059', 'lipid', 295, 'lipid')]
PMC3001618	1/2011	S168-PMC3001618	['briefly, Hepatic cryosections were fixed for 1\u200ah in 3.7% Formaldehyde, incubated in a 37% oil red o Solution for 30\u200amin and washed with distilled Water.']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'hepatic'), ('CHEBI_16842', 'formaldehyde', 57, 'formaldehyde'), ('CHEBI_75958', 'solution', 100, 'solution'), ('CHEBI_15377', 'water', 146, 'water')]
PMC3001618	1/2011	S179-PMC3001618	['total rna isolation and rt\ntotal rna was extracted from ∼500\u200amg of frozen Liver Tissue using Tri-Reagent (sigma).']	N/A	N/A	[('UBERON_0002107', 'liver', 74, 'liver'), ('UBERON_0000479', 'tissue', 80, 'tissue'), ('14', 'AAMP (human)', 93, 'Tri'), ('CHEBI_33893', 'reagent', 97, 'Reagent')]
PMC3001618	1/2011	S195-PMC3001618	['Hepatic Lipid content and Gene Expression data were first analysed by a univariate general linear model (glm) procedure with the treatment group as a fixed factor.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_18059', 'lipid', 8, 'lipid'), ('GO_0010467', 'gene expression', 26, 'gene expression'), ('SO_0000704', 'gene', 26, 'gene')]
PMC3028350	2/2011	S82-PMC3028350	['determination of Liver, muscle, and Plasma free Fatty Acids; Triacylglycerol; Cholesterol; and Cholesterol Esters (subgroup b).']	N/A	N/A	[('UBERON_0002107', 'liver', 17, 'liver'), ('UBERON_0001969', 'blood plasma', 36, 'plasma'), ('CHEBI_35366', 'fatty acid', 48, 'fatty acids'), ('CHEBI_17515', 'L-gamma-glutamyl-L-cysteine', 61, 'triacylglycerol'), ('CHEBI_16113', 'cholesterol', 78, 'cholesterol'), ('CHEBI_23129', 'chloroamino acid', 95, 'cholesterol esters')]
PMC3028350	2/2011	S87-PMC3028350	['Liver and Skeletal Muscle Tissues from nonfasted Rats or from Rats after a 16-h fast were homogenized, and the amount of Triacylglycerol, Cholesterol Ester, Cholesterol, and ceramides was determined by fast protein liquid chromatography as previously described (32).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0001134', 'skeletal muscle tissue', 10, 'skeletal muscle'), ('UBERON_0000479', 'tissue', 26, 'tissues'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 49, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 62, 'rats'), ('CHEBI_17515', 'L-gamma-glutamyl-L-cysteine', 121, 'triacylglycerol'), ('CHEBI_17002', 'cholesteryl ester', 138, 'cholesterol ester'), ('CHEBI_16113', 'cholesterol', 157, 'cholesterol')]
PMC3028350	2/2011	S153-PMC3028350	['in addition, hf-Fed iugr Rats also exhibited higher concentrations of Triacylglycerol and ceramides in their Livers and Gastrocnemius Muscles than hf-Fed control offspring (table 2).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 16, 'fed'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 25, 'rats'), ('CHEBI_17515', 'L-gamma-glutamyl-L-cysteine', 70, 'triacylglycerol'), ('UBERON_0002107', 'liver', 109, 'livers'), ('UBERON_0001388', 'gastrocnemius', 120, 'gastrocnemius muscles'), ('GO_0007631', 'feeding behavior', 150, 'fed')]
PMC3028350	2/2011	S154-PMC3028350	['caption (table-wrap): table 2\n\ncirculating and Tissue Lipid concentrations of control and iugr Rats Fed lf and hf dietslf diethf diettwo-way anovacontroliugrcontroliugriugrdietintplasma\u2003Triglycerides (mg/dl)86.7 ± 18.486.7 ± 14.6196.1 ± 25.2298.7 ± 31.7†**\u2003cholesterol esters (mg/dl)48.4 ± 8.955.7 ± 3.971.6 ± 4.272.9 ± 3.1*\u2003Cholesterol (mg/dl)29.0 ± 2.630.0 ± 1.241.5 ± 4.243.6 ± 5.6*\u2003Free Fatty Acid (mmol/l)0.53 ± 0.010.51 ± 0.010.60 ± 0.010.69 ± 0.02†***Liver\u2003Triglycerides (μg/mg protein)47.7 ± 14.4154.6 ± 26.3158.2 ± 20.0*249.0 ± 32.1†**\u2003cholesterol esters (μg/mg protein)80.8 ± 10.286.7 ± 2.386.2 ± 4.684.1 ± 6.3\u2003Cholesterol (μg/mg protein)22.5 ± 3.327.0 ± 2.420.0 ± 2.027.1 ± 2.1*\u2003Ceramides (pmol/g protein)274.9 ± 14.3271.9 ± 16.1334.5 ± 21.6394.4 ± 16.3†*Gastrocnemius Muscle\u2003Triglycerides (μg/mg protein)15.1 ± 3.629.5 ± 7.197.4 ± 18.7132.2 ± 33.1†***\u2003Cholesterol Esters (μg/mg protein)22.0 ± 3.326.1 ± 6.739.1 ± 7.645.3 ± 10.4*\u2003Cholesterol (μg/mg protein)4.4 ± 0.46.98 ± 2.78.9 ± 0.58.1 ± 1.3\u2003Ceramides (pmol/g protein)60.5 ± 4.362.2 ± 3.168.1 ± 4.686.5 ± 6.0†**\ndata are means ± sem.']	N/A	N/A	[('UBERON_0000479', 'tissue', 47, 'tissue'), ('CHEBI_18059', 'lipid', 54, 'lipid'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 95, 'rats'), ('GO_0007631', 'feeding behavior', 100, 'fed'), ('CHEBI_17855', 'triglyceride', 186, 'Triglycerides'), ('CHEBI_16113', 'cholesterol', 325, 'Cholesterol'), ('CHEBI_30823', 'oleate', 386, 'Free'), ('CHEBI_35366', 'fatty acid', 391, 'fatty acid'), ('UBERON_0002107', 'liver', 458, 'Liver'), ('CHEBI_17855', 'triglyceride', 464, 'Triglycerides'), ('CHEBI_16113', 'cholesterol', 621, 'Cholesterol'), ('CHEBI_23089', 'chelate-forming peptide', 690, 'Ceramides'), ('UBERON_0001388', 'gastrocnemius', 766, 'Gastrocnemius muscle'), ('CHEBI_17855', 'triglyceride', 787, 'Triglycerides'), ('CHEBI_16113', 'cholesterol', 864, 'Cholesterol'), ('CHEBI_35701', 'ester', 876, 'esters'), ('CHEBI_16113', 'cholesterol', 941, 'Cholesterol'), ('CHEBI_23089', 'chelate-forming peptide', 1006, 'Ceramides')]
PMC3028350	2/2011	S183-PMC3028350	['effect of iugr and either lf or hf diets on Hepatic and Skeletal muscle Insulin-Signaling elements including Phosphorylation Of Akt (ratio p-Akt/Akt) ( a and b ), phosphorylation of Irs-1 (ratio p-irs/irs) ( c and d ), and phosphorylation of Pkcθ (p-Pkcθ/Tubulin) ( e and f ).']	N/A	N/A	[('UBERON_0002107', 'liver', 44, 'hepatic'), ('UBERON_0004288', 'skeleton', 56, 'skeletal'), ('GO_0060494', 'inductive mesenchymal-endodermal cell signaling', 72, 'insulin-signaling'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('GO_0006607', 'NLS-bearing protein import into nucleus', 109, 'phosphorylation of Akt'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 128, 'Akt'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 141, 'Akt'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 145, 'Akt'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 182, 'IRS-1'), ('PR_000003059', 'protein kinase C beta type', 242, 'PKCθ'), ('PR_000003059', 'protein kinase C beta type', 250, 'PKCθ'), ('PR_000028799', 'tubulin', 255, 'tubulin')]
PMC3032617	5/2010	S41-PMC3032617	['exclusion criteria were: referred Pregnancy of more than three months by lmp, concomitant hiv infection status, active or recent (< two weeks) Sexually Transmitted disease (std) infection, medical record of any severe Organ disease such as Heart, Liver or Renal failure at the time of assessment, diagnosis of Pregnancy during inpatient admission for any other reason, recent history of multivitamin supplementation (<12 weeks) for any reason, except for Pregnancy, and patients incapable to read and write.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 143, 'sexually transmitted'), ('UBERON_0000062', 'organ', 218, 'organ'), ('UBERON_0000948', 'heart', 240, 'heart'), ('UBERON_0002107', 'liver', 247, 'liver'), ('UBERON_0002113', 'kidney', 256, 'renal'), ('GO_0007565', 'female pregnancy', 310, 'pregnancy'), ('GO_0007565', 'female pregnancy', 455, 'pregnancy')]
PMC3039633	2/2011	S62-PMC3039633	['[16]84 children (norway)1(at 4 yrs)kaufman assessment battery for childrencod Liver oil vs. Corn oil18 weeks Gestation to three months post-Birth+ 112/21helland et al.']	N/A	N/A	[('UBERON_0002107', 'liver', 78, 'liver'), ('CHEBI_33306', 'carbon group element atom', 92, 'corn'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('GO_0007567', 'parturition', 140, 'birth')]
PMC3039633	2/2011	S63-PMC3039633	['[15]143 children (norway)1(at 7 yrs)kaufman assessment battery for childrencod Liver oil vs. Corn oil18 weeks Gestation to three months post-Birth∅ 115/21innis & friesen [19]135 infants (british columbia)4(at 60 d)teller acuity card proceduredha vs. Corn/Soybean oil16 weeks Gestation to Birth∅ 416/21joos et al.']	N/A	N/A	[('UBERON_0002107', 'liver', 79, 'liver'), ('CHEBI_33306', 'carbon group element atom', 93, 'corn'), ('GO_0007565', 'female pregnancy', 110, 'gestation'), ('GO_0007567', 'parturition', 141, 'birth'), ('GO_0007567', 'parturition', 146, '∅'), ('CHEBI_33306', 'carbon group element atom', 250, 'corn'), ('CHEBI_36933', 'oxygen-19 atom', 255, 'soybean'), ('GO_0007565', 'female pregnancy', 275, 'gestation'), ('GO_0007567', 'parturition', 288, 'birth'), ('GO_0007567', 'parturition', 293, '∅')]
PMC3095978	4/2011	S190-PMC3095978	['further Abdominal adiposity increases Insulin secretion, and it would be exaggerated by decreased Hepatic clearance leading to hyperinsulinemia [31].']	N/A	N/A	[('UBERON_0000916', 'abdomen', 8, 'abdominal'), ('PR_000045358', 'insulin family protein', 38, 'insulin'), ('UBERON_0002107', 'liver', 98, 'hepatic')]
PMC3131279	7/2011	S49-PMC3131279	['Livers were collected into liquid nitrogen on day 70, mrna extracted and the Expression of the transcriptome assessed by microarray using mrna pooled from six female offspring in each generation.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers'), ('GO_0010467', 'gene expression', 77, 'expression')]
PMC3131279	7/2011	S57-PMC3131279	['no other Genes were among the twenty most altered Genes in more than one generation.10.1371/journal.pone.0021668.t001\n\ncaption (table-Wrap): table 1\nHepatic Genes showing the greatest difference between pr and ps offspring.difference between ps and pr offspring (fold differences between pr and ps)f1f2f3up-regulateddown-regulatedup-regulateddown-regulatedup-regulateddown-regulatedcytochrome P450, 3,A nm_153312 (69.4)Transmembrane Protein 27 nm_020976 (174.3) Trefoil Factor 2 nm_053844 (13.9) Olfactory receptor 144 nm_001000164 (15.3)Surfactant associated protein c nm_017342 (25.1)Pancreatic Lipase Related Protein 1 nm_032081 (47.5)α2μ globulin nm_001024248 (40.2)Uromodulin nm_017082 (105.3)Hyaluronan mediated motility receptor nm_012964 (12.9)Egf-Like Domain 7 nm_139104 (14) Lymphocyte-Activation Gene 3 nm_212513 (17.4) Pancreatic lipase nm_013161 (39.6)α2μ globulin Pgcl4 nm_147215 (38.3)Cytochrome P450 (11B) nm_012537 (104.9)Sarcolipin nm_001013247 (10.0)Type i keratin Ka11 nm_001008750 (7.1)Caveolin 3 nm_019155 (11.2) Pancreatic Amylase 2 nm_031502 (39.4)Lymphocyte-Activation Gene 3 nm_212513 (35.9) Chromogranin B nm_012526 (98.8)Cathepsin R nm_001017509 (7.9)T-Cell receptor Β-Chain mrna v-region m23885 (6.6)Telethonin xm_001081394 (9.9)Glycoprotein 2 nm_134418 (38.5)Α2Μ Globulin Pgcl3 nm_147212 (29.1)Chloride channel kb nm_173103 (98.1)Threonyl-Trna Synthetase-Like 2 nm_001014020 (7.6)Stathmin-Like 3 nm_024346 (5.5)Bile Acid Coenzyme A: amino acid n-acyltransferasexm_001055067 (9.7)Cationic Trypsinogen nm_173127 (34.4)α2μ globulin Pgcl1 nm_147214 (16.4)Solute Carrier Family 7 (y+ system) member 13 nm_001012100 (92.6) Lymphocyte-Activation Gene 3 nm_212513 (7.5) Myelin-Associated Basic Protein-99 X89638 (5.2)riken nm_001039686 (7.9)Serine Protease-2 nm_012729 (26.0)myosin ixb xm_346173 (15.2)Defensin Β1 nm_031810 (81.4)C-Myc Promoter binding protein xr_009072 (7.3)Cystatin nm_133566 (5.0)Myosin, Light Polypeptide 3 nm_012606 (7.9)Pancreatic Trypsin 1 nm_012635 (24.8)α2μ globulin Pgcl5 nm_147213 (12.8)Solute Carrier Family 26 (4) nm_019214 (80.1)Gastrokine 1 Xm_001074955 (6.4)Socs Box-Containing Protein 3 Xm_344277 (4.5)Immunoglobulin variable region z93370 (7.8)Pancreatic lipase-related Protein-2 nm_057206 (22.5)Caldesmon 1 nm_013146 (12.3)Protein Phosphatase 1, Regulatory Subunit 1A nm_022676 (76.6)Membrane-associated dhhc17 zinc finger protein nm_001039340 (5.8)Fun14 Domain Containing-1 nm_001025027 (4.5)Pancreatitis-Associated Protein nm_053289 (7.8)Ribonuclease A nm_001029904 (19.8)Major Urinary Protein 5 nm_203325 (11.3)Solute Carrier Family 3 nm_017216 (71.0)unknown af433878 (5.3)arachidonate 5-lipoxygenase nm_012822 (4.5)Actin-Α Cardiac- 1 nm_019183 (7.7)Chymotrypsin C nm_001077649 (19.1)Cytochrome P450 (2C13) nm_138514 (10.4)Kidney Androgen Regulated Protein nm_052802 (67.6)Glycosylation Dependent Cell Adhesion Molecule 1 nm_012794 (5.2)Protocadherin-Α nm_201422 (4.5)Ec1-V2R Pheromone Receptor Xm_236825 (7.0)Pancreatic Elastase-1 nm_012552 (18.9)α2μ globulin (l type) nm_001003409 (10.1)Deoxyribonuclease 1 nm_013097 (60.8)Actin Α Cardiac 1 nm_019183 (5.2)Thioesterase Superfamily Member 4 (Them4), mrna nm_001025017 (4.4)S100 Calcium Binding protein g nm_012521 (7.0)Chymotrypsin-Like nm_054009 (17.0)Kpl2 protein nm_022620 (10.0)Degenerative Spermatocyte Homolog 2 nm_001017457 (58.0)serine dehydratase x13119 (5.0)Endothelial differentiation, Sphingolipid G-Protein-Coupled Receptor, 8 nm_021775 (4.3) Trefoil Factor 2 nm_053844 (6.9) Carboxypeptidase B1 nm_012533 (16.5)Cytochrome P450 (iic) nm_019184 (8.1)solute carrier family 5 (Sodium/Glucose co-Transporter), nm_022590 (57.6)phosphodiesterase 4d interacting protein nm_022382 (4.9)Olfactory Receptor 74 nm_001000134 (4.3)Type i keratin Ka15 nm_001004022 (6.9)Trypsin 10 nm_001004097 (16.5)protein tyrosine kinase c-yes xm_343644 (7.5)Tonin nm_012677 (49.7)Olfactory receptor 1250 nm_001000806 (4.8)Olfactory Receptor 821 nm_001000842 (4.3)Topoisomerase -2Α nm_022183 (6.7)chymotrypsinogen b nm_012536 (15.1)Diamine Acetyltransferase 1 Xm_228448 (7.0)myosin, heavy polypeptide 7 nm_017240 (48.1)pparγ1 co-activator 1α nm_031347 (4.6)Kiss1 receptor nm_023992 (4.2)cleavage and Polyadenylation specificity Factor 3 Xr_005746 (6.3)Elastase 2 nm_012553 (11.9) Pancreatic Amylase 2 nm_031502 (6.8) Cadherin 16 nm_001012055 (47.6)Olfactory receptor 1467 nm_001000025 (4.6)Calmodulin-sensitive Plasma Membrane Ca2+-Transporting atpase j05087 (4.2)atp-binding Cassette (Sub-Family B, Member 11) xm_579531 (6.2)Pancreatic colipase nm_013139 (10.6)absent 1 Isoform b xm_232591 (6.8)Solute Carrier Family 7 (y+ system), member 12 nm_001017465 (47.1)Cysteine And Tyrosine-Rich Protein 1 nm_001013980 (4.6)Seminal Vesicle Protein 4 nm_012662 (4.1)Annexin A8 nm_001031654 (6.1)syncollin nm_139086 (9.4)Glandular Kallikrein 11 nm_001003977 (5.5)Hydroxyacid Oxidase-2 nm_032082 (45.1)Neurogenic Differentiation- 2 nm_019326 (4.6)Rt1 class ib Gene nm_012646 (4.1)Olfactory receptor 272 nm_001000230 (6.0)serpin x99773 (9.2)Rab3A nm_013018 (5.5)Solute Carrier Family 12, Member 1 nm_019134 (41.9)Rt1 Class Ii, locus dob nm_001008846 (4.3)Dual Oxidase 1 nm_153739 (4.1)lectin, Galactose binding, soluble 4 nm_012975 (5.8)Carboxyl Ester lipase nm_016997 (9.2)\nGenes which were among the twenty most different between pr and ps offspring in more than one generation are in bold font.']	N/A	N/A	[('SO_0000704', 'gene', 9, 'genes'), ('SO_0000704', 'gene', 50, 'genes'), ('PR_000017453', 'protein Wnt-9b', 134, 'WRAP'), ('UBERON_0002107', 'liver', 149, 'Hepatic'), ('SO_0000704', 'gene', 157, 'genes'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 393, 'P450'), ('PR_000013139', "serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha", 393, 'P450, 3,a'), ('GO_0032588', 'trans-Golgi network membrane', 419, 'Transmembrane'), ('PR_000029823', 'E3 ubiquitin ligase TRIM40', 419, 'Transmembrane protein 27'), ('PR_000016470', 'transmembrane and ubiquitin-like domain-containing protein 1', 462, 'Trefoil factor 2'), ('GO_0007608', 'sensory perception of smell', 496, 'Olfactory'), ('CHEBI_35195', 'surfactant', 538, 'Surfactant'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 586, 'Pancreatic lipase related protein 1'), ('UBERON_0001264', 'pancreas', 586, 'Pancreatic'), ('PR_000004483', 'V-type proton ATPase subunit C 1', 670, 'Uromodulin'), ('CHEBI_5828', 'Hymexazol O-glucoside', 698, 'Hyaluronan'), ('PR_000006911', 'selenocysteine-specific elongation factor', 752, 'EGF-like domain 7'), ('SO_0000417', 'polypeptide_domain', 761, 'domain'), ('CL_0000824', 'mature natural killer cell', 785, 'Lymphocyte'), ('GO_0036364', 'transforming growth factor beta1 activation', 785, 'Lymphocyte-activation'), ('PR_000009658', 'laminin subunit gamma-1', 785, 'Lymphocyte-activation gene 3'), ('SO_0000704', 'gene', 807, 'gene'), ('UBERON_0001264', 'pancreas', 831, 'Pancreatic'), ('PR_000012388', 'protocadherin gamma-A10', 878, 'PGCL4'), ('CHEBI_4056', 'cytochrome', 900, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 900, 'Cytochrome P450'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 917, '11B'), ('PR_000000364', 'smad2', 939, 'Sarcolipin'), ('PR_000016580', 'tropomyosin beta chain', 969, 'Type'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 984, 'KA11'), ('PR_000004967', 'calbindin', 1007, 'Caveolin 3'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 1035, 'Pancreatic amylase 2'), ('UBERON_0001264', 'pancreas', 1035, 'Pancreatic'), ('CL_0000824', 'mature natural killer cell', 1072, 'Lymphocyte'), ('GO_0036364', 'transforming growth factor beta1 activation', 1072, 'Lymphocyte-activation'), ('PR_000009658', 'laminin subunit gamma-1', 1072, 'Lymphocyte-activation gene 3'), ('SO_0000704', 'gene', 1094, 'gene'), ('CHEBI_68805', 'chaetomugilin A', 1118, 'Chromogranin B'), ('PR_000001204', 'C-C chemokine receptor type 8', 1149, 'Cathepsin R'), ('CL_0000084', 'T cell', 1179, 'T-cell'), ('PR_000003676', 'actin, cytoplasmic 1', 1195, 'β-chain'), ('PR_000016393', 'transmembrane channel-like protein 2', 1229, 'Telethonin'), ('CHEBI_17089', 'glycoprotein', 1258, 'Glycoprotein'), ('PR_000007898', 'glutamate--cysteine ligase regulatory subunit', 1258, 'Glycoprotein 2'), ('PR_000001990', 'C-C motif chemokine 18', 1289, 'α2μ'), ('CHEBI_5386', 'globin', 1293, 'globulin'), ('PR_000012591', 'pepsin A-5', 1302, 'PGCL3'), ('CHEBI_17996', 'chloride', 1324, 'Chloride'), ('PR_000016296', 'protein-glutamine gamma-glutamyltransferase 5', 1360, 'Threonyl-tRNA synthetase-like 2'), ('PR_000015293', 'sphingomyelin phosphodiesterase 2', 1410, 'Stathmin-like 3'), ('CHEBI_3098', 'bile acid', 1441, 'Bile acid'), ('UBERON_0001970', 'bile', 1441, 'Bile'), ('CHEBI_15346', 'coenzyme A', 1451, 'Coenzyme A'), ('CHEBI_36916', 'cation', 1509, 'Cationic'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 1518, 'trypsinogen'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 1559, 'PGCL1'), ('PR_000015439', 'nuclear body protein SP140-like protein', 1581, 'Solute carrier family 7 ...'), ('CL_0000824', 'mature natural killer cell', 1647, 'Lymphocyte'), ('PR_000004680', 'breast carcinoma-amplified sequence 3', 1657, '-activation gene 3'), ('SO_0000704', 'gene', 1669, 'gene'), ('PR_000029266', 'alkylglycerol monooxygenase', 1692, 'Myelin-associated Basic Protein-99 X89638'), ('UBERON_0000345', 'myelin', 1692, 'Myelin'), ('PR_000014506', 'secretoglobin family 1D member 1', 1763, 'Serine protease-2'), ('PR_000006525', 'delta-like protein 4', 1824, 'Defensin β1'), ('PR_000000084', 'c-myc protein', 1852, 'C-myc'), ('SO_0000167', 'promoter', 1858, 'promoter'), ('PR_000005890', 'crooked neck-like protein 1', 1898, 'Cystatin'), ('PR_000010876', 'myoferlin', 1922, 'Myosin, light polypeptide 3'), ('PR_000014709', 'neuroserpin', 1965, 'Pancreatic'), ('UBERON_0001264', 'pancreas', 1965, 'Pancreatic'), ('PR_000027795', 'trypsin', 1976, 'trypsin 1'), ('PR_000012388', 'protocadherin gamma-A10', 2015, 'PGCL5'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 2037, 'Solute carrier family 26'), ('PR_000007220', 'ethanolamine kinase 2', 2082, 'Gastrokine 1 XM_001074955'), ('PR_000029264', 'AT-hook DNA-binding motif-containing protein 1', 2113, 'SOCS box-containing protein 3 XM_344277'), ('GO_0019815', 'B cell receptor complex', 2158, 'Immunoglobulin'), ('UBERON_0001264', 'pancreas', 2201, 'Pancreatic'), ('PR_000014700', 'serpin B9', 2227, 'protein-2'), ('PR_000002199', 'cytochrome c protein', 2253, 'Caldesmon 1'), ('PR_000013086', 'peptidyl-prolyl cis-trans isomerase-like 4', 2281, 'Protein phosphatase 1, regulatory subunit 1A'), ('GO_0065007', 'biological regulation', 2304, 'regulatory'), ('GO_0016020', 'membrane', 2342, 'Membrane'), ('PR_000007693', 'ferritin, mitochondrial', 2407, 'FUN14 domain containing-1'), ('SO_0000417', 'polypeptide_domain', 2413, 'domain'), ('PR_000013199', 'prolargin', 2451, 'Pancreatitis-associated protein'), ('PR_000023799', 'ribonuclease R', 2498, 'Ribonuclease A'), ('PR_000010045', 'transcription factor Maf', 2532, 'Major urinary protein 5'), ('UBERON_0001088', 'urine', 2538, 'urinary'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 2572, 'Solute carrier family 3'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 2677, 'Actin-α cardiac- 1'), ('UBERON_0000948', 'heart', 2685, 'cardiac'), ('PR_000006022', 'lysosomal protective protein', 2711, 'Chymotrypsin C'), ('CHEBI_4056', 'cytochrome', 2745, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 2745, 'Cytochrome P450'), ('PR_000005173', 'CD59 glycoprotein', 2762, '2c13'), ('PR_000009204', 'lysine-specific demethylase 5A', 2784, 'Kidney androgen regulated protein'), ('UBERON_0002113', 'kidney', 2784, 'Kidney'), ('CHEBI_50113', 'androgen', 2791, 'androgen'), ('GO_0065007', 'biological regulation', 2800, 'regulated'), ('GO_0006277', 'DNA amplification', 2834, 'Glycosylation'), ('PR_000007775', 'gamma-aminobutyric acid receptor subunit delta', 2834, 'Glycosylation dependent cell adhesion molecule 1'), ('CHEBI_36357', 'polyatomic entity', 2872, 'molecule'), ('PR_000012194', 'P2X purinoceptor 7', 2898, 'Protocadherin-α'), ('PR_000006897', 'endothelin-1', 2929, 'EC1-'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2933, 'V2R pheromone receptor XM_236825'), ('PR_000012529', 'PDZK1-interacting protein 1', 2971, 'Pancreatic elastase-1'), ('UBERON_0001264', 'pancreas', 2971, 'Pancreatic'), ('PR_000006605', 'dynamin-binding protein', 3050, 'Deoxyribonuclease 1'), ('PR_000003564', 'ATP-binding cassette sub-family C member 9', 3086, 'Actin α cardiac 1'), ('UBERON_0000948', 'heart', 3094, 'cardiac'), ('PR_000016139', 'TATA box-binding protein-like 2', 3119, 'Thioesterase superfamily member 4'), ('PR_000016329', 'T-lymphoma invasion and metastasis-inducing protein 2', 3154, 'Them4'), ('PR_000014411', 'protein S100-A4', 3185, 'S100 calcium binding'), ('PR_000005875', 'cysteine-rich protein 3', 3231, 'Chymotrypsin-like'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 3265, 'KPL2'), ('PR_000006460', 'dihydroorotate dehydrogenase (quinone), mitochondrial', 3294, 'Degenerative spermatocyte homolog 2'), ('CL_0000017', 'spermatocyte', 3307, 'spermatocyte'), ('SO_0000853', 'homologous_region', 3320, 'homolog'), ('UBERON_0001986', 'endothelium', 3380, 'Endothelial'), ('CHEBI_26739', 'sphingolipid', 3409, 'sphingolipid'), ('PR_000001703', 'mas-related G-protein coupled receptor X2', 3409, 'sphingolipid G-protein-coupled receptor, 8'), ('PR_000016470', 'transmembrane and ubiquitin-like domain-containing protein 1', 3468, 'Trefoil factor 2'), ('PR_000005347', 'centrosome-associated protein CEP250', 3501, 'Carboxypeptidase B1'), ('CHEBI_4056', 'cytochrome', 3537, 'Cytochrome'), ('PR_000006137', 'cytochrome P450 4B1', 3537, 'Cytochrome P450'), ('CHEBI_52632', 'potassium-39 atom', 3599, 'sodium'), ('CHEBI_17234', 'glucose', 3606, 'glucose'), ('PR_000014938', 'urea transporter 1', 3617, 'transporter'), ('GO_0007608', 'sensory perception of smell', 3703, 'Olfactory'), ('PR_000014368', 'RuvB-like 1', 3713, 'receptor'), ('PR_000016580', 'tropomyosin beta chain', 3743, 'Type'), ('PR_000009486', 'keratin, type II cytoskeletal 71', 3758, 'KA15'), ('PR_000016869', 'thioredoxin-like protein 4A', 3781, 'Trypsin 10'), ('PR_000016331', 'tigger transposable element-derived protein 1', 3856, 'Tonin'), ('GO_0007608', 'sensory perception of smell', 3878, 'Olfactory'), ('GO_0007608', 'sensory perception of smell', 3920, 'Olfactory'), ('PR_000029714', 'roquin-2', 3930, 'receptor 821'), ('PR_000016842', 'trafficking regulator of GLUT4 1', 3961, 'Topoisomerase -2α'), ('CHEBI_4514', 'dicyclomine', 4029, 'Diamine'), ('PR_000029427', 'DnaJ homolog subfamily C member 7', 4029, 'Diamine acetyltransferase 1 XM_228448'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 4154, 'KISS1'), ('GO_0043631', 'RNA polyadenylation', 4197, 'polyadenylation'), ('PR_000049700', 'protein Wnt-9b, signal peptide removed form (human)', 4225, 'factor 3 XR_005746'), ('PR_000007002', 'eukaryotic translation initiation factor 5', 4249, 'Elastase 2'), ('PR_000012527', 'Na(+)/H(+) exchange regulatory cofactor NHE-RF4', 4277, 'Pancreatic amylase 2'), ('UBERON_0001264', 'pancreas', 4277, 'Pancreatic'), ('PR_000004968', 'calretinin', 4314, 'Cadherin 16'), ('GO_0007608', 'sensory perception of smell', 4345, 'Olfactory'), ('PR_000004967', 'calbindin', 4387, 'Calmodulin'), ('GO_0005886', 'plasma membrane', 4408, 'plasma membrane'), ('CHEBI_81233', 'Schizonepetoside B', 4424, 'Ca2+-'), ('GO_0016554', 'cytidine to uridine editing', 4424, 'Ca2+-transporting'), ('SO_0005853', 'gene_cassette', 4473, 'cassette'), ('PR_000015900', 'putative synaptotagmin-14-like protein', 4483, 'sub-family B, member 11'), ('UBERON_0001264', 'pancreas', 4523, 'Pancreatic'), ('SO_0001060', 'sequence_variant', 4568, 'isoform'), ('PR_000015439', 'nuclear body protein SP140-like protein', 4593, 'Solute carrier family 7 ...'), ('PR_000005866', 'cAMP-responsive element modulator', 4659, 'Cysteine and tyrosine-rich protein 1'), ('PR_000014892', 'NAD-dependent protein deacetylase sirtuin-6', 4714, 'Seminal vesicle protein 4'), ('UBERON_0000997', 'mammalian vulva', 4714, 'Seminal'), ('PR_000004080', 'annexin A7', 4755, 'Annexin A8'), ('UBERON_0002530', 'gland', 4809, 'Glandular'), ('PR_000009309', 'kinesin-like protein KIF2B', 4819, 'kallikrein 11'), ('CHEBI_16240', 'hydrogen peroxide', 4851, 'Hydroxyacid'), ('PR_000008453', 'hepatitis A virus cellular receptor 1', 4851, 'Hydroxyacid oxidase-2'), ('GO_0001822', 'kidney development', 4889, 'Neurogenic'), ('PR_000011461', 'endonuclease III-like protein 1', 4889, 'Neurogenic differentiation- 2'), ('PR_000012993', 'DNA-directed RNA polymerase II subunit RPB7', 4934, 'RT1'), ('SO_0000704', 'gene', 4947, 'gene'), ('GO_0007608', 'sensory perception of smell', 4967, 'Olfactory'), ('PR_000013610', 'Ras-related protein Rab-34', 5027, 'RAB3A'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 5048, 'Solute carrier family 12, member 1'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 5099, 'RT1 class II'), ('PR_000006745', 'dual specificity protein phosphatase 19', 5141, 'Dual oxidase 1'), ('CHEBI_28260', 'galactose', 5179, 'galactose'), ('CHEBI_3385', 'carbachol', 5223, 'Carboxyl ester'), ('SO_0000704', 'gene', 5261, 'Genes')]
PMC3131279	7/2011	S86-PMC3131279	['the results of kegg analysis of pathways which are relevant to Hepatic function which contained at least ten Genes which differed by 2 fold or more between ps and pr lines are shown infigure 6.']	N/A	N/A	[('UBERON_0002107', 'liver', 63, 'hepatic'), ('SO_0000704', 'gene', 109, 'genes')]
PMC3131279	7/2011	S93-PMC3131279	['the adherens junction pathway was over-represented amongst the up-regulated Genes in all three generations.10.1371/journal.pone.0021668.g006\n\ncaption (fig): figure 6\ncanonical pathways involved in Hepatic function which differed between ps and pr offspring.']	N/A	N/A	[('SO_0000704', 'gene', 76, 'genes'), ('UBERON_0002107', 'liver', 197, 'hepatic')]
PMC3131279	7/2011	S112-PMC3131279	['Hsf, Heat Shock Factor; C/Ebp, Catt Enhancer-Binding Protein; Hnf1, Hepatic Nuclear Factor-1; kltfs, krueppel-like transcription factors; cre, Camp-response element.']	N/A	N/A	[('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 0, 'HSF'), ('PR_000008480', 'histone deacetylase 11', 5, 'heat shock factor'), ('PR_000005309', 'CCAAT/enhancer-binding protein delta', 24, 'C/EBP'), ('PR_000005269', 'cyclin-dependent kinase-like 1', 31, 'CATT enhancer-binding protein'), ('SO_0000165', 'enhancer', 36, 'enhancer'), ('PR_000008653', 'hepatocyte nuclear factor 1-beta', 62, 'HNF1'), ('PR_000008477', 'hematopoietic cell signal transducer', 68, 'hepatic nuclear factor-1'), ('UBERON_0002107', 'liver', 68, 'hepatic'), ('GO_0005634', 'nucleus', 76, 'nuclear'), ('CHEBI_17489', "3',5'-cyclic AMP", 143, 'cAMP')]
PMC3131279	7/2011	S116-PMC3131279	['the differences in the Expression of the Liver transcriptome between ps and pr lines differed between f1, f2 and f3 generations in terms of the number of Genes which showed altered Expression, the magnitude of difference, the distribution of up and down regulated Genes and the ontologies affected.']	N/A	N/A	[('GO_0010467', 'gene expression', 23, 'expression'), ('UBERON_0002107', 'liver', 41, 'liver'), ('SO_0000704', 'gene', 154, 'genes'), ('GO_0010467', 'gene expression', 181, 'expression'), ('SO_0000704', 'gene', 264, 'genes')]
PMC3131279	7/2011	S172-PMC3131279	['Livers were frozen immediately in liquid nitrogen.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers')]
PMC3131279	7/2011	S175-PMC3131279	["rna isolation and measurement of the Expression of the Liver transcription by agilent oligonucleotide array hybridisation\nrna was extracted from Livers from ps and pr offspring (n\u200a=\u200a6 per f0 dietary group in each generation) using trizol Reagent (invitrogen) according to manufacturer's instructions."]	N/A	N/A	[('GO_0010467', 'gene expression', 37, 'expression'), ('UBERON_0002107', 'liver', 55, 'liver'), ('UBERON_0002107', 'liver', 145, 'livers'), ('CHEBI_33893', 'reagent', 238, 'reagent')]
PMC3131279	7/2011	S192-PMC3131279	['mrna Expression of Hepatic Genes was measured by real-time pcr.']	N/A	N/A	[('GO_0010467', 'gene expression', 5, 'expression'), ('UBERON_0002107', 'liver', 19, 'hepatic'), ('SO_0000704', 'gene', 27, 'genes')]
PMC3138750	7/2011	S5-PMC3138750	['Hepatic transcriptome profiles of the offspring were analyzed at Prenatal (94 dpc) and Postnatal stages (1, 28, 188 dpn).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('GO_0007567', 'parturition', 87, 'postnatal')]
PMC3138750	7/2011	S39-PMC3138750	["we investigated their offspring's Hepatic Gene Expression in one Prenatal and three Postnatal stages with the help of Porcine 24 k-microarrays."]	N/A	N/A	[('UBERON_0002107', 'liver', 34, 'hepatic'), ('GO_0010467', 'gene expression', 42, 'gene expression'), ('SO_0000704', 'gene', 42, 'gene'), ('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('GO_0007567', 'parturition', 84, 'postnatal'), ('NCBITaxon_10088', 'Mus <genus>', 118, 'porcine')]
PMC3138750	7/2011	S70-PMC3138750	['the numbers at vertical arrows are the number of probe-sets differentially Expressed between ap and hp offspring at the same Ontogenetic stage (arrows between boxes show direction of the comparisons; small arrows to top\u200a=\u200aup-regulated, small arrows to bottom\u200a=\u200adown-regulated probe-sets).10.1371/journal.pone.0021691.t001\n\ncaption (table-wrap): table 1\nsignificantly Regulated Transcripts of Metabolic pathways in Liver Tissue within different Ontogenetic stages (ingenuity pathway analysis).Ontogenetic stageregulated pathwayregulation p valueno.']	N/A	N/A	[('GO_0010467', 'gene expression', 75, 'expressed'), ('GO_0042476', 'odontogenesis', 125, 'ontogenetic'), ('GO_0065007', 'biological regulation', 367, 'regulated'), ('SO_0000673', 'transcript', 377, 'transcripts'), ('GO_0008152', 'metabolic process', 392, 'metabolic'), ('UBERON_0002107', 'liver', 414, 'liver'), ('UBERON_0000479', 'tissue', 420, 'tissue'), ('GO_0042476', 'odontogenesis', 444, 'ontogenetic'), ('GO_0001503', 'ossification', 492, 'Ontogenetic')]
PMC3138750	7/2011	S229-PMC3138750	['injection of t61 (intervet, unterschleissheim, germany) in the v. Cava cranialis and Liver samples were immediately collected (approximately 500 mg), frozen in liquid nitrogen, and stored atuntil analysis.']	N/A	N/A	[('UBERON_0003124', 'chorion', 66, 'cava'), ('UBERON_0002107', 'liver', 85, 'liver')]
PMC3138750	7/2011	S247-PMC3138750	['Liver Tissue was immediately collected from Lobus sinister Hepaticus, frozen in liquid nitrogen, and stored atuntil use for rna isolation.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000479', 'tissue', 6, 'tissue'), ('UBERON_0009911', 'lobule', 44, 'lobus'), ('UBERON_0002107', 'liver', 59, 'hepaticus')]
PMC3138750	7/2011	S254-PMC3138750	["rna isolation, target preparation and hybridization\naccording to the manufacturer's protocol total rna from individual Liver samples was isolated using Tri-Reagent (sigma-aldrich, taufkirchen, germany)."]	N/A	N/A	[('UBERON_0002107', 'liver', 119, 'liver'), ('14', 'AAMP (human)', 152, 'Tri'), ('CHEBI_33893', 'reagent', 156, 'Reagent')]
PMC3138750	7/2011	S277-PMC3138750	['pathway analysis\nGene lists from microarray results were submitted to the manually curated database ‘ingenuity pathways analysis’ to elucidate putative pathways associated with an altered Gene Expression in Porcine Liver.']	N/A	N/A	[('SO_0000704', 'gene', 17, 'Gene'), ('GO_0010467', 'gene expression', 188, 'gene expression'), ('SO_0000704', 'gene', 188, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 207, 'porcine'), ('UBERON_0002107', 'liver', 215, 'liver')]
PMC3138750	7/2011	S282-PMC3138750	['in order to survey Expression of the Liver Tissue samples, total Transcript levels of selected target and reference Genes (table 4) were quantified by real-time quantitative pcr (qpcr) performed on a lightcycler 480 system using the lightcycler 480 Sybr Green i master (roche, mannheim, germany).']	N/A	N/A	[('GO_0010467', 'gene expression', 19, 'expression'), ('UBERON_0002107', 'liver', 37, 'liver'), ('UBERON_0000479', 'tissue', 43, 'tissue'), ('SO_0000673', 'transcript', 65, 'transcript'), ('SO_0000704', 'gene', 116, 'genes'), ('CHEBI_51461', 'SYBR Green I', 249, 'SYBR Green')]
PMC3138750	7/2011	S288-PMC3138750	['in total, 28 individual Liver mrna samples were analyzed in duplicate per stage.']	N/A	N/A	[('UBERON_0002107', 'liver', 24, 'liver')]
PMC3138750	7/2011	S290-PMC3138750	['differences were considered significant at.10.1371/journal.pone.0021691.t004\n\ncaption (table-Wrap): table 4\nPrimer used to verify microarray experiments in Liver Tissue by qrt-pcr.Gene nameprobe set idsequence 5′ – 3′accession no.t(c)size (Bp)dhcr7ssc.5455.1.s1_atfor gcatgacactgacttcttctc Rev cccacctccactttattc be23296660136gadd45bssc.14764.1.a1_atfor ggacttagactttgggacttg Rev gtaagcctcccatctctctt bf70859460140hmgcrssc.16088.1.s1_atfor gtgctggtctgttttgattt rev tgcagtgatttgttttcttg bp43694760159ndufa 4ssc.7315.1.s1_atfor tcctgcttagtccccgacctt Rev acagtgctgctccagtacctcc cf79332960164ndufs 7ssc.1681.1.s1_atfor cggctactaccactactcct Rev atccgcagtctcttctcc ck45553560156ndufs 8ssc.2312.1.s1_atfor agtttgtgaacatgcgtgag Rev ctcaaatgggtagttgatgg bi18100660152ppargc1assc.16864.1.s1_atfor gtaaatctgcgggatgatgg Rev tggtggaagcaggatcaaag ab10610860208prkaa 1ssc.8107.1.a1_atfor ttgttaatttcataaactttgcttc Rev gtgcagccttgacatactc bf71253360193prkaa 2ssc.16257.1.s1_atfor tctgtaattctgttttgcctacg Rev agcaagaaggtgatgccaag nm21426660168rpl 10*Ssc.9130.1.a1_atfor ctgtgttcgtcttttcttcc Rev tcatccacttttgccttct bi18129760199\ndhcr7 - 7-Dehydrocholesterol reductase; Gadd45B - growth arrest and Dna-Damage-Inducible, Beta; hmgcr - 3-Hydroxy-3-Methylglutaryl-Coenzyme A reductase; ndufa4 - Nadh-ubiquinone oxidoreductase Mlrq subunit; Ndufs7 - Nadh-Ubiquinone Oxidoreductase 20 Kda Subunit; Ndufs8 - Nadh-Ubiquinone Oxidoreductase 23 Kda Subunit; Ppargc1A - Peroxisome Proliferator Activated Receptor Gamma Coactivator 1 alpha; Prkaa1 – 5′-Amp-Activated protein Kinase, catalytic alpha-1 chain; Prkaa2 – 5′-Amp-activated protein Kinase, catalytic alpha-2 chain; Rpl10 - Ribosomal Protein 10.']	N/A	N/A	[('PR_000017453', 'protein Wnt-9b', 93, 'WRAP'), ('SO_0000112', 'primer', 108, 'Primer'), ('UBERON_0002107', 'liver', 156, 'liver'), ('UBERON_0000479', 'tissue', 162, 'tissue'), ('SO_0000704', 'gene', 180, 'Gene'), ('SO_0000028', 'base_pair', 240, 'bp'), ('SO_0001434', 'cassette_pseudogene', 290, 'Rev'), ('SO_0001434', 'cassette_pseudogene', 376, 'Rev'), ('SO_0001434', 'cassette_pseudogene', 548, 'Rev'), ('SO_0001434', 'cassette_pseudogene', 636, 'Rev'), ('SO_0001434', 'cassette_pseudogene', 720, 'Rev'), ('SO_0001434', 'cassette_pseudogene', 808, 'Rev'), ('SO_0001434', 'cassette_pseudogene', 899, 'Rev'), ('SO_0001434', 'cassette_pseudogene', 988, 'Rev'), ('PR_000014775', 'pulmonary surfactant-associated protein D', 1033, 'Ssc'), ('SO_0001434', 'cassette_pseudogene', 1074, 'Rev'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1120, '7-dehydrocholesterol'), ('PR_000007774', 'gamma-aminobutyric acid receptor subunit beta-3', 1152, 'GADD45B'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 1180, 'DNA-damage-inducible, beta'), ('CHEBI_60337', 'N-salicyloyl-L-seryl group', 1216, '3-hydroxy-3-methylglutaryl'), ('CHEBI_15346', 'coenzyme A', 1243, 'coenzyme A'), ('CHEBI_13389', 'NAD', 1274, 'NADH'), ('PR_000010425', 'proliferation marker protein Ki-67', 1305, 'MLRQ'), ('PR_000011050', 'kinetochore protein NDC80', 1319, 'NDUFS7'), ('PR_000011119', 'neurofilament light polypeptide', 1328, 'NADH-ubiquinone oxidoreductase 20 kDa subunit'), ('PR_000011050', 'kinetochore protein NDC80', 1375, 'NDUFS8'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1384, 'NADH-ubiquinone oxidoreductase 23 kDa subunit'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 1431, 'PPARGC1A'), ('GO_0005777', 'peroxisome', 1442, 'Peroxisome'), ('PR_000012723', 'phosphoinositide-3-kinase-interacting protein 1', 1442, 'Peroxisome proliferator activated receptor gamma coactivator 1'), ('PR_000013282', 'pre-mRNA-processing factor 39', 1512, 'PRKAA1'), ('CHEBI_16027', "adenosine 5'-monophosphate", 1524, 'AMP'), ('PR_000000363', 'smad1', 1527, '-activated'), ('PR_000009210', 'Jun dimerization protein 2', 1546, 'kinase'), ('PR_000013282', 'pre-mRNA-processing factor 39', 1579, 'PRKAA2'), ('CHEBI_16027', "adenosine 5'-monophosphate", 1591, 'AMP'), ('PR_000009210', 'Jun dimerization protein 2', 1613, 'kinase'), ('PR_000014219', '60S ribosomal protein L36', 1646, 'RPL10'), ('GO_0005768', 'endosome', 1654, 'Ribosomal'), ('PR_000014368', 'RuvB-like 1', 1654, 'Ribosomal protein 10')]
PMC3156909	9/2011	S52-PMC3156909	['Adipose Tissue and Liver samples were paraffin embedded.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('UBERON_0002107', 'liver', 19, 'liver')]
PMC3156909	9/2011	S62-PMC3156909	['Hepatic neutral Lipids content\nHepatic Cholesterol, Cholesterol Esters, and Triglycerides were determined by gas chromatography analysis as described elsewhere11from snap frozen Liver biopsies.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_18059', 'lipid', 16, 'lipids'), ('UBERON_0002107', 'liver', 31, 'Hepatic'), ('CHEBI_16113', 'cholesterol', 39, 'cholesterol'), ('CHEBI_23129', 'chloroamino acid', 52, 'cholesterol esters'), ('CHEBI_17855', 'triglyceride', 76, 'triglycerides'), ('UBERON_0002107', 'liver', 178, 'liver')]
PMC3156909	9/2011	S124-PMC3156909	['caption (fig): figure\xa05\n\nlipistase prevents Hepatic steatosis.']	N/A	N/A	[('UBERON_0002107', 'liver', 44, 'hepatic')]
PMC3156909	9/2011	S125-PMC3156909	['( a ) Liver paraffin-embedded sections, stained with Haematoxylin and eosin (upper panels) from Animals after 10-month lipistase treatment vs .']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'Liver'), ('CHEBI_51686', 'haematoxylin', 53, 'haematoxylin'), ('NCBITaxon_33208', 'Metazoa', 96, 'animals')]
PMC3156909	9/2011	S127-PMC3156909	['( b ) levels of Cholesterol Esters and Triglycerides in the Liver of the same Animals.']	N/A	N/A	[('CHEBI_23129', 'chloroamino acid', 16, 'cholesterol esters'), ('CHEBI_17855', 'triglyceride', 39, 'triglycerides'), ('UBERON_0002107', 'liver', 60, 'liver'), ('NCBITaxon_33208', 'Metazoa', 78, 'animals')]
PMC3156909	9/2011	S156-PMC3156909	['lipistase treatment in ldlrko Mice increased Lipid Utilization by Skeletal muscle and reduced fat accumulation in White Adipose Tissue and Liver by stimulating Fatty Acid Uptake and Catabolism and by reducing Lipogenesis.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 30, 'mice'), ('CHEBI_18059', 'lipid', 45, 'lipid'), ('GO_0006264', 'mitochondrial DNA replication', 45, 'lipid utilization'), ('UBERON_0004288', 'skeleton', 66, 'skeletal'), ('UBERON_0001347', 'white adipose tissue', 114, 'white adipose tissue'), ('UBERON_0002107', 'liver', 139, 'liver'), ('CHEBI_35366', 'fatty acid', 160, 'fatty acid'), ('GO_0033565', 'ESCRT-0 complex', 160, 'fatty acid uptake'), ('GO_0009056', 'catabolic process', 182, 'catabolism'), ('GO_0008610', 'lipid biosynthetic process', 209, 'lipogenesis')]
PMC3184661	9/2006	S30-PMC3184661	['caption (table-wrap): table i\n- mean content of omega 3 fatty acids of selected fish and seafoodfishepa/+Dha content (g) per 100 g serving of fish (edible portion)amount of fish (in g) required to provide 1 g Epa+/dhatuna (fresh)0.28–1.5166–357atlantic salmon1.28–2.1542.5–70.9mackerel0.4–1.8554–250atlantic herring2.0150rainbow trout1.1587sardines1.15–250–87halibut0.47–1.1885–213tuna (canned)0.31323cod0.28357haddock0.24417catfish0.18556flounder or sole0.49204oyster0.44227shrimp0.32313scallop0.2500cod Liver oil capsule0.195\nEpa=Eicosapentanoic Acid, Dha=Docosahexanoic Acid.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 105, 'DHA'), ('CHEBI_34733', 'EPN', 209, 'EPA'), ('UBERON_0002107', 'liver', 505, 'liver'), ('CHEBI_34733', 'EPN', 528, 'EPA'), ('CHEBI_36003', 'decenoic acid', 532, 'eicosapentanoic acid'), ('CHEBI_17874', 'dihydrozeatin', 554, 'DHA'), ('CHEBI_36006', 'icosapentaenoic acid', 558, 'docosahexanoic acid')]
PMC3208550	11/2011	S7-PMC3208550	['Hepatic 11Β-Hsd1 enzyme activity in sl Rats was elevated from w3 to w16 compared to nl Rats.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 8, '11β-HSD1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 39, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 87, 'rats')]
PMC3208550	11/2011	S8-PMC3208550	['Hepatic 5Αr1 and 5Βr Expression was higher in sl compared to nl Rats after weaning until w6, whereupon Expression decreased in the sl Rats and remained similar to that in nl Rats.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000001623', 'neuropeptide Y receptor type 4', 8, '5αR1'), ('PR_000001164', '5-hydroxytryptamine receptor 1E', 17, '5βR'), ('GO_0010467', 'gene expression', 21, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 64, 'rats'), ('GO_0010467', 'gene expression', 103, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 134, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 174, 'rats')]
PMC3208550	11/2011	S20-PMC3208550	['11Β-Hsd1 is mainly distributed in the Liver, Adipose Tissue, and Brain[9].']	N/A	N/A	[('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 0, '11β-'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 4, 'HSD1'), ('UBERON_0002107', 'liver', 38, 'liver'), ('UBERON_0001013', 'adipose tissue', 45, 'adipose tissue'), ('UBERON_0000955', 'brain', 65, 'brain')]
PMC3208550	11/2011	S21-PMC3208550	['Adipose- or Liver-specific 11Β-Hsd1 Overexpression in transgenic Mice exhibit elevated intra-Adipose and portal Corticosterone levels, abdominal obesity, dyslipidemia, Insulin resistance, and hypertension[10],[11].']	N/A	N/A	[('UBERON_2000442', 'supraneural bone', 0, 'Adipose'), ('UBERON_0002107', 'liver', 12, 'liver'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 27, '11β-HSD1'), ('GO_0007308', 'oocyte construction', 36, 'overexpression'), ('NCBITaxon_10088', 'Mus <genus>', 65, 'mice'), ('UBERON_2000251', 'adipose fin', 93, 'adipose'), ('CHEBI_16827', 'corticosterone', 112, 'corticosterone'), ('PR_000045358', 'insulin family protein', 168, 'insulin')]
PMC3208550	11/2011	S23-PMC3208550	['the principal enzymes responsible for Gc Catabolism in the Liver are a-ring reductases (5α-reductase type 1 (5Αr1) and 5β-reductase (5βr)).']	N/A	N/A	[('GO_0042182', 'ketone catabolic process', 38, 'GC catabolism'), ('UBERON_0002107', 'liver', 59, 'liver'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 106, '1'), ('PR_000001623', 'neuropeptide Y receptor type 4', 109, '5αR1')]
PMC3208550	11/2011	S42-PMC3208550	['Epididymal and Retroperitoneal White Adipose Tissue and Liver samples were removed, snap-frozen in liquid nitrogen, and kept at −80°c until Gene Expression and activity analysis.']	N/A	N/A	[('UBERON_0004360', 'cauda epididymis', 0, 'Epididymal ...'), ('UBERON_0003693', 'retroperitoneal space', 15, 'retroperitoneal'), ('UBERON_0001347', 'white adipose tissue', 31, 'white adipose tissue'), ('UBERON_0002107', 'liver', 56, 'liver'), ('GO_0010467', 'gene expression', 140, 'gene expression'), ('SO_0000704', 'gene', 140, 'gene')]
PMC3208550	11/2011	S54-PMC3208550	["quantitative real-time pcr\ntotal rna was isolated from Adipose Tissue and Liver with trizol (invitrogen, carlsbad, ca, usa) according to the manufacturer's instructions and quantified spectrophotometrically at od260."]	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 55, 'adipose tissue'), ('UBERON_0002107', 'liver', 74, 'liver')]
PMC3208550	11/2011	S66-PMC3208550	['samples of Adipose Tissue (0.5 mg protein/ml) or Liver (10 µg protein/ml) homogenate were incubated with 2 mm Nadp and 100 nm 1,2,6,7-[3H]4-Corticosterone (amersham, berkshire, uk).']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 11, 'adipose tissue'), ('UBERON_0002107', 'liver', 49, 'liver'), ('CHEBI_25524', 'NAD(P)', 110, 'NADP'), ('CHEBI_29238', 'tritium atom', 135, '3H'), ('CHEBI_52029', 'dilC18(3) dye', 138, '4-'), ('CHEBI_16827', 'corticosterone', 140, 'corticosterone')]
PMC3208550	11/2011	S67-PMC3208550	['after incubation in a shaking Water bath at 37°c for 2 h or 1 h for Adipose Tissue or Liver, respectively, the reaction was interrupted; Steroids were extracted with Ethyl Acetate and then dried, dissolved in Ethanol, separated by thin-layer chromatography (mobile phase Chloroform∶Ethanol [92∶8]), and exposed to a phosphorimager tritium screen (ge healthcare europe, freiburg, germany).']	N/A	N/A	[('CHEBI_15377', 'water', 30, 'water'), ('UBERON_0001013', 'adipose tissue', 68, 'adipose tissue'), ('UBERON_0002107', 'liver', 86, 'liver'), ('CHEBI_35341', 'steroid', 137, 'steroids'), ('CHEBI_27750', 'ethyl acetate', 166, 'ethyl acetate'), ('CHEBI_16236', 'ethanol', 209, 'ethanol'), ('CHEBI_35255', 'chloroform', 271, 'chloroform'), ('CHEBI_24870', 'ion', 281, '∶'), ('CHEBI_16236', 'ethanol', 282, 'ethanol')]
PMC3208550	11/2011	S128-PMC3208550	['Hepatic 11Β-Hsd1 and a-ring reductases in nl and sl Rats\n11Β-Hsd1 mrna Expression and activity in the Liver did not change with increasing Postnatal age in either nl or sl Rats.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 8, '11β-HSD1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 52, 'rats'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 57, '11β-HSD1'), ('GO_0010467', 'gene expression', 71, 'expression'), ('UBERON_0002107', 'liver', 102, 'liver'), ('GO_0007567', 'parturition', 139, 'postnatal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 172, 'rats')]
PMC3208550	11/2011	S130-PMC3208550	['6a), and Hepatic 11Β-Hsd1 activity was significantly elevated in sl Rats from w3 to w16 compared to nl Rats (except for w8) (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'hepatic'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 17, '11β-HSD1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 68, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 103, 'rats')]
PMC3208550	11/2011	S132-PMC3208550	['Hepatic 5Αr1 decreased with Postnatal age and reached minimum levels at w5 in both the nl and sl groups ( p<0.05 vs. w3) (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000001623', 'neuropeptide Y receptor type 4', 8, '5αR1'), ('GO_0007567', 'parturition', 28, 'postnatal')]
PMC3208550	11/2011	S135-PMC3208550	['compared to the nl Rats, Hepatic 5Αr1 (fig.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 19, 'rats'), ('UBERON_0002107', 'liver', 25, 'hepatic'), ('PR_000001623', 'neuropeptide Y receptor type 4', 33, '5αR1')]
PMC3208550	11/2011	S138-PMC3208550	['5Βr mrna Expression was actually lower in sl Rats compared to nl Rats in w16 ( p<0.05).10.1371/journal.pone.0025726.g006\n\ncaption (fig): figure 6\nHepatic 11Β-Hsd1 mrna Expression (a) and enzyme activity (b) from w3 to w16 in sl and nl Rats.']	N/A	N/A	[('PR_000001164', '5-hydroxytryptamine receptor 1E', 0, '5βR'), ('GO_0010467', 'gene expression', 9, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 45, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 65, 'rats'), ('UBERON_0002107', 'liver', 146, 'Hepatic'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 154, '11β-HSD1'), ('GO_0010467', 'gene expression', 168, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 235, 'rats')]
PMC3208550	11/2011	S141-PMC3208550	['* p<0.05 sl vs. nl groups at the corresponding time points ( n \u200a=\u200a6–9).10.1371/journal.pone.0025726.g007\n\ncaption (fig): figure 7\nHepatic 5Αr1 (a) and 5Βr (b) mrna Expression from w3 to w16 in sl and nl Rats.']	N/A	N/A	[('UBERON_0002107', 'liver', 130, 'Hepatic'), ('PR_000001623', 'neuropeptide Y receptor type 4', 138, '5αR1'), ('PR_000001164', '5-hydroxytryptamine receptor 1E', 151, '5βR'), ('GO_0010467', 'gene expression', 164, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 203, 'rats')]
PMC3208550	11/2011	S152-PMC3208550	['Gr mrna and protein Expression in Adipose Tissue and Liver of nl and sl Rats\nthere were no significant differences in Gr mrna and protein Expression in Liver, Retroperitoneal and Epididymal Adipose Tissue, with regard to either age or litter size (data not shown).']	N/A	N/A	[('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 0, 'GR'), ('GO_0010467', 'gene expression', 20, 'expression'), ('UBERON_0001013', 'adipose tissue', 34, 'adipose tissue'), ('UBERON_0002107', 'liver', 53, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 72, 'rats'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 118, 'GR'), ('GO_0010467', 'gene expression', 138, 'expression'), ('UBERON_0002107', 'liver', 152, 'liver'), ('UBERON_0003693', 'retroperitoneal space', 159, 'retroperitoneal'), ('UBERON_0004360', 'cauda epididymis', 179, 'epididymal adipose tissue')]
PMC3208550	11/2011	S177-PMC3208550	['Mouse transgenic Overexpression of 11Β-Hsd1 in the Liver results in Insulin resistance, dyslipidemia, hypertension, and fatty Liver[11].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mouse'), ('GO_0007308', 'oocyte construction', 17, 'overexpression'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 35, '11β-HSD1'), ('UBERON_0002107', 'liver', 51, 'liver'), ('PR_000045358', 'insulin family protein', 68, 'insulin'), ('UBERON_0002107', 'liver', 126, 'liver')]
PMC3208550	11/2011	S181-PMC3208550	['circulating Gc is inactivated by a-ring reductases in the Liver.']	N/A	N/A	[('CL_0000740', 'retinal ganglion cell', 12, 'GC'), ('UBERON_0002107', 'liver', 58, 'liver')]
PMC3227644	11/2011	S55-PMC3227644	['different letters indicate significantly different (p<0.05) values between generations.10.1371/journal.pone.0028282.g003\n\ncaption (fig): figure 3\nmaternal Blood Metabolite concentrations and mrna Expression of Genes involved in Hepatic Gluconeogenesis and Ketogenesis.']	N/A	N/A	[('UBERON_0000178', 'blood', 155, 'blood'), ('CHEBI_39382', 'flufenoxuron', 161, 'metabolite'), ('GO_0010467', 'gene expression', 196, 'expression'), ('SO_0000704', 'gene', 210, 'genes'), ('UBERON_0002107', 'liver', 228, 'hepatic'), ('GO_0006094', 'gluconeogenesis', 236, 'gluconeogenesis'), ('GO_0001822', 'kidney development', 256, 'ketogenesis')]
PMC3227644	11/2011	S57-PMC3227644	['Hepatic Pparα, Carnitine Palmitoyltransferase-1 (Cpt-1), Glucocorticoid receptor (gr), Phosphoenolpyruvate carboxykinase (pepck), (g) Glucose-6-phosphatase (g-6-pase) mrna Expression.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 8, 'PPARα'), ('CHEBI_17126', 'carnitine', 15, 'carnitine'), ('PR_000005848', 'protein crumbs homolog 1', 15, 'carnitine palmitoyltransferase-1'), ('PR_000005855', 'cyclic AMP-responsive element-binding protein 3', 49, 'CPT-1'), ('CHEBI_24261', 'glucocorticoid', 57, 'glucocorticoid'), ('CHEBI_18021', 'phosphoenolpyruvate', 87, 'phosphoenolpyruvate'), ('CHEBI_17234', 'glucose', 134, 'glucose'), ('GO_0010467', 'gene expression', 172, 'expression')]
PMC3227644	11/2011	S73-PMC3227644	['Hepatic Pparα, Carnitine Palmitoyltransferase-1 (Cpt-1), Glucocorticoid receptor (gr), Phosphoenolpyruvate carboxykinase (pepck), (i) Glucose-6-phosphatase (g-6-pase) mrna Expression.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 8, 'PPARα'), ('CHEBI_17126', 'carnitine', 15, 'carnitine'), ('PR_000005848', 'protein crumbs homolog 1', 15, 'carnitine palmitoyltransferase-1'), ('PR_000005855', 'cyclic AMP-responsive element-binding protein 3', 49, 'CPT-1'), ('CHEBI_24261', 'glucocorticoid', 57, 'glucocorticoid'), ('CHEBI_18021', 'phosphoenolpyruvate', 87, 'phosphoenolpyruvate'), ('CHEBI_17234', 'glucose', 134, 'glucose'), ('GO_0010467', 'gene expression', 172, 'expression')]
PMC3227644	11/2011	S85-PMC3227644	['known transcription factor response Elements are indicated by curved brackets; (1), heat shock factor, (2) ppar, (3) catt Enhancer-binding protein, (4), Glucocorticoid receptor (5) Hepatic Nuclear Factor-1, (6), krueppel-like transcription factors, (7) Camp-response element[38].']	N/A	N/A	[('SO_0001434', 'cassette_pseudogene', 36, 'elements'), ('SO_0000165', 'enhancer', 122, 'enhancer'), ('CHEBI_24261', 'glucocorticoid', 153, 'glucocorticoid'), ('PR_000008477', 'hematopoietic cell signal transducer', 181, 'hepatic nuclear factor-1'), ('UBERON_0002107', 'liver', 181, 'hepatic'), ('GO_0005634', 'nucleus', 189, 'nuclear'), ('CHEBI_17489', "3',5'-cyclic AMP", 253, 'cAMP')]
PMC3227644	11/2011	S88-PMC3227644	['putative transcription factor response elements are indicated by curved brackets; (1) Nuclear factor of Activated T Cells, (2) Retinol X Receptor, (3) Neurone-Restrictive Silencer Factor, (4) Mouse krueppel factor.10.1371/journal.pone.0028282.g006\n\ncaption (fig): figure 6\nmethylation of individual cpgs in the Pepck Promoter in the Liver of the Adult offspring.']	N/A	N/A	[('GO_0005634', 'nucleus', 86, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 104, 'activated T cells'), ('CHEBI_26536', 'retinoic acid', 127, 'retinol'), ('PR_000001655', 'prostacyclin receptor', 127, 'retinol x receptor'), ('CL_0000540', 'neuron', 151, 'neurone'), ('PR_000011041', 'nuclear receptor coactivator 2', 151, 'neurone-restrictive silencer factor'), ('SO_0000625', 'silencer', 171, 'silencer'), ('NCBITaxon_10088', 'Mus <genus>', 192, 'mouse'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 311, 'PEPCK'), ('SO_0000167', 'promoter', 317, 'promoter'), ('UBERON_0002107', 'liver', 333, 'liver'), ('UBERON_0007023', 'adult organism', 346, 'adult')]
PMC3227644	11/2011	S92-PMC3227644	['the mrna Expression of Dnmt1, 3a and 3b was measured in the Liver of both Adult non-Pregnant and Pregnant offspring (figure 7).']	N/A	N/A	[('GO_0010467', 'gene expression', 9, 'expression'), ('PR_000006543', 'doublesex- and mab-3-related transcription factor 2', 23, 'Dnmt1'), ('UBERON_0002107', 'liver', 60, 'liver'), ('UBERON_0007023', 'adult organism', 74, 'adult'), ('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 97, 'pregnant')]
PMC3227644	11/2011	S102-PMC3227644	['Dnmt 1, Dnmt 3A2 and dnmt3b mrna Expression in the Liver of non-Pregnant Adult offspring on Postnatal day 70.']	N/A	N/A	[('PR_000006543', 'doublesex- and mab-3-related transcription factor 2', 0, 'Dnmt 1'), ('PR_000006603', 'dynamin-2', 8, 'Dnmt 3a2'), ('GO_0010467', 'gene expression', 33, 'expression'), ('UBERON_0002107', 'liver', 51, 'liver'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('UBERON_0007023', 'adult organism', 73, 'adult'), ('GO_0007567', 'parturition', 92, 'postnatal')]
PMC3227644	11/2011	S167-PMC3227644	['mrna Expression of Hepatic Genes was measured by real-time pcr.']	N/A	N/A	[('GO_0010467', 'gene expression', 5, 'expression'), ('UBERON_0002107', 'liver', 19, 'hepatic'), ('SO_0000704', 'gene', 27, 'genes')]
PMC3240629	12/2011	S52-PMC3240629	['Liver, Left and right Kidneys, Heart, Lungs and Brain were dissected, weighed, and snap frozen in liquid nitrogen prior to storage at −80°c.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0003907', 'left atrioventricular canal', 7, 'left ... kidneys'), ('UBERON_0000948', 'heart', 31, 'heart'), ('UBERON_0002048', 'lung', 38, 'lungs'), ('UBERON_0000955', 'brain', 48, 'brain')]
PMC3241136	9/2010	S5-PMC3241136	['chemical etiology of cancer\nmany chemical Compounds are known to cause cancer in Humans, smoking and Lung cancer (e.g., loeb et al.,1984; iarc,1986), and aflatoxin and Liver cancer (e.g., wogan,1992; wild and montesano,2009) as prime examples.']	N/A	N/A	[('CHEBI_36357', 'polyatomic entity', 42, 'compounds'), ('NCBITaxon_9606', 'Homo sapiens', 81, 'humans'), ('UBERON_0002048', 'lung', 101, 'lung'), ('UBERON_0002107', 'liver', 168, 'liver')]
PMC3241920	4/2011	S4-PMC3241920	['the levels of Fe, zn, and cu in the Livers and Kidneys were determined by the f-aas method.']	N/A	N/A	[('CHEBI_33290', 'food', 14, 'Fe'), ('UBERON_0002107', 'liver', 36, 'livers'), ('UBERON_0002113', 'kidney', 47, 'kidneys')]
PMC3241920	4/2011	S7-PMC3241920	['both Prenatal protein restriction and Folic Acid supplementation increased the Liver zn content ( p \u2009<\u20090.05) and the Kidney zn content ( p \u2009<\u20090.001; p \u2009<\u20090.05, respectively), while Folic Acid supplementation resulted in a reduction in Renal Cu level ( p \u2009<\u20090.05).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 5, 'prenatal'), ('CHEBI_30751', 'formic acid', 38, 'folic acid'), ('UBERON_0002107', 'liver', 79, 'liver'), ('UBERON_0002113', 'kidney', 117, 'kidney'), ('CHEBI_30751', 'formic acid', 181, 'folic acid'), ('UBERON_0002113', 'kidney', 235, 'renal'), ('CHEBI_17996', 'chloride', 241, 'Cu')]
PMC3241920	4/2011	S46-PMC3241920	['the Liver and Kidneys were dissected, accurately weighted, and kept frozen (−70°c) until analysis for Fe, zn, and Cu contents.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('UBERON_0002113', 'kidney', 14, 'kidneys'), ('CHEBI_33290', 'food', 102, 'Fe'), ('CHEBI_17996', 'chloride', 114, 'Cu')]
PMC3241920	4/2011	S57-PMC3241920	['within each row, values without a common letter differ at p \u2009<\u20090.05\n\ncaption (table-wrap): table\xa03\n\nHepatic and Renal Mineral contents in the offspringgroupfezncuhepatic Fe contentrenal Fe contenthepatic zn contentrenal zn contenthepatic Cu contentrenal Cu contentmeansemeansemeansemeansemeansemeansenp-nf ainfemale1,250.1191463.824108.43112.7515.0158.4ab6male522.643337.135123.31295.8515.4236.8a3np-nf hffemale2,266.679565.612133.75102.6718.7147.9ab11male505.536511.21588.84113.659.4140.6ab8pr-Nf Ainfemale1,278.4128527.044139.05115.01019.4190.7b4male426.13428.530116.03113.5211.6036.4a1pr-Nf hffemale1,655.8197444.99136.510108.3916.3342.4ab2male562.720486.745120.55114.7211.7031.0a2pr-fs ainfemale1,719.9180437.517157.111129.4220.4343.5ab8male300.414443.985134.58125.4112.5330.3a2pr-fs hffemale1,858.7178549.130130.56135.5615.3235.6a4male614.56350.74102.322123.4167.9131.5a13np-fs ainfemale1,192.955523.614124.66105.7323.1778.7ab16male532.915363.925144.2790.8114.3130.0a2np-fs hffemale1,442.995401.123138.312125.7914.9138.5ab9male660.920472.991104.28100.0311.0233.9a0\nvalues are given in micrograms per gram of dry mass.']	N/A	N/A	[('UBERON_0002107', 'liver', 100, 'Hepatic'), ('UBERON_0002113', 'kidney', 112, 'renal'), ('CHEBI_46662', 'mineral', 118, 'mineral'), ('CHEBI_33290', 'food', 170, 'Fe'), ('CHEBI_33290', 'food', 186, 'Fe'), ('CHEBI_17996', 'chloride', 238, 'Cu'), ('CHEBI_17996', 'chloride', 254, 'Cu'), ('GO_0005883', 'neurofilament', 495, 'NF'), ('PR_000003888', 'A-kinase anchor protein 14', 498, 'AINFemale1'), ('GO_0005883', 'neurofilament', 591, 'NF')]
PMC3241920	4/2011	S58-PMC3241920	['within a column, values without a common letter differ at p \u2009<\u20090.05\n\ncaption (table-wrap): table\xa04\n\neffects of experimental factors on mineral levels in offspring’s Liver and Kidneysmineral contentmain effectsinteraction effectspfafsp\u2009×\u2009fafa\u2009×\u2009sfa\u2009×\u2009ff\u2009×\u2009sp\u2009×\u2009f\u2009×\u2009sp\u2009×\u2009Fa\u2009×\u2009fp\u2009×\u2009Fa\u2009×\u2009sfa\u2009×\u2009f\u2009×\u2009sp\u2009×\u2009Fa\u2009×\u2009f×\u2009sfe Liver***************fe Kidneys****zn Liver***********zn Kidneys********cu Liver****cu Kidneys*************\np maternal dietary protein, Fa maternal dietary Folic Acid, f dietary fat, s offspring sex\n* p \u2009<\u20090.05; ** p \u2009<\u20090.01; *** p \u2009<\u20090.001; significant levels\n\nresults\nthe average Intakes of dietary Micronutrients (Fe, zn, and cu) were significantly different between the groups.']	N/A	N/A	[('UBERON_0002107', 'liver', 165, 'liver'), ('UBERON_0001224', 'renal pelvis', 175, 'kidneysMineral'), ('CHEBI_30751', 'formic acid', 269, 'FA'), ('CHEBI_30751', 'formic acid', 279, 'FA'), ('CHEBI_30751', 'formic acid', 299, 'FA'), ('UBERON_0002107', 'liver', 311, 'liver'), ('UBERON_0002113', 'kidney', 334, 'kidneys'), ('UBERON_0002107', 'liver', 348, 'liver'), ('UBERON_0002113', 'kidney', 367, 'kidneys'), ('UBERON_0002107', 'liver', 385, 'liver'), ('UBERON_0002113', 'kidney', 397, 'kidneys'), ('CHEBI_30751', 'formic acid', 446, 'FA'), ('CHEBI_30751', 'formic acid', 466, 'folic acid'), ('GO_0007631', 'feeding behavior', 592, 'intakes'), ('CHEBI_33839', 'macromolecule', 611, 'micronutrients'), ('CHEBI_33290', 'food', 627, 'Fe')]
PMC3241920	4/2011	S69-PMC3241920	['Postnatal high-fat Feeding resulted in the Adult Rats’ Hepatic zn content being decreased by 8% ( p \u2009<\u20090.01), but this was less marked in the female Rats (tables\xa03and4).']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Postnatal'), ('GO_0007631', 'feeding behavior', 19, 'feeding'), ('UBERON_0007023', 'adult organism', 43, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 49, 'rats'), ('UBERON_0002107', 'liver', 55, 'hepatic'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 149, 'rats')]
PMC3241920	4/2011	S71-PMC3241920	['maternal protein deficiency, as well as Folic Acid supplementation, increased the Hepatic zn content (by 7% and 9%, respectively) in the Adult offspring ( p \u2009<\u20090.05).']	N/A	N/A	[('CHEBI_30751', 'formic acid', 40, 'folic acid'), ('UBERON_0002107', 'liver', 82, 'hepatic'), ('UBERON_0007023', 'adult organism', 137, 'adult')]
PMC3241920	4/2011	S76-PMC3241920	['the highest level of zn was detected in the Liver of the pr-fs Rats (128.7\u2009±\u20093.1\xa0μg/g d.m.)']	N/A	N/A	[('UBERON_0002107', 'liver', 44, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 63, 'rats')]
PMC3241920	4/2011	S78-PMC3241920	['in the Rats Fed the high-fat diet, Hepatic Cu contents were decreased by 20% ( p \u2009<\u20090.05), independently of Prenatal nutrition, and Renal Cu levels declined by 25% ( p \u2009<\u20090.001).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 7, 'rats'), ('GO_0007631', 'feeding behavior', 12, 'fed'), ('UBERON_0002107', 'liver', 35, 'hepatic'), ('CHEBI_17996', 'chloride', 43, 'Cu'), ('GO_0007565', 'female pregnancy', 108, 'prenatal'), ('UBERON_0002113', 'kidney', 132, 'renal'), ('CHEBI_17996', 'chloride', 138, 'Cu')]
PMC3241920	4/2011	S96-PMC3241920	['independent of maternal dietary history, Consumption of the high-fat diet resulted in the increased Hepatic fe content.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 41, 'consumption'), ('UBERON_0002107', 'liver', 100, 'hepatic')]
PMC3241920	4/2011	S104-PMC3241920	['in the study of wapnir and devas [30], Rats Fed a 45% fat diet had increased Hepatic fe content.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 39, 'rats'), ('GO_0007631', 'feeding behavior', 44, 'fed'), ('UBERON_0002107', 'liver', 77, 'hepatic')]
PMC3241920	4/2011	S119-PMC3241920	['in this study, the offspring of mothers Fed the protein-deficient, Folic Acid-supplemented diet had increased Hepatic zn contents.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 40, 'fed'), ('CHEBI_30751', 'formic acid', 67, 'folic acid'), ('UBERON_0002107', 'liver', 110, 'hepatic')]
PMC3248362	11/2011	S37-PMC3248362	['adverse conditions were defined as convulsions (eclampsia), diastolic pressure > 110 mm hg, Platelet count < 100,000 × 109/l, oliguria, protein Excretion ≥ 3 g/day, Pulmonary edema, elevated Liver enzymes, severe nausea and vomiting, frontal headache, Visual disturbances, persistent Abdominal pain in right upper quadrant, Chest pain or shortness of Breath, suspected abruptio Placentae, hellp syndrome, Intrauterine growth restriction, oligohydramnios, or absent or reverse Umbilical Artery end diastolic flow, as detected by doppler velocitometry.']	N/A	N/A	[('CL_0000233', 'platelet', 92, 'platelet'), ('GO_0007588', 'excretion', 144, 'excretion'), ('UBERON_0002048', 'lung', 165, 'pulmonary'), ('UBERON_0002107', 'liver', 191, 'liver'), ('GO_0007601', 'visual perception', 252, 'visual'), ('UBERON_0000916', 'abdomen', 284, 'abdominal'), ('UBERON_0001443', 'chest', 324, 'chest'), ('UBERON_0000310', 'breast', 351, 'breath'), ('UBERON_0001987', 'placenta', 378, 'placentae'), ('UBERON_0022293', 'reproductive gland secretion', 405, 'intrauterine'), ('UBERON_0001310', 'umbilical artery', 476, 'umbilical artery')]
PMC3257641	3/2010	S14-PMC3257641	['both sunlight-derived (Vitamin D3) or Ingested (Vitamin D2Or Vitamin D3) Vitamin D are transported to the Liver where 25-hydroxylase enzymes catalyze conversion to the primary storage form (and the usual Serum measure of Vitamin D status), 25-Hydroxyvitamin D (25(Oh)D) [4].']	N/A	N/A	[('CHEBI_33279', 'vitamin D5', 23, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 23, 'vitamin D3'), ('GO_0007631', 'feeding behavior', 38, 'ingested'), ('CHEBI_27329', 'xanthosine phosphate', 48, 'vitamin D2or'), ('PR_000017209', 'utrophin', 48, 'vitamin D2or'), ('CHEBI_33279', 'vitamin D5', 61, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 61, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0002107', 'liver', 106, 'liver'), ('UBERON_0001977', 'blood serum', 204, 'serum'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 240, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 261, '25(OH)D')]
PMC3262346	12/2011	S19-PMC3262346	['Liver transaminases and Bilirubin were normal.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_16990', 'bilirubin IXalpha', 24, 'bilirubin'), ('UBERON_0004058', 'biliary ductule', 24, 'bilirubin')]
PMC3263630	1/2012	S21-PMC3263630	['contributing to the risk of t2dm, the oji-cree-speaking aboriginal People of northern manitoba possess a private polymorphism in the Hepatic Nuclear transcription factor Gene at Codon 319 (Hnf-1 Α g319s).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 67, 'people'), ('UBERON_0002107', 'liver', 133, 'hepatic'), ('GO_0005634', 'nucleus', 141, 'nuclear'), ('SO_0000704', 'gene', 170, 'gene'), ('SO_0000360', 'codon', 178, 'codon'), ('PR_000008650', 'jupiter microtubule associated homolog 1', 189, 'HNF-1 α')]
PMC3268605	8/2011	S8-PMC3268605	['no direct effects of Molsidomine were observed on Cellular Proliferation in Kidneys at any age, and the changes induced by Molsidomine in Renal polysome profiles at 2 weeks were absent in the Livers of the same Rats.']	N/A	N/A	[('CHEBI_30629', 'diethylenetriamine', 21, 'molsidomine'), ('GO_0008283', 'cell proliferation', 50, 'cellular proliferation'), ('UBERON_0002113', 'kidney', 76, 'kidneys'), ('CHEBI_30629', 'diethylenetriamine', 123, 'molsidomine'), ('UBERON_0002113', 'kidney', 138, 'renal'), ('UBERON_0002107', 'liver', 192, 'livers'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 211, 'rats')]
PMC3268605	8/2011	S73-PMC3268605	['Livers from 2-week-old pups were used to determine Tissue-specificity.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers'), ('UBERON_0000479', 'tissue', 51, 'tissue')]
PMC3268605	8/2011	S82-PMC3268605	['Tissue No content\nendogenous No levels in Kidney and Liver Tissues of fhh pups were assayed at 2 weeks by No trapping with Iron-Dithiocarbamate (Fe-Detc) Complexes, as previously described (koeners et al.,2007; van faassen et al.,2008).']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('CHEBI_16382', 'iodide', 7, 'NO'), ('CHEBI_16382', 'iodide', 29, 'NO'), ('UBERON_0002113', 'kidney', 42, 'kidney'), ('UBERON_0002107', 'liver', 53, 'liver'), ('UBERON_0000479', 'tissue', 59, 'tissues'), ('CHEBI_16382', 'iodide', 106, 'NO'), ('CHEBI_75832', 'iron(2+) sulfate (anhydrous)', 123, 'iron-dithiocarbamate'), ('CHEBI_33290', 'food', 145, 'Fe'), ('CHEBI_15946', 'keto-D-fructose 6-phosphate', 148, 'DETC'), ('GO_0032991', 'protein-containing complex', 154, 'complexes')]
PMC3268605	8/2011	S112-PMC3268605	['caption (table-wrap): table 2\n\nNitric Oxide yields (pmol mnic/mg Tissue) determined by epr in Kidneys and Liver in of 2-week-old control fhh and 2-week-old fhh offspring of dams treated with Molsidomine .malesfemalescontrolsmolsidominecontrolsmolsidomine 2 weeks number/litters4/27/44/28/4No yield in Kidney (left and right)0.49\u2009±\u20090.030.53\u2009±\u20090.010.50\u2009±\u20090.040.49\u2009±\u20090.02no yield in Liver1.30\u2009±\u20090.081.39\u2009±\u20090.041.35\u2009±\u20090.081.32\u2009±\u20090.04\nmnic, mononitrosyl-Iron Complexes .']	N/A	N/A	[('CHEBI_16480', 'nitric oxide', 31, 'Nitric oxide'), ('UBERON_0000479', 'tissue', 65, 'tissue'), ('UBERON_0002113', 'kidney', 94, 'kidneys'), ('UBERON_0002107', 'liver', 106, 'liver'), ('CHEBI_30629', 'diethylenetriamine', 191, 'molsidomine'), ('CHEBI_37042', "purine 2'-deoxyribonucleoside 5'-triphosphate", 288, '4NO'), ('UBERON_0002113', 'kidney', 301, 'kidney'), ('UBERON_0002107', 'liver', 380, 'liver1'), ('GO_0030054', 'cell junction', 449, 'iron'), ('GO_0032991', 'protein-containing complex', 454, 'complexes')]
PMC3268605	8/2011	S150-PMC3268605	['caption (fig): figure 5\n\npolysome profiles of Livers .']	N/A	N/A	[('UBERON_0002107', 'liver', 46, 'livers')]
PMC3268605	8/2011	S151-PMC3268605	['Livers from 2-week-old fhh males were profiled to measure the total number of assembled Ribosome structures.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers'), ('GO_0005840', 'ribosome', 88, 'ribosome')]
PMC3270452	1/2012	S135-PMC3270452	['242 of the 251 infants were Breastfed at least until 3 months of age, and a subset ( n = 130) were started on supplement of cod Liver oil (5\u2009ml daily from 4 wks of age).']	N/A	N/A	[('GO_0007567', 'parturition', 28, 'breastfed'), ('UBERON_0002107', 'liver', 128, 'liver')]
PMC3273459	2/2012	S239-PMC3273459	['in fetuses of Rat dams Fed a low protein diet, Plasma and Liver Igf-I were lower than in controls[56].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 14, 'rat'), ('GO_0007631', 'feeding behavior', 23, 'fed'), ('UBERON_0001969', 'blood plasma', 47, 'plasma'), ('UBERON_0002107', 'liver', 58, 'liver'), ('PR_000008919', 'interferon alpha-6', 64, 'IGF-I')]
PMC3316748	10/2011	S5-PMC3316748	['the Expression patterns of Pparα, Pparγ, and Lxrα in the Liver and Adipose Tissue were examined by real-time pcr.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 27, 'PPARα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 34, 'PPARγ'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 45, 'LXRα'), ('UBERON_0002107', 'liver', 57, 'liver'), ('UBERON_0001013', 'adipose tissue', 67, 'adipose tissue')]
PMC3316748	10/2011	S16-PMC3316748	['furthermore, the Expression of Lxrα , Pparα , and Pparγ in the Liver and Adipose Tissue largely depends on the protein and Folic Acid content in the maternal diet during Gestation.']	N/A	N/A	[('GO_0010467', 'gene expression', 17, 'expression'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 31, 'LXRα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 38, 'PPARα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 50, 'PPARγ'), ('UBERON_0002107', 'liver', 63, 'liver'), ('UBERON_0001013', 'adipose tissue', 73, 'adipose tissue'), ('CHEBI_30751', 'formic acid', 123, 'folic acid'), ('GO_0007565', 'female pregnancy', 170, 'gestation')]
PMC3316748	10/2011	S30-PMC3316748	['lxrs operate as Cholesterol sensors, protecting against Cholesterol overload through decreasing the levels of Intestinal Absorption Of Cholesterol, and by stimulating Cholesterol efflux to hdl, its transport to the Liver, its conversion to Bile Acids, and Biliary Excretion (wójcicka et al.2007).']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 16, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 56, 'cholesterol'), ('UBERON_0000160', 'intestine', 110, 'intestinal'), ('GO_0090459', 'aspartate homeostasis', 121, 'absorption of cholesterol'), ('CHEBI_16113', 'cholesterol', 135, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 167, 'cholesterol'), ('UBERON_0002107', 'liver', 215, 'liver'), ('CHEBI_3098', 'bile acid', 240, 'bile acids'), ('UBERON_0001970', 'bile', 240, 'bile'), ('GO_0007567', 'parturition', 256, 'biliary'), ('UBERON_0002294', 'biliary system', 256, 'biliary'), ('GO_0007588', 'excretion', 264, 'excretion')]
PMC3316748	10/2011	S68-PMC3316748	['Liver samples were taken and the total amount of visible fat in the Abdominal Cavity was removed and accurately weighed.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0003684', 'abdominal cavity', 68, 'abdominal cavity')]
PMC3316748	10/2011	S72-PMC3316748	['rna extraction\ntotal rna was extracted from the Liver and Visceral Fat Tissues using tripure isolation Reagent (roche) according to the manufacturer’s protocol.']	N/A	N/A	[('UBERON_0002107', 'liver', 48, 'liver'), ('UBERON_0003714', 'neural tissue', 58, 'visceral fat tissues'), ('CHEBI_33893', 'reagent', 103, 'Reagent')]
PMC3316748	10/2011	S142-PMC3316748	['Gene Expression—Liver\nthe Expression of Lxrα , Pparα , and Pparγ was analyzed in the Liver of the 10-week-old Rats.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Gene expression'), ('SO_0000704', 'gene', 0, 'Gene'), ('UBERON_0002107', 'liver', 16, 'liver'), ('GO_0010467', 'gene expression', 26, 'expression'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 40, 'LXRα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 47, 'PPARα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 59, 'PPARγ'), ('UBERON_0002107', 'liver', 85, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 110, 'rats')]
PMC3316748	10/2011	S149-PMC3316748	['4\n\nquantification of mrna levels of Lxrα ( a ), Pparγ ( b ), and Pparα ( c ) in the Livers of Rats belonging to different maternal dietary groups.']	N/A	N/A	[('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 36, 'LXRα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 48, 'PPARγ'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 65, 'PPARα'), ('UBERON_0002107', 'liver', 84, 'livers'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 94, 'rats')]
PMC3316748	10/2011	S201-PMC3316748	['the Expression of Pparγ in the Liver is found at a very low level, and its activation leads to Lipid accumulation and stimulation of several Adipogenic target Genes in Hepatocytes (schadinger et al.2005).']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 18, 'PPARγ'), ('UBERON_0002107', 'liver', 31, 'liver'), ('CHEBI_18059', 'lipid', 95, 'lipid'), ('GO_0060612', 'adipose tissue development', 141, 'adipogenic'), ('SO_0000704', 'gene', 159, 'genes'), ('CL_0000182', 'hepatocyte', 168, 'hepatocytes')]
PMC3316748	10/2011	S205-PMC3316748	['Mice without Hepatic Pparγ develop relative fat intolerance, increased adiposity, hyperlipidemia, and Insulin resistance (gavrilova et al.2003).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('UBERON_0002107', 'liver', 13, 'hepatic'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 21, 'PPARγ'), ('PR_000045358', 'insulin family protein', 102, 'insulin')]
PMC3316748	10/2011	S206-PMC3316748	['decreased Expression of Pparγ in the Liver and Adipose Tissue leads to reduced body weight, reduced total fat mass, and dyslipidemia (tsai et al.2009).']	N/A	N/A	[('GO_0010467', 'gene expression', 10, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 24, 'PPARγ'), ('UBERON_0002107', 'liver', 37, 'liver'), ('UBERON_0001013', 'adipose tissue', 47, 'adipose tissue')]
PMC3316748	10/2011	S224-PMC3316748	['a twofold decrease in the Hepatic Expression of Lxrα in the progeny of Folic Acid supplemented dams was observed ( p \xa0<\xa00.001).']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'hepatic'), ('GO_0010467', 'gene expression', 34, 'expression'), ('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 48, 'LXRα'), ('CHEBI_30751', 'formic acid', 71, 'folic acid')]
PMC3316748	10/2011	S253-PMC3316748	['the Lxrα Promoter was hypermethylated in the fetal Liver upon maternal protein restriction (van straten et al.2010).']	N/A	N/A	[('PR_000009929', 'alpha-2-macroglobulin receptor-associated protein', 4, 'LXRα'), ('SO_0000167', 'promoter', 9, 'promoter'), ('UBERON_0002107', 'liver', 51, 'liver')]
PMC3322122	4/2012	S137-PMC3322122	['also the temporal sequences of shifts differ between the central Metabolic Organ, the Liver, and the Peripheral Tissue of muscle.']	N/A	N/A	[('GO_0008152', 'metabolic process', 65, 'metabolic'), ('UBERON_0000062', 'organ', 75, 'organ'), ('UBERON_0002107', 'liver', 86, 'liver'), ('UBERON_0012101', 'perinatal stage', 101, 'peripheral'), ('UBERON_0000479', 'tissue', 112, 'tissue')]
PMC3325178	4/2012	S53-PMC3325178	['of the Imprinted Genes on the array, the majority were found to be Expressed in f1 e16.5 Placenta and Liver (78% and 54% respectively).10.1371/journal.pgen.1002605.g001\n\ncaption (fig): figure 1\ncharacterisation of the e16.5 Hepatic and Placental transcriptome response to undernourishment.']	N/A	N/A	[('GO_0071514', 'genetic imprinting', 7, 'imprinted'), ('SO_0000704', 'gene', 17, 'genes'), ('GO_0010467', 'gene expression', 67, 'expressed'), ('UBERON_0001987', 'placenta', 89, 'placenta'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0002107', 'liver', 224, 'hepatic'), ('UBERON_0001987', 'placenta', 236, 'placental')]
PMC3325178	4/2012	S60-PMC3325178	['(b, c) Gene ontology (go) analysis of the f1 undernourished Hepatic transcriptome at e16.5: functional enrichment analysis using (b) david[27]–[28]and (c) ingenuity pathway analysis functional analysis tools.']	N/A	N/A	[('SO_0000704', 'gene', 7, 'Gene'), ('UBERON_0002107', 'liver', 60, 'hepatic')]
PMC3325178	4/2012	S61-PMC3325178	['among Genes upregulated in the Liver, both tools identify significant enrichment (after benjamini-hochberg correction for multiple testing) of Gene groups associated with Metabolism, particularly of Lipids.']	N/A	N/A	[('SO_0000704', 'gene', 6, 'genes'), ('UBERON_0002107', 'liver', 31, 'liver'), ('SO_0000704', 'gene', 143, 'gene'), ('GO_0008152', 'metabolic process', 171, 'metabolism'), ('CHEBI_18059', 'lipid', 199, 'lipids')]
PMC3325178	4/2012	S62-PMC3325178	['among Genes downregulated in the Liver, both tools identify significant enrichment of categories related to Cell-Cycle and the Control Of Proliferation.']	N/A	N/A	[('SO_0000704', 'gene', 6, 'genes'), ('UBERON_0002107', 'liver', 33, 'liver'), ('GO_0007049', 'cell cycle', 108, 'cell-cycle'), ('GO_1990863', 'acinar cell proliferation', 127, 'control of proliferation')]
PMC3325178	4/2012	S63-PMC3325178	['(d) transcriptome analysis of e16.5 undernourished versus control Liver.']	N/A	N/A	[('UBERON_0002107', 'liver', 66, 'liver')]
PMC3325178	4/2012	S65-PMC3325178	['lists of housekeeping Genes and Adult Hepatic fasting-response Genes curated from the literature were used as negative and positive controls respectively and their rankings shown.']	N/A	N/A	[('SO_0000704', 'gene', 22, 'genes'), ('UBERON_0007023', 'adult organism', 32, 'adult'), ('UBERON_0002107', 'liver', 38, 'hepatic'), ('SO_0000704', 'gene', 63, 'genes')]
PMC3325178	4/2012	S68-PMC3325178	['the Placental Response to maternal Undernourishment is undetermined, and is different to that of the Liver, as fasting response Genes are largely unperturbed.']	N/A	N/A	[('GO_0006955', 'immune response', 4, 'placental response'), ('UBERON_0001987', 'placenta', 4, 'placental'), ('GO_0048658', 'anther wall tapetum development', 35, 'undernourishment'), ('UBERON_0002107', 'liver', 101, 'liver'), ('SO_0000704', 'gene', 128, 'genes')]
PMC3325178	4/2012	S85-PMC3325178	['as a positive control of a group of Genes expected to have altered Expression in f1 undernourished foetal Liver, a Gene set was curated from the literature documenting the Adult Hepatic transcriptional response to starvation[29]–[32].']	N/A	N/A	[('SO_0000704', 'gene', 36, 'genes'), ('GO_0010467', 'gene expression', 67, 'expression'), ('UBERON_0002107', 'liver', 106, 'liver'), ('SO_0000704', 'gene', 115, 'gene'), ('UBERON_0007023', 'adult organism', 172, 'adult'), ('UBERON_0002107', 'liver', 178, 'hepatic')]
PMC3325178	4/2012	S96-PMC3325178	['Grb10 is Expressed from the maternally-inherited Allele in the Liver, but from the paternally-inherited Allele in the Brain, and these two Transcript classes utilise Alternative Transcriptional Start Sites[33].']	N/A	N/A	[('PR_000008210', 'glutathione peroxidase 1', 0, 'Grb10'), ('GO_0010467', 'gene expression', 9, 'expressed'), ('SO_0001023', 'allele', 49, 'allele'), ('UBERON_0002107', 'liver', 63, 'liver'), ('SO_0001023', 'allele', 104, 'allele'), ('UBERON_0000955', 'brain', 118, 'brain'), ('SO_0000673', 'transcript', 139, 'transcript'), ('SO_0001508', 'alteration_attribute', 166, 'alternative'), ('SO_0000315', 'TSS', 178, 'transcriptional start sites')]
PMC3325178	4/2012	S105-PMC3325178	['(d) Liver: per condition n\u200a=\u200a36, 5 litters h19 p\u200a=\u200a0.02, igf2r p\u200a=\u200a0.008, Zac1 p\u200a=\u200a0.02, Grb10 p\u200a=\u200a0.0002, Peg3 p\u200a=\u200a0.005.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'Liver'), ('PR_000017638', 'zinc finger protein 30 homolog', 74, 'Zac1'), ('PR_000008210', 'glutathione peroxidase 1', 89, 'Grb10'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 107, 'Peg3')]
PMC3325178	4/2012	S106-PMC3325178	['(e) the increased Hepatic Expression of Grb10 in f1 e16.5 Liver is of the appropriate maternal-type Isoforms ( mgrb10α and mgrb10δ ).']	N/A	N/A	[('UBERON_0002107', 'liver', 18, 'hepatic'), ('GO_0010467', 'gene expression', 26, 'expression'), ('PR_000008210', 'glutathione peroxidase 1', 40, 'Grb10'), ('UBERON_0002107', 'liver', 58, 'liver'), ('SO_0001060', 'sequence_variant', 100, 'isoforms')]
PMC3325178	4/2012	S108-PMC3325178	['(f) in the few Individuals where some Expression of paternal-type Isoforms ( mgrb10β1 and mgrb10β2 ) is detectable in e16.5 Liver, this Expression is dwarfed by that of maternal-type Isoforms.']	N/A	N/A	[('NCBITaxon_1', 'root', 15, 'individuals'), ('GO_0010467', 'gene expression', 38, 'expression'), ('SO_0001060', 'sequence_variant', 66, 'isoforms'), ('UBERON_0002107', 'liver', 124, 'liver'), ('GO_0010467', 'gene expression', 136, 'expression'), ('SO_0001060', 'sequence_variant', 183, 'isoforms')]
PMC3325178	4/2012	S114-PMC3325178	['in utero Undernutrition does not affect the methylation status of the Peg3 Promoter dmr in (h) f1 e16.5 Brain (i) f1 e16.5 Liver.']	N/A	N/A	[('GO_0019653', 'anaerobic purine nucleobase catabolic process', 9, 'undernutrition'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 70, 'Peg3'), ('SO_0000167', 'promoter', 75, 'promoter'), ('UBERON_0000955', 'brain', 104, 'brain'), ('UBERON_0002107', 'liver', 123, 'liver')]
PMC3325178	4/2012	S128-PMC3325178	['increased Peg3 Expression was observed in Liver and Placenta, but not Brain or muscle.']	N/A	N/A	[('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 10, 'Peg3'), ('GO_0010467', 'gene expression', 15, 'expression'), ('UBERON_0002107', 'liver', 42, 'liver'), ('UBERON_0001987', 'placenta', 52, 'placenta'), ('UBERON_0000955', 'brain', 70, 'brain')]
PMC3325178	4/2012	S130-PMC3325178	['Peg3 dmr methylation was at the expected level of ∼50% in control Individuals (figure 2h, 2i) and was unchanged in both Brain and Liver in un Individuals.']	N/A	N/A	[('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 0, 'Peg3'), ('NCBITaxon_1', 'root', 66, 'individuals'), ('UBERON_0000955', 'brain', 120, 'brain'), ('UBERON_0002107', 'liver', 130, 'liver'), ('NCBITaxon_1', 'root', 142, 'individuals')]
PMC3325178	4/2012	S146-PMC3325178	['(b) distribution of the ranked difference in Gene Expression in cu e16.5 Liver according to fdr q-value.']	N/A	N/A	[('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('UBERON_0002107', 'liver', 73, 'liver')]
PMC3325178	4/2012	S147-PMC3325178	['a list of Genes comprising a network involved in Lipid Metabolism, identified as enriched in cu Liver using ipa software was used as a positive control.']	N/A	N/A	[('SO_0000704', 'gene', 10, 'genes'), ('CHEBI_18059', 'lipid', 49, 'lipid'), ('GO_0006629', 'lipid metabolic process', 49, 'lipid metabolism'), ('UBERON_0002107', 'liver', 96, 'liver')]
PMC3325178	4/2012	S152-PMC3325178	['in e16.5 f2 Liver, 1330 Genes demonstrated significantly different Expression levels between cc and cu Animals (fdr q<0.05 following bh correction for multiple testing).']	N/A	N/A	[('UBERON_0002107', 'liver', 12, 'liver'), ('SO_0000704', 'gene', 24, 'genes'), ('GO_0010467', 'gene expression', 67, 'expression'), ('NCBITaxon_33208', 'Metazoa', 103, 'animals')]
PMC3325178	4/2012	S157-PMC3325178	['the Placenta has a greater variety of cell types than the Liver and is morphologically plastic in response to foetal and maternal cues[47].']	N/A	N/A	[('UBERON_0001987', 'placenta', 4, 'placenta'), ('UBERON_0002107', 'liver', 58, 'liver')]
PMC3325178	4/2012	S160-PMC3325178	['of the Imprinted Genes on the array, the majority were found to be Expressed in f2 e16.5 Placenta and Liver (94% and 86% respectively).']	N/A	N/A	[('GO_0071514', 'genetic imprinting', 7, 'imprinted'), ('SO_0000704', 'gene', 17, 'genes'), ('GO_0010467', 'gene expression', 67, 'expressed'), ('UBERON_0001987', 'placenta', 89, 'placenta'), ('UBERON_0002107', 'liver', 102, 'liver')]
PMC3325178	4/2012	S166-PMC3325178	['the distribution of Imprinted Genes in both the f2 e16.5 Hepatic and Placental transcriptomes most closely resembles that of the randomly selected Gene group (figure 3b, 3c).']	N/A	N/A	[('GO_0071514', 'genetic imprinting', 20, 'imprinted'), ('SO_0000704', 'gene', 30, 'genes'), ('UBERON_0002107', 'liver', 57, 'hepatic'), ('UBERON_0001987', 'placenta', 69, 'placental'), ('SO_0000704', 'gene', 147, 'gene')]
PMC3325178	4/2012	S175-PMC3325178	['(b) there are no significant differences in the f2 Hepatic Expression of Imprinted Genes at e16.5.']	N/A	N/A	[('UBERON_0002107', 'liver', 51, 'hepatic'), ('GO_0010467', 'gene expression', 59, 'expression'), ('GO_0071514', 'genetic imprinting', 73, 'imprinted'), ('SO_0000704', 'gene', 83, 'genes')]
PMC3325178	4/2012	S183-PMC3325178	['Sperm from both control and in utero undernourished males showed the expected hypermethylation in comparison to somatic Tissues (Liver).']	N/A	N/A	[('CL_0000019', 'sperm', 0, 'Sperm'), ('UBERON_0000479', 'tissue', 120, 'tissues'), ('UBERON_0002107', 'liver', 129, 'liver')]
PMC3325178	4/2012	S208-PMC3325178	['of the four Tissues analysed in the f1 generation, the Liver showed the greatest perturbation of Imprinted Gene Expression, with upregulation of h19 , igf2r , Zac1 , Grb10 and Peg3 Expression.']	N/A	N/A	[('UBERON_0000479', 'tissue', 12, 'tissues'), ('UBERON_0002107', 'liver', 55, 'liver'), ('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 97, 'imprinted gene expression'), ('SO_0000704', 'gene', 107, 'gene'), ('PR_000017638', 'zinc finger protein 30 homolog', 159, 'Zac1'), ('PR_000008210', 'glutathione peroxidase 1', 166, 'Grb10'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 176, 'Peg3'), ('GO_0010467', 'gene expression', 181, 'expression')]
PMC3325178	4/2012	S217-PMC3325178	['f1 Hepatic Expression of Grb10 , H19 and Peg3 is significantly increased in both sexes following undernourishment.']	N/A	N/A	[('UBERON_0002107', 'liver', 3, 'hepatic'), ('GO_0010467', 'gene expression', 11, 'expression'), ('PR_000008210', 'glutathione peroxidase 1', 25, 'Grb10'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 33, 'H19'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 41, 'Peg3')]
PMC3325178	4/2012	S223-PMC3325178	['we detect an increase in Peg3 Expression in f1 undernourished Liver and Placenta and protein levels were found to be increased in the Brain of f1 undernourished Animals.']	N/A	N/A	[('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 25, 'Peg3'), ('GO_0010467', 'gene expression', 30, 'expression'), ('UBERON_0002107', 'liver', 62, 'liver'), ('UBERON_0001987', 'placenta', 72, 'placenta'), ('UBERON_0000955', 'brain', 134, 'brain'), ('NCBITaxon_33208', 'Metazoa', 161, 'animals')]
PMC3325178	4/2012	S275-PMC3325178	['microarrays\nLiver Gene Expression was analysed in f1 e16.5 Mice using illumina Mouse wg6v2 microarrays.']	N/A	N/A	[('UBERON_0002107', 'liver', 12, 'Liver'), ('GO_0010467', 'gene expression', 18, 'gene expression'), ('SO_0000704', 'gene', 18, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 59, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 79, 'Mouse')]
PMC3325178	4/2012	S278-PMC3325178	['for f2 Liver and Placental arrays, crna from fifteen control Conceptuses from three independent litters, and eighteen Cu Conceptuses from three independent litters, was hybridised to affymetrix moe430-2 arrays in five and six pools per condition, respectively.']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('UBERON_0001987', 'placenta', 17, 'placental'), ('UBERON_0004716', 'conceptus', 61, 'conceptuses'), ('UBERON_2005020', 'central artery', 118, 'CU'), ('UBERON_0004716', 'conceptus', 121, 'conceptuses')]
PMC3325178	4/2012	S297-PMC3325178	['f1 generation: as a positive control of a group of Genes expected to have altered Expression in undernourished foetal Liver, a Gene set was curated from the literature documenting the Adult Hepatic transcriptional response to starvation[29]–[32].']	N/A	N/A	[('SO_0000704', 'gene', 51, 'genes'), ('GO_0010467', 'gene expression', 82, 'expression'), ('UBERON_0002107', 'liver', 118, 'liver'), ('SO_0000704', 'gene', 127, 'gene'), ('UBERON_0007023', 'adult organism', 184, 'adult'), ('UBERON_0002107', 'liver', 190, 'hepatic')]
PMC3325178	4/2012	S325-PMC3325178	['f1 e16.5 Liver has an auc of 0.520232 which is higher than 70 out of 100 randomly labeled sets; f1 e16.5 Placenta has an auc of 0.53781 which is higher than 91 out of 100 randomly labeled sets.']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'Liver'), ('UBERON_0001987', 'placenta', 105, 'Placenta')]
PMC3325178	4/2012	S326-PMC3325178	['f2 cu Placenta has an auc of 0.534822 which is higher than 88 out of 100 randomly labeled sets; f2 cu Liver has an auc of 0.567148 which is higher than 99 out of 100 randomly labeled sets.']	N/A	N/A	[('UBERON_0001987', 'placenta', 6, 'Placenta'), ('UBERON_0002107', 'liver', 102, 'Liver')]
PMC3335729	3/2012	S153-PMC3335729	['one of the pgsc stocks has a natural deletion of the Alcohol dehydrogenase (adh) Gene [121], which has proven useful for delimiting the relative roles of adh and microsomal oxidases in Ethanol Metabolism [122] and the Metabolic basis of Ethanol-induced Hepatic and Pancreatic injury [123].']	N/A	N/A	[('CHEBI_30879', 'alcohol', 53, 'alcohol'), ('SO_0000704', 'gene', 81, 'gene'), ('CHEBI_16236', 'ethanol', 185, 'ethanol'), ('GO_0006067', 'ethanol metabolic process', 185, 'ethanol metabolism'), ('GO_0008152', 'metabolic process', 218, 'metabolic'), ('CHEBI_16236', 'ethanol', 237, 'ethanol'), ('UBERON_0002107', 'liver', 253, 'hepatic'), ('UBERON_0001264', 'pancreas', 265, 'pancreatic')]
PMC3342123	3/2012	S7-PMC3342123	['results\nanalyses of the Hepatic Gene Expression of the offspring at Prenatal (94 dies post Conceptionem , dpc) and Postnatal stages (1, 28, 188 dies post Natum , dpn) included comparisons between dietary groups within stages as well as comparisons between ontogenetic stages within diets to separate diet-specific transcriptional changes and maturation processes.']	N/A	N/A	[('UBERON_0002107', 'liver', 24, 'hepatic'), ('GO_0010467', 'gene expression', 32, 'gene expression'), ('SO_0000704', 'gene', 32, 'gene'), ('GO_0007565', 'female pregnancy', 68, 'prenatal'), ('GO_0006936', 'muscle contraction', 91, 'conceptionem'), ('GO_0007567', 'parturition', 115, 'postnatal'), ('GO_0007567', 'parturition', 154, 'natum')]
PMC3342123	3/2012	S34-PMC3342123	["we investigated the offspring's Hepatic Gene Expression at 94 dpc, 1 dpn, 28 dpn and 188 dpn by 24 k-microarray analysis."]	N/A	N/A	[('UBERON_0002107', 'liver', 32, 'hepatic'), ('GO_0010467', 'gene expression', 40, 'gene expression'), ('SO_0000704', 'gene', 40, 'gene')]
PMC3342123	3/2012	S58-PMC3342123	['caption (fig): figure 1\n\nnumber of Regulated probe-sets in Liver Tissue .']	N/A	N/A	[('GO_0065007', 'biological regulation', 35, 'regulated'), ('UBERON_0002107', 'liver', 59, 'liver'), ('UBERON_0000479', 'tissue', 65, 'tissue')]
PMC3342123	3/2012	S62-PMC3342123	['caption (table-wrap): table 2\n\nsignificantly Regulated Transcripts of Metabolic pathways in Liver Tissue within different ontogenetic stages (ingenuity pathway analysis).Ontogenetic stageregulated pathwaydirection of Regulation p valueno.']	N/A	N/A	[('GO_0065007', 'biological regulation', 45, 'regulated'), ('SO_0000673', 'transcript', 55, 'transcripts'), ('GO_0008152', 'metabolic process', 70, 'metabolic'), ('UBERON_0002107', 'liver', 92, 'liver'), ('UBERON_0000479', 'tissue', 98, 'tissue'), ('GO_0001503', 'ossification', 170, 'Ontogenetic'), ('GO_0065007', 'biological regulation', 217, 'regulation')]
PMC3342123	3/2012	S83-PMC3342123	['caption (table-wrap): table 3\n\nsignificantly Regulated Transcripts of Metabolic pathways in Liver Tissue between two ontogenetic stages within one dietary group (ingenuity pathway analysis)ontogenetic comparisondietregulated pathwaydirection of Regulation p valueno.']	N/A	N/A	[('GO_0065007', 'biological regulation', 45, 'regulated'), ('SO_0000673', 'transcript', 55, 'transcripts'), ('GO_0008152', 'metabolic process', 70, 'metabolic'), ('UBERON_0002107', 'liver', 92, 'liver'), ('UBERON_0000479', 'tissue', 98, 'tissue'), ('GO_0065007', 'biological regulation', 245, 'regulation')]
PMC3342123	3/2012	S101-PMC3342123	['caption (fig): figure 2\n\nRegulated pathways in Liver Tissue between Ontogenetic stages and diets .']	N/A	N/A	[('GO_0065007', 'biological regulation', 25, 'Regulated'), ('UBERON_0002107', 'liver', 47, 'liver'), ('UBERON_0000479', 'tissue', 53, 'tissue'), ('GO_0042476', 'odontogenesis', 68, 'ontogenetic')]
PMC3342123	3/2012	S111-PMC3342123	['following in utero exposure to a Gestational low protein diet at 1 dpn we could not find significant Regulatory changes of Genes of any molecular route in Porcine Perinatal Liver.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 33, 'gestational'), ('GO_0065007', 'biological regulation', 101, 'regulatory'), ('SO_0000704', 'gene', 123, 'genes'), ('NCBITaxon_10088', 'Mus <genus>', 155, 'porcine'), ('GO_0036268', 'swimming', 163, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 163, 'perinatal'), ('UBERON_0002107', 'liver', 173, 'liver')]
PMC3342123	3/2012	S120-PMC3342123	['due to the lp diet a number of molecular routes related to Cell Cycle and Cellular Turnover, response to stimuli, as well as energy-, Lipid- and amino Acid metabolic pathways are shifted on the transcriptional level in the Liver at Prenatal stages under the direct influence of limited protein and/or Amino acid supply, but also Postnatal.']	N/A	N/A	[('GO_0007049', 'cell cycle', 59, 'cell cycle'), ('GO_0042048', 'olfactory behavior', 74, 'cellular turnover'), ('CHEBI_18059', 'lipid', 134, 'lipid'), ('CHEBI_37527', 'acid', 151, 'acid'), ('UBERON_0002107', 'liver', 223, 'liver'), ('GO_0007565', 'female pregnancy', 232, 'prenatal'), ('CHEBI_48310', 'apiitol', 301, 'amino'), ('GO_0007567', 'parturition', 329, 'postnatal')]
PMC3342123	3/2012	S156-PMC3342123	['obviously, Hepatic ontogenetic growth is not finished at Adult stage in lp offspring in contrast to ap offspring.']	N/A	N/A	[('UBERON_0002107', 'liver', 11, 'hepatic'), ('UBERON_0007023', 'adult organism', 57, 'adult')]
PMC3342123	3/2012	S200-PMC3342123	['injection of t61 in the V. Cava cranialis and Liver samples were immediately collected (approximately 500 mg), frozen in liquid nitrogen, and stored at -80°c until analysis.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 24, 'V. cava'), ('UBERON_0003124', 'chorion', 27, 'cava'), ('UBERON_0002107', 'liver', 46, 'liver')]
PMC3342123	3/2012	S223-PMC3342123	['Liver Tissue was immediately collected from Lobus sinister Hepaticus, frozen in liquid nitrogen, and stored at - 80°c until use for rna isolation.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000479', 'tissue', 6, 'tissue'), ('UBERON_0009911', 'lobule', 44, 'lobus'), ('UBERON_0002107', 'liver', 59, 'hepaticus')]
PMC3342123	3/2012	S224-PMC3342123	["rna isolation, target preparation and hybridisation\naccording to the manufacturer's protocol total rna from individual Liver samples was isolated using Tri-Reagent (sigma-aldrich, taufkirchen, germany)."]	N/A	N/A	[('UBERON_0002107', 'liver', 119, 'liver'), ('14', 'AAMP (human)', 152, 'Tri'), ('CHEBI_33893', 'reagent', 156, 'Reagent')]
PMC3342123	3/2012	S246-PMC3342123	["pathway analysis\nGene lists from microarray results were submitted to the manually curated database 'ingenuity pathways analysis' to elucidate putative pathways associated with an altered Gene Expression in Porcine Liver."]	N/A	N/A	[('SO_0000704', 'gene', 17, 'Gene'), ('GO_0010467', 'gene expression', 188, 'gene expression'), ('SO_0000704', 'gene', 188, 'gene'), ('NCBITaxon_10088', 'Mus <genus>', 207, 'porcine'), ('UBERON_0002107', 'liver', 215, 'liver')]
PMC3342123	3/2012	S250-PMC3342123	['in order to survey Expression of the Liver Tissue samples, total Transcript levels of selected target and reference Genes (table5) were quantified by real-time quantitative pcr (qpcr) performed on a lightcycler®480 system using the lightcycler 480 Sybr Green i master(roche, mannheim, germany).']	N/A	N/A	[('GO_0010467', 'gene expression', 19, 'expression'), ('UBERON_0002107', 'liver', 37, 'liver'), ('UBERON_0000479', 'tissue', 43, 'tissue'), ('SO_0000673', 'transcript', 65, 'transcript'), ('SO_0000704', 'gene', 116, 'genes'), ('CHEBI_51461', 'SYBR Green I', 248, 'SYBR Green')]
PMC3342123	3/2012	S256-PMC3342123	['in total, 28 individual Liver mrna samples were analyzed in duplicate per stage.']	N/A	N/A	[('UBERON_0002107', 'liver', 24, 'liver')]
PMC3342123	3/2012	S259-PMC3342123	["caption (table-Wrap): table 5\n\nPrimer used to verify microarray experiments in Liver Tissue by qrt-pcrgene nameprobe-set idsequence 5' - 3't(°c)size (Bp)Ccnd2Ssc.15749.1.s1_atfor aggagcagattgaggtcgtg86185rev caaccagagagaaggaaggagancapgssc.28512.1.s1_atfor cttgtagatttgacgagacca60156rev ggctttagtatagacccgaacmgmtssc.19639.1.a1_atfor gcaactactcgggaggaatg88171rev ctgcgaacgctcagtcttggadd45bssc.14764.1.a1_atfor ggacttagactttgggacttg60140rev gtaagcctcccatctctcttsdhbssc.8939.1.s1_atfor gcaggacccgttctctctgt60170rev ggttacagtcacgttaggttggppargc1assc.16864.1.s1_atfor gtaaatctgcgggatgatgg60208rev tggtggaagcaggatcaaagprkaa1ssc.8107.1.a1_atfor ttgttaatttcataaactttgcttc60193rev gtgcagccttgacatactcprkaa2ssc.16257.1.s1_atfor tctgtaattctgttttgcctacga60168rev agcaagaaggtgatgccaagrpl10*ssc.9130.1.a1_atfor ctgtgttcgtcttttcttcc60199rev tcatccacttttgccttct\nccnd2 - cyclin d2; ncapg - non-Smc Condensin I Complex, subunit g; Mgmt - o-6-Methylguanine-dna methyltransferase; Gadd45B - growth arrest and dna-damage-Inducible, Β ; Sdhb - Succinate Dehydrogenase Complex, Subunit B, iron sulfur (ip); Ppargc1A - Peroxisome Proliferator Activated Receptor Γ Coactivator-1 Α ; Prkaa1 - 5'-Amp-Activated Protein Kinase, catalytic α 1 chain; Prkaa2 - 5'-Amp-Activated Protein Kinase, catalytic α 2 chain; Rpl10 - Ribosomal Protein 10; * house keeping Gene."]	N/A	N/A	[('PR_000017453', 'protein Wnt-9b', 15, 'WRAP'), ('SO_0000112', 'primer', 31, 'Primer'), ('UBERON_0002107', 'liver', 79, 'liver'), ('UBERON_0000479', 'tissue', 85, 'tissue'), ('SO_0000028', 'base_pair', 150, 'bp'), ('PR_000005122', 'G1/S-specific cyclin-D2', 153, 'CCND2Ssc'), ('PR_000015279', 'mitochondrial dynamics protein MID51', 876, 'SMC'), ('GO_0000796', 'condensin complex', 880, 'condensin I complex'), ('PR_000010364', 'microfibril-associated glycoprotein 4', 912, 'MGMT'), ('CHEBI_20689', '6-O-methylguanine', 921, '6-methylguanine'), ('PR_000007774', 'gamma-aminobutyric acid receptor subunit beta-3', 960, 'GADD45B'), ('PR_000008979', 'interleukin-10 receptor subunit beta', 999, 'inducible, β'), ('PR_000014460', 'serine--tRNA ligase, mitochondrial', 1014, 'SDHB'), ('GO_0045281', 'succinate dehydrogenase complex', 1021, 'succinate dehydrogenase complex'), ('PR_000015619', 'sorcin', 1021, 'succinate dehydrogenase complex, subunit B'), ('PR_000013059', 'peroxisome proliferator-activated receptor gamma coactivator 1-alpha', 1083, 'PPARGC1A'), ('GO_0005777', 'peroxisome', 1094, 'Peroxisome'), ('PR_000012203', 'proteasomal ATPase-associated factor 1', 1094, 'Peroxisome proliferator activated receptor γ coactivator-1 α'), ('PR_000013282', 'pre-mRNA-processing factor 39', 1157, 'PRKAA1'), ('CHEBI_16027', "adenosine 5'-monophosphate", 1169, 'AMP'), ('PR_000004693', 'Bcl-2-like protein 10', 1172, '-activated protein kinase'), ('PR_000013282', 'pre-mRNA-processing factor 39', 1220, 'PRKAA2'), ('CHEBI_16027', "adenosine 5'-monophosphate", 1232, 'AMP'), ('PR_000004693', 'Bcl-2-like protein 10', 1235, '-activated protein kinase'), ('PR_000014219', '60S ribosomal protein L36', 1283, 'RPL10'), ('GO_0005768', 'endosome', 1291, 'Ribosomal'), ('PR_000014368', 'RuvB-like 1', 1291, 'Ribosomal protein 10'), ('SO_0000704', 'gene', 1329, 'gene')]
PMC3347028	3/2012	S45-PMC3347028	['once 25(Oh)D is formed in the Liver, it enters the circulation.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 5, '25(OH)D'), ('UBERON_0002107', 'liver', 30, 'liver')]
PMC3354634	4/2012	S96-PMC3354634	['Alcohol, shellfish, Liver) were removed from the questionnaire.']	N/A	N/A	[('CHEBI_30879', 'alcohol', 0, 'alcohol'), ('UBERON_0002107', 'liver', 20, 'liver')]
PMC3354911	12/2011	S101-PMC3354911	['(50) among primary prevention interventions for cancers, immunization against Liver cancer (Hbv) is currently in widespread use.']	N/A	N/A	[('UBERON_0002107', 'liver', 78, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 92, 'HBV')]
PMC3356951	4/2012	S93-PMC3356951	['[9] Phenobarbital and Phenytoin increase the Hepatic Metabolism Of Vitamin D to inactive Compounds and decrease calcium absorption, which also impairs Vitamin D Metabolism.']	N/A	N/A	[('CHEBI_8069', 'phenobarbital', 4, 'Phenobarbital'), ('CHEBI_8107', 'phenytoin', 22, 'phenytoin'), ('UBERON_0002107', 'liver', 45, 'hepatic'), ('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 53, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_36357', 'polyatomic entity', 89, 'compounds'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 151, 'vitamin D metabolism')]
PMC3356951	4/2012	S97-PMC3356951	['Cod Liver oil is a good source of Vitamin D, but in large doses there is a risk of Vitamin A toxicity.']	N/A	N/A	[('CHEBI_33290', 'food', 0, 'Cod'), ('UBERON_0002107', 'liver', 4, 'liver'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin A')]
PMC3356951	4/2012	S163-PMC3356951	['it becomes active by the Liver without needing to go through hydroxylation in the Kidneys.']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('UBERON_0002113', 'kidney', 82, 'kidneys')]
PMC3357266	6/2012	S76-PMC3357266	['all Animals were subjected to an overnight fast for ∼16 h prior to the clamp to standardize Liver Glycogen and Hepatic Glucose output.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'animals'), ('UBERON_0002107', 'liver', 92, 'liver'), ('CHEBI_24384', 'glycogens', 98, 'glycogen'), ('UBERON_0002107', 'liver', 111, 'hepatic'), ('CHEBI_17234', 'glucose', 119, 'glucose')]
PMC3357266	6/2012	S92-PMC3357266	['Tissue samples, which included the Liver, White Fat, Soleus Muscle, Extensor Digitorum Longus Muscle, and Gastrocnemius, were treated with 1 mol/l Naoh at 60°c for 45 min.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('UBERON_0002107', 'liver', 35, 'liver'), ('UBERON_0001347', 'white adipose tissue', 42, 'white fat'), ('UBERON_0001389', 'soleus muscle', 53, 'soleus muscle'), ('UBERON_0001386', 'extensor digitorum longus', 68, 'extensor digitorum longus muscle'), ('UBERON_0001388', 'gastrocnemius', 106, 'gastrocnemius'), ('CHEBI_32145', 'sodium hydroxide', 147, 'NaOH')]
PMC3357266	6/2012	S202-PMC3357266	['there were no intergroup differences observed in the Insulin-induced Glucose Uptake by the Extensor Digitorum Longus Muscle (Glycolytic type), Gastrocnemius (mixed type), Liver, or Wat (fig.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 53, 'insulin'), ('CHEBI_17234', 'glucose', 69, 'glucose'), ('GO_0046323', 'glucose import', 69, 'glucose uptake'), ('UBERON_0001386', 'extensor digitorum longus', 91, 'extensor digitorum longus muscle'), ('GO_0006096', 'glycolytic process', 125, 'glycolytic'), ('UBERON_0001388', 'gastrocnemius', 143, 'gastrocnemius'), ('UBERON_0002107', 'liver', 171, 'liver'), ('UBERON_0006337', 'distal early tubule', 181, 'WAT')]
PMC3357266	6/2012	S212-PMC3357266	['d : Insulin-stimulated Glucose Uptake in Skeletal muscles, Liver (liv), and Wat in all groups is shown ( n = 6 each in all groups).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 4, 'Insulin'), ('CHEBI_17234', 'glucose', 23, 'glucose'), ('GO_0046323', 'glucose import', 23, 'glucose uptake'), ('UBERON_0004288', 'skeleton', 41, 'skeletal'), ('UBERON_0002107', 'liver', 59, 'liver'), ('UBERON_0006337', 'distal early tubule', 76, 'WAT')]
PMC3360698	5/2012	S20-PMC3360698	['male offspring developed Liver and Adrenal tumors and female offspring developed Ovarian and Lung tumors[6].']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('UBERON_0002369', 'adrenal gland', 35, 'adrenal'), ('UBERON_0000992', 'ovary', 81, 'ovarian'), ('UBERON_0002048', 'lung', 93, 'lung')]
PMC3365381	3/2011	S41-PMC3365381	['the Perinatal exposure to environmental Pollutants, Benzpyrene (present in the exhaust gas of cars), and tcdd=Dioxin (which is present in the exhaust gas of diesel motors and cigarette smoke, as well as refuse burners) decrease the number of Glucocorticoid receptors and increase the activity of Liver enzymes in Adult Rats (csaba and inczefi-gonda1984; csaba et al.1991a).']	N/A	N/A	[('GO_0036268', 'swimming', 4, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 4, 'perinatal'), ('CHEBI_26199', 'polyprenol', 40, 'pollutants'), ('CHEBI_29865', 'benzo[a]pyrene', 52, 'benzpyrene'), ('CHEBI_4553', 'dihydroanhydropodorhizol', 110, 'dioxin'), ('CHEBI_24261', 'glucocorticoid', 242, 'glucocorticoid'), ('UBERON_0002107', 'liver', 296, 'liver'), ('UBERON_0007023', 'adult organism', 313, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 319, 'rats')]
PMC3365381	3/2011	S108-PMC3365381	["if neonatal Rats are treated with a single dose of Insulin and are Mated when matured, the Insulin binding capacity of the f1 progenies' Liver changes: increases in females and decreases in males (csaba et al.1984)."]	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 12, 'rats'), ('CHEBI_66075', 'inflexin', 51, 'insulin'), ('PR_000045358', 'insulin family protein', 51, 'insulin'), ('GO_0007618', 'mating', 67, 'mated'), ('PR_000045358', 'insulin family protein', 91, 'insulin'), ('UBERON_0002107', 'liver', 137, 'liver')]
PMC3378453	4/2012	S84-PMC3378453	['Pon1 is synthesized in the Liver and Secreted in Blood where it is incorporated into high density lipoproteins (hdl).']	N/A	N/A	[('PR_000013050', 'suppressor of SWI4 1', 0, 'PON1'), ('UBERON_0002107', 'liver', 27, 'liver'), ('GO_0046903', 'secretion', 37, 'secreted'), ('UBERON_0000178', 'blood', 49, 'blood')]
PMC3387724	7/2012	S129-PMC3387724	['maternal Folic Acid supplementation in the Rat following protein restriction prevents epigenetic modification Of Hepatic Gene Expression in the offspring including Ppar-Α and -Γ (lillycrop et al.,2005).']	N/A	N/A	[('CHEBI_30751', 'formic acid', 9, 'folic acid'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 43, 'rat'), ('GO_0007608', 'sensory perception of smell', 110, 'of ...'), ('UBERON_0002107', 'liver', 113, 'hepatic'), ('GO_0010467', 'gene expression', 121, 'gene expression'), ('SO_0000704', 'gene', 121, 'gene'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 164, 'PPAR-α'), ('PR_000000164', 'BMP2', 175, '-Γ')]
PMC3403156	7/2012	S112-PMC3403156	['Prenatal hypoxia increased Dna Fragmentation and Lipid Peroxidation in fetal guinea pig Livers, which was reversed by the antioxidant, N-Acetylcysteine [46].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('GO_0006306', 'DNA methylation', 27, 'DNA fragmentation'), ('CHEBI_18059', 'lipid', 49, 'lipid'), ('GO_0032622', 'interleukin-19 production', 49, 'lipid peroxidation'), ('UBERON_0002107', 'liver', 88, 'livers'), ('CHEBI_70981', '6-formylpterin', 135, 'N-acetylcysteine')]
PMC3403156	7/2012	S113-PMC3403156	['in Livers of iugr offspring, there is an upregulation of mnsod as a compensatory adaptation that counters the decrease in Pyruvate Oxidation [91].']	N/A	N/A	[('UBERON_0002107', 'liver', 3, 'livers'), ('CHEBI_15361', 'pyruvate', 122, 'pyruvate'), ('GO_0015671', 'oxygen transport', 131, 'oxidation')]
PMC3403156	7/2012	S115-PMC3403156	['oxidative stress in Hepatic Tissue renders the Adult Liver susceptible to Nonalcohol-associated fatty Liver disease [92].']	N/A	N/A	[('UBERON_0001744', 'lymphoid tissue', 20, 'hepatic tissue'), ('UBERON_0007023', 'adult organism', 47, 'adult'), ('UBERON_0002107', 'liver', 53, 'liver'), ('CHEBI_7622', 'norathyriol', 74, 'nonalcohol'), ('UBERON_0002107', 'liver', 102, 'liver')]
PMC3407995	7/2012	S242-PMC3407995	['one of the earliest randomized, double-blind, Placebo-controlled trials included 84 children whose mothers took either 1183 mg/day Dha from cod Liver oil or a Corn oil placebo from week 18 of Pregnancy until 3 months after Delivery [120].']	N/A	N/A	[('CHEBI_26130', 'biological pigment', 46, 'placebo'), ('CHEBI_17874', 'dihydrozeatin', 131, 'DHA'), ('UBERON_0002107', 'liver', 144, 'liver'), ('CHEBI_33306', 'carbon group element atom', 159, 'corn'), ('GO_0007565', 'female pregnancy', 192, 'pregnancy'), ('GO_0007567', 'parturition', 223, 'delivery')]
PMC3415211	5/2012	S30-PMC3415211	['also, present is an Abdominal Wall defect of omphalocele (extruded Liver and Intestines omphalocele covered with the Peritoneum and Amnion).']	N/A	N/A	[('UBERON_0003697', 'abdominal wall', 20, 'abdominal wall'), ('UBERON_0002107', 'liver', 67, 'liver'), ('UBERON_0000160', 'intestine', 77, 'intestines'), ('UBERON_0003055', 'periderm', 117, 'peritoneum'), ('UBERON_0000305', 'amnion', 132, 'amnion')]
PMC3415211	5/2012	S106-PMC3415211	['also, careful removal of Embryos at this stage reveals the Abdominal Wall defect to include Peritoneal membrane enclosing the extruded Liver and Intestines that is characteristic of omphalocele (fig.']	N/A	N/A	[('UBERON_0000922', 'embryo', 25, 'embryos'), ('UBERON_0003697', 'abdominal wall', 59, 'abdominal wall'), ('UBERON_0001179', 'peritoneal cavity', 92, 'peritoneal'), ('UBERON_0002107', 'liver', 135, 'liver'), ('UBERON_0000160', 'intestine', 145, 'intestines')]
PMC3415211	5/2012	S124-PMC3415211	['e : a side view at e16.5 that shows the extruded Liver and Intestines covered with the Peritoneum and Amnion defining an omphalocele (arrow head).']	N/A	N/A	[('UBERON_0002107', 'liver', 49, 'liver'), ('UBERON_0000160', 'intestine', 59, 'intestines'), ('UBERON_0003055', 'periderm', 87, 'peritoneum'), ('UBERON_0000305', 'amnion', 102, 'amnion')]
PMC3415211	5/2012	S169-PMC3415211	['a : staining (H&e) of an e15.5 Embryo shows the spina bifida defect (double arrows) and omphalocele with extruded Liver (omph).']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 14, 'H'), ('UBERON_0000922', 'embryo', 31, 'embryo'), ('UBERON_0002107', 'liver', 114, 'liver')]
PMC3415211	5/2012	S177-PMC3415211	['e : Pelvic anatomy of an e16.5 chrna7:cre ablated fetus.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'Pelvic')]
PMC3415261	7/2012	S54-PMC3415261	['at week 10, the Thymus has differentiated Cortical and Medullar zones with T Cells and, at week 13, T Cells colonize the fetal Liver, Spleen, and Bone Marrow [23].']	N/A	N/A	[('UBERON_0002370', 'thymus', 16, 'thymus'), ('UBERON_0001851', 'cortex', 42, 'cortical'), ('UBERON_0000958', 'medulla of organ', 55, 'medullar'), ('CL_0000084', 'T cell', 75, 'T cells'), ('CL_0000084', 'T cell', 100, 'T cells'), ('UBERON_0002107', 'liver', 127, 'liver'), ('UBERON_0002106', 'spleen', 134, 'spleen'), ('UBERON_0002371', 'bone marrow', 146, 'bone marrow')]
PMC3415261	7/2012	S59-PMC3415261	['data from Humans report that B Cells appear in the fetal Spleen together with Liver, Bone Marrow, and Lymph Nodes at 7-8 weeks of Gestation, and these B Cells possess an immature phenotype with no Surface Immunoglobulins but Cytoplasmic Igm [26].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 10, 'humans'), ('CL_0000236', 'B cell', 29, 'B cells'), ('UBERON_0002106', 'spleen', 57, 'spleen'), ('UBERON_0002107', 'liver', 78, 'liver'), ('UBERON_0002371', 'bone marrow', 85, 'bone marrow'), ('UBERON_0000029', 'lymph node', 102, 'lymph nodes'), ('GO_0007565', 'female pregnancy', 130, 'gestation'), ('CL_0000236', 'B cell', 151, 'B cells'), ('GO_0097420', 'skein-like inclusion', 197, 'surface immunoglobulins'), ('GO_0005737', 'cytoplasm', 225, 'cytoplasmic'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 237, 'IgM')]
PMC3420688	5/2012	S36-PMC3420688	['Liver, Renal function, and Bilirubin were normal.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0002113', 'kidney', 7, 'renal'), ('CHEBI_16990', 'bilirubin IXalpha', 27, 'bilirubin'), ('UBERON_0004058', 'biliary ductule', 27, 'bilirubin')]
PMC3420688	5/2012	S67-PMC3420688	['no Portosystemic collaterals, Splenomegaly, or Hepatic dysfunction had developed.']	N/A	N/A	[('UBERON_2000623', 'basipterygium bone', 3, 'portosystemic'), ('UBERON_0001154', 'vermiform appendix', 30, 'splenomegaly'), ('UBERON_0002107', 'liver', 47, 'hepatic')]
PMC3423345	8/2012	S23-PMC3423345	['major dietary sources of Choline include Liver, eggs and Milk[17].']	N/A	N/A	[('CHEBI_15354', 'choline', 25, 'choline'), ('UBERON_0002107', 'liver', 41, 'liver'), ('UBERON_0001913', 'milk', 57, 'milk')]
PMC3426771	1/2012	S97-PMC3426771	['the Kidney Secretes the enzyme Renin, which cleaves the Liver produced angiotensinogen to produce angiotensin i (ang i).']	N/A	N/A	[('UBERON_0002113', 'kidney', 4, 'kidney'), ('GO_0046903', 'secretion', 11, 'secretes'), ('PR_000014368', 'RuvB-like 1', 31, 'renin'), ('UBERON_0002107', 'liver', 56, 'liver')]
PMC3427250	8/2012	S20-PMC3427250	['as few Food items contain or are fortified with Vitamin D (such as Liver, fatty fish, eggs, milk and dairy products, soy milk, butter, margarines), the skin Synthesis Of Vitamin D induced by ultraviolet b radiation (uvb) is the main determinant of Vitamin D status in the population[23].']	N/A	N/A	[('CHEBI_33290', 'food', 7, 'food'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0002107', 'liver', 67, 'liver'), ('GO_0030474', 'spindle pole body duplication', 157, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin D')]
PMC3427250	8/2012	S21-PMC3427250	['Vitamin D once synthesized in the skin is Metabolized into 25-Dihydroxyvitamin D [25-(Oh)D] in the Liver.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('GO_0008152', 'metabolic process', 42, 'metabolized'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 59, '25-dihydroxyvitamin D'), ('CHEBI_72657', '19,20-DiHDPA', 82, '25-(OH)D'), ('UBERON_0002107', 'liver', 99, 'liver')]
PMC3436706	2/2011	S52-PMC3436706	['it is transported to the Liver where more than 80% is oxidated to Acetaldehyde by the enzyme Alcohol dehydrogenase (adh) and subsequently converted to Acetic Acid by the enzyme Aldehyde dehydrogenase (aldh).']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('CHEBI_15343', 'acetaldehyde', 66, 'acetaldehyde'), ('CHEBI_30879', 'alcohol', 93, 'Alcohol'), ('CHEBI_15366', 'acetic acid', 151, 'acetic acid'), ('CHEBI_17478', 'aldehyde', 177, 'Aldehyde')]
PMC3436706	2/2011	S57-PMC3436706	['the oxidative enzymes in the Liver are present from the 2nd month but remain mostly inactive in the foetus.']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver')]
PMC3463445	9/2012	S15-PMC3463445	['the electrical stimulation of the Ventromedial Hypothalamic Nucleus induces the immediate activation of Hepatic Glycogenolysis [10], whereas the stimulation of the Lateral Hypothalamus leads to a prompt enhancement of Glycogen Synthesis that allows an increase in Blood Glucose levels [11].']	N/A	N/A	[('UBERON_0001925', 'ventral lateral nucleus of thalamus', 34, 'ventromedial hypothalamic nucleus'), ('UBERON_0002107', 'liver', 104, 'hepatic'), ('GO_0005981', 'regulation of glycogen catabolic process', 112, 'glycogenolysis'), ('UBERON_0002736', 'lateral nuclear group of thalamus', 164, 'lateral hypothalamus'), ('CHEBI_24384', 'glycogens', 218, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 218, 'glycogen synthesis'), ('UBERON_0000178', 'blood', 264, 'blood'), ('CHEBI_17234', 'glucose', 270, 'glucose')]
PMC3463445	9/2012	S17-PMC3463445	['the Hepatic Vagus Nerve senses Glucose Production in the Liver and sends signals to the Central Nervous System, which integrates this Message to Control the Metabolism [13].']	N/A	N/A	[('UBERON_0001148', 'median nerve', 4, 'hepatic vagus nerve'), ('CHEBI_17234', 'glucose', 31, 'glucose'), ('GO_0006094', 'gluconeogenesis', 31, 'glucose production'), ('UBERON_0002107', 'liver', 57, 'liver'), ('UBERON_0001017', 'central nervous system', 88, 'central nervous system'), ('CHEBI_33695', 'information biomacromolecule', 134, 'message'), ('GO_0065007', 'biological regulation', 145, 'control'), ('GO_0008152', 'metabolic process', 157, 'metabolism')]
PMC3465343	10/2012	S8-PMC3465343	['Liver and vertebral body Expression of Retinaldehyde dehydrogenase (raldhs) and rars mrna was assessed by Reverse Transcription-real time pcr.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('GO_0010467', 'gene expression', 25, 'expression'), ('CHEBI_17173', 'D-ribulose', 39, 'retinaldehyde'), ('GO_0001171', 'reverse transcription', 106, 'reverse transcription')]
PMC3465343	10/2012	S11-PMC3465343	['furthermore, Vitamin A deficiency negatively regulate the Liver and verterbral body mrna levels of Raldh1, Raldh2, Raldh3, Rar-Α, Rar-Β and Rar-γ.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 13, 'vitamin A'), ('UBERON_0002107', 'liver', 58, 'liver'), ('PR_000013779', 'histone-binding protein RBBP7', 99, 'RALDH1'), ('PR_000013779', 'histone-binding protein RBBP7', 107, 'RALDH2'), ('PR_000013779', 'histone-binding protein RBBP7', 115, 'RALDH3'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 123, 'RAR-α'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 130, 'RAR-β'), ('PR_000013644', 'Ras-related protein Rab-9A', 140, 'RAR')]
PMC3465343	10/2012	S108-PMC3465343	['Vad altered the mrna Expression of Raldhs and Rars in Liver\nas shown infig.']	N/A	N/A	[('CHEBI_16695', "uridine 5'-monophosphate", 0, 'VAD'), ('GO_0010467', 'gene expression', 21, 'expression'), ('PR_000013739', 'retinoic acid receptor responder protein 1', 35, 'RALDHs'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 46, 'RARs'), ('UBERON_0002107', 'liver', 54, 'liver')]
PMC3465343	10/2012	S109-PMC3465343	['4, significant decreases in Raldh2 and Rar-Γ mrna Expression were observed in Livers of vad Rats compared with those of the control Rats (p<0.05).']	N/A	N/A	[('PR_000013779', 'histone-binding protein RBBP7', 28, 'RALDH2'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 39, 'RAR-γ'), ('GO_0010467', 'gene expression', 50, 'expression'), ('UBERON_0002107', 'liver', 78, 'livers'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 92, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 132, 'rats')]
PMC3465343	10/2012	S110-PMC3465343	['furthermore, the Expression of Raldh1, Raldh3, Rar-Α, and Rar-Β mrna in Livers of the vad Rats was significantly lower than those in the control group as determined by real-time pcr (p<0.01).10.1371/journal.pone.0046565.g004\n\ncaption (fig): figure 4\ntranscription levels of Retinaldehyde dehydrogenase (Raldh1, Raldh2 and Raldh3) and Retinoid Acid receptors (Rarα, Rarβ, Rarγ) in the liver of control, vad Rat.']	N/A	N/A	[('GO_0010467', 'gene expression', 17, 'expression'), ('PR_000013779', 'histone-binding protein RBBP7', 31, 'RALDH1'), ('PR_000013779', 'histone-binding protein RBBP7', 39, 'RALDH3'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 47, 'RAR-α'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 58, 'RAR-β'), ('UBERON_0002107', 'liver', 72, 'livers'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 90, 'rats'), ('CHEBI_17173', 'D-ribulose', 274, 'retinaldehyde'), ('PR_000013779', 'histone-binding protein RBBP7', 303, 'RALDH1'), ('PR_000013779', 'histone-binding protein RBBP7', 311, 'RALDH2'), ('PR_000013779', 'histone-binding protein RBBP7', 322, 'RALDH3'), ('CHEBI_26536', 'retinoic acid', 334, 'retinoid acid'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 359, 'RARα'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 365, 'RARβ'), ('PR_000013672', 'DNA repair protein RAD51 homolog 1', 371, 'RARγ'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 406, 'rat')]
PMC3465343	10/2012	S170-PMC3465343	['our results also have observed that vad suppressed raldhs and Rars mrna Expression in the Liver and Vertebral Body of vad neonatal Rats at the day of Birth.']	N/A	N/A	[('PR_000013672', 'DNA repair protein RAD51 homolog 1', 62, 'RARs'), ('GO_0010467', 'gene expression', 72, 'expression'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0001075', 'bony vertebral centrum', 100, 'vertebral body'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 131, 'rats'), ('GO_0007567', 'parturition', 150, 'birth')]
PMC3465343	10/2012	S201-PMC3465343	['three random neonatal Rats from each group were killed by Cervical dislocation to analyze mrna Expression of Liver and vertebral body and to detect Serum Retinol level on the day of Birth.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 22, 'rats'), ('UBERON_0005434', 'cervical region', 58, 'cervical'), ('GO_0010467', 'gene expression', 95, 'expression'), ('UBERON_0002107', 'liver', 109, 'liver'), ('UBERON_0001977', 'blood serum', 148, 'serum'), ('CHEBI_26536', 'retinoic acid', 154, 'retinol'), ('GO_0007567', 'parturition', 182, 'birth')]
PMC3465343	10/2012	S212-PMC3465343	["rna extraction and real-time pcr\ntotal Liver and vertebral body mrna was obtained on day 1 of the Birth from the two groups and was extracted from frozen Liver by using trizol Reagent (invitrogen, ca, usa) according to the manufacturer's instructions."]	N/A	N/A	[('UBERON_0002107', 'liver', 39, 'liver'), ('GO_0007567', 'parturition', 98, 'birth'), ('UBERON_0002107', 'liver', 154, 'liver'), ('CHEBI_33893', 'reagent', 176, 'reagent')]
PMC3470091	9/2012	S13-PMC3470091	['trial registration number: irct138902113840n1\n\nintroduction\nVitamin D is a Secosteroid, which is Metabolized in Liver and Kidney.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 60, 'Vitamin D'), ('CHEBI_35785', 'sphingoid', 75, 'secosteroid'), ('GO_0008152', 'metabolic process', 97, 'metabolized'), ('UBERON_0002107', 'liver', 112, 'liver'), ('UBERON_0002113', 'kidney', 122, 'kidney')]
PMC3470091	9/2012	S28-PMC3470091	['the patients had gdm if 50 g resulted in a Glucose Serum concentration of 7.2 mmol/lit, and if 100 g gtt test was disturbed on the basis of carpenter and coustan criteria.25the study inclusion criteria were the absence of Thyroid, Kidney and Liver diseases as well as malabsorption.']	N/A	N/A	[('CHEBI_17234', 'glucose', 43, 'glucose'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('UBERON_0002046', 'thyroid gland', 222, 'thyroid'), ('UBERON_0002113', 'kidney', 231, 'kidney'), ('UBERON_0002107', 'liver', 242, 'liver')]
PMC3471827	10/2012	S0-PMC3471827	['the Α-Tocopherol transfer protein is essential for Vertebrate Embryogenesis\n\nabstract\nthe Hepatic α-Tocopherol transfer protein (ttp) is required for optimal Α-Tocopherol bioavailability in Humans; mutations in the Human Ttpa Gene result in the heritable disorder ataxia with Vitamin E deficiency (aved, omim #277460).']	N/A	N/A	[('CHEBI_27725', 'butin', 4, 'α-Tocopherol'), ('GO_0030730', 'sequestering of triglyceride', 51, 'Vertebrate'), ('GO_0009790', 'embryo development', 62, 'Embryogenesis'), ('UBERON_0002107', 'liver', 90, 'hepatic'), ('CHEBI_27013', 'tocopherol', 100, 'tocopherol'), ('CHEBI_27725', 'butin', 158, 'α-tocopherol'), ('NCBITaxon_9606', 'Homo sapiens', 190, 'humans'), ('NCBITaxon_9606', 'Homo sapiens', 215, 'human'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 221, 'TTPA'), ('SO_0000704', 'gene', 226, 'gene'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin E')]
PMC3471827	10/2012	S34-PMC3471827	['Adult Zebrafish Liver homogenate reacted with the Antibody with a single band at 33 kd, the expected size of the Zebrafish protein (left lane, figure 1b ); the Antibody reacted with Mouse ttp, but not with homogenate from a ttp−/− Mouse Liver (middle and right lanes, figure 1b ).10.1371/journal.pone.0047402.g001\n\ncaption (fig): figure 1\nthe Zebrafish Α-Tocopherol transfer protein.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('NCBITaxon_7955', 'Danio rerio', 6, 'zebrafish'), ('UBERON_0002107', 'liver', 16, 'liver'), ('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody'), ('NCBITaxon_7955', 'Danio rerio', 113, 'zebrafish'), ('GO_0042571', 'immunoglobulin complex, circulating', 160, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mouse'), ('NCBITaxon_10088', 'Mus <genus>', 231, 'mouse'), ('UBERON_0002107', 'liver', 237, 'liver'), ('NCBITaxon_7955', 'Danio rerio', 343, 'zebrafish'), ('CHEBI_16199', 'urea', 353, 'α-'), ('CHEBI_27013', 'tocopherol', 355, 'tocopherol')]
PMC3471827	10/2012	S42-PMC3471827	['b. anti-Human ttp Antibody cross-reacts with ttp from Adult Zebrafish Liver homogenate.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibody'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('NCBITaxon_7955', 'Danio rerio', 60, 'zebrafish'), ('UBERON_0002107', 'liver', 70, 'liver')]
PMC3471827	10/2012	S45-PMC3471827	['we chose Embryos aged 1-day post Fertilization (dpf) prior to Development Of the Liver to define the spatial Expression pattern of ttp using rna in situ hybridization.']	N/A	N/A	[('UBERON_0000922', 'embryo', 9, 'embryos'), ('GO_0009566', 'fertilization', 33, 'fertilization'), ('GO_0001889', 'liver development', 62, 'development of ... liver'), ('UBERON_0002107', 'liver', 81, 'liver'), ('GO_0010467', 'gene expression', 109, 'expression')]
PMC3471827	10/2012	S148-PMC3471827	['immunoblotting\nAdult Zebrafish were euthanized by overdose of buffered Tricaine, Livers were dissected out, frozen in liquid nitrogen and homogenized in ripa buffer (150 mm Sodium Chloride, 1% Np-40, 0.5% Sodium Deoxycholate, 0.1% Sds (Sodium Dodecyl Sulphate), 50 mm Tris, ph 8.)']	N/A	N/A	[('UBERON_0007023', 'adult organism', 15, 'Adult'), ('NCBITaxon_7955', 'Danio rerio', 21, 'zebrafish'), ('CHEBI_9672', 'triangularine', 71, 'tricaine'), ('UBERON_0002107', 'liver', 81, 'livers'), ('CHEBI_26710', 'sodium chloride', 173, 'sodium chloride'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 193, 'NP-40'), ('CHEBI_9177', 'sodium deoxycholate', 205, 'sodium deoxycholate'), ('CHEBI_8984', 'sodium dodecyl sulfate', 231, 'SDS'), ('CHEBI_8984', 'sodium dodecyl sulfate', 236, 'sodium dodecyl sulphate'), ('CHEBI_9754', 'tris', 268, 'Tris')]
PMC3476426	8/2012	S14-PMC3476426	['Vitamin D3 undergoes a 25-hydroxylation in the Liver, with the resulting product, 25-Hydroxy Vitamin D or Calcidiol, being the main circulating form of Vitamin D. therefor, 25-Hydroxy Vitamin D levels are used to determine the Vitamin D status of a given Individual [1,2].']	N/A	N/A	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('UBERON_0002107', 'liver', 47, 'liver'), ('CHEBI_43141', '3-hydroxypropoxy group', 82, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 101, 'D'), ('CHEBI_17933', 'calcidiol', 106, 'calcidiol'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 173, '25-hydroxy vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('NCBITaxon_1', 'root', 255, 'individual')]
PMC3482177	10/2012	S143-PMC3482177	['fetal Liver iron and Hct levels measured at day 21.5 mirrored maternal concentration at the same point of Gestation, i.e.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('PR_000008443', 'huntingtin-associated protein 1', 21, 'Hct'), ('GO_0007565', 'female pregnancy', 106, 'gestation')]
PMC3482177	10/2012	S145-PMC3482177	['at day 21.5 of Gestation, Placental and maternal Liver Transferrin Receptor (tfr) Expression was increased with iron-deficiency.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 15, 'gestation'), ('UBERON_0001987', 'placenta', 26, 'placental'), ('PR_000009791', 'LIM/homeobox protein Lhx1', 49, 'liver'), ('UBERON_0002107', 'liver', 49, 'liver'), ('PR_000001679', 'trace amine-associated receptor 5', 55, 'transferrin receptor'), ('GO_0010467', 'gene expression', 82, 'expression')]
PMC3482177	10/2012	S147-PMC3482177	['fetal Liver tfr Expression was unchanged by maternal iron deficiency throughout Pregnancy[39], while Tfr2 Expression was decreased.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('GO_0010467', 'gene expression', 16, 'expression'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('PR_000016222', 'alpha-tectorin', 101, 'TfR2'), ('GO_0010467', 'gene expression', 106, 'expression')]
PMC3483668	10/2012	S115-PMC3483668	['there were no significant differences on the kaufman assessment battery for children test at 7 years of age between children whose mothers had taken cod Liver oil (N-3 lcpufas rich) or Corn oil (n - 6 Pufa rich) [59].']	N/A	N/A	[('UBERON_0002107', 'liver', 153, 'liver'), ('31', 'ACACA (human)', 164, 'n'), ('CHEBI_33306', 'carbon group element atom', 185, 'corn'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 201, 'PUFA')]
PMC3513828	11/2012	S5-PMC3513828	['we report a woman who developed acute Liver failure during the first Trimester of Pregnancy and underwent successful Liver transplantation at 11-week Gestation, followed by successful Delivery of the fetus at 30 weeks.']	N/A	N/A	[('UBERON_0002107', 'liver', 38, 'liver'), ('GO_0009294', 'DNA mediated transformation', 69, 'trimester'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('UBERON_0002107', 'liver', 117, 'liver'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0007567', 'parturition', 184, 'delivery')]
PMC3513828	11/2012	S11-PMC3513828	['conditions unrelated to Pregnancy, such as Viral hepatitis, gallstones, and Drug-induced Liver injury can occur at any time during Pregnancy, including the first and second Trimesters, and cause significant Liver dysfunction.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 24, 'pregnancy'), ('NCBITaxon_1', 'root', 43, 'viral'), ('CHEBI_23888', 'drug', 76, 'drug'), ('UBERON_0002107', 'liver', 89, 'liver'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy'), ('GO_0043033', 'isoamylase complex', 173, 'trimesters'), ('UBERON_0002107', 'liver', 207, 'liver')]
PMC3513828	11/2012	S15-PMC3513828	['according to the european Liver transplantation registry (eltr), ten of 75,530 Liver transplants performed between 1968 and 2008 were performed for acute Liver failure due to Aflp and hellp syndrome [3].']	N/A	N/A	[('GO_0040011', 'locomotion', 26, 'Liver'), ('UBERON_0002107', 'liver', 26, 'Liver'), ('UBERON_0002107', 'liver', 79, 'liver'), ('UBERON_0002107', 'liver', 154, 'liver'), ('SO_0001830', 'AFLP_fragment', 175, 'AFLP')]
PMC3513828	11/2012	S20-PMC3513828	['both mother and child are healthy 4 years after Liver transplantation and Delivery.']	N/A	N/A	[('UBERON_0002107', 'liver', 48, 'liver'), ('GO_0007567', 'parturition', 74, 'delivery')]
PMC3513828	11/2012	S24-PMC3513828	['there was no family history of Liver disease.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'liver')]
PMC3513828	11/2012	S32-PMC3513828	['an Abdominal ultrasound with dopplers showed heterogeneous appearing Liver with patent Hepatic Vasculature, without Intra- or Extrahepatic Biliary dilatation.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 3, 'abdominal'), ('UBERON_0002107', 'liver', 69, 'liver'), ('UBERON_0002107', 'liver', 87, 'hepatic'), ('UBERON_0002049', 'vasculature', 95, 'vasculature'), ('UBERON_0001273', 'ilium', 116, 'intra'), ('UBERON_0001388', 'gastrocnemius', 126, 'extrahepatic biliary')]
PMC3513828	11/2012	S33-PMC3513828	['an mri of the Abdomen showed heterogeneous enhancement of the Liver with periportal edema, patent Portal, and Hepatic Veins but no cirrhosis.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 14, 'abdomen'), ('UBERON_0002107', 'liver', 62, 'liver'), ('UBERON_0010166', 'coat of hair', 98, 'portal ...'), ('UBERON_0001143', 'hepatic vein', 110, 'hepatic veins')]
PMC3513828	11/2012	S34-PMC3513828	['on the third hospital day, a Transjugular Liver biopsy was performed that showed intense, active, interface hepatitis (figures1(a)and1(b)) with Lymphocytes, Neutrophils, and scant Plasma Cells, Bile Ductular Proliferation, and massive Hepatocyte dropout.']	N/A	N/A	[('UBERON_0008605', 'tragicus muscle', 29, 'transjugular'), ('UBERON_0002107', 'liver', 42, 'liver'), ('CL_0000542', 'lymphocyte', 144, 'lymphocytes'), ('CL_0000775', 'neutrophil', 157, 'neutrophils'), ('CL_0000786', 'plasma cell', 180, 'plasma cells'), ('UBERON_0004058', 'biliary ductule', 194, 'bile ductular'), ('GO_0008283', 'cell proliferation', 208, 'proliferation'), ('CL_0000182', 'hepatocyte', 235, 'hepatocyte')]
PMC3513828	11/2012	S36-PMC3513828	['Liver biopsy hsv stains were negative.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC3513828	11/2012	S38-PMC3513828	['she underwent emergent evaluation for Liver transplantation and was listed for Liver transplant.']	N/A	N/A	[('UBERON_0002107', 'liver', 38, 'liver'), ('UBERON_0002107', 'liver', 79, 'liver')]
PMC3513828	11/2012	S41-PMC3513828	['on the morning of the eighth day, she was lethargic and developed asterixis, but was arousable, consistent with stage 3 Hepatic encephalopathy.']	N/A	N/A	[('UBERON_0002107', 'liver', 120, 'hepatic')]
PMC3513828	11/2012	S42-PMC3513828	['on the eight hospital day, she underwent orthotopic Liver transplantation from a 25 year-old donor who died from a self-inflicted gunshot wound to the head.']	N/A	N/A	[('UBERON_0002107', 'liver', 52, 'liver')]
PMC3513828	11/2012	S48-PMC3513828	['Liver transplantation was performed with Venovenous bypass.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0007316', 'deep external pudendal artery', 41, 'venovenous')]
PMC3513828	11/2012	S49-PMC3513828	['a Suprahepatic Caval anastomosis was created between the donor Liver and the Hepatic Vein confluence of the recipient.']	N/A	N/A	[('UBERON_2001990', 'epibranchial arborescent organ', 2, 'suprahepatic caval'), ('UBERON_0002107', 'liver', 63, 'liver'), ('UBERON_0001143', 'hepatic vein', 77, 'hepatic vein')]
PMC3513828	11/2012	S52-PMC3513828	['there was excellent perfusion of the Liver, and it synthesized Bile within 5 minutes of recirculation.']	N/A	N/A	[('UBERON_0002107', 'liver', 37, 'liver'), ('UBERON_0001970', 'bile', 63, 'bile')]
PMC3513828	11/2012	S56-PMC3513828	['intraoperative fetal monitoring was not performed during the Liver transplant since the fetus was less than 24 weeks and not viable.']	N/A	N/A	[('UBERON_0002107', 'liver', 61, 'liver')]
PMC3513828	11/2012	S58-PMC3513828	['pathology from her explanted Liver revealed a small Organ (total weight 509 grams), prominent interface hepatitis, extensive Hepatocyte necrosis, and confluent collapse (figures1(c)–1(f)), but there was focal preservation of some Lobules (figure 1(d)).']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver'), ('UBERON_0000062', 'organ', 52, 'organ'), ('CL_0000182', 'hepatocyte', 125, 'hepatocyte'), ('UBERON_0009911', 'lobule', 230, 'lobules')]
PMC3513828	11/2012	S60-PMC3513828	['the findings from explant were different from the Transjugular Liver biopsy which showed stage 3 fibrosis.']	N/A	N/A	[('UBERON_0008605', 'tragicus muscle', 50, 'transjugular'), ('UBERON_0002107', 'liver', 63, 'liver')]
PMC3513828	11/2012	S61-PMC3513828	["Tacrolimus was administered with goal Plasma trough levels of 10–12\u2009ng/ml, and our center's standard Steroid protocol were administered for immunosuppression (table 2) after Liver transplantation."]	N/A	N/A	[('CHEBI_9388', 'Taccalonolide A', 0, 'Tacrolimus'), ('UBERON_0001969', 'blood plasma', 38, 'plasma'), ('CHEBI_35341', 'steroid', 101, 'steroid'), ('UBERON_0002107', 'liver', 174, 'liver')]
PMC3513828	11/2012	S73-PMC3513828	['there was no evidence of Liver graft Rejection or posttransplant Biliary stricture.']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('GO_0060033', 'anatomical structure regression', 37, 'rejection'), ('UBERON_0002294', 'biliary system', 65, 'biliary')]
PMC3513828	11/2012	S88-PMC3513828	['among those six cases, first Trimester (14 weeks or less) Liver transplantation was performed only in two patients.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 29, 'trimester'), ('UBERON_0002107', 'liver', 58, 'liver')]
PMC3513828	11/2012	S110-PMC3513828	['etiologies of acute Liver failure during Pregnancy include causes that occur in the general population or Pregnancy specific conditions, such as hellp syndrome and Aflp [2].']	N/A	N/A	[('UBERON_0002107', 'liver', 20, 'liver'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('SO_0001830', 'AFLP_fragment', 164, 'AFLP')]
PMC3513828	11/2012	S113-PMC3513828	['in the fifteen cases that we reviewed, six (40%) were cryptogenic [7–9,14–16], three (20%) were due to hepatitis b [17–19], two (13%) were due to Drug induced Liver injury [11,20], two (13%) were due to aih [6,21], one (6%) patient had pbc [10], and a cause was not reported in one case [22] (table 2).']	N/A	N/A	[('CHEBI_23888', 'drug', 146, 'drug'), ('UBERON_0002107', 'liver', 159, 'liver')]
PMC3513828	11/2012	S115-PMC3513828	['in our patient, a thorough evaluation for a cause of alf, including the histology of explanted Liver, did not reveal a definitive cause.']	N/A	N/A	[('UBERON_0002107', 'liver', 95, 'liver')]
PMC3513828	11/2012	S131-PMC3513828	['she received fresh frozen Plasma for procedures, such as transjugular Liver biopsy.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 26, 'plasma'), ('UBERON_0002107', 'liver', 70, 'liver')]
PMC3513828	11/2012	S140-PMC3513828	['hemodynamic monitoring and volume management were performed similar to nonpregnant patients undergoing Liver transplantation.']	N/A	N/A	[('UBERON_0002107', 'liver', 103, 'liver')]
PMC3518064	11/2012	S129-PMC3518064	['leptin mainly acts by binding to specific central and peripheral receptors in the Hypothalamus, Adipose Tissue, Liver, and Pancreatic Β -Cells [97].']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 82, 'hypothalamus'), ('UBERON_0001013', 'adipose tissue', 96, 'adipose tissue'), ('UBERON_0002107', 'liver', 112, 'liver'), ('CL_0000173', 'pancreatic D cell', 123, 'pancreatic β -cells'), ('UBERON_0001264', 'pancreas', 123, 'pancreatic')]
PMC3556415	1/2013	S23-PMC3556415	['all laboratory investigations, including full Blood count, Liver function tests, and Thyroid function tests were within normal range.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('UBERON_0002107', 'liver', 59, 'liver'), ('UBERON_0002046', 'thyroid gland', 85, 'thyroid')]
PMC3558353	12/2012	S78-PMC3558353	['results\n\nefhl recruitment\nfigure1presents a flow diagram of the recruitment process, including all Births in the australian reference population and the study population (logan, beaudesert, gold coast and northern Rivers health districts) from 2006 to 2010 inclusive [22,23].']	N/A	N/A	[('GO_0007567', 'parturition', 99, 'births'), ('UBERON_0002107', 'liver', 214, 'Rivers')]
PMC3575022	2/2013	S37-PMC3575022	['Heart, Fat Pad ( Inguinal ), Liver, and Skeletal muscle ( Tibialis Anterior ) weights were recorded.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Heart'), ('UBERON_0003916', 'fat pad', 7, 'fat pad'), ('UBERON_0008337', 'inguinal part of abdomen', 17, 'inguinal'), ('UBERON_0002107', 'liver', 29, 'liver'), ('UBERON_0004288', 'skeleton', 40, 'skeletal'), ('UBERON_0001385', 'tibialis anterior', 58, 'tibialis anterior')]
PMC3575022	2/2013	S106-PMC3575022	['caption (table-wrap): table 2\n\nbody weight (bw), Inguinal Fat Pad mass, Heart, Liver, and muscle weights (Tibialis Anterior) of 3 months old offspring of control and high Sucrose Fed dams ( n = 6–8 per group) .sex/groupbody weight (g)Fat Pad weight (mg/g bw)Heart weight (mg/g bw)Liver weight(mg/g bw)Muscle weight (mg/g bw)Kidney weight(mg/g bw)male oc23.2 ± 0.412.7 ± 0.87.1 ± 0.338.9 ± 1.76.5 ± 0.217.4 ± 0.8osf24.9 ± 0.712.4 ± 1.87.2 ± 0.439.7 ± 2.65.7 ± 0.516.9 ± 0.9 female oc20.8 ± 0.411.7 ± 0.97.2 ± 0.237.4 ± 0.86.3 ± 0.215.4 ± 0.7osf22.2 ± 0.1*15.1 ± 0.7*8.3 ± 0.3*40.5 ± 1.0*5.1 ± 0.2†9.8 ± 0.6$\np < 0.05;\np < 0.01;\np < 0.001 vs. offspring of control dams (two-tailed t-test).']	N/A	N/A	[('UBERON_0010410', 'inguinal fat pad', 49, 'Inguinal fat pad'), ('UBERON_0000948', 'heart', 72, 'heart'), ('UBERON_0002107', 'liver', 79, 'liver'), ('UBERON_0001385', 'tibialis anterior', 106, 'tibialis anterior'), ('CHEBI_17992', 'sucrose', 171, 'sucrose'), ('GO_0007631', 'feeding behavior', 179, 'fed'), ('UBERON_0003123', 'pharyngeal arch artery 6', 234, 'Fat pad'), ('UBERON_0000948', 'heart', 258, 'Heart'), ('UBERON_0002107', 'liver', 280, 'Liver'), ('UBERON_0001015', 'musculature', 301, 'Muscle'), ('UBERON_0002113', 'kidney', 324, 'Kidney')]
PMC3575022	2/2013	S163-PMC3575022	['Inguinal fat mass, and Liver weight were increased in females whilst muscle mass was decreased.']	N/A	N/A	[('UBERON_0008337', 'inguinal part of abdomen', 0, 'Inguinal'), ('UBERON_0002107', 'liver', 23, 'liver')]
PMC3578836	2/2013	S47-PMC3578836	['Nucleic Acid isolation\ntotal rna was isolated from Liver, Splenic T Cells and Monocytes using rneasy mini (qiagen, ca) according to the manufacturer’s instructions.']	N/A	N/A	[('CHEBI_17497', 'glycolic acid', 0, 'Nucleic Acid'), ('GO_0005634', 'nucleus', 0, 'Nucleic'), ('UBERON_0002107', 'liver', 51, 'liver'), ('CL_0000084', 'T cell', 58, 'splenic T cells'), ('UBERON_0002106', 'spleen', 58, 'splenic'), ('CL_0000576', 'monocyte', 78, 'monocytes')]
PMC3578836	2/2013	S49-PMC3578836	['Genomic dna from Livers and T Cells was isolated using the genelute Mammalian Genomic dna miniprep kit (sigma, mo).']	N/A	N/A	[('SO_0001026', 'genome', 0, 'Genomic'), ('UBERON_0002107', 'liver', 17, 'livers'), ('CL_0000084', 'T cell', 28, 'T cells'), ('NCBITaxon_33208', 'Metazoa', 68, 'Mammalian'), ('SO_0001026', 'genome', 78, 'Genomic')]
PMC3578836	2/2013	S50-PMC3578836	['Livers were flash-frozen in liquid n2and pulverized prior to Genomic dna preparation.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers'), ('SO_0001026', 'genome', 61, 'genomic')]
PMC3578836	2/2013	S69-PMC3578836	['T Cell and Liver Dna Methylation was also quantified with the methylflash methylated dna quantification kit following manufacturer’s instructions (epigentek).']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T cell'), ('UBERON_0002107', 'liver', 11, 'liver'), ('GO_0006306', 'DNA methylation', 17, 'DNA methylation')]
PMC3578836	2/2013	S130-PMC3578836	['17 wk: n\u200a=\u200a7 control and 5 ms Mice; 28 wk: n\u200a=\u200a9 control and 8 ms Mice * p<0.05.10.1371/journal.pone.0056253.g004\n\ncaption (fig): figure 4\nT Cells and Liver from ms f1 Mice are hypermethylated relative to control Mice.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 30, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 66, 'mice'), ('CL_0000084', 'T cell', 139, 'T cells'), ('UBERON_0002107', 'liver', 151, 'Liver'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 213, 'mice')]
PMC3578836	2/2013	S131-PMC3578836	['T Cell ( a ) and Liver ( b ) dna were isolated from 4 wk, 17 wk, 28 wk or 34 wk old f1 Apoe−/−Mice and the level of methylation measured by elisa.']	N/A	N/A	[('CL_0000084', 'T cell', 0, 'T cell'), ('UBERON_0002107', 'liver', 17, 'Liver'), ('PR_000004155', 'apolipoprotein E', 87, 'ApoE'), ('NCBITaxon_10088', 'Mus <genus>', 94, 'mice')]
PMC3578836	2/2013	S155-PMC3578836	['ms-f1 Liver had 165% and 65% higher Sr-B1; 141%, and 56% higher hmgcor; 55% and 95% higher ppar-Γ at 17 wk and 28 wk, respectively, relative to control-f1 Mice.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('PR_000014774', 'pulmonary surfactant-associated protein C', 36, 'SR-B1'), ('PR_000000164', 'BMP2', 95, '-γ'), ('NCBITaxon_10088', 'Mus <genus>', 155, 'mice')]
PMC3578836	2/2013	S160-PMC3578836	['*** p<0.001, ns\u200a=\u200anot significant.10.1371/journal.pone.0056253.g007\n\ncaption (fig): figure 7\nms diet Modulates the Expression of Hepatic Genes involved in de Novo Synthesis, Regulation, and Transport Of Cholesterol.']	N/A	N/A	[('GO_0065007', 'biological regulation', 101, 'modulates'), ('GO_0010467', 'gene expression', 115, 'expression'), ('UBERON_0002107', 'liver', 129, 'hepatic'), ('SO_0000704', 'gene', 137, 'genes'), ('GO_0007567', 'parturition', 158, 'novo'), ('GO_0007416', 'synapse assembly', 163, 'synthesis ...'), ('GO_0065007', 'biological regulation', 174, 'regulation ...'), ('GO_0030730', 'sequestering of triglyceride', 190, 'transport of cholesterol'), ('CHEBI_16113', 'cholesterol', 203, 'cholesterol')]
PMC3578836	2/2013	S161-PMC3578836	['Liver mrna from control and ms-f1 Apoe−/−Mice was harvested at the age of 17 wk, and 28 wk and levels of Hmgcor, ppar-γ, ldlr, and Sr-B1 were measured by qrt-pcr.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('PR_000004155', 'apolipoprotein E', 34, 'ApoE'), ('NCBITaxon_10088', 'Mus <genus>', 41, 'mice'), ('PR_000008839', 'serine protease HTRA2, mitochondrial', 105, 'HMGCoR'), ('PR_000014774', 'pulmonary surfactant-associated protein C', 131, 'SR-B1')]
PMC3578836	2/2013	S221-PMC3578836	['Cholesterol Esterification is Controlled by the Liver.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 0, 'Cholesterol'), ('GO_0009658', 'chloroplast organization', 0, 'Cholesterol esterification'), ('GO_0065007', 'biological regulation', 30, 'controlled'), ('UBERON_0002107', 'liver', 48, 'liver')]
PMC3578836	2/2013	S225-PMC3578836	['we observed an increase in the Expression of Ppar-Γ and Sr-B1 mrna in ms-f1 Liver relative to control Mice.']	N/A	N/A	[('GO_0010467', 'gene expression', 31, 'expression'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 45, 'PPAR-γ'), ('PR_000014774', 'pulmonary surfactant-associated protein C', 56, 'SR-B1'), ('UBERON_0002107', 'liver', 76, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 102, 'mice')]
PMC3578836	2/2013	S245-PMC3578836	['Il-6 can alter the pattern of Protein Biosynthesis in the Liver, augmenting the synthesis of C-Reactive Protein, a marker of inflammation measurable in peripheral Blood[45].']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 0, 'IL-6'), ('GO_0006412', 'translation', 30, 'protein biosynthesis'), ('UBERON_0002107', 'liver', 58, 'liver'), ('PR_000005890', 'crooked neck-like protein 1', 93, 'C-reactive protein'), ('UBERON_0000178', 'blood', 163, 'blood')]
PMC3581200	3/2013	S3-PMC3581200	['clamp period Insulin, glucagon, and Glucose concentrations and Hepatic Glucose loads did not differ among groups.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 13, 'insulin'), ('CHEBI_17234', 'glucose', 36, 'glucose'), ('UBERON_0002107', 'liver', 63, 'hepatic'), ('CHEBI_17234', 'glucose', 71, 'glucose')]
PMC3581200	3/2013	S4-PMC3581200	['the n Dogs reached near-maximal nhgu rates within 30 min; mean ± sem nhgu was 105 ± 9 µmol⋅100 g Liver−1⋅min−1.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 6, 'dogs'), ('UBERON_0002107', 'liver', 97, 'liver')]
PMC3581200	3/2013	S5-PMC3581200	['the p and p-hff Dogs reached maximal nhgu in 90–120 min; their nhgu was blunted (68 ± 9 and 16 ± 17 µmol⋅100 g Liver−1⋅min−1, respectively).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 16, 'dogs'), ('UBERON_0002107', 'liver', 111, 'liver')]
PMC3581200	3/2013	S6-PMC3581200	['Hepatic Glycogen Synthesis was reduced 20% in p versus n and 40% in p-hff versus p Dogs.']	N/A	N/A	[('GO_0000237', 'leptotene', 0, 'Hepatic'), ('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_24384', 'glycogens', 8, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 8, 'glycogen synthesis'), ('NCBITaxon_33208', 'Metazoa', 83, 'dogs')]
PMC3581200	3/2013	S11-PMC3581200	['net Hepatic Glucose balance is the sum of two processes, Hepatic Glucose output (hgo) and Hepatic Glucose Uptake (hgu), which often occur simultaneously.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'hepatic'), ('CHEBI_17234', 'glucose', 12, 'glucose'), ('UBERON_0002107', 'liver', 57, 'hepatic'), ('CHEBI_17234', 'glucose', 65, 'glucose'), ('UBERON_0002107', 'liver', 90, 'hepatic'), ('CHEBI_17234', 'glucose', 98, 'glucose'), ('GO_0046323', 'glucose import', 98, 'glucose uptake')]
PMC3581200	3/2013	S40-PMC3581200	['Glucose 21.7 ± 0.11 µmol⋅kg–1⋅min−1mixed with P -Aminohippuric Acid 0.4 mg⋅kg–1⋅min−1was infused intraportally, and additional Glucose was infused intravenously as needed to maintain the Hepatic Glucose load at twofold basal.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('CHEBI_35697', 'trans-cinnamic acid', 46, 'p -aminohippuric acid'), ('CHEBI_17234', 'glucose', 127, 'glucose'), ('UBERON_0002107', 'liver', 187, 'hepatic'), ('CHEBI_17234', 'glucose', 195, 'glucose')]
PMC3581200	3/2013	S41-PMC3581200	['at 240 min, Hepatic biopsy specimens were obtained under Pentobarbital anesthesia, and Dogs were then killed.']	N/A	N/A	[('UBERON_0002107', 'liver', 12, 'hepatic'), ('CHEBI_7983', 'pentobarbital', 57, 'pentobarbital'), ('NCBITaxon_33208', 'Metazoa', 87, 'dogs')]
PMC3581200	3/2013	S43-PMC3581200	['analysis of Blood Lactate, Glycerol, and alanine levels; plasma Glucose, Insulin, glucagon, Cortisol, and nonesterified fatty acid (nefa) levels; specific radioactivity of [3H]Glucose; and Hepatic Glycogen were carried out as described previously (7,10,15,16).']	N/A	N/A	[('UBERON_0000178', 'blood', 12, 'blood'), ('CHEBI_24996', 'lactate', 18, 'lactate'), ('CHEBI_17754', 'glycerol', 27, 'glycerol'), ('CHEBI_17234', 'glucose', 64, 'glucose'), ('PR_000045358', 'insulin family protein', 73, 'insulin'), ('CHEBI_17650', 'cortisol', 92, 'cortisol'), ('CHEBI_29238', 'tritium atom', 173, '3H'), ('CHEBI_17234', 'glucose', 176, 'glucose'), ('UBERON_0002107', 'liver', 189, 'hepatic'), ('CHEBI_24384', 'glycogens', 197, 'glycogen')]
PMC3581200	3/2013	S45-PMC3581200	['Hepatic Glycogen synthase (gs) activity was determined by measuring incorporation of [14C]Glucose from uridine diphosphate (udp)-[14C]Glucose into Glycogen at low (160 μmol/l) or high (6.7 mmol/l) Glucose-6-Phosphate (g6p) concentrations with low Udp-Glucose (134 μmol/l) (17).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_24384', 'glycogens', 8, 'glycogen'), ('CHEBI_36927', 'carbon-14 atom', 86, '14C'), ('CHEBI_17234', 'glucose', 90, 'glucose'), ('CHEBI_36927', 'carbon-14 atom', 130, '14C'), ('CHEBI_17234', 'glucose', 134, 'glucose'), ('CHEBI_24384', 'glycogens', 147, 'glycogen'), ('CHEBI_14314', 'D-glucose 6-phosphate', 197, 'glucose-6-phosphate'), ('CHEBI_17983', 'UDP-L-arabinose', 247, 'UDP-glucose')]
PMC3581200	3/2013	S47-PMC3581200	['Hepatic gp activity was measured by the method of gilboe et al.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic')]
PMC3581200	3/2013	S55-PMC3581200	['mixing of the Glucose infusate in the Hepatic circulation was evaluated by recovery of P -Aminohippuric Acid in the Portal and Hepatic Vein Blood, using predefined exclusion criteria (15).']	N/A	N/A	[('CHEBI_17234', 'glucose', 14, 'glucose'), ('UBERON_0002107', 'liver', 38, 'hepatic'), ('CHEBI_35697', 'trans-cinnamic acid', 87, 'p -aminohippuric acid'), ('UBERON_0010166', 'coat of hair', 116, 'portal ...'), ('UBERON_0001143', 'hepatic vein', 127, 'hepatic vein'), ('UBERON_0000178', 'blood', 140, 'blood')]
PMC3581200	3/2013	S57-PMC3581200	['the Hepatic load (rate of substrate delivery to the Liver), net Hepatic substrate balance (nhb), net Hepatic fractional substrate extraction, and Hepatic sinusoidal hormone concentrations were calculated as described previously (21).']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'hepatic'), ('GO_0008611', 'ether lipid biosynthetic process', 52, 'liver'), ('UBERON_0002107', 'liver', 52, 'liver'), ('UBERON_0002107', 'liver', 64, 'hepatic'), ('UBERON_0002107', 'liver', 101, 'hepatic'), ('UBERON_0002107', 'liver', 146, 'hepatic')]
PMC3581200	3/2013	S58-PMC3581200	['net Hepatic balance of Glucose was calculated with both a direct and an indirect method to minimize the impact of any error introduced by streaming of the Glucose infusate in the Portal Vein (15).']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'hepatic'), ('CHEBI_17234', 'glucose', 23, 'glucose'), ('CHEBI_17234', 'glucose', 155, 'glucose'), ('UBERON_0002017', 'portal vein', 179, 'portal vein')]
PMC3581200	3/2013	S60-PMC3581200	['Hepatic balance data are expressed per 100 g Liver to normalize for differences in maternal body composition.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('UBERON_0002107', 'liver', 45, 'liver')]
PMC3581200	3/2013	S61-PMC3581200	['Livers weighed 541 ± 14, 552 ± 25, and 519 ± 26 g in n, p, and p-hff Dogs, respectively ( p = 0.61).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers'), ('NCBITaxon_33208', 'Metazoa', 69, 'dogs')]
PMC3581200	3/2013	S62-PMC3581200	['Hepatic sinusoidal hormone concentrations were calculated as those for Hepatic load and divided by Hepatic Plasma flow.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('UBERON_0002107', 'liver', 71, 'hepatic'), ('UBERON_0002107', 'liver', 99, 'hepatic'), ('UBERON_0001969', 'blood plasma', 107, 'plasma')]
PMC3581200	3/2013	S65-PMC3581200	['direct pathway Hepatic Glycogen Synthesis was estimated as the3h disintegrations per minute in Hepatic Glycogen divided by the inflowing [3H]Glucose-specific radioactivity.']	N/A	N/A	[('GO_0007568', 'aging', 15, 'hepatic'), ('UBERON_0002107', 'liver', 15, 'hepatic'), ('CHEBI_24384', 'glycogens', 23, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 23, 'glycogen synthesis'), ('UBERON_0002107', 'liver', 95, 'hepatic'), ('CHEBI_24384', 'glycogens', 103, 'glycogen'), ('CHEBI_29238', 'tritium atom', 138, '3H'), ('CHEBI_17234', 'glucose', 141, 'glucose')]
PMC3581200	3/2013	S66-PMC3581200	['net Hepatic Carbon retention, an index of Glycogen Synthesis, and nonhepatic Glucose Uptake (non-hgu) were calculated as previously described (24).']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'hepatic'), ('CHEBI_33306', 'carbon group element atom', 12, 'carbon'), ('CHEBI_24384', 'glycogens', 42, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 42, 'glycogen synthesis'), ('CHEBI_17234', 'glucose', 77, 'glucose'), ('GO_0046323', 'glucose import', 77, 'glucose uptake')]
PMC3581200	3/2013	S73-PMC3581200	['however, during the experimental period, the Arterial and Hepatic sinusoidal concentrations increased to similar levels in all groups (reaching concentrations equivalent to approximately four- and fivefold basal in n in the Artery and the sinusoids, respectively).']	N/A	N/A	[('UBERON_0001637', 'artery', 45, 'arterial'), ('UBERON_0002107', 'liver', 58, 'hepatic'), ('UBERON_0001637', 'artery', 224, 'artery')]
PMC3581200	3/2013	S74-PMC3581200	['Arterial and Hepatic sinusoidal Glucagon concentrations remained near basal concentrations in all groups; the sinusoidal concentration was lower in p-hff than in p during the experimental period (table 1).']	N/A	N/A	[('UBERON_0001637', 'artery', 0, 'Arterial'), ('UBERON_0002107', 'liver', 13, 'hepatic'), ('CHEBI_17754', 'glycerol', 32, 'glucagon')]
PMC3581200	3/2013	S76-PMC3581200	['caption (table-wrap): table 1\n\nPlasma Insulin, glucagon, and Cortisol concentrations\n\nHepatic Blood flow.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 31, 'Plasma'), ('PR_000045358', 'insulin family protein', 38, 'insulin'), ('CHEBI_17650', 'cortisol', 61, 'cortisol'), ('UBERON_0002107', 'liver', 86, 'Hepatic'), ('UBERON_0000178', 'blood', 94, 'blood')]
PMC3581200	3/2013	S79-PMC3581200	['caption (table-wrap): table 2\n\nHepatic Blood flow\n\nGlucose Metabolism.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'Hepatic'), ('UBERON_0000178', 'blood', 39, 'blood'), ('CHEBI_17234', 'glucose', 51, 'Glucose'), ('GO_0006006', 'glucose metabolic process', 51, 'Glucose metabolism')]
PMC3581200	3/2013	S83-PMC3581200	['1 a and b ) and the Hepatic Glucose loads were clamped at the same levels in all groups (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 20, 'hepatic'), ('CHEBI_17234', 'glucose', 28, 'glucose')]
PMC3581200	3/2013	S87-PMC3581200	['Arterial ( a ) and Portal Vein ( b ) Plasma Glucose concentrations and Hepatic Glucose loads ( c ) in the n, p, and p-hff groups were well matched during the hyperinsulinemic-hyperglycemic clamp period in the presence of the portal Glucose signal.']	N/A	N/A	[('UBERON_0001637', 'artery', 0, 'Arterial'), ('UBERON_0002017', 'portal vein', 19, 'portal vein'), ('UBERON_0001969', 'blood plasma', 37, 'plasma'), ('CHEBI_17234', 'glucose', 44, 'glucose'), ('UBERON_0002107', 'liver', 71, 'hepatic'), ('CHEBI_17234', 'glucose', 79, 'glucose'), ('CHEBI_17234', 'glucose', 232, 'glucose')]
PMC3581200	3/2013	S88-PMC3581200	['nhgu ( d ), fractional extraction ( e ), and net Hepatic Glycogen Synthesis (Carbon retention) ( f ) during the clamp period were greatest in the n group.']	N/A	N/A	[('GO_0007568', 'aging', 49, 'hepatic'), ('UBERON_0002107', 'liver', 49, 'hepatic'), ('CHEBI_24384', 'glycogens', 57, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 57, 'glycogen synthesis'), ('CHEBI_33306', 'carbon group element atom', 77, 'carbon')]
PMC3581200	3/2013	S92-PMC3581200	['with the onset of the experimental period, the n group switched rapidly to nhgu, and within 30 min, the rate had reached 96 ± 20 µmol⋅100 g Liver−1⋅min−1, not significantly different from the maximal rate that occurred during the last hour (117 ± 11 µmol⋅100 g Liver−1⋅min−1).']	N/A	N/A	[('UBERON_0002107', 'liver', 140, 'liver'), ('UBERON_0002107', 'liver', 261, 'liver')]
PMC3581200	3/2013	S93-PMC3581200	['the p group switched from net hgo to nhgu within 30 min, but the rate was very low (11 ± 14 µmol⋅100 g Liver−1⋅min−1) and did not approach maximal until 90–120 min; during the last hour of study, it averaged 83 ± 8 µmol⋅100 g Liver−1⋅min−1( p< 0.05 vs. n).']	N/A	N/A	[('UBERON_0002107', 'liver', 103, 'liver'), ('UBERON_0002107', 'liver', 226, 'liver')]
PMC3581200	3/2013	S98-PMC3581200	['the rate of endogenous Glucose appearance during the basal period was not significantly different between n and p or between p and p-hff (63 ± 8, 65 ± 6, and 77 ± 8 µmol⋅100 g Liver−1⋅min−1in n, p, and p-Hff, respectively), and it declined similarly to 33 ± 11, 35 ± 31, and 44 ± 21 µmol⋅100 g Liver−1⋅min−1during the last hour of the experimental period.']	N/A	N/A	[('CHEBI_17234', 'glucose', 23, 'glucose'), ('UBERON_0002107', 'liver', 176, 'liver'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 204, 'HFF'), ('UBERON_0002107', 'liver', 294, 'liver')]
PMC3581200	3/2013	S113-PMC3581200	['under basal conditions, n exhibited net Hepatic Lactate output (nhlo), whereas p and p-hff were in a state of net Hepatic Lactate Uptake (nhlu) (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 40, 'hepatic'), ('CHEBI_24996', 'lactate', 48, 'lactate'), ('UBERON_0002107', 'liver', 114, 'hepatic'), ('CHEBI_24996', 'lactate', 122, 'lactate'), ('GO_0019244', 'lactate biosynthetic process from pyruvate', 122, 'lactate uptake')]
PMC3581200	3/2013	S121-PMC3581200	['lactate concentrations ( a ) and Hepatic ( b ) and Hindlimb ( c ) balance data in the n, p, and p-hff groups.']	N/A	N/A	[('UBERON_0002107', 'liver', 33, 'hepatic'), ('UBERON_0002103', 'hindlimb', 51, 'hindlimb')]
PMC3581200	3/2013	S123-PMC3581200	['* p< 0.05 for p vs. n.\nArterial alanine concentrations and net Hepatic alanine uptakes were significantly lower in p than in n (fig.']	N/A	N/A	[('UBERON_0001637', 'artery', 23, 'Arterial'), ('UBERON_0002107', 'liver', 63, 'hepatic')]
PMC3581200	3/2013	S129-PMC3581200	['Arterial alanine, Glycerol, and Nefa concentrations ( a , d , and g , respectively), net Hepatic uptake rates ( b , e , and h , respectively), and Hindlimb alanine and Glycerol balance data ( c and f ).']	N/A	N/A	[('UBERON_0001637', 'artery', 0, 'Arterial'), ('CHEBI_17754', 'glycerol', 18, 'glycerol'), ('CHEBI_13389', 'NAD', 32, 'NEFA'), ('UBERON_0002107', 'liver', 89, 'hepatic'), ('UBERON_0002103', 'hindlimb', 147, 'hindlimb'), ('CHEBI_17754', 'glycerol', 168, 'glycerol')]
PMC3581200	3/2013	S131-PMC3581200	['* p< 0.05 for p vs. n.\nbasal Arterial concentrations and net Hepatic uptakes of Glycerol were significantly higher in p than in n, but they fell in both groups during Hyperinsulinemic hyperglycemia to values that were not significantly different between groups (fig.']	N/A	N/A	[('UBERON_0001637', 'artery', 29, 'arterial'), ('UBERON_0002107', 'liver', 61, 'hepatic'), ('CHEBI_17754', 'glycerol', 80, 'glycerol'), ('GO_0030097', 'hemopoiesis', 167, 'hyperinsulinemic')]
PMC3581200	3/2013	S136-PMC3581200	['the basal nefa concentrations and net Hepatic Nefa Uptakes were higher in p than in n, but they fell to levels not significantly different from those in n during the clamp, and p-Hff did not differ significantly from p (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 38, 'hepatic'), ('GO_0051935', 'glutamate reuptake', 46, 'NEFA uptakes'), ('PR_000008530', 'hairy/enhancer-of-split related with YRPW motif-like protein', 179, 'HFF')]
PMC3581200	3/2013	S138-PMC3581200	['Hepatic Glycogen Synthesis and Tissue analyses.']	N/A	N/A	[('GO_0000237', 'leptotene', 0, 'Hepatic'), ('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_24384', 'glycogens', 8, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 8, 'glycogen synthesis'), ('UBERON_0000479', 'tissue', 31, 'tissue')]
PMC3581200	3/2013	S139-PMC3581200	['the Hepatic Glycogen concentrations at the end of study were significantly lower ( p< 0.05) in p than in n (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'hepatic'), ('CHEBI_24384', 'glycogens', 12, 'glycogen')]
PMC3581200	3/2013	S141-PMC3581200	['in p, Hepatic Glycogen Synthesis calculated from net Hepatic carbon retention initially lagged behind that in n (fig.']	N/A	N/A	[('GO_0007568', 'aging', 6, 'hepatic'), ('UBERON_0002107', 'liver', 6, 'hepatic'), ('CHEBI_24384', 'glycogens', 14, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 14, 'glycogen synthesis'), ('UBERON_0002107', 'liver', 53, 'hepatic')]
PMC3581200	3/2013	S145-PMC3581200	['Hepatic Glycogen Synthesis from [3H]Glucose did not differ between n and p. in p-hff, Hepatic Glycogen concentrations, total Glycogen Synthetic rate, and Glycogen Synthesis from [3H]Glucose were reduced ∼35% ( p ns), 56% ( p< 0.05), and 53% ( p< 0.05), respectively, compared with p.\n\ncaption (fig): fig.']	N/A	N/A	[('GO_0000237', 'leptotene', 0, 'Hepatic'), ('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_24384', 'glycogens', 8, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 8, 'glycogen synthesis'), ('CHEBI_29238', 'tritium atom', 33, '3H'), ('CHEBI_17234', 'glucose', 36, 'glucose'), ('UBERON_0002107', 'liver', 86, 'hepatic'), ('CHEBI_24384', 'glycogens', 94, 'glycogen'), ('CHEBI_24384', 'glycogens', 125, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 125, 'glycogen synthetic'), ('CHEBI_24384', 'glycogens', 154, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 154, 'glycogen synthesis'), ('CHEBI_29238', 'tritium atom', 179, '3H'), ('CHEBI_17234', 'glucose', 182, 'glucose')]
PMC3581200	3/2013	S147-PMC3581200	['Liver Tissue analyses and Glycogen Synthesis.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000479', 'tissue', 6, 'tissue'), ('CHEBI_24384', 'glycogens', 26, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 26, 'glycogen synthesis')]
PMC3581200	3/2013	S148-PMC3581200	['Glycogen concentrations at the end of study ( a ); net Glycogen Synthesis ( b ) (cold indicates the area under the curve of net Hepatic carbon retention during the clamp, and3h depos[deposition] indicates incorporation of3h from Glucose into Hepatic Glycogen, i.e., synthesis through the direct pathway); Gk protein Expressed relative to Β-Actin ( c ); catalytic gk activity ( d ) at near half-maximal and maximal velocity (in the presence of 8 mmol/l [solid bars] and 100 mmol/l [open bars] Glucose, respectively); Akt ( e ) and Gsk3Β ( f ) phosphorylation, expressed relative to total Akt and Gsk3Β protein, respectively; and activity ratios of gs ( g ), gp ( h ), and gs/gp ( i ) at the end of a 4-h hyperinsulinemic-hyperglycemic clamp in the presence of the portal signal.']	N/A	N/A	[('CHEBI_28087', 'glycogen', 0, 'Glycogen'), ('CHEBI_24384', 'glycogens', 55, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 55, 'glycogen synthesis'), ('UBERON_0002107', 'liver', 128, 'hepatic'), ('CHEBI_17234', 'glucose', 229, 'glucose'), ('UBERON_0002107', 'liver', 242, 'hepatic'), ('CHEBI_24384', 'glycogens', 250, 'glycogen'), ('PR_000008000', 'gap junction beta-4 protein', 305, 'GK'), ('GO_0010467', 'gene expression', 316, 'expressed'), ('PR_000003676', 'actin, cytoplasmic 1', 338, 'β-actin'), ('CHEBI_17234', 'glucose', 492, 'glucose'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 516, 'Akt'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 530, 'GSK3β'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 587, 'Akt'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 595, 'GSK3β')]
PMC3581200	3/2013	S155-PMC3581200	['the catalytic activity of Hepatic Gk did not differ between n and p or between p and p-hff (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'hepatic'), ('PR_000008000', 'gap junction beta-4 protein', 34, 'GK')]
PMC3581200	3/2013	S157-PMC3581200	['Hepatic phosphorylated Akt, Expressed relative to Akt (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 23, 'Akt'), ('GO_0010467', 'gene expression', 28, 'expressed'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 50, 'Akt')]
PMC3581200	3/2013	S181-PMC3581200	['selective sympathetic Hepatic denervation in the normal Dog impairs both Limbs of the response, reducing the enhancement of nhgu and preventing the suppression of non-hgu (29).']	N/A	N/A	[('UBERON_0002107', 'liver', 22, 'hepatic'), ('NCBITaxon_33208', 'Metazoa', 56, 'dog'), ('UBERON_0002101', 'limb', 73, 'limbs')]
PMC3581200	3/2013	S188-PMC3581200	['Hepatic gk catalyzes the rate-determining step in Regulation Of Hepatic Glucose Metabolism (35).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010906', 'regulation of glucose metabolic process', 50, 'regulation of ... glucose metabolism'), ('UBERON_0002107', 'liver', 64, 'hepatic'), ('CHEBI_17234', 'glucose', 72, 'glucose')]
PMC3581200	3/2013	S195-PMC3581200	['after a mixed meal, Hepatic Glycogen Synthetic rates are several times higher in Pregnant versus nonpregnant Dogs (5) and Rats (26).']	N/A	N/A	[('GO_0007568', 'aging', 20, 'hepatic'), ('UBERON_0002107', 'liver', 20, 'hepatic'), ('CHEBI_24384', 'glycogens', 28, 'glycogen'), ('GO_0005978', 'glycogen biosynthetic process', 28, 'glycogen synthetic'), ('GO_0007565', 'female pregnancy', 81, 'pregnant'), ('NCBITaxon_33208', 'Metazoa', 109, 'dogs'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 122, 'rats')]
PMC3581200	3/2013	S209-PMC3581200	['activity is increased (by as much as twice the rate in nonpregnant females) at 7, 16, and 21 days Gestation in Rats (42) but reduced as much as 50% during Pregnancy in Mice (43), with no information available regarding Human Liver gk activity during Pregnancy.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 98, 'gestation'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 111, 'rats'), ('GO_0007565', 'female pregnancy', 155, 'pregnancy'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 219, 'human'), ('UBERON_0002107', 'liver', 225, 'liver'), ('GO_0007565', 'female pregnancy', 250, 'pregnancy')]
PMC3581200	3/2013	S226-PMC3581200	['the Liver’s response to hyperinsulinemia, hyperglycemia, and portal Glucose Delivery was delayed and blunted during the third Trimester of normal Pregnancy.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('CHEBI_17234', 'glucose', 68, 'glucose'), ('GO_0007567', 'parturition', 76, 'delivery'), ('GO_0009294', 'DNA mediated transformation', 126, 'trimester'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC3586494	2/2013	S202-PMC3586494	['in addition, low protein-exposed offspring had increased Hepatic Triglycerides and Hepatic Expression of Lipogenic enzymes favoring Fat Synthesis.']	N/A	N/A	[('UBERON_0002107', 'liver', 57, 'hepatic'), ('CHEBI_17855', 'triglyceride', 65, 'triglycerides'), ('UBERON_0002107', 'liver', 83, 'hepatic'), ('GO_0010467', 'gene expression', 91, 'expression'), ('GO_0008610', 'lipid biosynthetic process', 105, 'lipogenic'), ('GO_0006634', 'hexadecanal biosynthetic process', 132, 'fat synthesis')]
PMC3586494	2/2013	S223-PMC3586494	['offspring of Sucrose-Fed dams displayed higher adiposity and increases in Triglyceride Liver content together with higher low-density lipoprotein (ldl) Cholesterol concentrations.']	N/A	N/A	[('CHEBI_17992', 'sucrose', 13, 'sucrose'), ('GO_0007631', 'feeding behavior', 21, 'fed'), ('CHEBI_17855', 'triglyceride', 74, 'triglyceride'), ('UBERON_0002107', 'liver', 87, 'liver'), ('CHEBI_16113', 'cholesterol', 152, 'cholesterol')]
PMC3586494	2/2013	S243-PMC3586494	['offspring of high fat diet dams also exhibited elevated Hepatic Expression of Gluconeogenic enzymes and transcription factors.']	N/A	N/A	[('UBERON_0002107', 'liver', 56, 'hepatic'), ('GO_0010467', 'gene expression', 64, 'expression'), ('GO_0006094', 'gluconeogenesis', 78, 'gluconeogenic')]
PMC3607807	3/2013	S83-PMC3607807	['(2003) in norway used a design which supplemented women from 18 weeks of Pregnancy until 3 months Postpartum with cod Liver oil containing 1183 mg Dha.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('GO_0007565', 'female pregnancy', 98, 'postpartum'), ('UBERON_0002107', 'liver', 118, 'liver'), ('CHEBI_17874', 'dihydrozeatin', 147, 'DHA')]
PMC3608974	2/2013	S51-PMC3608974	['Pelvic incidence and lordosis (anterior pelvic tilt).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Pelvic')]
PMC3610650	3/2013	S27-PMC3610650	['systemic Regulation Of Iron Absorption is achieved through Hepcidin (encoded by hamp ), a Liver-derived iron Regulatory hormone sensitive to Serum iron, iron stores and Erythroid signals[11].']	N/A	N/A	[('GO_0043921', 'modulation by host of viral transcription', 9, 'regulation of iron absorption'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 59, 'hepcidin'), ('UBERON_0002107', 'liver', 90, 'liver'), ('GO_0065007', 'biological regulation', 109, 'regulatory'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('CL_0000764', 'erythroid lineage cell', 169, 'erythroid')]
PMC3610650	3/2013	S37-PMC3610650	['copper injection alleviated copper deficiency anemia, reduced Tissue hypoxia and Modulated Hif-2Α and iron absorption Genes ( Slc40A1 , Slc11A2 , and cybrd1 ) independently of Intestinal iron levels or Liver hepcidin.']	N/A	N/A	[('UBERON_0000479', 'tissue', 62, 'tissue'), ('GO_0065007', 'biological regulation', 81, 'modulated'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 91, 'HIF-2α'), ('SO_0000704', 'gene', 118, 'genes'), ('PR_000015124', 'zinc transporter ZIP10', 126, 'Slc40a1'), ('PR_000014968', 'vesicular acetylcholine transporter', 136, 'Slc11a2'), ('UBERON_0000160', 'intestine', 176, 'intestinal'), ('UBERON_0002107', 'liver', 202, 'liver')]
PMC3610650	3/2013	S63-PMC3610650	['real-time pcr\nrna from Liver and Duodenum (strip of most proximal Duodenum, 2–3 mm in diameter) was extracted using rna Tissue midi kit (quiagen).']	N/A	N/A	[('UBERON_0002107', 'liver', 23, 'liver'), ('UBERON_0002114', 'duodenum', 33, 'duodenum'), ('UBERON_0002114', 'duodenum', 66, 'duodenum'), ('UBERON_0000479', 'tissue', 120, 'tissue')]
PMC3610650	3/2013	S89-PMC3610650	['iron and copper content was measured in the proximal Duodenum, Plasma and Liver using atomic absorption spectrometry.']	N/A	N/A	[('UBERON_0002114', 'duodenum', 53, 'duodenum'), ('UBERON_0001969', 'blood plasma', 63, 'plasma'), ('UBERON_0002107', 'liver', 74, 'liver')]
PMC3610650	3/2013	S96-PMC3610650	['(d) Liver Hamp1 mrna levels.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'Liver'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 10, 'Hamp1')]
PMC3610650	3/2013	S98-PMC3610650	['(e) Liver iron and copper concentrations.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'Liver')]
PMC3610650	3/2013	S144-PMC3610650	['these changes were concomitant with iron mobilization from the Liver (figure 1e).']	N/A	N/A	[('UBERON_0002107', 'liver', 63, 'liver')]
PMC3614838	9/2011	S3-PMC3614838	['in neonates, total Serum Triglyceride, total and individual Serum Fatty Acid concentrations, Hepatic Glut2 and Gk mrna and protein Expression were determined.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 19, 'serum'), ('CHEBI_17855', 'triglyceride', 25, 'triglyceride'), ('UBERON_0001977', 'blood serum', 60, 'serum'), ('CHEBI_35366', 'fatty acid', 66, 'fatty acid'), ('UBERON_0002107', 'liver', 93, 'hepatic'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 101, 'GLUT2'), ('PR_000008000', 'gap junction beta-4 protein', 111, 'GK'), ('GO_0010467', 'gene expression', 131, 'expression')]
PMC3614838	9/2011	S14-PMC3614838	['circulating ffa increase Hepatic Glucose output by increasing Gluconeogenesis or Glycogenolysis (8).']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'hepatic'), ('CHEBI_17234', 'glucose', 33, 'glucose'), ('GO_0006094', 'gluconeogenesis', 62, 'gluconeogenesis'), ('GO_0005981', 'regulation of glycogen catabolic process', 81, 'glycogenolysis')]
PMC3614838	9/2011	S19-PMC3614838	['Glucose Transporter 2 (Glut2) and glucokinase (gk) represent Glucose sensors that are functional in the Liver, Pancreatic Beta Cells, Kidneys and Brain.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('PR_000015060', 'solute carrier family 2, facilitated glucose transporter member 11', 0, 'Glucose transporter 2'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 23, 'GLUT2'), ('CHEBI_17234', 'glucose', 61, 'glucose'), ('UBERON_0002107', 'liver', 104, 'liver'), ('CL_0000169', 'type B pancreatic cell', 111, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 111, 'pancreatic'), ('UBERON_0002113', 'kidney', 134, 'kidneys'), ('UBERON_0000955', 'brain', 146, 'brain')]
PMC3614838	9/2011	S22-PMC3614838	['in addition, neonatal gender distribution, Liver, Pancreas and Heart weights were determined.']	N/A	N/A	[('UBERON_0002107', 'liver', 43, 'liver'), ('UBERON_0001264', 'pancreas', 50, 'pancreas'), ('UBERON_0000948', 'heart', 63, 'heart')]
PMC3614838	9/2011	S23-PMC3614838	['further, maternal Food Intake, body weight, Organ weights (Liver, Pancreas, Heart and Retroperitoneal fat), circulating Glucose, Insulin and glucagon concentrations were also measured.']	N/A	N/A	[('CHEBI_33290', 'food', 18, 'food'), ('GO_0007631', 'feeding behavior', 18, 'food intake'), ('UBERON_0000062', 'organ', 44, 'organ'), ('UBERON_0002107', 'liver', 59, 'liver'), ('UBERON_0001264', 'pancreas', 66, 'pancreas'), ('UBERON_0000948', 'heart', 76, 'heart'), ('UBERON_0003693', 'retroperitoneal space', 86, 'retroperitoneal'), ('CHEBI_17234', 'glucose', 120, 'glucose'), ('PR_000045358', 'insulin family protein', 129, 'insulin')]
PMC3614838	9/2011	S35-PMC3614838	['0.4-0.5 ml Intraperitonealy per 200-250 g Rat), the Liver, Pancreas, Heart and Retroperitoneal Fat were excised followed by exsanguation.']	N/A	N/A	[('UBERON_0003094', 'infraorbital lateral line', 11, 'intraperitonealy'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 42, 'rat'), ('UBERON_0002107', 'liver', 52, 'liver'), ('UBERON_0001264', 'pancreas', 59, 'pancreas'), ('UBERON_0000948', 'heart', 69, 'heart'), ('UBERON_0034749', 'retrolenticular part of internal capsule', 79, 'retroperitoneal fat')]
PMC3614838	9/2011	S36-PMC3614838	['the Liver, Pancreas, Heart and Retroperitoneal fat weights were weighed on a digital scale measuring up to 10-4 g (n=4 per group).']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('UBERON_0001264', 'pancreas', 11, 'pancreas'), ('UBERON_0000948', 'heart', 21, 'heart'), ('UBERON_0003693', 'retroperitoneal space', 31, 'retroperitoneal')]
PMC3614838	9/2011	S38-PMC3614838	['neonatal gender distribution, Blood sampling, Liver, Pancreas and Heart collection\nwithin 24 h of Birth, the gender was identified in the neonatal offspring.']	N/A	N/A	[('UBERON_0000178', 'blood', 30, 'blood'), ('UBERON_0002107', 'liver', 46, 'liver'), ('UBERON_0001264', 'pancreas', 53, 'pancreas'), ('UBERON_0000948', 'heart', 66, 'heart'), ('GO_0007567', 'parturition', 98, 'birth')]
PMC3614838	9/2011	S42-PMC3614838	['whole Liver was rapidly excised, weighed (n=38-56 per group) and then either snap-frozen at -800c for quantification of mrna expression (n=10 per group for quantitative real-time (rt)-pcr) or fixed in buffered Formalin for the determination of protein Expression (n=4 per group for immunohistochemistry and image analysis) of Glut2 and Gk.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('CHEBI_16842', 'formaldehyde', 210, 'formalin'), ('GO_0010467', 'gene expression', 252, 'expression'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 326, 'GLUT2'), ('PR_000008000', 'gap junction beta-4 protein', 336, 'GK')]
PMC3614838	9/2011	S53-PMC3614838	['quantitative rt-pcr\nwhole Liver was harvested and snap frozen at -80°c in liquid nitrogen for molecular biology studies.']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'liver')]
PMC3614838	9/2011	S54-PMC3614838	['Hepatic Tissue was homogenized for rna extraction with Tri-Reagent (sigma, st. louis, missouri).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('UBERON_0000479', 'tissue', 8, 'tissue'), ('14', 'AAMP (human)', 55, 'Tri'), ('CHEBI_33893', 'reagent', 59, 'reagent')]
PMC3614838	9/2011	S66-PMC3614838	['immunohistochemistry\nharvested Livers were fixed in 4% buffered Formaldehyde for 12 h, processed, embedded in paraffin Wax, sectioned and sections were mounted onto aminosaline (apes) coated slides.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'livers'), ('CHEBI_16842', 'formaldehyde', 64, 'formaldehyde'), ('CHEBI_73702', 'wax', 119, 'wax')]
PMC3614838	9/2011	S67-PMC3614838	['for immunohistochemical studies and image analysis (n=4 per group), Liver sections were immunostained for Glut2 (1:100; wak-chemie, bad soden, germany) and gk (1:100; a kind gift from prof shiota, vanderbilt university, tennessee).']	N/A	N/A	[('UBERON_0002107', 'liver', 68, 'liver'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 106, 'GLUT2')]
PMC3614838	9/2011	S76-PMC3614838	['the area of Glut2 and Gk immunoreactivity was expressed as a percentage of the total Hepatic Tissue per field.']	N/A	N/A	[('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 12, 'GLUT2'), ('PR_000008000', 'gap junction beta-4 protein', 22, 'GK'), ('UBERON_0002107', 'liver', 85, 'hepatic'), ('UBERON_0000479', 'tissue', 93, 'tissue')]
PMC3614838	9/2011	S92-PMC3614838	['maternal Organ weights\nno significant differences were found in either unadjusted or adjusted maternal Liver, Pancreas, Heart or Retroperitoneal fat weights (table2).']	N/A	N/A	[('UBERON_0000062', 'organ', 9, 'organ'), ('UBERON_0002107', 'liver', 103, 'liver'), ('UBERON_0001264', 'pancreas', 110, 'pancreas'), ('UBERON_0000948', 'heart', 120, 'heart'), ('UBERON_0003693', 'retroperitoneal space', 129, 'retroperitoneal')]
PMC3614838	9/2011	S93-PMC3614838	['caption (table-wrap): table 2\n\nmaternal Liver, Pancreas, Heart and Retroperitoneal fat weight (unadjusted and adjusted for body weight)control20f30f40fliver weight (g)9.71 ± 0.389.53 ± 0.2511.12 ± 0.3110.45 ± 0.52adjusted Liver weights3.389 ± 0.1143.745 ± 0.1553.531 ± 0.05453.347 ± 0.126pancreas weight (g)0.92 ± 0.191.13 ± 0.150.94 ± 0.161.14 ± 0.41adjusted Pancreas weights0.328 ± 0.0610.417 ± 0.0750.304 ± 0.0630.366 ± 0.138heart weight (g)0.91 ± 0.090.94 ± 0.070.99 ± 0.020.84 ± 0.04adjusted Heart weights0.317 ± 0.0250.346 ± 0.0120.315 ± 0.0130.271 ± 0.014retroperitoneal fat weight (g)6.20 ± 2.515.55 ± 0.976.94 ± 1.898.21 ± 0.67adjusted Retroperitoneal fat weights2.167 ± 0.8822.473 ± 0.3802.295 ± 0.6752.668 ± 0.324\ndata are means ± sem.']	N/A	N/A	[('UBERON_0002107', 'liver', 40, 'liver'), ('UBERON_0001264', 'pancreas', 47, 'pancreas'), ('UBERON_0000948', 'heart', 57, 'heart'), ('UBERON_0003693', 'retroperitoneal space', 67, 'retroperitoneal'), ('UBERON_0002107', 'liver', 222, 'liver'), ('UBERON_0001264', 'pancreas', 360, 'pancreas'), ('UBERON_0000948', 'heart', 497, 'heart'), ('UBERON_0003693', 'retroperitoneal space', 645, 'retroperitoneal')]
PMC3614838	9/2011	S105-PMC3614838	['caption (table-wrap): table 3\n\nneonatal gender distribution, Liver, Pancreas, Heart and Brain weights in neonatal Rats (unadjusted and adjusted for body weight)control20f30f40fmale (%)46.28 ± 4.9134.24 ± 13.1454.67 ± 2.8450.88 ± 8.58female (%)53.72 ± 4.9165.76 ± 13.1445.33 ± 2.8449.12 ± 8.58liver weights (g)0.200 ± 0.0050.215 ± 0.0080.220 ± 0.0080.225 ± 0.007adjusted Liver weights3.342 ± 0.0773.223 ± 0.0853.180 ± 0.0913.671 ± 0.111bcpancreas weights (g)0.0128 ± 0.00040.0147 ± 0.00070.0156 ± 0.00130.0139 ± 0.0005adjusted Pancreas weights0.214 ± 0.0070.225 ± 0.0130.232 ± 0.0240.228 ± 0.008heart weights (g)0.0343 ± 0.00070.0353 ± 0.00100.0355 ± 0.00110.0303 ± 0.0009abcadjusted Heart weights0.569 ± 0.0090.532 ± 0.0130.515 ± 0.013a0.492 ± 0.013abrain weights (g)0.217 ± 0.0060.196 ± 0.0070.225 ± 0.007bd0.199 ± 0.005 (11)adjusted Brain weights3.557 ± 0.1132.912 ± 0.146a3.175 ± 0.1313.258 ± 0.092\ndata are means ± sem.']	N/A	N/A	[('UBERON_0002107', 'liver', 61, 'liver'), ('UBERON_0001264', 'pancreas', 68, 'pancreas'), ('UBERON_0000948', 'heart', 78, 'heart'), ('UBERON_0000955', 'brain', 88, 'brain'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 114, 'rats'), ('UBERON_0002107', 'liver', 370, 'liver'), ('UBERON_0001264', 'pancreas', 526, 'pancreas'), ('UBERON_0000948', 'heart', 683, 'heart'), ('UBERON_0000955', 'brain', 835, 'brain')]
PMC3614838	9/2011	S109-PMC3614838	['there were no differences in neonatal Liver and Pancreas weights (table3).']	N/A	N/A	[('UBERON_0002107', 'liver', 38, 'liver'), ('UBERON_0001264', 'pancreas', 48, 'pancreas')]
PMC3614838	9/2011	S110-PMC3614838	['when adjusted for body weight, 40f neonates had increased Liver weights compared to the 20f and 30f neonates with no further differences amongst the groups.']	N/A	N/A	[('UBERON_0002107', 'liver', 58, 'liver')]
PMC3614838	9/2011	S130-PMC3614838	['neonatal Hepatic Glut2 and Gk mrna Expression and immunoreactivity\nneonatal Hepatic Glut2 mrna Expression was not altered after dietary fat exposure (fig.3a).']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'hepatic'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 17, 'GLUT2'), ('PR_000008000', 'gap junction beta-4 protein', 27, 'GK'), ('GO_0010467', 'gene expression', 35, 'expression'), ('UBERON_0002107', 'liver', 76, 'hepatic'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 84, 'GLUT2'), ('GO_0010467', 'gene expression', 95, 'expression')]
PMC3614838	9/2011	S134-PMC3614838	['caption (fig): figure 3\n\nneonatal Hepatic Glut2 and Gk mrna Expression and immunoreactivity.']	N/A	N/A	[('UBERON_0002107', 'liver', 34, 'hepatic'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 42, 'GLUT2'), ('PR_000008000', 'gap junction beta-4 protein', 52, 'GK'), ('GO_0010467', 'gene expression', 60, 'expression')]
PMC3614838	9/2011	S135-PMC3614838	['(a), neonatal Hepatic Glut2 mrna Expression; (b), neonatal Hepatic Glut2 immunoreactivity; (c), neonatal Hepatic Gk mrna Expression; (d), neonatal Hepatic Gk immunoreactivity.']	N/A	N/A	[('UBERON_0002107', 'liver', 14, 'hepatic'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 22, 'GLUT2'), ('GO_0010467', 'gene expression', 33, 'expression'), ('UBERON_0002107', 'liver', 59, 'hepatic'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 67, 'GLUT2'), ('UBERON_0002107', 'liver', 105, 'hepatic'), ('PR_000008000', 'gap junction beta-4 protein', 113, 'GK'), ('GO_0010467', 'gene expression', 121, 'expression'), ('UBERON_0002107', 'liver', 147, 'hepatic'), ('PR_000008000', 'gap junction beta-4 protein', 155, 'GK')]
PMC3614838	9/2011	S153-PMC3614838	['altered Organ weights (Liver, Pancreas, Heart and Brain) presented after adjustment for body weight.']	N/A	N/A	[('UBERON_0000062', 'organ', 8, 'organ'), ('UBERON_0002107', 'liver', 23, 'liver'), ('UBERON_0001264', 'pancreas', 30, 'pancreas'), ('UBERON_0000948', 'heart', 40, 'heart'), ('UBERON_0000955', 'brain', 50, 'brain')]
PMC3616124	4/2013	S6-PMC3616124	['the primary outcome was severe pah, or mild or severe pah with elevated Liver enzymes, elevated Serum creatinine, thrombocytopenia, eclampsia, fetal growth restriction, medically indicated Preterm Birth or Perinatal death.']	N/A	N/A	[('UBERON_0002107', 'liver', 72, 'liver'), ('UBERON_0001977', 'blood serum', 96, 'serum'), ('GO_0007565', 'female pregnancy', 189, 'preterm'), ('GO_0007567', 'parturition', 197, 'birth'), ('GO_0036268', 'swimming', 206, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 206, 'perinatal')]
PMC3616124	4/2013	S61-PMC3616124	['outcomes\nthe primary outcome was severe pah, or mild or severe pah with elevated Liver enzymes (aspartate aminotransferase ≥100 u per liter), elevated Serum creatinine (≥1.5 mg/dl), thrombocytopenia (<100,000 Platelets/mm3), eclampsia, fetal growth restriction (<3rdcentile adjusted for sex and race/ethnicity), medically indicated Preterm Birth before 32 weeks due to pah, or fetal death after 20 weeks Gestation, or neonatal death.']	N/A	N/A	[('UBERON_0002107', 'liver', 81, 'liver'), ('UBERON_0001977', 'blood serum', 151, 'serum'), ('CL_0000233', 'platelet', 209, 'platelets'), ('GO_0007565', 'female pregnancy', 332, 'preterm'), ('GO_0007567', 'parturition', 340, 'birth'), ('GO_0007565', 'female pregnancy', 404, 'gestation')]
PMC3616124	4/2013	S103-PMC3616124	['the case-control cohort included all remaining subjects who developed the primary outcome only (severe pah, or mild or severe pah with elevated Liver enzymes, elevated Serum creatinine, thrombocytopenia, eclampsia, fetal growth restriction, medically indicated Preterm Birth or Perinatal death) (n\u200a=\u200a190), Preeclampsia only (n\u200a=\u200a280), or the primary outcome and Preeclampsia (n\u200a=\u200a233), and 1,406 controls matched for center and race/ethnicity.']	N/A	N/A	[('UBERON_0002107', 'liver', 144, 'liver'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('GO_0007565', 'female pregnancy', 261, 'preterm'), ('GO_0007567', 'parturition', 269, 'birth'), ('GO_0036268', 'swimming', 278, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 278, 'perinatal'), ('GO_0007128', 'meiotic prophase I', 306, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 362, 'preeclampsia')]
PMC3616124	4/2013	S128-PMC3616124	['the primary outcome was severe pah, or mild or severe pah with elevated Liver enzymes, elevated Serum creatinine, thrombocytopenia, eclampsia, fetal growth restriction, medically indicated Preterm Birth or Perinatal death.']	N/A	N/A	[('UBERON_0002107', 'liver', 72, 'liver'), ('UBERON_0001977', 'blood serum', 96, 'serum'), ('GO_0007565', 'female pregnancy', 189, 'preterm'), ('GO_0007567', 'parturition', 197, 'birth'), ('GO_0036268', 'swimming', 206, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 206, 'perinatal')]
PMC3616124	4/2013	S213-PMC3616124	['*adjusted for treatment group (Vitamins vs. placebo), age, race/ethnicity, education, Vitamin use prior to randomization, and diastolic Blood pressure at randomization.†the primary outcome was severe pah, or mild or severe pah with elevated Liver enzymes, elevated Serum creatinine, thrombocytopenia, eclamptic seizure, fetal growth restriction, medically indicated Preterm Birth or Perinatal death.']	N/A	N/A	[('CHEBI_33277', 'gamma-tocotrienol', 31, 'vitamins'), ('CHEBI_33229', 'vitamin (role)', 86, 'vitamin'), ('UBERON_0000178', 'blood', 136, 'blood'), ('UBERON_0002107', 'liver', 241, 'liver'), ('UBERON_0001977', 'blood serum', 265, 'serum'), ('GO_0007565', 'female pregnancy', 366, 'preterm'), ('GO_0007567', 'parturition', 374, 'birth'), ('GO_0036268', 'swimming', 383, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 383, 'perinatal')]
PMC3635203	2/2013	S68-PMC3635203	['thirteen commonly used Vitamin, Mineral and cod Liver oil/fish oil supplements were pre-coded and followed by 6 open-ended spaces where the women were asked to record the name and manufacturer of the supplement(s) used, but not listed.']	N/A	N/A	[('CHEBI_33229', 'vitamin (role)', 23, 'vitamin'), ('CHEBI_46662', 'mineral', 32, 'mineral'), ('UBERON_0002107', 'liver', 48, 'liver')]
PMC3639110	4/2013	S47-PMC3639110	['Choline in the diet that reaches the Large Intestine (it is normally absorbed in the Small Intestine) can be converted by Gut microbes to form trimethylamine (tma) which is then absorbed and oxidized in the Liver to form trimethylamine Oxide (Tmao).']	N/A	N/A	[('CHEBI_15354', 'choline', 0, 'Choline'), ('UBERON_0000059', 'large intestine', 37, 'large intestine'), ('UBERON_0002108', 'small intestine', 85, 'small intestine'), ('UBERON_0001555', 'digestive tract', 122, 'gut'), ('UBERON_0002107', 'liver', 207, 'liver'), ('CHEBI_25741', 'oxide', 236, 'oxide'), ('CHEBI_32149', 'sodium sulfate', 243, 'TMAO')]
PMC3650171	2/2013	S101-PMC3650171	['in the Adult male offspring of dams Fed a protein-restricted diet, 311 Genes in the Liver differed significantly from those in the offspring of control dams, as determined by the agilent 014879 whole Rat Genome array (agilent technologies, santa clara, ca) [64].']	N/A	N/A	[('UBERON_0007023', 'adult organism', 7, 'adult'), ('GO_0007631', 'feeding behavior', 36, 'fed'), ('SO_0000704', 'gene', 71, 'genes'), ('UBERON_0002107', 'liver', 84, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 200, 'rat'), ('SO_0001026', 'genome', 204, 'genome')]
PMC3650171	2/2013	S119-PMC3650171	['for example, the offspring of Rat dams Fed a protein-restricted diet had lower levels of Cpg Methylation and greater Expression of the Peroxisome Proliferators-Activated receptor (Ppar) Α and Glucocorticoid receptor (gr) Genes in the Liver than control Animals [77].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 30, 'rat'), ('GO_0007631', 'feeding behavior', 39, 'fed'), ('GO_0010424', 'DNA methylation on cytosine within a CG sequence', 89, 'CpG methylation'), ('GO_0010467', 'gene expression', 117, 'expression'), ('GO_0005777', 'peroxisome', 135, 'peroxisome'), ('PR_000024990', 'type II interferon', 146, 'proliferators-activated'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 180, 'PPAR ... α'), ('CHEBI_24261', 'glucocorticoid', 192, 'glucocorticoid'), ('SO_0000704', 'gene', 221, 'genes'), ('UBERON_0002107', 'liver', 234, 'liver'), ('NCBITaxon_33208', 'Metazoa', 253, 'animals')]
PMC3653849	5/2013	S2-PMC3653849	['in this study, 14 primiparous purebred meishan sows were Fed either standard- (sp, 12% crude protein) or low-protein (lp; 6% crude protein) diets throughout Gestation, and the Hepatic Expression and transcriptional Regulation of mtdna-encoded oxphos Genes were analyzed in newborn Piglets.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 57, 'fed'), ('GO_0007565', 'female pregnancy', 157, 'gestation'), ('UBERON_0002107', 'liver', 176, 'hepatic'), ('GO_0010467', 'gene expression', 184, 'expression'), ('GO_0065007', 'biological regulation', 215, 'regulation'), ('SO_0000704', 'gene', 250, 'genes'), ('NCBITaxon_33208', 'Metazoa', 281, 'piglets')]
PMC3653849	5/2013	S29-PMC3653849	['bw, body weight; d, diet; lp, low protein; lw: Liver weight; s, sex; sp, standard protein; t3, Triiodothyronine; t4, thyronine.']	N/A	N/A	[('UBERON_0002107', 'liver', 47, 'liver'), ('CHEBI_28909', 'iprodione', 95, 'Triiodothyronine')]
PMC3653849	5/2013	S30-PMC3653849	['the content of atp, adp, Amp, nad, nadh and mtdna copy number in Liver\nHepatic nadh concentration ( p<0.01), as well as the ratio of nadh to nad ( p<0.01), were significantly higher in lp piglets compared with sp piglets (table 2).']	N/A	N/A	[('CHEBI_16027', "adenosine 5'-monophosphate", 25, 'AMP'), ('UBERON_0002107', 'liver', 65, 'liver'), ('UBERON_0002107', 'liver', 71, 'Hepatic')]
PMC3653849	5/2013	S37-PMC3653849	['mtdna, Mitochondrial Dna.10.1371/journal.pone.0063855.t002\n\ncaption (table-wrap): table 2\neffect of maternal lp diet on Hepatic atp, adp, Amp, nadh and nad in newborn Piglets.parametermalefemale2-way anova p-valuesplpsplpdsd × satp µmol/g, Liver 1.48±0.121.55±0.111.22±0.091.69±0.220.060.640.17adp µmol/g, Liver 1.18±0.161.42±0.211.12±0.181.32±0.140.250.690.93Amp µmol/g, Liver 4.91±0.59ab6.12±0.26a5.99±0.75a3.32±0.81b0.310.230.01ec0.36±0.01ab0.32±0.01b0.29±0.03b0.47±0.08a0.760.280.01nadh µmol/g, Liver 0.40±0.090.69±0.060.36±0.100.65±0.040.010.660.97nad µmol/g, Liver 3.45±0.263.73±0.243.87±0.263.38±0.180.660.900.14nadh/nad0.10±0.020.16±0.010.08±0.020.17±0.010.010.830.50\nvalues are mean ± sem, means without a common letter differ, p<0.05.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 7, 'mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 7, 'mitochondrial DNA'), ('UBERON_0002107', 'liver', 120, 'hepatic'), ('CHEBI_16027', "adenosine 5'-monophosphate", 138, 'AMP'), ('NCBITaxon_33208', 'Metazoa', 167, 'piglets'), ('UBERON_0002107', 'liver', 240, 'liver'), ('UBERON_0002107', 'liver', 306, 'liver'), ('CHEBI_75599', 'EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor', 358, '93AMP'), ('UBERON_0002107', 'liver', 372, 'liver'), ('UBERON_0002107', 'liver', 499, 'liver'), ('UBERON_0002107', 'liver', 565, 'liver')]
PMC3653849	5/2013	S40-PMC3653849	['Mitochondrial Dna-encoded mrna Expression and Cytochrome C oxidase (cox) enzyme activity\nthe mrna abundances of 13 Genes involved in Hepatic oxphos were determined by real-time pcr, and a sexual dimorphic response of these Genes to maternal lp diet was observed in the Liver of newborn Piglets.']	N/A	N/A	[('GO_0005739', 'mitochondrion', 0, 'Mitochondrial'), ('SO_0001032', 'mitochondrial_DNA', 0, 'Mitochondrial DNA'), ('GO_0010467', 'gene expression', 31, 'expression'), ('CHEBI_18070', 'cytochrome c', 46, 'cytochrome c'), ('PR_000002199', 'cytochrome c protein', 46, 'cytochrome c'), ('SO_0000704', 'gene', 115, 'genes'), ('UBERON_0002107', 'liver', 133, 'hepatic'), ('SO_0000704', 'gene', 223, 'genes'), ('UBERON_0002107', 'liver', 269, 'liver'), ('NCBITaxon_33208', 'Metazoa', 286, 'piglets')]
PMC3653849	5/2013	S41-PMC3653849	['among these Genes, Cox1 ( p<0.05), Cox2 ( p<0.05), Cox3 ( p<0.05), Nadh dehydrogenase Subunit 3 ( Nd3 ) ( p<0.05) and Cytochrome B ( Cytb ) ( p<0.05) were significantly up-regulated in the Liver of lp males compared to sp males (figure 2a), but no difference was observed in females (figure 2b).']	N/A	N/A	[('SO_0000704', 'gene', 12, 'genes'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 19, 'COX1'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 35, 'COX2'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 51, 'COX3'), ('CHEBI_13389', 'NAD', 67, 'NADH'), ('PR_000015308', 'zinc finger protein SNAI1', 86, 'subunit 3'), ('PR_000011040', 'nuclear receptor coactivator 1', 98, 'ND3'), ('CHEBI_38551', 'cytochrome b', 118, 'cytochrome b'), ('PR_000002311', 'caspase-2', 118, 'cytochrome b'), ('PR_000006090', 'cytoplasmic FMR1-interacting protein 1', 133, 'CYTB'), ('UBERON_0002107', 'liver', 189, 'liver')]
PMC3653849	5/2013	S43-PMC3653849	['(a) Expression of mtdna-encoded Genes in Liver of male newborn piglets.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'Expression'), ('SO_0000704', 'gene', 32, 'genes'), ('UBERON_0002107', 'liver', 41, 'liver')]
PMC3653849	5/2013	S44-PMC3653849	['(b) Expression of mtdna-encoded Genes in Liver of female newborn piglets.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'Expression'), ('SO_0000704', 'gene', 32, 'genes'), ('UBERON_0002107', 'liver', 41, 'liver')]
PMC3653849	5/2013	S45-PMC3653849	['(c) cox enzyme activity in Liver of both male and female newborn piglets.']	N/A	N/A	[('UBERON_0002107', 'liver', 27, 'liver')]
PMC3653849	5/2013	S49-PMC3653849	['Hepatic gr Expression and gr binding to the control region of mtdna\ngr mrna Expression was significantly up-regulated ( p<0.05) in the Liver of both male and female lp piglets (figure 3a).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010467', 'gene expression', 11, 'expression'), ('GO_0010467', 'gene expression', 76, 'expression'), ('UBERON_0002107', 'liver', 135, 'liver')]
PMC3653849	5/2013	S51-PMC3653849	['(a) Hepatic gr Gene Expression in both male and female newborn piglets.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'Hepatic'), ('GO_0010467', 'gene expression', 15, 'gene expression'), ('SO_0000704', 'gene', 15, 'gene')]
PMC3653849	5/2013	S52-PMC3653849	['(b) the content of Hepatic gr protein in both male and female newborn piglets.']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'hepatic')]
PMC3653849	5/2013	S59-PMC3653849	['lp males responded with significantly higher ( p<0.01) gr binding, whereas lp females demonstrated significantly reduced ( p<0.01) gr binding to the control region of mtdna, compared to their sp counterparts of the same gender, respectively.10.1371/journal.pone.0063855.g004\n\ncaption (fig): figure 4\nthe levels of gr binding and 5(h)mc modifications on mtdna Promoter in the Liver of newborn Piglets.']	N/A	N/A	[('SO_0000167', 'promoter', 359, 'promoter'), ('UBERON_0002107', 'liver', 375, 'liver'), ('NCBITaxon_33208', 'Metazoa', 392, 'piglets')]
PMC3653849	5/2013	S84-PMC3653849	['elevated nadh/Nad ratio favors Free Radical Production[35], inhibits Tca Cycle and Fatty Acid Oxidation[36],[37], while increases the generation of Lactate for Hepatic Gluconeogenesis[38].']	N/A	N/A	[('GO_0036367', 'light adaption', 14, 'NAD'), ('CHEBI_26519', 'radical', 31, 'free radical'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 31, 'free radical production'), ('GO_0006099', 'tricarboxylic acid cycle', 69, 'TCA cycle'), ('CHEBI_35366', 'fatty acid', 83, 'fatty acid'), ('GO_0019395', 'fatty acid oxidation', 83, 'fatty acid oxidation'), ('CHEBI_24996', 'lactate', 148, 'lactate'), ('GO_0007568', 'aging', 160, 'hepatic'), ('UBERON_0002107', 'liver', 160, 'hepatic'), ('GO_0006094', 'gluconeogenesis', 168, 'gluconeogenesis')]
PMC3653849	5/2013	S134-PMC3653849	['Blood was collected immediately, and the Liver (without the Gall Bladder) samples were snap-frozen in liquid nitrogen immediately and stored at −80°c for further analysis.10.1371/journal.pone.0063855.t003\n\ncaption (table-wrap): table 3\ncomposition and Nutrient content of experimental diets.splpingredient ( g/kg )corn580528soybean meal1200bran150110bone meal105corn sugar100270cahpo407fiber11010attapulgite030premix24040calculated compositiondigestible energy ( mj/kg )13.113.1crude protein (%)12.16.1crude fiber (%)2.72.3n-free extracts640.7713.0cp135.967.7protein∶Carbohydrate31∶10.51∶4.7Calcium (%)1.21.2phosphorous (%)0.40.4\nthe fiber concentrate arbocel®was purchased from jrs (germany)\nthe premix contains (per kilogram): Vitamin a: 72 mg; Cholecalciferol.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002107', 'liver', 41, 'liver'), ('UBERON_0002110', 'gall bladder', 60, 'gall bladder'), ('CHEBI_33284', 'nutrient', 252, 'nutrient'), ('CHEBI_52472', 'alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-D-GlcpNAc', 567, 'carbohydrate31'), ('CHEBI_24870', 'ion', 581, '∶'), ('CHEBI_33325', 'radium atom', 590, '7Calcium'), ('CHEBI_33229', 'vitamin (role)', 729, 'vitamin'), ('CHEBI_52550', 'theopalauamide', 747, 'cholecalciferol')]
PMC3653849	5/2013	S138-PMC3653849	['measurement of atp, adp, amp, nad and nadh levels in Liver\nconcentrations of amp, adp, atp, nad, and nadh in Liver were determined according to previous publications with some modifications[60],[61].']	N/A	N/A	[('UBERON_0002107', 'liver', 53, 'liver'), ('UBERON_0002107', 'liver', 109, 'liver')]
PMC3653849	5/2013	S139-PMC3653849	['Tissue extracts were prepared from frozen Liver using 0.6 m Perchloric Acid, and the extracts were centrifuged at 10,000× g for 10 min at 4°c.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('UBERON_0002107', 'liver', 42, 'liver'), ('CHEBI_29221', 'perchloric acid', 60, 'perchloric acid')]
PMC3653849	5/2013	S146-PMC3653849	['determination of mtdna copy number\ntotal Genomic dna was isolated from Liver samples and the mtdna copy number was determined using real-time pcr as previously described with some modifications[62].']	N/A	N/A	[('SO_0001026', 'genome', 41, 'genomic'), ('UBERON_0002107', 'liver', 71, 'liver')]
PMC3653849	5/2013	S148-PMC3653849	["relative mtdna copy number was calculated with 2−δδctmethod[63].10.1371/journal.pone.0063855.t004\n\ncaption (table-wrap): table 4\nPrimers.namesequenceproduct (Bp)mrna Expression \u2003Cox1 F: tggtgcctgagcaggaatagtg88r: atcatcgccaagtagggttccg \u2003Cox2 F: gcttccaagacgccacttcac154r: tgggcatccattgtgctagtgt \u2003Cox3 F: ggctacagggtttcacgggttg130r: tcagtatcaggctgcggcttca \u2003nd3 f: agcacgcctcccattctcaat172r: tgctaggcttgctgctagtagg \u2003cytb F: ctgaggagctacggtcatcaca162r: gctgcgagggcggtaatgat \u2003nd1 F: tcctactggccgtagcattcct165r: ttgaggatgtggctggtcgtag \u2003nd2 F: atcggagggtgaggagggctaa191r: gttgtggttgctgagctgtgga \u2003nd4l f: gatcgcccttgcagggttactt182r: ctagtgcagcttcgcaggct \u2003nd4 f: tcgcctattcatcagtaagtca174r: ggattatggttcggctgtgta \u2003nd5 F: cggatgagaaggcgtaggaa103r: gcggttgtataggattgcttgt \u2003nd6 F: actgctatggctactgagatgt124r: cttcctcttccttcaacgcata \u2003Atp8 F: tgccacaactagatacatcc107r: gcttgctgggtatgagtag \u2003atp6 F: actcattcacacccaccacaca232r: cctgctgtaatgttggctgtca \u2003ppia f: gactgagtggttggatgg116r: tgatcttcttgctggtcttmtdna copy number, medip and chip \u2003g6pc F: aagccaagcgaaggtgtgagc165r: ggaacgggaaccacttgctgagmpf: acacaccctataacgccttgcc149r: gggtaggtgcctgctttcgtag\nAtp8 , Atp Synthase F0 Subunit 8; Atp6 : Atp Synthase F0 Subunit 6; Cox1 , Cytochrome C Oxidase Subunit 1; Cox2 , Cytochrome C oxidase subunit 2; Cox3 , Cytochrome C Oxidase Subunit 3, Cytb , Cytochrome B; g6pc , Glucose-6-phosphatase; mp, Mitochondrial dna Promoter; Nd1 , Nadh Dehydrogenase Subunit 1; Nd2 , nadh dehydrogenase Subunit 2; Nd3 , Nadh Dehydrogenase Subunit 3; Nd4 , Nadh Dehydrogenase Subunit 4; Nd4L , Nadh Dehydrogenase Subunit 4 L; Nd5 , nadh dehydrogenase subunit 5; Nd6 , Nadh Dehydrogenase Subunit 6; Ppia , Peptidylprolyl Isomerase A.\n\nrna isolation, cdna synthesis and real-time pcr\ntotal rna was isolated from Liver samples using trizol Reagent (15596026, invitrogen) according to the manufacturer's instructions and Reverse Transcribed with the primescript 1st strand cdna synthesis kit (d6110a, takara)."]	N/A	N/A	[('SO_0000112', 'primer', 129, 'Primers'), ('SO_0000028', 'base_pair', 158, 'bp'), ('GO_0010467', 'gene expression', 166, 'expression'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 178, 'COX1'), ('SO_0001030', 'forward', 183, 'F'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 237, 'COX2'), ('SO_0001030', 'forward', 242, 'F'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 296, 'COX3'), ('SO_0001030', 'forward', 301, 'F'), ('SO_0001030', 'forward', 419, 'F'), ('SO_0001030', 'forward', 476, 'F'), ('SO_0001030', 'forward', 535, 'F'), ('SO_0001030', 'forward', 710, 'F'), ('SO_0001030', 'forward', 767, 'F'), ('PR_000004409', 'autophagy-related protein 16-1', 822, 'ATP8'), ('SO_0001030', 'forward', 827, 'F'), ('SO_0001030', 'forward', 882, 'F'), ('SO_0001030', 'forward', 1028, 'F'), ('PR_000004409', 'autophagy-related protein 16-1', 1136, 'ATP8'), ('PR_000004516', 'aurora kinase A-interacting protein', 1143, 'ATP synthase F0 subunit 8'), ('PR_000004450', 'calcium-transporting ATPase type 2C member 2', 1170, 'ATP6'), ('PR_000004516', 'aurora kinase A-interacting protein', 1177, 'ATP synthase F0 subunit 6'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 1204, 'COX1'), ('CHEBI_18070', 'cytochrome c', 1211, 'cytochrome c'), ('PR_000005960', 'cysteine-rich protein 2-binding protein', 1211, 'cytochrome c oxidase subunit 1'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 1243, 'COX2'), ('CHEBI_18070', 'cytochrome c', 1250, 'cytochrome c'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 1282, 'COX3'), ('CHEBI_18070', 'cytochrome c', 1289, 'cytochrome c'), ('PR_000005991', 'cTAGE family member 4', 1289, 'cytochrome c oxidase subunit 3'), ('PR_000006090', 'cytoplasmic FMR1-interacting protein 1', 1321, 'CYTB'), ('CHEBI_38551', 'cytochrome b', 1328, 'cytochrome b'), ('PR_000002311', 'caspase-2', 1328, 'cytochrome b'), ('CHEBI_79307', 'glas#26', 1349, 'glucose-6'), ('GO_0005739', 'mitochondrion', 1376, 'mitochondrial'), ('SO_0000167', 'promoter', 1394, 'promoter'), ('PR_000011040', 'nuclear receptor coactivator 1', 1404, 'ND1'), ('PR_000011039', 'nicalin', 1410, 'NADH dehydrogenase subunit 1'), ('PR_000011040', 'nuclear receptor coactivator 1', 1440, 'ND2'), ('PR_000028799', 'tubulin', 1465, 'subunit 2'), ('PR_000011040', 'nuclear receptor coactivator 1', 1476, 'ND3'), ('PR_000011039', 'nicalin', 1482, 'NADH dehydrogenase subunit 3'), ('PR_000011040', 'nuclear receptor coactivator 1', 1512, 'ND4'), ('PR_000011039', 'nicalin', 1518, 'NADH dehydrogenase subunit 4'), ('PR_000011279', 'neuromedin-B', 1548, 'ND4L'), ('PR_000011049', 'nicastrin', 1555, 'NADH dehydrogenase subunit 4 L'), ('PR_000011040', 'nuclear receptor coactivator 1', 1587, 'ND5'), ('PR_000011040', 'nuclear receptor coactivator 1', 1623, 'ND6'), ('PR_000011039', 'nicalin', 1629, 'NADH dehydrogenase subunit 6'), ('PR_000013058', 'peroxisome proliferator-activated receptor gamma', 1659, 'PPIA'), ('CHEBI_50099', '(4-chloro-2-methylphenoxy)acetic acid', 1666, 'peptidylprolyl'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1666, 'peptidylprolyl isomerase A'), ('UBERON_0002107', 'liver', 1771, 'liver'), ('CHEBI_33893', 'reagent', 1798, 'Reagent'), ('GO_0001171', 'reverse transcription', 1878, 'reverse transcribed')]
PMC3653849	5/2013	S152-PMC3653849	['cox enzyme activity assay\nLiver Mitochondria were isolated according to a previously described protocol with some modifications[64].']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'Liver'), ('GO_0005739', 'mitochondrion', 32, 'mitochondria')]
PMC3653849	5/2013	S153-PMC3653849	['two hundred micrograms of frozen Liver samples were homogenized in a dounce homogenizer with 20 strokes using the isolation buffer (w∶v\u200a=\u200a1∶5) containing 0.1 m Tris–Mops, 0.1 m egta/Tris, and 1 m Sucrose (ph 7.4), and protease inhibitor cocktail (11697498001, roche) was added to the isolation buffer.']	N/A	N/A	[('UBERON_0002107', 'liver', 33, 'liver'), ('CHEBI_9754', 'tris', 160, 'Tris'), ('CHEBI_39074', 'MOPS', 165, 'MOPS'), ('CHEBI_9754', 'tris', 182, 'Tris'), ('CHEBI_17992', 'sucrose', 196, 'sucrose')]
PMC3653849	5/2013	S161-PMC3653849	['cox activity in Liver Mitochondria was determined according to the instruction of a commercial kit (gms10014.2, genmed scientifics, inc.).']	N/A	N/A	[('UBERON_0002107', 'liver', 16, 'liver'), ('GO_0005739', 'mitochondrion', 22, 'mitochondria')]
PMC3653849	5/2013	S173-PMC3653849	['briefly, 200 mg of frozen Liver samples were ground in liquid nitrogen and washed with phosphate-buffered saline containing protease inhibitor Cocktail (11697498001, roche).']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'liver'), ('CHEBI_60004', 'mixture', 143, 'cocktail')]
PMC3654972	5/2013	S8-PMC3654972	['there were considerable differences in Hepatic maternal and fetal iron content between strains.']	N/A	N/A	[('UBERON_0002107', 'liver', 39, 'hepatic')]
PMC3654972	5/2013	S43-PMC3654972	['Placentas and maternal and fetal Livers were removed, weighed and snap frozen in liquid nitrogen, and stored at −80°c until analysis.']	N/A	N/A	[('UBERON_0001987', 'placenta', 0, 'Placentas'), ('UBERON_0002107', 'liver', 33, 'livers')]
PMC3654972	5/2013	S54-PMC3654972	['rna was extracted from snap-frozen Placenta and Liver Tissue by the trizol procedure (invitrogen, uk) and subjected to dnase treatment (promega, uk), Phenol-Chloroform extraction and Ethanol precipitation.']	N/A	N/A	[('UBERON_0001987', 'placenta', 35, 'placenta'), ('UBERON_0002107', 'liver', 48, 'liver'), ('UBERON_0000479', 'tissue', 54, 'tissue'), ('CHEBI_15882', 'phenol', 150, 'phenol'), ('CHEBI_35255', 'chloroform', 157, 'chloroform'), ('CHEBI_16236', 'ethanol', 183, 'ethanol')]
PMC3654972	5/2013	S71-PMC3654972	['blots were probed with the following anti-Rat Antibodies: tfr diluted 1:1000 (serotec) for both fetal Liver and Placental samples, ferroportin (alpha diagnostics) diluted 1:30,000 for Placental samples and 1:700 for fetal Liver samples, Tubulin (abcam, uk) diluted 1:60,000 for both fetal Liver and Placental samples.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 42, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0001987', 'placenta', 112, 'placental'), ('UBERON_0001987', 'placenta', 184, 'placental'), ('UBERON_0002107', 'liver', 222, 'liver'), ('PR_000016845', 'twinfilin-2', 237, 'Tubulin'), ('UBERON_0002107', 'liver', 289, 'liver'), ('UBERON_0001987', 'placenta', 299, 'placental')]
PMC3654972	5/2013	S91-PMC3654972	['Maternal and Fetal Liver and Placental iron content\nin both strains of Rat, the iron content of the maternal Liver was significantly lower in Animals Fed a low iron diet (diet effect: p<0.001, figure\u20091a), being decreased by 52% in wistar Rats and 48% in rhl Rats.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0000922', 'embryo', 13, 'fetal'), ('UBERON_0002107', 'liver', 19, 'liver'), ('UBERON_0001987', 'placenta', 29, 'placental'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 71, 'rat'), ('UBERON_0002107', 'liver', 109, 'liver'), ('NCBITaxon_33208', 'Metazoa', 142, 'animals'), ('GO_0007631', 'feeding behavior', 150, 'fed'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 238, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 258, 'rats')]
PMC3654972	5/2013	S93-PMC3654972	['similarly, the iron content of the fetal Liver was significantly lower in Animals exposed to a low iron diet in utero (diet effect: p<0.01, figure\u20091b), being decreased by 51% in both strains of Rat.']	N/A	N/A	[('UBERON_0002107', 'liver', 41, 'liver'), ('NCBITaxon_33208', 'Metazoa', 74, 'animals'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 194, 'rat')]
PMC3654972	5/2013	S94-PMC3654972	['in contrast to the maternal Livers, wistar fetuses had significantly lower Liver iron content than those of the rhl strain (strain effect: p<0.01, figure\u20091b).']	N/A	N/A	[('UBERON_0002107', 'liver', 28, 'livers'), ('UBERON_0002107', 'liver', 75, 'liver')]
PMC3654972	5/2013	S95-PMC3654972	['caption (fig): figure 1\n\nmaternal and fetal Liver iron content.']	N/A	N/A	[('UBERON_0002107', 'liver', 44, 'liver')]
PMC3654972	5/2013	S96-PMC3654972	['maternal ( a ) and fetal ( b ) Liver iron content at day 21 of Gestation in rowett hooded lister (rhl) and wistar Rats exposed to a control or low iron diet prior to and during Pregnancy.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'liver'), ('GO_0007565', 'female pregnancy', 63, 'gestation'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 114, 'rats'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
PMC3654972	5/2013	S106-PMC3654972	['maternal Liver Iron Homeostasis\nExpression of tfr mrna in the maternal Liver was significantly greater in Animals Fed a low iron diet prior to and during Gestation (figure\u20093a, diet effect: p<0.001), with Expression tending to be higher in wistar compared to rhl Rats (figure\u20093a, strain effect: p=0.058).']	N/A	N/A	[('GO_0008611', 'ether lipid biosynthetic process', 9, 'liver'), ('UBERON_0002107', 'liver', 9, 'liver'), ('GO_0055090', 'acylglycerol homeostasis', 15, 'iron homeostasis'), ('GO_0010467', 'gene expression', 32, 'Expression'), ('UBERON_0002107', 'liver', 71, 'liver'), ('NCBITaxon_33208', 'Metazoa', 106, 'animals'), ('GO_0007631', 'feeding behavior', 114, 'fed'), ('GO_0007565', 'female pregnancy', 154, 'gestation'), ('GO_0010467', 'gene expression', 204, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 262, 'rats')]
PMC3654972	5/2013	S107-PMC3654972	['Expression of Hepcidin mrna in the maternal Liver was significantly reduced in Rats Fed a low iron diet prior to and during Gestation to the extent that Expression was barely detectable (figure\u20093b, diet effect: p<0.001).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 14, 'hepcidin'), ('UBERON_0002107', 'liver', 44, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 79, 'rats'), ('GO_0007631', 'feeding behavior', 84, 'fed'), ('GO_0007565', 'female pregnancy', 124, 'gestation'), ('GO_0010467', 'gene expression', 153, 'expression')]
PMC3654972	5/2013	S109-PMC3654972	['there was no effect of diet or strain on the mrna Expression of Ceruloplasmin in the maternal Liver (data not shown).']	N/A	N/A	[('GO_0010467', 'gene expression', 50, 'expression'), ('PR_000005005', 'calnexin', 64, 'ceruloplasmin'), ('UBERON_0002107', 'liver', 94, 'liver')]
PMC3654972	5/2013	S110-PMC3654972	['caption (fig): figure 3\n\nmaternal Liver tfr and Hepcidin Expression.']	N/A	N/A	[('UBERON_0002107', 'liver', 34, 'liver'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 48, 'hepcidin'), ('GO_0010467', 'gene expression', 57, 'expression')]
PMC3654972	5/2013	S111-PMC3654972	['Maternal Liver tfr ( a ) and Hepcidin ( b ) mrna Expression in rowett hooded lister (rhl) and wistar Rats exposed to a control or low iron diet prior to and during Pregnancy.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002107', 'liver', 9, 'liver'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 29, 'hepcidin'), ('GO_0010467', 'gene expression', 49, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 101, 'rats'), ('GO_0007565', 'female pregnancy', 164, 'pregnancy')]
PMC3654972	5/2013	S118-PMC3654972	['fetal Liver Hepcidin mrna Expression was significantly higher in wistar Rats compared to rhl Rats (figure\u20095a, 43%, p<0.001), and was significantly decreased by exposure to a maternal low iron diet in both strains (figure\u20095a, 61%, p<0.001).']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 12, 'hepcidin'), ('GO_0010467', 'gene expression', 26, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 72, 'rats'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 93, 'rats')]
PMC3654972	5/2013	S120-PMC3654972	['caption (fig): figure 4\n\nfetal Liver tfr and ferroportin Expression.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'liver'), ('GO_0010467', 'gene expression', 57, 'expression')]
PMC3654972	5/2013	S121-PMC3654972	['fetal Liver protein Expression of tfr ( a&b ) and ferroportin ( c&d ) proteins in rowett hooded lister ( a&c ) and wistar ( b&d ) Rats exposed to a control or low iron diet prior to and during Pregnancy.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('GO_0010467', 'gene expression', 20, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 130, 'rats'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
PMC3654972	5/2013	S126-PMC3654972	['caption (fig): figure 5\n\nfetal Liver hepcidin and Ceruloplasmin Expression.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'liver'), ('PR_000005005', 'calnexin', 50, 'ceruloplasmin'), ('GO_0010467', 'gene expression', 64, 'expression')]
PMC3654972	5/2013	S127-PMC3654972	['fetal Liver mrna Expression of Hepcidin ( a ) and Ceruloplasmin ( b ) in rowett hooded lister (rhl) and wistar Rats exposed to a control or low iron diet prior to and during Pregnancy.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('GO_0010467', 'gene expression', 17, 'expression'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 31, 'hepcidin'), ('PR_000005005', 'calnexin', 50, 'ceruloplasmin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 111, 'rats'), ('GO_0007565', 'female pregnancy', 174, 'pregnancy')]
PMC3654972	5/2013	S151-PMC3654972	['Expression of the Transferrin Receptor (tfr) mrna was up-regulated in the maternal Liver by more than two-fold in both strains of Rat.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000001679', 'trace amine-associated receptor 5', 18, 'transferrin receptor'), ('UBERON_0002107', 'liver', 83, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 130, 'rat')]
PMC3654972	5/2013	S153-PMC3654972	['Maternal Hepatic Hepcidin mrna Expression was vastly down-regulated in response to the Feeding of a low iron diet in both strains of Rat, almost to the point of being undetectable.']	N/A	N/A	[('UBERON_0000976', 'humerus', 0, 'Maternal'), ('UBERON_0002107', 'liver', 9, 'hepatic'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 17, 'hepcidin'), ('GO_0010467', 'gene expression', 31, 'expression'), ('GO_0007631', 'feeding behavior', 87, 'feeding'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 133, 'rat')]
PMC3654972	5/2013	S172-PMC3654972	['the opposite was observed in the fetal Liver, where total iron content was significantly higher in fetuses of the rhl strain.']	N/A	N/A	[('UBERON_0002107', 'liver', 39, 'liver')]
PMC3659910	1/2013	S63-PMC3659910	['dietary sources of Vitamin D include: fatty fish species, such as Catfish, salmon, mackerel, Tuna etc., egg, beef and fish Liver oils.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 66, 'Catfish'), ('NCBITaxon_10088', 'Mus <genus>', 93, 'Tuna'), ('UBERON_0002107', 'liver', 123, 'liver')]
PMC3659910	1/2013	S108-PMC3659910	['in an uncontrolled trial, supplementation with a multivitamin/Mineral supplement and halibut Liver oil (containing 900 iu/d Vitamin D) provided at 20 wk Gestation reduced the odds of preeclampsia by 32% (95% ci, 11-47%).']	N/A	N/A	[('CHEBI_46662', 'mineral', 62, 'mineral'), ('UBERON_0002107', 'liver', 93, 'liver'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('GO_0007565', 'female pregnancy', 153, 'gestation')]
PMC3668200	5/2013	S6-PMC3668200	['Previtamin D3 then binds to the Vitamin D-binding protein and is transported to the Liver, where it is converted to 25-Hydroxyvitamin D (25[Oh]D) by 25-Hydroxylase.']	N/A	N/A	[('CHEBI_34939', 'prostaglandin D3', 0, 'Previtamin D3'), ('PR_000013347', 'pregnancy-specific beta-1-glycoprotein 1', 0, 'Previtamin D3'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0002107', 'liver', 84, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 116, '25-hydroxyvitamin D'), ('CHEBI_23995', 'N-ethyl-N-nitrosourea', 140, 'OH]D'), ('CHEBI_17816', '1D-myo-inositol 1,4-bisphosphate', 149, '25-hydroxylase')]
PMC3668200	5/2013	S17-PMC3668200	['Human can take Vitamin D through fatty fish, certain fish oils, Animal Liver, aquatic Mammal fat and Egg Yolks of Vitamin D-Fed chickens.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 64, 'animal'), ('UBERON_0002107', 'liver', 71, 'liver'), ('NCBITaxon_40674', 'Mammalia', 86, 'mammal'), ('UBERON_0005079', 'eggshell', 101, 'egg yolks'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007631', 'feeding behavior', 124, 'fed')]
PMC3669365	5/2013	S76-PMC3669365	['real time rt-pcr analysis\nfor molecular analyses, fetal Mice were sacrificed at zt9-10, and then Liver and whole Brain were extracted at Gestation day 17.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 56, 'mice'), ('UBERON_0002107', 'liver', 97, 'liver'), ('UBERON_0000955', 'brain', 113, 'brain'), ('GO_0007565', 'female pregnancy', 137, 'gestation')]
PMC3669365	5/2013	S77-PMC3669365	['Adult offspring Mice at the age of 8–9 weeks were sacrificed at zt4-5, and then Liver and Brain were extracted.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('NCBITaxon_10088', 'Mus <genus>', 16, 'mice'), ('UBERON_0002107', 'liver', 80, 'liver'), ('UBERON_0000955', 'brain', 90, 'brain')]
PMC3669365	5/2013	S80-PMC3669365	['Brain and Liver Tissue were immediately frozen in liquid nitrogen, and stored at −80°c until use.']	N/A	N/A	[('UBERON_0000955', 'brain', 0, 'Brain'), ('UBERON_0002107', 'liver', 10, 'liver'), ('UBERON_0000479', 'tissue', 16, 'tissue')]
PMC3669365	5/2013	S146-PMC3669365	['they also showed increases in the Expression of pparα and 3-Hydroxy-3-Methylglutaryl-Coenzyme A Synthase 2 (Hmgcs2, encoded by Hmgcs2 ) mrnas in the Liver (figure 5b).']	N/A	N/A	[('GO_0010467', 'gene expression', 34, 'expression'), ('CHEBI_27472', '3-tert-Butyl-5-methylcatechol', 58, '3-hydroxy-3-methylglutaryl-Coenzyme A'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 84, '-Coenzyme A synthase 2'), ('PR_000008651', 'jupiter microtubule associated homolog 2', 108, 'HMGCS2'), ('PR_000008466', 'hepatitis B virus X-interacting protein', 127, 'Hmgcs2'), ('UBERON_0002107', 'liver', 149, 'liver')]
PMC3669365	5/2013	S156-PMC3669365	['in the Liver, no significant differences were observed in pparα and Hmgcs2 mrnas (figure 6h).']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('PR_000008466', 'hepatitis B virus X-interacting protein', 68, 'Hmgcs2')]
PMC3674738	5/2013	S78-PMC3674738	['the disorder leads to Metabolic Acidosis and Neurological injury, and patients can present with hypoglycemia, absent Ketones, elevated Liver transaminases, and seizures [24].']	N/A	N/A	[('GO_0008152', 'metabolic process', 22, 'metabolic acidosis'), ('UBERON_0001016', 'nervous system', 45, 'neurological'), ('CHEBI_17087', 'ketone', 117, 'ketones'), ('UBERON_0002107', 'liver', 135, 'liver')]
PMC3685533	6/2013	S46-PMC3685533	['exclusion criteria were the presence of any organic diseases in particular Neurological, Endocrine, Liver and Kidney abnormalities in the mother or in the newborns.']	N/A	N/A	[('UBERON_0001016', 'nervous system', 75, 'neurological'), ('GO_0006397', 'mRNA processing', 89, 'endocrine'), ('UBERON_0002049', 'vasculature', 89, 'endocrine'), ('UBERON_0002107', 'liver', 100, 'liver'), ('UBERON_0002113', 'kidney', 110, 'kidney')]
PMC3685567	5/2013	S93-PMC3685567	['the same Organ-based analysis was carried out on selected internal Organs: the Brain, Heart, and Liver.']	N/A	N/A	[('UBERON_0000062', 'organ', 9, 'organ'), ('UBERON_0000062', 'organ', 67, 'organs'), ('UBERON_0000955', 'brain', 79, 'brain'), ('UBERON_0000948', 'heart', 86, 'heart'), ('UBERON_0002107', 'liver', 97, 'liver')]
PMC3685567	5/2013	S101-PMC3685567	['caption (fig): figure 6\n\npercentage volume (mean±stdv) occupied by the Brain, Heart, and Liver at e13.5 (nsd\u2009=\u200927, nkd\u2009=\u200932) and e17.5 (nsd\u2009=\u2009nkd\u2009=\u200910).']	N/A	N/A	[('UBERON_0000955', 'brain', 71, 'brain'), ('UBERON_0000948', 'heart', 78, 'heart'), ('UBERON_0002107', 'liver', 89, 'liver')]
PMC3693910	6/2013	S190-PMC3693910	['after inducing Liver injury in f0 and/or f1 males, they showed a reduction of Liver Fibrogenesis in f2 male offspring, illustrating an unquestionable transgenerational inheritance.']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'liver'), ('GO_0008584', 'male gonad development', 78, 'liver fibrogenesis'), ('UBERON_0002107', 'liver', 78, 'liver')]
PMC3698442	7/2013	S0-PMC3698442	['maternal fat Intake in Rats alters 20:4n-6 and 22:6n-3 status and the epigenetic Regulation of Fads2 in offspring Liver☆☆☆★\n\nabstract\npoor Prenatal nutrition, acting through epigenetic processes, induces persistent changes in offspring phenotype.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 13, 'intake'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 23, 'rats'), ('GO_0065007', 'biological regulation', 81, 'regulation'), ('PR_000007440', 'Fc receptor-like protein 1', 95, 'Fads2'), ('UBERON_0002107', 'liver', 114, 'liver'), ('GO_0007565', 'female pregnancy', 139, 'prenatal')]
PMC3698442	7/2013	S4-PMC3698442	['20:4n-6 and 22:6n-3 levels were lower in Liver Phosphatidylcholine (Pc) and Phosphatidylethanolamine and Plasma pc (all p<.0001) in offspring of dams Fed 21% than 3.5% or 7% fat regardless of type.']	N/A	N/A	[('UBERON_0002107', 'liver', 41, 'liver'), ('CHEBI_36710', 'interferon inducer', 47, 'phosphatidylcholine'), ('CHEBI_16199', 'urea', 68, 'PC'), ('CHEBI_16038', 'phosphatidylethanolamine', 76, 'phosphatidylethanolamine'), ('UBERON_0001969', 'blood plasma', 105, 'plasma'), ('GO_0007631', 'feeding behavior', 150, 'fed')]
PMC3698442	7/2013	S8-PMC3698442	['feeding Adult female Rats 7% fat reduced 20:4n-6 status in Liver pc and Fads2 Expression and increased methylation of cpgs −623, −394, −84 and −76 that reversed in Animals switched from 7% to 4% fat diets.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 8, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 21, 'rats'), ('UBERON_0002107', 'liver', 59, 'liver'), ('PR_000007440', 'Fc receptor-like protein 1', 72, 'Fads2'), ('GO_0010467', 'gene expression', 78, 'expression'), ('NCBITaxon_33208', 'Metazoa', 164, 'animals')]
PMC3698442	7/2013	S23-PMC3698442	['feeding Adult Rats a high fat (hf) diet reduced the Messenger Rna (mrna) Expression of Fads2 that encodes δ6 desaturase the rate-limiting enzyme in 20:4n-6 and 22:6n-3 synthesis in Liver[17].']	N/A	N/A	[('UBERON_0007023', 'adult organism', 8, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 14, 'rats'), ('SO_0000233', 'mature_transcript', 52, 'messenger RNA'), ('GO_0010467', 'gene expression', 73, 'expression'), ('PR_000007440', 'Fc receptor-like protein 1', 87, 'Fads2'), ('UBERON_0002107', 'liver', 181, 'liver')]
PMC3698442	7/2013	S49-PMC3698442	['Livers were removed immediately into liquid nitrogen and stored at −80°c.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers')]
PMC3698442	7/2013	S50-PMC3698442	['measurement of Fatty Acid composition\nPlasma and Liver Fatty Acid compositions were measured as described[23].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 15, 'fatty acid'), ('UBERON_0001969', 'blood plasma', 38, 'Plasma'), ('UBERON_0002107', 'liver', 49, 'liver'), ('CHEBI_35366', 'fatty acid', 55, 'fatty acid')]
PMC3698442	7/2013	S51-PMC3698442	['briefly, Liver (approximately 100\xa0mg) was powdered under liquid nitrogen and total Lipids extracted with Chloroform and Methanol[24].']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'liver'), ('CHEBI_18059', 'lipid', 83, 'lipids'), ('CHEBI_35255', 'chloroform', 105, 'chloroform'), ('CHEBI_17790', 'methanol', 120, 'methanol')]
PMC3698442	7/2013	S57-PMC3698442	['total rna was isolated from Liver using Tri Reagent (sigma, poole, dorset, uk).']	N/A	N/A	[('UBERON_0002107', 'liver', 28, 'liver'), ('14', 'AAMP (human)', 40, 'Tri'), ('CHEBI_33893', 'reagent', 44, 'Reagent')]
PMC3698442	7/2013	S81-PMC3698442	['the proportions of 20:4n-6 and 22:6n-3 were significantly lower in Liver pc from the offspring of dams Fed hf diets compared to those Fed the lf and af diets.']	N/A	N/A	[('UBERON_0002107', 'liver', 67, 'liver'), ('GO_0007631', 'feeding behavior', 103, 'fed'), ('GO_0007631', 'feeding behavior', 134, 'fed')]
PMC3698442	7/2013	S86-PMC3698442	['there were relatively small differences between maternal dietary groups in the proportion of 20:5n-3 in offspring Liver pc and in the proportion of 20:3n-6 in Liver pe (supplemental tables 4 and 5).']	N/A	N/A	[('UBERON_0002107', 'liver', 114, 'liver'), ('UBERON_0002107', 'liver', 159, 'liver')]
PMC3698442	7/2013	S87-PMC3698442	['18:2n-6 was significantly higher in Liver pc and pe of the offspring of dams Fed the hf diet compared to those Fed the lf or af diet (supplemental tables 4 and 5).']	N/A	N/A	[('UBERON_0002107', 'liver', 36, 'liver'), ('GO_0007631', 'feeding behavior', 77, 'fed'), ('GO_0007631', 'feeding behavior', 111, 'fed')]
PMC3698442	7/2013	S89-PMC3698442	['maternal dietary fat Intake altered the mrna Expression of Fads2 in Adult offspring Liver\nthere were no statistically significant differences between groups in Fads1 mrna Expression in male or female offspring (fig.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 21, 'intake'), ('GO_0010467', 'gene expression', 45, 'expression'), ('PR_000007440', 'Fc receptor-like protein 1', 59, 'Fads2'), ('UBERON_0007023', 'adult organism', 68, 'adult'), ('UBERON_0002107', 'liver', 84, 'liver'), ('PR_000007440', 'Fc receptor-like protein 1', 160, 'Fads1'), ('GO_0010467', 'gene expression', 171, 'expression')]
PMC3698442	7/2013	S97-PMC3698442	['1), was measured in the Liver of the offspring.']	N/A	N/A	[('UBERON_0002107', 'liver', 24, 'liver')]
PMC3698442	7/2013	S110-PMC3698442	['Feeding the fo af diet to non-Pregnant females for 9\xa0weeks decreased the proportion of 20:4n-6 and increased the proportion of 22:6n-3 in Liver pc compared to females maintained on the ain-94m diet (fig.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 0, 'Feeding'), ('GO_0007565', 'female pregnancy', 30, 'pregnant'), ('UBERON_0002107', 'liver', 138, 'liver')]
PMC3698442	7/2013	S139-PMC3698442	['a modest increase in the fat Intake of Adult non-Pregnant female Rats induced decreased Liver pc 20:4n-6 and Fads2 mrna Expression and increased the methylation of the same cpgs that were altered in the offspring of dams Fed an hf diet.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 29, 'intake'), ('UBERON_0007023', 'adult organism', 39, 'adult'), ('GO_0007565', 'female pregnancy', 49, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 65, 'rats'), ('UBERON_0002107', 'liver', 88, 'liver'), ('PR_000007440', 'Fc receptor-like protein 1', 109, 'Fads2'), ('GO_0010467', 'gene expression', 120, 'expression'), ('GO_0007631', 'feeding behavior', 221, 'fed')]
PMC3720837	7/2013	S71-PMC3720837	['the total weight of the foetus and the weights of the Head, Trunk and main Organs (Brain, Heart, Liver, Intestine and Kidneys) were also assessed.']	N/A	N/A	[('UBERON_0000033', 'head', 54, 'head'), ('UBERON_0002100', 'trunk', 60, 'trunk'), ('UBERON_0000062', 'organ', 75, 'organs'), ('UBERON_0000955', 'brain', 83, 'brain'), ('UBERON_0000948', 'heart', 90, 'heart'), ('UBERON_0002107', 'liver', 97, 'liver'), ('UBERON_0000160', 'intestine', 104, 'intestine'), ('UBERON_0002113', 'kidney', 118, 'kidneys')]
PMC3720837	7/2013	S72-PMC3720837	['afterwards, the following weight ratios were considered: weight of the Uterus relative to the Individual and total foetal weight, weight of the foetal Head relative to total weight and Trunk weight and Brain weight relative to the weight of total Viscera, Heart, Liver, Kidneys and Intestine.']	N/A	N/A	[('UBERON_0000995', 'uterus', 71, 'uterus'), ('NCBITaxon_1', 'root', 94, 'individual'), ('UBERON_0000033', 'head', 151, 'head'), ('UBERON_0002100', 'trunk', 185, 'trunk'), ('UBERON_0000955', 'brain', 202, 'brain'), ('UBERON_0002075', 'viscus', 247, 'viscera'), ('UBERON_0000948', 'heart', 256, 'heart'), ('UBERON_0002107', 'liver', 263, 'liver'), ('UBERON_0002113', 'kidney', 270, 'kidneys'), ('UBERON_0000160', 'intestine', 282, 'intestine')]
PMC3720837	7/2013	S162-PMC3720837	['furthermore, the relative Liver to body weight ratio was higher in iberian female foetuses compared to males.']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'liver')]
PMC3736889	11/2010	S35-PMC3736889	['quantitative-pcr analysis\nLiver Tissues from sacrificed Animals were snap frozen in liquid nitrogen and stored at −70 °c until further analysis.']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'Liver'), ('UBERON_0000479', 'tissue', 32, 'tissues'), ('NCBITaxon_33208', 'Metazoa', 56, 'animals')]
PMC3736889	11/2010	S36-PMC3736889	['total rna was isolated from the Liver samples as previously described.17reverse transcription of total rna into cdna was performed using one-step Reverse Transcription kit from roche diagnostics (pq, canada).']	N/A	N/A	[('UBERON_0002107', 'liver', 32, 'liver'), ('GO_0001171', 'reverse transcription', 146, 'reverse transcription')]
PMC3736889	11/2010	S91-PMC3736889	['the Hepatic mrna Expression of Lcat was significantly higher in the offspring obtained from mothers Fed an N -6 Pufa-rich diet and those who continued on the control diet post-weaning (ie, p/c) compared to all other offspring (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'hepatic'), ('GO_0010467', 'gene expression', 17, 'expression'), ('PR_000009685', 'putative BPIFA4P protein', 31, 'LCAT'), ('GO_0007631', 'feeding behavior', 100, 'fed'), ('CHEBI_70674', 'erythro-carolignan E', 107, 'n -'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 112, 'PUFA')]
PMC3756974	8/2013	S61-PMC3756974	['then, Pentobarbital anesthesia was induced and Blood samples were collected, then the Livers, Kidneys, and Heart were removed immediately and weighed.']	N/A	N/A	[('CHEBI_7983', 'pentobarbital', 6, 'pentobarbital'), ('UBERON_0000178', 'blood', 47, 'blood'), ('UBERON_0002107', 'liver', 86, 'livers'), ('UBERON_0002113', 'kidney', 94, 'kidneys'), ('UBERON_0000948', 'heart', 107, 'heart')]
PMC3756974	8/2013	S173-PMC3756974	['a similar pattern was observed between amounts of phosphorylated ampk in the Kidney of 3 week old female and in Liver of 3 week old male Animals.']	N/A	N/A	[('UBERON_0002113', 'kidney', 77, 'kidney'), ('UBERON_0002107', 'liver', 112, 'liver'), ('NCBITaxon_33208', 'Metazoa', 137, 'animals')]
PMC3763666	7/2012	S139-PMC3763666	['2nd: Lgg to mothers during breastfeeding for 4 weeksafter 4 weeks significant scorad score reduction (extent, intensity and subjective score) in Probiotic group.']	N/A	N/A	[('UBERON_0002107', 'liver', 5, 'LGG'), ('CHEBI_73033', 'pterocarpan', 145, 'probiotic')]
PMC3794936	10/2013	S4-PMC3794936	['Genetic ablation of Gcn2 in the offspring exhibited reduced Hepatic Triglyceride storage and repressed Expression of the Peroxisome Proliferator-Activated Receptor Gamma 2 ( pparγ2 ) and two Lipid droplet protein Genes, Fsp27 and Cidea .']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Genetic'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 20, 'Gcn2'), ('UBERON_0002107', 'liver', 60, 'hepatic'), ('CHEBI_17855', 'triglyceride', 68, 'triglyceride'), ('GO_0010467', 'gene expression', 103, 'expression'), ('GO_0005777', 'peroxisome', 121, 'peroxisome'), ('PR_000009218', 'bifunctional arginine demethylase and lysyl-hydroxylase JMJD6', 121, 'peroxisome proliferator-activated receptor gamma 2'), ('CHEBI_18059', 'lipid', 191, 'lipid'), ('SO_0000704', 'gene', 213, 'genes'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 220, 'Fsp27'), ('PR_000004968', 'calretinin', 230, 'Cidea')]
PMC3794936	10/2013	S32-PMC3794936	['Liver-specific Gcn2 ko ( ligcn2 ko ) and Brain-specific Gcn2 ko ( brgcn2 ko ) Mice were generated by crossing the Albumin-cre and Nestin-cre transgenic Mice to the Gcn2 Floxed Mouse.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 15, 'Gcn2'), ('UBERON_0000955', 'brain', 41, 'brain'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 56, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 78, 'mice'), ('PR_000004080', 'annexin A7', 114, 'Albumin'), ('PR_000011041', 'nuclear receptor coactivator 2', 130, 'Nestin'), ('NCBITaxon_10088', 'Mus <genus>', 152, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 164, 'Gcn2'), ('SO_0000359', 'floxed', 169, 'floxed'), ('NCBITaxon_10088', 'Mus <genus>', 176, 'mouse')]
PMC3794936	10/2013	S40-PMC3794936	['Serum and Liver metabolites measurements\nMice were sacrificed by Co2Euthanization.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0002107', 'liver', 10, 'Liver'), ('NCBITaxon_10088', 'Mus <genus>', 41, 'Mice'), ('CHEBI_63136', '[6)-alpha-D-Glcp-(1->4)-alpha-D-Neup5,7Ac2-(2->]n', 65, 'CO2euthanization')]
PMC3794936	10/2013	S46-PMC3794936	['Liver Lipids were extracted from ∼80 mg Liver samples as previously described[41]for Triglyceride assay.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_18059', 'lipid', 6, 'lipids'), ('UBERON_0002107', 'liver', 40, 'liver'), ('CHEBI_17855', 'triglyceride', 85, 'triglyceride')]
PMC3794936	10/2013	S47-PMC3794936	['for Cholesterol assay, Liver Lipids were extracted with Chloroform: Isopropanol: Np-40 (7∶11∶0.1) and dissolved in 200 μl Cholesterol assay buffer according to instructions of the assay kit.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 4, 'cholesterol'), ('UBERON_0002107', 'liver', 23, 'liver'), ('CHEBI_18059', 'lipid', 29, 'lipids'), ('CHEBI_35255', 'chloroform', 56, 'chloroform'), ('CHEBI_17824', 'propan-2-ol', 68, 'isopropanol'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 81, 'NP-40'), ('CHEBI_16113', 'cholesterol', 122, 'cholesterol')]
PMC3794936	10/2013	S49-PMC3794936	['Liver Fatty Acid Oxidation assay\nPeroxisome-mediated Fatty Acid Β-Oxidation activity was measured as previously described[42],[43].']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_35366', 'fatty acid', 6, 'Fatty Acid'), ('GO_0019395', 'fatty acid oxidation', 6, 'Fatty Acid Oxidation'), ('GO_0005777', 'peroxisome', 33, 'Peroxisome'), ('CHEBI_35366', 'fatty acid', 53, 'fatty acid'), ('GO_0006635', 'fatty acid beta-oxidation', 53, 'fatty acid β-oxidation')]
PMC3794936	10/2013	S50-PMC3794936	['briefly, 50 mg Livers were homogenized in 500 μl cold 0.25 m Sucrose, centrifuged at 600× g for 10 min and the upper Lipid layer was aspirated.']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'livers'), ('CHEBI_17992', 'sucrose', 61, 'sucrose'), ('CHEBI_18059', 'lipid', 117, 'lipid')]
PMC3794936	10/2013	S67-PMC3794936	['oil red o, Hematoxylin & eosin and immunofluorescence staining\nLiver pieces were fixed in 10% Formalin Solution for 2 hours at room temperature, transferred to 20% Sucrose at 4°c overnight, and then were embedded in shandon cryomatrix (thermo) for cryosectioning.']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 11, 'Hematoxylin'), ('UBERON_0002107', 'liver', 63, 'Liver'), ('CHEBI_16842', 'formaldehyde', 94, 'formalin'), ('CHEBI_75958', 'solution', 103, 'solution'), ('CHEBI_17992', 'sucrose', 164, 'sucrose')]
PMC3794936	10/2013	S68-PMC3794936	['frozen sections of Liver (5 μm) were stained with oil red o for Lipids or anti-cidea Antibody (santa cruz) for if labeling of cidea proteins.']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'liver'), ('CHEBI_18059', 'lipid', 64, 'lipids'), ('GO_0042571', 'immunoglobulin complex, circulating', 85, 'antibody')]
PMC3794936	10/2013	S69-PMC3794936	['Formalin-fixed, paraffin-embedded sections (5 μm) of Liver were stained with Hematoxylin and eosin for histological analysis.']	N/A	N/A	[('CHEBI_16842', 'formaldehyde', 0, 'Formalin'), ('UBERON_0002107', 'liver', 53, 'liver'), ('CHEBI_51686', 'haematoxylin', 77, 'hematoxylin')]
PMC3794936	10/2013	S80-PMC3794936	['briefly, the cross-linked Chromatin was extracted from frozen Liver samples and sheared by sonication to 500–1000 Bp fragments and chip was performed with chip assay kit (millipore).']	N/A	N/A	[('GO_0000785', 'chromatin', 26, 'chromatin'), ('UBERON_0002107', 'liver', 62, 'liver'), ('SO_0000028', 'base_pair', 114, 'bp')]
PMC3794936	10/2013	S87-PMC3794936	['body weight and adiposity of Gcn2 ko Mice were normal, but they exhibited reduced Liver weight, a 3-fold reduction in Hepatic Triglycerides (fig.']	N/A	N/A	[('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 29, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 37, 'mice'), ('UBERON_0002107', 'liver', 82, 'liver'), ('UBERON_0002107', 'liver', 118, 'hepatic'), ('CHEBI_17855', 'triglyceride', 126, 'triglycerides')]
PMC3794936	10/2013	S113-PMC3794936	['the activities of key lipoprotein lipases responsible for Lipid Uptake into peripheral Tissues were normal in the Liver, Adipose Tissue, and muscle of Gcn2 ko Mice (fig.']	N/A	N/A	[('CHEBI_18059', 'lipid', 58, 'lipid'), ('GO_0051626', 'regulation of epinephrine uptake', 58, 'lipid uptake'), ('UBERON_0000479', 'tissue', 87, 'tissues'), ('UBERON_0002107', 'liver', 114, 'liver'), ('UBERON_0001013', 'adipose tissue', 121, 'adipose tissue'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 151, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 159, 'mice')]
PMC3794936	10/2013	S115-PMC3794936	['Expression of Genes that Regulated Lipid Uptake and secretion in the Liver was also found not to be significantly different in Gcn2 deficient Mice (fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('SO_0000704', 'gene', 14, 'genes'), ('GO_0065007', 'biological regulation', 25, 'regulated'), ('CHEBI_18059', 'lipid', 35, 'lipid'), ('GO_0051626', 'regulation of epinephrine uptake', 35, 'lipid uptake'), ('UBERON_0002107', 'liver', 69, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 127, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 142, 'mice')]
PMC3794936	10/2013	S117-PMC3794936	['the cause of the marked reduction in Stored Triglycerides in the Liver was explored by examining the Metabolism Of Lipids within the Liver.']	N/A	N/A	[('GO_0042989', 'sequestering of actin monomers', 37, 'stored triglycerides'), ('CHEBI_17855', 'triglyceride', 44, 'triglycerides'), ('UBERON_0002107', 'liver', 65, 'liver'), ('GO_0019428', 'allantoin biosynthetic process', 101, 'metabolism of lipids'), ('CHEBI_18059', 'lipid', 115, 'lipids'), ('UBERON_0002107', 'liver', 133, 'liver')]
PMC3794936	10/2013	S125-PMC3794936	['Hepatic Lipogenic Gene Expression was unaltered in Gcn2 ko Mice (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0008610', 'lipid biosynthetic process', 8, 'lipogenic'), ('GO_0010467', 'gene expression', 18, 'gene expression'), ('SO_0000704', 'gene', 18, 'gene'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 51, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 59, 'mice')]
PMC3794936	10/2013	S131-PMC3794936	['the Expression of pparγ2, Fsp27, and Cid Ea mrna was reduced by 40%, 75%, and 85%, respectively in the Liver of Gcn2 ko Mice (fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 26, 'Fsp27'), ('PR_000004968', 'calretinin', 37, 'Cid ea'), ('UBERON_0002107', 'liver', 103, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 112, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'mice')]
PMC3794936	10/2013	S135-PMC3794936	['the large differences in the Expression of pparγ2, Fsp27 , and Cidea in the Liver of Gcn2 ko Mice were erased when Animals were fasted for 24 hours (fig.']	N/A	N/A	[('GO_0010467', 'gene expression', 29, 'expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 51, 'Fsp27'), ('PR_000004968', 'calretinin', 63, 'Cidea'), ('UBERON_0002107', 'liver', 76, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 85, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 93, 'mice'), ('NCBITaxon_33208', 'Metazoa', 115, 'animals')]
PMC3794936	10/2013	S138-PMC3794936	['upon refeeding, however, the his/loh tg phenotype and repression of pparγ2, Fsp27 , and Cidea mrnas in the Liver was restored in Gcn2 ko Mice (fig 2b).']	N/A	N/A	[('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 76, 'Fsp27'), ('PR_000004968', 'calretinin', 88, 'Cidea'), ('UBERON_0002107', 'liver', 107, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 129, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 137, 'mice')]
PMC3794936	10/2013	S141-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 , Cidea , Plin1, Plin2 and Sgms2 mrnas in Livers of wild type (wt) and Gcn2 ko (ko) Mice, 8 months of age, (normalized to wt Mice, mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs .']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 39, 'Cidea'), ('PR_000012867', 'plasminogen', 47, 'Plin1'), ('PR_000012867', 'plasminogen', 54, 'Plin2'), ('PR_000015619', 'sorcin', 64, 'Sgms2'), ('UBERON_0002107', 'liver', 79, 'livers'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 108, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 121, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 162, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 195, 'Gcn2')]
PMC3794936	10/2013	S144-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 and Cidea mrnas in Livers of random Fed, 24 hr-fasted and refed wild type (wt) and Gcn2 ko (ko) Mice (normalized to wt Mice, mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs .']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 41, 'Cidea'), ('UBERON_0002107', 'liver', 56, 'livers'), ('GO_0007631', 'feeding behavior', 73, 'fed'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 120, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 133, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 156, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 189, 'Gcn2')]
PMC3794936	10/2013	S157-PMC3794936	['Liver Triglyceride (tg) content of Mice of indicated genotypes after low fat Chow (lfc) and medium fat Chow (mfc) Feeding (mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs .']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_17855', 'triglyceride', 6, 'triglyceride'), ('NCBITaxon_10088', 'Mus <genus>', 35, 'mice'), ('CHEBI_33290', 'food', 77, 'Chow'), ('CHEBI_33290', 'food', 103, 'Chow'), ('GO_0007631', 'feeding behavior', 114, 'feeding'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 150, 'Gcn2')]
PMC3794936	10/2013	S163-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 , Cidea , Plin1, Plin2 and Sgms2 mrnas in Livers of Mice of indicated genotypes Fed with lfc and mfc (normalized to wildtype Mice on lfc, mean ± sem, n\u200a=\u200a4, *p<0.05 Gcn2 ko vs .']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 39, 'Cidea'), ('PR_000012867', 'plasminogen', 47, 'Plin1'), ('PR_000012867', 'plasminogen', 54, 'Plin2'), ('PR_000015619', 'sorcin', 64, 'Sgms2'), ('UBERON_0002107', 'liver', 79, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice'), ('GO_0007631', 'feeding behavior', 117, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 162, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 202, 'Gcn2')]
PMC3794936	10/2013	S172-PMC3794936	['4d) and extreme Liver steatosis typically seen in db/db Mice was substantially ameliorated (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 16, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 56, 'mice')]
PMC3794936	10/2013	S177-PMC3794936	['pparγ2, Fsp27 , and Cid Ea mrnas were dramatically repressed in the Liver of Gcn2;db dko Mice compared to db/db Mice (fig.']	N/A	N/A	[('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 8, 'Fsp27'), ('PR_000004968', 'calretinin', 20, 'Cid ea'), ('UBERON_0002107', 'liver', 68, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 77, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 112, 'mice')]
PMC3794936	10/2013	S181-PMC3794936	['in contrast to the Liver, the Expression of pparγ2, Fsp27 , and Cidea in Wat was not repressed in Gcn2;db dko Mice (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'liver'), ('GO_0010467', 'gene expression', 30, 'expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 52, 'Fsp27'), ('PR_000004968', 'calretinin', 64, 'Cidea'), ('UBERON_0006337', 'distal early tubule', 73, 'WAT'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 98, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'mice')]
PMC3794936	10/2013	S184-PMC3794936	['body weight (b) Blood Glucose (c) Serum Triglyceride (d) Liver Triglyceride of Gcn2;db dko ( Gcn2 −/−; db/db ) and db/db ( Gcn2+/+;db/db ) Mice (mean ± sem, n\u200a=\u200a4, *p<0.05, Gcn2;db dko versus db/d b Mice).']	N/A	N/A	[('UBERON_0000178', 'blood', 16, 'Blood'), ('CHEBI_17234', 'glucose', 22, 'glucose'), ('UBERON_0001977', 'blood serum', 34, 'Serum'), ('CHEBI_17855', 'triglyceride', 40, 'triglyceride'), ('UBERON_0002107', 'liver', 57, 'Liver'), ('CHEBI_17855', 'triglyceride', 63, 'triglyceride'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 79, 'Gcn2'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 93, 'Gcn2'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 123, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 139, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 173, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 199, 'mice')]
PMC3794936	10/2013	S186-PMC3794936	['oil red o staining of representative Liver sections of Gcn2;db dko Mice and (f) db/db Mice.']	N/A	N/A	[('UBERON_0002107', 'liver', 37, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 55, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 67, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 86, 'mice')]
PMC3794936	10/2013	S188-PMC3794936	['H&e staining of representative Liver sections of Gcn2;db dko Mice and (h) db/db Mice.']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 0, 'H'), ('UBERON_0002107', 'liver', 31, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 49, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 61, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 80, 'mice')]
PMC3794936	10/2013	S191-PMC3794936	['mmunofluorescent (if) staining of cieda proteins (green) in representative Liver sections of Gcn2;db dko Mice and (j) db/db Mice.']	N/A	N/A	[('UBERON_0002107', 'liver', 75, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 93, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 124, 'mice')]
PMC3794936	10/2013	S194-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 , Cidea , Plin1, Plin2 and Sgms2 mrnas in Livers of Mice of indicated genotypes (normalized to db/db Mice, mean ± sem, n\u200a=\u200a8, *p<0.05, Gcn2;db dko vs. db/db ).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 39, 'Cidea'), ('PR_000012867', 'plasminogen', 47, 'Plin1'), ('PR_000012867', 'plasminogen', 54, 'Plin2'), ('PR_000015619', 'sorcin', 64, 'Sgms2'), ('UBERON_0002107', 'liver', 79, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 138, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 172, 'Gcn2')]
PMC3794936	10/2013	S196-PMC3794936	['Pparγ and Fsp27 protein western blotting from whole Liver lysates of Mice of indicated genotypes.']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 0, 'PPARγ'), ('PR_000007690', 'ferritin heavy chain', 10, 'FSP27'), ('UBERON_0002107', 'liver', 52, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 69, 'mice')]
PMC3794936	10/2013	S198-PMC3794936	['at weaning pparγ2, Fsp27 , and Cidea are Expressed at very low levels in the Liver but increase several fold in mature wild type Adults reared on mfc (fig.']	N/A	N/A	[('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 19, 'Fsp27'), ('PR_000004968', 'calretinin', 31, 'Cidea'), ('GO_0010467', 'gene expression', 41, 'expressed'), ('UBERON_0002107', 'liver', 77, 'liver'), ('UBERON_0007023', 'adult organism', 129, 'adults')]
PMC3794936	10/2013	S202-PMC3794936	['pparγ1 , pparγ2, Fsp27 and Cidea mrna levels relative to gapdh mrna in Livers of 3 weeks, 6 months and 8 months old wild type (wt) and Gcn2 ko (ko) Mice (mean ± sem, n\u200a=\u200a4, *p<0.05 Gcn2 ko vs .']	N/A	N/A	[('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 17, 'Fsp27'), ('PR_000004968', 'calretinin', 27, 'Cidea'), ('UBERON_0002107', 'liver', 71, 'livers'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 135, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 181, 'Gcn2')]
PMC3794936	10/2013	S208-PMC3794936	['Mice in both experiments were euthanized at 8 months of age for analysis of Serum and Hepatic Triglycerides and Gene Expression.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mice'), ('UBERON_0001977', 'blood serum', 76, 'serum'), ('UBERON_0002107', 'liver', 86, 'hepatic'), ('CHEBI_17855', 'triglyceride', 94, 'triglycerides'), ('GO_0010467', 'gene expression', 112, 'gene expression'), ('SO_0000704', 'gene', 112, 'gene')]
PMC3794936	10/2013	S210-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 , Cidea , Plin1, Plin2 and Sgms2 mrnas in Livers of Mice of indicated genotypes, which were reared on mfc Chow diet from Conception to 2 months of age and then switched to the lower fat Chow diet (lfc) for additional 6 months (normalized to wt Mice, mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs .']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 39, 'Cidea'), ('PR_000012867', 'plasminogen', 47, 'Plin1'), ('PR_000012867', 'plasminogen', 54, 'Plin2'), ('PR_000015619', 'sorcin', 64, 'Sgms2'), ('UBERON_0002107', 'liver', 79, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice'), ('CHEBI_33290', 'food', 143, 'chow'), ('GO_0007620', 'copulation', 158, 'conception'), ('CHEBI_33290', 'food', 223, 'chow'), ('NCBITaxon_10088', 'Mus <genus>', 281, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 314, 'Gcn2')]
PMC3794936	10/2013	S213-PMC3794936	['Expression of pparγ2, Fsp27 , Cidea mrnas in Livers of Mice of indicated genotypes, which were reared on mfc Chow diet before weaning and then switched to the lower fat Chow diet (lfc) until 8 months old (normalized to wt Mice, mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs .']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 22, 'Fsp27'), ('PR_000004968', 'calretinin', 30, 'Cidea'), ('UBERON_0002107', 'liver', 45, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 55, 'mice'), ('CHEBI_33290', 'food', 109, 'chow'), ('CHEBI_33290', 'food', 169, 'chow'), ('NCBITaxon_10088', 'Mus <genus>', 222, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 255, 'Gcn2')]
PMC3794936	10/2013	S216-PMC3794936	['Liver Triglyceride content in Mice of indicated genotypes, which were Reared on mfc Chow diet before weaning and then switched to the lower fat Chow diet (lfc) until 8 months old (normalized to wt Mice, mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs .']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_17855', 'triglyceride', 6, 'triglyceride'), ('NCBITaxon_10088', 'Mus <genus>', 30, 'mice'), ('GO_0000003', 'reproduction', 70, 'reared'), ('CHEBI_33290', 'food', 84, 'chow'), ('CHEBI_33290', 'food', 144, 'chow'), ('NCBITaxon_10088', 'Mus <genus>', 197, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 230, 'Gcn2')]
PMC3794936	10/2013	S223-PMC3794936	['thus Gcn2 genotype sets the ld Gene Expression program during development as a function of dietary fat content several months in advance of when either the Gene Expression or Hepatic Triglyceride differences are first apparent.']	N/A	N/A	[('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 5, 'Gcn2'), ('GO_0010467', 'gene expression', 31, 'gene expression'), ('SO_0000704', 'gene', 31, 'gene'), ('GO_0010467', 'gene expression', 156, 'gene expression'), ('SO_0000704', 'gene', 156, 'gene'), ('UBERON_0002107', 'liver', 175, 'hepatic'), ('CHEBI_17855', 'triglyceride', 183, 'triglyceride')]
PMC3794936	10/2013	S237-PMC3794936	['Fsp27 and Cidea mrna levels in Livers relative to gapdh mrna of Gcn2 ko (ko) and wild type (wt) Mice after Rosiglitazone Feeding Rosiglitazone or vehicle treated medium fat Chow diet (mfc) for 3 weeks (mean ± sem, n\u200a=\u200a3–7, *p<0.05 Fsp27 and cidea Gcn2 ko Rosiglitazone vs .']	N/A	N/A	[('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 0, 'Fsp27'), ('PR_000004968', 'calretinin', 10, 'Cidea'), ('UBERON_0002107', 'liver', 31, 'livers'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 64, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 96, 'mice'), ('CHEBI_8875', 'Rizatriptan benzoate', 107, 'rosiglitazone'), ('GO_0007631', 'feeding behavior', 121, 'feeding'), ('CHEBI_8875', 'Rizatriptan benzoate', 129, 'rosiglitazone'), ('CHEBI_33290', 'food', 173, 'chow'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 231, 'Fsp27'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 247, 'Gcn2'), ('CHEBI_8875', 'Rizatriptan benzoate', 255, 'rosiglitazone')]
PMC3794936	10/2013	S242-PMC3794936	['Liver Triglyceride of Gcn2 ko (ko) and wild type (wt) Mice after Rosiglitazone Feeding 3 weeks (mean ± sem, n\u200a=\u200a3–7, *p\u200a=\u200a0.08 Gcn2 ko Rosiglitazone vs .']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_17855', 'triglyceride', 6, 'triglyceride'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 22, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'mice'), ('CHEBI_8875', 'Rizatriptan benzoate', 65, 'rosiglitazone'), ('GO_0007631', 'feeding behavior', 79, 'feeding'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 127, 'Gcn2'), ('CHEBI_8875', 'Rizatriptan benzoate', 135, 'rosiglitazone')]
PMC3794936	10/2013	S251-PMC3794936	['H3K4Me3 is suppressed at all four locations surrounding the pparγ2 Promoter in the Liver of Gcn2 ko Mice compared to wildtype Mice (fig.']	N/A	N/A	[('SO_0001734', 'H3K4_methylation_site', 0, 'H3K4me3'), ('SO_0000167', 'promoter', 67, 'promoter'), ('UBERON_0002107', 'liver', 83, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 92, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 100, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 126, 'mice')]
PMC3794936	10/2013	S259-PMC3794936	['chip assay of H3K4Me3, H3K9Me3 and h3k27me3 on pparγ2 Promoters in Livers of 3 weeks old Gcn2 ko (ko) and wild type (wt) Mice.']	N/A	N/A	[('SO_0001734', 'H3K4_methylation_site', 14, 'H3K4me3'), ('SO_0001707', 'H3K9_trimethylation_site', 23, 'H3K9me3'), ('SO_0000167', 'promoter', 54, 'promoters'), ('UBERON_0002107', 'liver', 67, 'livers'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 89, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 121, 'mice')]
PMC3794936	10/2013	S263-PMC3794936	['chip assay of H3K4Me3, H3K9Me3 and h3k27me3 on pparγ1 Promoters in Livers of 3 weeks old Gcn2 ko (ko) and wild type (wt) Mice.']	N/A	N/A	[('SO_0001734', 'H3K4_methylation_site', 14, 'H3K4me3'), ('SO_0001707', 'H3K9_trimethylation_site', 23, 'H3K9me3'), ('SO_0000167', 'promoter', 54, 'promoters'), ('UBERON_0002107', 'liver', 67, 'livers'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 89, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 121, 'mice')]
PMC3794936	10/2013	S267-PMC3794936	['chip assay of H3K4Me3, H3K9Me3 and h3k27me3 on pparγ2 Promoters in Livers of 8 months old Gcn2 ko (ko) and wild type (wt) Mice.']	N/A	N/A	[('SO_0001734', 'H3K4_methylation_site', 14, 'H3K4me3'), ('SO_0001707', 'H3K9_trimethylation_site', 23, 'H3K9me3'), ('SO_0000167', 'promoter', 54, 'promoters'), ('UBERON_0002107', 'liver', 67, 'livers'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 90, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 122, 'mice')]
PMC3794936	10/2013	S275-PMC3794936	['8a–b), and pparγ2, Fsp27 , and Cidea were substantially reduced in the Liver (fig.']	N/A	N/A	[('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 19, 'Fsp27'), ('PR_000004968', 'calretinin', 31, 'Cidea'), ('UBERON_0002107', 'liver', 71, 'liver')]
PMC3794936	10/2013	S279-PMC3794936	['to confirm that Gcn2 Gene Expression was ablated in the Brain and not the Liver, we examined the Expression of Gcn2 mrna by qrtpcr using Primers specific for Exon-12, which should be deleted through the action of the cre recombinase on the Floxed Allele of Gcn2 [37].']	N/A	N/A	[('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 16, 'Gcn2'), ('GO_0010467', 'gene expression', 21, 'gene expression'), ('SO_0000704', 'gene', 21, 'gene'), ('UBERON_0000955', 'brain', 56, 'brain'), ('UBERON_0002107', 'liver', 74, 'liver'), ('GO_0010467', 'gene expression', 97, 'expression'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 111, 'Gcn2'), ('SO_0000112', 'primer', 137, 'primers'), ('SO_0000147', 'exon', 158, 'exon'), ('SO_0000359', 'floxed', 240, 'floxed'), ('SO_0001023', 'allele', 247, 'allele'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 257, 'Gcn2')]
PMC3794936	10/2013	S280-PMC3794936	['Exon-12 Gcn2 mrna was reduced by 74.3% in the Brain (p<0.001) whereas no reduction was seen in the Liver.']	N/A	N/A	[('SO_0000147', 'exon', 0, 'Exon'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 8, 'Gcn2'), ('UBERON_0000955', 'brain', 46, 'brain'), ('UBERON_0002107', 'liver', 99, 'liver')]
PMC3794936	10/2013	S281-PMC3794936	['we conclude that Gcn2, or a factor Regulated by Gcn2, acts as a Lipid sensor in the Brain and then programs the pparγ2 Gene in the Liver to Regulate the Lipid droplet protein Fsp27 and Cidea and Triglyceride Storage (fig.']	N/A	N/A	[('PR_000007896', 'glucokinase regulatory protein', 17, 'GCN2'), ('GO_0065007', 'biological regulation', 35, 'regulated'), ('PR_000007896', 'glucokinase regulatory protein', 48, 'GCN2'), ('CHEBI_18059', 'lipid', 64, 'lipid'), ('UBERON_0000955', 'brain', 84, 'brain'), ('SO_0000704', 'gene', 119, 'gene'), ('UBERON_0002107', 'liver', 131, 'liver'), ('GO_0065007', 'biological regulation', 140, 'regulate'), ('CHEBI_18059', 'lipid', 153, 'lipid'), ('PR_000007690', 'ferritin heavy chain', 175, 'FSP27'), ('CHEBI_34606', 'caldarchaeol', 185, 'CIDEA'), ('PR_000005439', 'charged multivesicular body protein 5', 185, 'CIDEA'), ('CHEBI_17855', 'triglyceride', 195, 'triglyceride'), ('GO_0030730', 'sequestering of triglyceride', 195, 'triglyceride storage')]
PMC3794936	10/2013	S282-PMC3794936	['9).10.1371/journal.pone.0075917.g008\n\ncaption (fig): figure 8\nGcn2 Expressed in the Brain is responsible for Pparγ2, fsp27, and Cidea and Triglyceride Storage programming in the Liver.']	N/A	N/A	[('PR_000007896', 'glucokinase regulatory protein', 62, 'GCN2'), ('GO_0010467', 'gene expression', 67, 'expressed'), ('UBERON_0000955', 'brain', 84, 'brain'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 109, 'PPARγ2'), ('CHEBI_34606', 'caldarchaeol', 128, 'CIDEA'), ('CHEBI_17855', 'triglyceride', 138, 'triglyceride'), ('GO_0030730', 'sequestering of triglyceride', 138, 'triglyceride storage'), ('UBERON_0002107', 'liver', 178, 'liver')]
PMC3794936	10/2013	S284-PMC3794936	['Liver Triglyceride of Liver-specific Gcn2 knockout Mice ( Ligcn2 ko ), Brain-specific Gcn2 knockout ( brgcn2 ko ) and wildtype (wt) Mice (mean ± sem, n\u200a=\u200a8, *p<0.05, brgcn2 ko vs. wt).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_17855', 'triglyceride', 6, 'triglyceride'), ('UBERON_0002107', 'liver', 22, 'liver'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 37, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 51, 'mice'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 58, 'LiGcn2'), ('UBERON_0000955', 'brain', 71, 'brain'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 86, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 132, 'mice')]
PMC3794936	10/2013	S285-PMC3794936	['total Expression of wildtype Gcn2 mrna was reduced by approximately 65% in the Liver of the Ligcn2 ko Mice and 74.7% in the Brain of the brgcn2 ko Mice.']	N/A	N/A	[('GO_0010467', 'gene expression', 6, 'expression'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 29, 'Gcn2'), ('UBERON_0002107', 'liver', 79, 'liver'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 92, 'LiGcn2'), ('NCBITaxon_10088', 'Mus <genus>', 102, 'mice'), ('UBERON_0000955', 'brain', 124, 'brain'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice')]
PMC3794936	10/2013	S287-PMC3794936	['no reduction of wild-type Gcn2 mrna was seen in the Liver of the brgcn2ko Mice.']	N/A	N/A	[('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 26, 'Gcn2'), ('UBERON_0002107', 'liver', 52, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 74, 'mice')]
PMC3794936	10/2013	S291-PMC3794936	['Expression of pparγ1 , pparγ2, Fsp27 , Cidea , Plin1, Plin2 and Sgms2 mrnas in Livers of Liver-specific knockout ( Ligcn2 ko) and wildtype (wt) Mice (normalized to wt Mice, mean ± sem, n\u200a=\u200a8, *p<0.05, Ligcn2 ko vs.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 31, 'Fsp27'), ('PR_000004968', 'calretinin', 39, 'Cidea'), ('PR_000012867', 'plasminogen', 47, 'Plin1'), ('PR_000012867', 'plasminogen', 54, 'Plin2'), ('PR_000015619', 'sorcin', 64, 'Sgms2'), ('UBERON_0002107', 'liver', 79, 'livers'), ('UBERON_0002107', 'liver', 89, 'liver'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 115, 'LiGcn2'), ('NCBITaxon_10088', 'Mus <genus>', 144, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 167, 'mice'), ('PR_000009751', 'lymphoid enhancer-binding factor 1', 201, 'LiGcn2')]
PMC3794936	10/2013	S294-PMC3794936	['dietary Triglycerides increase free Fatty Acids (Fa) in circulation that are taken up by the Liver and acutely activate the pparγ2 Gene that in turn induces the Expression of the Lipid droplet Genes Fsp27 and Cidea and increases Triglyceride Storage.']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 8, 'triglycerides'), ('CHEBI_35366', 'fatty acid', 36, 'fatty acids'), ('CHEBI_30751', 'formic acid', 49, 'FA'), ('UBERON_0002107', 'liver', 93, 'liver'), ('SO_0000704', 'gene', 131, 'gene'), ('GO_0010467', 'gene expression', 161, 'expression'), ('CHEBI_18059', 'lipid', 179, 'lipid'), ('SO_0000704', 'gene', 193, 'genes'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 199, 'Fsp27'), ('PR_000004968', 'calretinin', 209, 'Cidea'), ('CHEBI_17855', 'triglyceride', 229, 'triglyceride'), ('GO_0030730', 'sequestering of triglyceride', 229, 'triglyceride storage')]
PMC3794936	10/2013	S295-PMC3794936	['during Perinatal Development Gcn2 in the developing Brain senses Lipid concentrations provided maternally and signals the Liver to program pparγ2 for future Triglyceride storage levels.']	N/A	N/A	[('GO_0007429', 'secondary branching, open tracheal system', 7, 'perinatal development'), ('UBERON_0012101', 'perinatal stage', 7, 'perinatal'), ('PR_000007896', 'glucokinase regulatory protein', 29, 'GCN2'), ('UBERON_0000955', 'brain', 52, 'brain'), ('CHEBI_18059', 'lipid', 65, 'lipid'), ('UBERON_0002107', 'liver', 122, 'liver'), ('CHEBI_17855', 'triglyceride', 157, 'triglyceride')]
PMC3794936	10/2013	S296-PMC3794936	['Gcn2 programming of pparγ2 will specifically dictate the future Expression of Fsp27 and Cidea and Hepatic Triglyceride storage but not that of Adipose Tissue.']	N/A	N/A	[('PR_000007896', 'glucokinase regulatory protein', 0, 'GCN2'), ('GO_0010467', 'gene expression', 64, 'expression'), ('PR_000007690', 'ferritin heavy chain', 78, 'FSP27'), ('CHEBI_34606', 'caldarchaeol', 88, 'CIDEA'), ('PR_000005439', 'charged multivesicular body protein 5', 88, 'CIDEA'), ('UBERON_0002107', 'liver', 98, 'hepatic'), ('CHEBI_17855', 'triglyceride', 106, 'triglyceride'), ('UBERON_0001013', 'adipose tissue', 143, 'adipose tissue')]
PMC3794936	10/2013	S297-PMC3794936	['Leptin and leptin Signaling are known to Regulate Fat Metabolism in part through communication between Adipose Tissue, the Brain, and Liver[48],[49].']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Leptin'), ('GO_0023051', 'regulation of signaling', 18, 'signaling'), ('GO_0065007', 'biological regulation', 41, 'regulate'), ('GO_0006631', 'fatty acid metabolic process', 50, 'fat metabolism'), ('UBERON_0001013', 'adipose tissue', 103, 'adipose tissue'), ('UBERON_0000955', 'brain', 123, 'brain'), ('UBERON_0002107', 'liver', 134, 'liver')]
PMC3794936	10/2013	S303-PMC3794936	['for example, during fasting Triglycerides are released from Adipose Tissue as Fatty Acids, which are used by Peripheral Tissues for energy or re-esterified and stored in the Liver.']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 28, 'triglycerides'), ('UBERON_0001013', 'adipose tissue', 60, 'adipose tissue'), ('CHEBI_35366', 'fatty acid', 78, 'fatty acids'), ('UBERON_0001021', 'nerve', 109, 'peripheral tissues'), ('UBERON_0002107', 'liver', 174, 'liver')]
PMC3794936	10/2013	S307-PMC3794936	['Pparγ is a key Regulatory factor that Controls Lipid Metabolism and storage both in the Liver and Adipose Tissue.']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 0, 'PPARγ'), ('GO_0065007', 'biological regulation', 15, 'regulatory'), ('GO_0065007', 'biological regulation', 38, 'controls'), ('CHEBI_18059', 'lipid', 47, 'lipid'), ('GO_0006629', 'lipid metabolic process', 47, 'lipid metabolism'), ('UBERON_0002107', 'liver', 88, 'liver'), ('UBERON_0001013', 'adipose tissue', 98, 'adipose tissue')]
PMC3794936	10/2013	S318-PMC3794936	['we conclude that the his/loh tg phenotype in Gcn2 deficient Mice is caused by a specific deficiency in Ld Formation in the Liver that secondarily results in the accumulation of Triglycerides in circulation.']	N/A	N/A	[('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 45, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 60, 'mice'), ('GO_0045210', 'FasL biosynthetic process', 103, 'LD formation'), ('UBERON_0002107', 'liver', 123, 'liver'), ('CHEBI_17855', 'triglyceride', 177, 'triglycerides')]
PMC3794936	10/2013	S319-PMC3794936	['basal Hepatic Triglyceride Storage in Gcn2 deficient Mice is normal when Mice are Reared on a relatively low fat Chow diet.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'hepatic'), ('CHEBI_17855', 'triglyceride', 14, 'triglyceride'), ('GO_0030730', 'sequestering of triglyceride', 14, 'triglyceride storage'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 38, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 53, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 73, 'mice'), ('GO_0000003', 'reproduction', 82, 'reared'), ('CHEBI_33290', 'food', 113, 'chow')]
PMC3794936	10/2013	S343-PMC3794936	['aspects of Glucose and Fat Metabolism are coordinated by both afferent and Efferent signaling through the Hepatic branch of the Vagus Nerve[62],[63].']	N/A	N/A	[('CHEBI_17234', 'glucose', 11, 'glucose'), ('GO_0006006', 'glucose metabolic process', 11, 'glucose ... fat metabolism'), ('UBERON_0006798', 'efferent nerve', 75, 'efferent'), ('UBERON_0002107', 'liver', 106, 'hepatic'), ('UBERON_0001759', 'vagus nerve', 128, 'vagus nerve')]
PMC3794936	10/2013	S355-PMC3794936	['lipolipase activities in Livers of Mice of indicated genotypes in random Fed or 24-hour fasting state (mean ± sem, n\u200a=\u200a8).']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 35, 'mice'), ('GO_0007631', 'feeding behavior', 73, 'fed')]
PMC3794936	10/2013	S361-PMC3794936	['Expression of Fatty Acid Uptake related Genes ( Fabp, Fatp, cd36, Lpl ) in Livers of Mice of indicated genotypes in random Fed, 24 hr and 72 hr fasting state (normalized to random Fed wt Mice, mean ± sem, n\u200a=\u200a4).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('CHEBI_35366', 'fatty acid', 14, 'fatty acid'), ('GO_0033565', 'ESCRT-0 complex', 14, 'fatty acid uptake'), ('SO_0000704', 'gene', 40, 'genes'), ('PR_000007319', 'fatty acid desaturase 3', 48, 'Fabp'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 54, 'Fatp'), ('PR_000009880', 'Lon protease, mitochondrial', 66, 'Lpl'), ('UBERON_0002107', 'liver', 75, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 85, 'mice'), ('GO_0007631', 'feeding behavior', 123, 'fed'), ('GO_0007631', 'feeding behavior', 180, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 187, 'mice')]
PMC3794936	10/2013	S363-PMC3794936	['Expression of Apob, Apoe, Apoa1 and Apoc1 mrnas in Livers of Mice of indicated genotypes in random Fed, 24 hr and 72 hr fasting state (normalized to random Fed wt Mice, mean ± sem, n\u200a=\u200a4).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000004155', 'apolipoprotein E', 14, 'Apob'), ('PR_000004155', 'apolipoprotein E', 20, 'Apoe'), ('PR_000004519', 'autism susceptibility gene 2 protein', 26, 'Apoa1'), ('PR_000004155', 'apolipoprotein E', 36, 'Apoc1'), ('UBERON_0002107', 'liver', 51, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 61, 'mice'), ('GO_0007631', 'feeding behavior', 99, 'fed'), ('GO_0007631', 'feeding behavior', 156, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'mice')]
PMC3794936	10/2013	S365-PMC3794936	['caption (supplementary-material): figure s2\n\nHepatic Oxidation and Synthesis Of Fatty Acids In the Liver are nearly normal ingcn2 komice related tofig.']	N/A	N/A	[('GO_0000237', 'leptotene', 45, 'Hepatic'), ('UBERON_0002107', 'liver', 45, 'Hepatic'), ('GO_0043057', 'backward locomotion', 53, 'oxidation ...'), ('GO_0031098', 'stress-activated protein kinase signaling cascade', 67, 'synthesis of fatty acids in ... liver'), ('CHEBI_35366', 'fatty acid', 80, 'fatty acids'), ('UBERON_0002107', 'liver', 99, 'liver')]
PMC3794936	10/2013	S368-PMC3794936	['Peroxisomal and total Fatty Acid Β-Oxidation activities in Livers of Fed and fasted wild type (wt) and Gcn2 ko (ko) Mice (mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs. wt).']	N/A	N/A	[('GO_0005777', 'peroxisome', 0, 'Peroxisomal'), ('CHEBI_35366', 'fatty acid', 22, 'fatty acid'), ('GO_0006635', 'fatty acid beta-oxidation', 22, 'fatty acid β-oxidation'), ('UBERON_0002107', 'liver', 59, 'livers'), ('GO_0007631', 'feeding behavior', 69, 'fed'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 103, 'Gcn2'), ('NCBITaxon_10088', 'Mus <genus>', 116, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 149, 'Gcn2')]
PMC3794936	10/2013	S370-PMC3794936	['Expression of mrnas of microsomal and Peroxisomal oxidation related Genes ( cyp4a14, cyp4a10, cyp2b10, Aldh3A2, cyp4a12a, Acaa1A, Ehhadh ) in Livers of Mice of indicated genotypes in random Fed state (normalized to wt Mice, mean ± sem, n\u200a=\u200a8, *p<0.05 Gcn2 ko vs. wt).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('GO_0005777', 'peroxisome', 38, 'peroxisomal'), ('SO_0000704', 'gene', 68, 'genes'), ('PR_000003920', 'retinal dehydrogenase 1', 103, 'Aldh3a2'), ('PR_000002190', 'RAC-alpha serine/threonine-protein kinase', 122, 'Acaa1a'), ('PR_000006879', 'extracellular matrix protein 1', 130, 'Ehhadh'), ('UBERON_0002107', 'liver', 142, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 152, 'mice'), ('GO_0007631', 'feeding behavior', 190, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 218, 'mice'), ('PR_000007759', 'gamma-aminobutyric acid receptor-associated protein-like 2', 251, 'Gcn2')]
PMC3794936	10/2013	S372-PMC3794936	['Expression of mrnas of Mitochondrial oxidation related Genes ( pparα, cpt1a, acox1, acadlv, acadl, acadm ) in Livers of Fed and fasted Mice of indicated genotypes (normalized to random Fed wt Mice, mean ± sem, n\u200a=\u200a8).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('GO_0005739', 'mitochondrion', 23, 'mitochondrial'), ('SO_0000704', 'gene', 55, 'genes'), ('UBERON_0002107', 'liver', 110, 'livers'), ('GO_0007631', 'feeding behavior', 120, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 135, 'mice'), ('GO_0007631', 'feeding behavior', 185, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 192, 'mice')]
PMC3794936	10/2013	S374-PMC3794936	['Pparα protein from Liver lysates of Mice of indicated genotypes (left, western blot; right, Pparα protein relative to Tubulin and normalized to wt Fed Mice, mean ± sem, n\u200a=\u200a3).']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 0, 'PPARα'), ('UBERON_0002107', 'liver', 19, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 36, 'mice'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 92, 'PPARα'), ('PR_000028799', 'tubulin', 118, 'tubulin'), ('GO_0007631', 'feeding behavior', 147, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 151, 'mice')]
PMC3794936	10/2013	S376-PMC3794936	['Expression of mrnas of Fatty Acid Synthesis related Genes ( srebp1c, srebp1a, Fas, Scd, acc1 ) in Livers of Fed and fasted Mice of indicated genotypes (normalized to random Fed wt Mice, mean ± sem, n\u200a=\u200a8).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('CHEBI_35366', 'fatty acid', 23, 'fatty acid'), ('GO_0006633', 'fatty acid biosynthetic process', 23, 'fatty acid synthesis'), ('SO_0000704', 'gene', 52, 'genes'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 78, 'Fas'), ('PR_000002095', 'sodium channel protein type 1 subunit alpha', 83, 'Scd'), ('UBERON_0002107', 'liver', 98, 'livers'), ('GO_0007631', 'feeding behavior', 108, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 123, 'mice'), ('GO_0007631', 'feeding behavior', 173, 'fed'), ('NCBITaxon_10088', 'Mus <genus>', 180, 'mice')]
PMC3809191	1/2013	S16-PMC3809191	['Serum fasting Insulin, 25 (Oh) D, creatinine, calcium (Ca), Phosphorus (p), magnesium (Mg), alkaline phosphatase (alp), Parathyroid hormone (pth), Thyroid-stimulating hormone (stsh), albumin, hba1c, Liver transaminases (ast and alt) were also measured and the body mass indexes (bmi) were calculated in all groups.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('PR_000045358', 'insulin family protein', 14, 'insulin'), ('CHEBI_71657', 'versiconol acetate', 23, '25 (OH) D'), ('CHEBI_32588', 'potassium chloride', 55, 'Ca'), ('CHEBI_35885', 'secondary phosphine', 60, 'phosphorus'), ('CHEBI_34829', 'Medrysone', 87, 'Mg'), ('UBERON_0001132', 'parathyroid gland', 120, 'parathyroid'), ('CHEBI_9437', 'temoporfin', 147, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 147, 'thyroid'), ('UBERON_0002107', 'liver', 199, 'liver')]
PMC3818269	11/2013	S0-PMC3818269	['induction of the Hepatic Stearoyl-Coa Desaturase 1 Gene in offspring after isocaloric administration of high fat Sucrose diet during Gestation\n\nabstract\nadverse early nutrition leads to Metabolic aberrations in Adulthood.']	N/A	N/A	[('UBERON_0002107', 'liver', 17, 'hepatic'), ('CHEBI_15541', 'stearoyl-CoA', 25, 'stearoyl-CoA'), ('PR_000014755', 'A-kinase anchor protein 17A', 25, 'stearoyl-CoA desaturase 1'), ('SO_0000704', 'gene', 51, 'gene'), ('CHEBI_17992', 'sucrose', 113, 'sucrose'), ('GO_0007565', 'female pregnancy', 133, 'gestation'), ('GO_0008152', 'metabolic process', 186, 'metabolic'), ('UBERON_0000113', 'post-juvenile adult stage', 211, 'adulthood')]
PMC3818269	11/2013	S9-PMC3818269	['significant inductions of Hepatic mrna Expression of Stearoyl-Coa desaturase1 and δ-5 desaturase Genes, were observed in high fat Sucrose diet and calorie restriction diet offspring.']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'hepatic'), ('GO_0010467', 'gene expression', 39, 'expression'), ('CHEBI_15541', 'stearoyl-CoA', 53, 'stearoyl-CoA'), ('SO_0000704', 'gene', 97, 'genes'), ('CHEBI_17992', 'sucrose', 130, 'sucrose')]
PMC3818269	11/2013	S63-PMC3818269	['rna preparation and quantitative rt-pcr\nOrgans including the Liver, Pancreas, Visceral Fat and Soleus Muscle were excised, weighted and stored at –80°c until analysis.']	N/A	N/A	[('UBERON_0000033', 'head', 40, 'Organs'), ('UBERON_0002107', 'liver', 61, 'liver'), ('UBERON_0001264', 'pancreas', 68, 'pancreas'), ('UBERON_0004754', 'foramen ovale of heart', 78, 'visceral fat'), ('UBERON_0001389', 'soleus muscle', 95, 'soleus muscle')]
PMC3818269	11/2013	S64-PMC3818269	['the mrna levels of Hepatic Lipid Homeostasis Genes were determined by Reverse Transcription of total rna followed by pcr analysis.']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'hepatic'), ('CHEBI_18059', 'lipid', 27, 'lipid'), ('GO_0055088', 'lipid homeostasis', 27, 'lipid homeostasis'), ('SO_0000704', 'gene', 45, 'genes'), ('GO_0001171', 'reverse transcription', 70, 'reverse transcription')]
PMC3818269	11/2013	S65-PMC3818269	['total rna was extracted from Liver sample using trizol Reagent (invitrogen, carlsbad, ca).']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver'), ('CHEBI_33893', 'reagent', 55, 'Reagent')]
PMC3818269	11/2013	S97-PMC3818269	['the Expressions of Scd-1 Gene ( p<0.05 for cr and isocaloric hfs diet vs control diet) and d5d Gene ( p<0.05 for isocaloric hfs diet) were significantly increased in the Liver of offspring in the isocaloric hfs diet group.']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expressions'), ('PR_000014459', 'serine--tRNA ligase, cytoplasmic', 19, 'SCD-1'), ('SO_0000704', 'gene', 25, 'gene'), ('SO_0000704', 'gene', 95, 'gene'), ('UBERON_0002107', 'liver', 170, 'liver')]
PMC3818269	11/2013	S100-PMC3818269	['the Hepatic Expressions of Cpt-1 Gene and acs Gene in the offspring in isocaloric hfs diet group were also significantly increased.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'hepatic'), ('GO_0010467', 'gene expression', 12, 'expressions'), ('PR_000005855', 'cyclic AMP-responsive element-binding protein 3', 27, 'CPT-1'), ('SO_0000704', 'gene', 33, 'gene'), ('SO_0000704', 'gene', 46, 'gene')]
PMC3818269	11/2013	S135-PMC3818269	['Scd-1 Gene a key Metabolic Gene is responsible for de novo Lipogenesis which increases Fatty Acids and Triglycerides in the Liver.']	N/A	N/A	[('PR_000014459', 'serine--tRNA ligase, cytoplasmic', 0, 'SCD-1'), ('SO_0000704', 'gene', 6, 'gene'), ('GO_0008152', 'metabolic process', 17, 'metabolic'), ('SO_0000704', 'gene', 27, 'gene'), ('GO_0008610', 'lipid biosynthetic process', 59, 'lipogenesis'), ('CHEBI_35366', 'fatty acid', 87, 'fatty acids'), ('CHEBI_17855', 'triglyceride', 103, 'triglycerides'), ('UBERON_0002107', 'liver', 124, 'liver')]
PMC3818269	11/2013	S140-PMC3818269	['(36,37)\nisocaloric administration of hfs diet also significantly increased Hepatic D5D Gene Expression in the offspring.']	N/A	N/A	[('UBERON_0002107', 'liver', 75, 'hepatic'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 83, 'D5D'), ('GO_0010467', 'gene expression', 87, 'gene expression'), ('SO_0000704', 'gene', 87, 'gene')]
PMC3820434	12/2012	S123-PMC3820434	['finally, in obese Mice, treatment with a Nox Inhibitor reduced ros in at, decreased inflammatory adipokines, and reduced diabetes, hyperlipidemia, and Hepatic steatosis [60].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 18, 'mice'), ('CHEBI_38926', 'dibenzooxepine', 41, 'Nox inhibitor'), ('PR_000011533', 'nuclear transport factor 2', 41, 'Nox'), ('UBERON_0002107', 'liver', 151, 'hepatic')]
PMC3820434	12/2012	S199-PMC3820434	['the supplementation of bifidobacterium breve and Linoleic Acid to different mammalian species compared to a Linoleic Acid-alone supplemented diet resulted in a two- to three-fold higher Intestinal, Hepatic, and at content of Cis -9, trans- 11 conjugated Linoleic Acid, Eicosapentaenoic Acid, and Docosahexaenoic Acid, concomitantly with a reduced proinflammatory cytokines Tnf- Α , Il-6, and Inf- Γ Expression, [90].']	N/A	N/A	[('CHEBI_30881', 'xanthine-8-carboxylic acid', 49, 'linoleic acid'), ('CHEBI_30881', 'xanthine-8-carboxylic acid', 108, 'linoleic acid'), ('UBERON_0000160', 'intestine', 186, 'intestinal'), ('UBERON_0002107', 'liver', 198, 'hepatic'), ('CHEBI_23243', 'cineole', 225, 'cis'), ('CHEBI_30881', 'xanthine-8-carboxylic acid', 254, 'linoleic acid'), ('CHEBI_36003', 'decenoic acid', 269, 'eicosapentaenoic acid'), ('CHEBI_36003', 'decenoic acid', 296, 'docosahexaenoic acid'), ('PR_000016492', 'TNFAIP3-interacting protein 1', 373, 'Tnf- α'), ('PR_000008988', 'interleukin-1 family member 5', 382, 'Il-6'), ('PR_000008919', 'interferon alpha-6', 392, 'Inf- γ'), ('GO_0010467', 'gene expression', 399, 'expression')]
PMC3820434	12/2012	S284-PMC3820434	['for example, Tbt was found to drive the Differentiation Of Adipocytes and it Modulates the Retinoid-x-Receptor- (rxr-) Ppar- Γ -dependent Proadipogenic Gene networks in Liver, at, and Bone Marrow [115–117].']	N/A	N/A	[('PR_000016191', 'trichoplein keratin filament-binding protein', 13, 'TBT'), ('GO_0048649', 'caste determination, influence by genetic factors', 40, 'differentiation of adipocytes'), ('CL_0000136', 'fat cell', 59, 'adipocytes'), ('GO_0065007', 'biological regulation', 77, 'modulates'), ('CHEBI_66314', 'rotundifolioside A', 91, 'retinoid-'), ('PR_000012990', 'DNA-directed RNA polymerase II subunit RPB4', 91, 'retinoid-'), ('CHEBI_35222', 'inhibitor', 102, 'receptor'), ('PR_000014368', 'RuvB-like 1', 102, 'receptor'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 119, 'PPAR- γ'), ('GO_0006508', 'proteolysis', 138, 'proadipogenic'), ('SO_0000704', 'gene', 152, 'gene'), ('UBERON_0002107', 'liver', 169, 'liver'), ('UBERON_0002371', 'bone marrow', 184, 'bone marrow')]
PMC3850030	9/2013	S422-PMC3850030	['age at Menarche was 11.4\u2009±\u20090.1\xa0years in untreated girls and 12.5\u2009±\u20090.2\xa0years in Metformin-treated girls; the latter girls were taller and much leaner (with less Visceral and Hepatic fat) and had more favorable levels of circulating Insulin, Androgens, and Lipids.']	N/A	N/A	[('GO_0042696', 'menarche', 7, 'menarche'), ('CHEBI_6801', 'metformin', 80, 'metformin'), ('UBERON_0002075', 'viscus', 161, 'visceral'), ('UBERON_0002107', 'liver', 174, 'hepatic'), ('PR_000045358', 'insulin family protein', 232, 'insulin'), ('CHEBI_50113', 'androgen', 241, 'androgens'), ('CHEBI_18059', 'lipid', 256, 'lipids')]
PMC3876120	12/2013	S3-PMC3876120	['physiological outcomes in the offspring were measured, including Hepatic mrna Expression and global Dna Methylation after weaning.']	N/A	N/A	[('UBERON_0002107', 'liver', 65, 'hepatic'), ('GO_0010467', 'gene expression', 78, 'expression'), ('GO_0006306', 'DNA methylation', 100, 'DNA methylation')]
PMC3876120	12/2013	S59-PMC3876120	['Dna Methylation Metabolism\n\nHepatic global Dna Methylation\nwith regard to epigenetic-related features, maternal hfs Feeding did not affect Hepatic global Dna Methylation (figure 4).']	N/A	N/A	[('GO_0018902', '1,3-dichloro-2-propanol metabolic process', 0, 'DNA Methylation Metabolism'), ('UBERON_0002107', 'liver', 28, 'Hepatic'), ('GO_0006306', 'DNA methylation', 43, 'DNA Methylation'), ('GO_0007631', 'feeding behavior', 116, 'feeding'), ('UBERON_0002107', 'liver', 139, 'hepatic'), ('GO_0006306', 'DNA methylation', 154, 'DNA methylation')]
PMC3876120	12/2013	S85-PMC3876120	['at the end of the experimental process (21 days) the offspring were euthanized by decapitation ( n between 6 to 8 males and females randomly selected 6–7 litters per maternal dietary group), Blood collected and Plasma stored at −20 °c, and Liver was dissected, weighted and stored at −80 °c for later analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 191, 'blood'), ('UBERON_0001969', 'blood plasma', 211, 'plasma'), ('UBERON_0002107', 'liver', 240, 'liver')]
PMC3876120	12/2013	S87-PMC3876120	['total body and Liver fat content\ntotal fat mass was measured by using an echomri analyzer (echo medical systems, houston, tx, usa), a quantitative magnetic resonance technique [47].']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'Liver')]
PMC3876120	12/2013	S89-PMC3876120	['Liver fat content was measured with a special adaptor for Tissue sample scanning, as described by the manufacturer (echo medical systems, houston, tx, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000479', 'tissue', 58, 'tissue')]
PMC3876120	12/2013	S92-PMC3876120	['dna and rna isolation\nLiver dna and rna were extracted ( n = 6 Animals from 5–6 litters per maternal dietary group) using the qiaamp dna and rna mini kit (qiagen gmbh, hilden, germany).']	N/A	N/A	[('UBERON_0002107', 'liver', 22, 'Liver'), ('NCBITaxon_33208', 'Metazoa', 63, 'animals')]
PMC3876120	12/2013	S93-PMC3876120	['Hepatic dna concentration was quantified with picogreen dna quantification Reagent (invitrogen, milpites, ca, usa) and rna levels with a nanodrop 1000 spectrophotometer (thermo & scientific, wilmington, de, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_33893', 'reagent', 75, 'Reagent')]
PMC3877003	12/2013	S36-PMC3877003	['results\n\nsample collection\nLivers were harvested from male offspring on Postnatal day 1 (p1) from Rat litters Fed on control (18% casein), low protein (9% casein) or low protein with Folate- supplemented diets previously described[16], respectively denoted c, mlp and mlp-f. one litter from each group was studied, generating up to 16 offspring in each case.']	N/A	N/A	[('UBERON_0002107', 'liver', 27, 'Livers'), ('GO_0007567', 'parturition', 72, 'postnatal'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 98, 'rat'), ('GO_0007631', 'feeding behavior', 110, 'fed'), ('CHEBI_30863', '5-azaorotic acid', 183, 'folate')]
PMC3877003	12/2013	S40-PMC3877003	['Gene Expression profiles\nGene Expression in individual Livers was assessed using the illumina ratref-12 Expression beadchip (n\u200a=\u200a4 rna samples for each Animal group).']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Gene expression'), ('SO_0000704', 'gene', 0, 'Gene'), ('GO_0010467', 'gene expression', 25, 'Gene expression'), ('SO_0000704', 'gene', 25, 'Gene'), ('UBERON_0002107', 'liver', 55, 'livers'), ('GO_0010467', 'gene expression', 104, 'Expression'), ('NCBITaxon_33208', 'Metazoa', 152, 'animal')]
PMC3877003	12/2013	S81-PMC3877003	['hypermethylated regions identified comparing mlp to c Livers had an average size of ∼800 Bp, a mean fold enrichment of ∼8, and average distance from the Transcription Start Site (Tss)∼80,000 Bp.']	N/A	N/A	[('UBERON_0002107', 'liver', 54, 'livers'), ('SO_0000028', 'base_pair', 89, 'bp'), ('SO_0000237', 'transcript_attribute', 153, 'Transcription Start Site'), ('SO_0001434', 'cassette_pseudogene', 179, 'TSS'), ('SO_0000028', 'base_pair', 191, 'bp')]
PMC3877003	12/2013	S89-PMC3877003	['the total number of unique Gene symbols that bore differential Dna Methylation at fdr 5% was 630.10.1371/journal.pone.0082989.g002\n\ncaption (fig): figure 2\nfigure panel representing five Genomic loci ( agtrap, Fgf5, Dnmt1, Mcm6 , S Fmbt 1) containing differentially methylated regions (dmrs) between Livers obtained from newborns whose mothers were Fed a control diet (18% protein) and Livers obtained from newborns whose mothers were Fed a low protein (9% protein) diet.']	N/A	N/A	[('SO_0000704', 'gene', 27, 'gene'), ('GO_0006306', 'DNA methylation', 63, 'DNA methylation'), ('SO_0001026', 'genome', 187, 'genomic'), ('PR_000007499', 'fibroblast growth factor 8', 210, 'Fgf5'), ('PR_000006543', 'doublesex- and mab-3-related transcription factor 2', 216, 'Dnmt1'), ('PR_000010249', 'DNA replication licensing factor MCM7', 223, 'Mcm6'), ('PR_000015293', 'sphingomyelin phosphodiesterase 2', 230, 'S fmbt'), ('UBERON_0002107', 'liver', 300, 'livers'), ('GO_0007631', 'feeding behavior', 349, 'fed'), ('UBERON_0002107', 'liver', 386, 'livers'), ('GO_0007631', 'feeding behavior', 435, 'fed')]
PMC3877003	12/2013	S90-PMC3877003	['for each locus, panel a shows the validation data obtained from Bisulfite Conversion followed by cloning and sequencing, which provides methylation status at single Cpg Site resolution for different Livers and different clones (black circles represent methylated cpg, white circles unmethylated cpg).']	N/A	N/A	[('CHEBI_29874', 'bromine dioxide', 64, 'bisulfite'), ('GO_0030153', 'bacteriocin immunity', 64, 'bisulfite conversion'), ('SO_0000409', 'binding_site', 165, 'CpG site'), ('UBERON_0002107', 'liver', 199, 'livers')]
PMC3877003	12/2013	S110-PMC3877003	['once more assuming reversal upon Folate supplementation, we compared mlp to mlp-f Livers.']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 33, 'folate'), ('UBERON_0002107', 'liver', 82, 'livers')]
PMC3877003	12/2013	S150-PMC3877003	['these are inevitably accompanied by maturation in Gene Expression patterns in both the Liver and elsewhere.']	N/A	N/A	[('GO_0010467', 'gene expression', 50, 'gene expression'), ('SO_0000704', 'gene', 50, 'gene'), ('UBERON_0002107', 'liver', 87, 'liver')]
PMC3877003	12/2013	S170-PMC3877003	['in response to Endocrine signals, or to Metabolic stressors, that are absent in the p1 Liver.']	N/A	N/A	[('GO_0006397', 'mRNA processing', 15, 'endocrine'), ('GO_0008152', 'metabolic process', 40, 'metabolic'), ('UBERON_0002107', 'liver', 87, 'liver')]
PMC3877003	12/2013	S197-PMC3877003	['Liver Tissue was collected, snap-frozen in liquid nitrogen and stored at −80°c.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000479', 'tissue', 6, 'tissue')]
PMC3877003	12/2013	S199-PMC3877003	['dna was pooled from Livers of 8 individual Animals per group.']	N/A	N/A	[('UBERON_0002107', 'liver', 20, 'livers'), ('NCBITaxon_33208', 'Metazoa', 43, 'animals')]
PMC3877003	12/2013	S200-PMC3877003	['four of these Livers also provided samples for rna preparations.']	N/A	N/A	[('UBERON_0002107', 'liver', 14, 'livers')]
PMC3877003	12/2013	S201-PMC3877003	['microarray experiment\ntotal rna were isolated from three groups of 1 day male Rat Livers using rneasy mini kit (qiagen), treated with turbo dnasei (ambion) for 30 min at 37°c, then with Phenol/Chloroform and Ethanol precipitated.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 78, 'rat'), ('UBERON_0002107', 'liver', 82, 'livers'), ('CHEBI_15882', 'phenol', 186, 'phenol'), ('CHEBI_35255', 'chloroform', 193, 'chloroform'), ('CHEBI_16236', 'ethanol', 208, 'ethanol')]
PMC3877003	12/2013	S247-PMC3877003	["Bisulphite sequencing\n1 µg of Genomic dna from each Liver sample was Bisulphite converted according to manufacture's instruction (ez Dna Methylation gold kit, zymo research)."]	N/A	N/A	[('CHEBI_3129', 'bispyribac', 0, 'Bisulphite'), ('SO_0001026', 'genome', 30, 'genomic'), ('UBERON_0002107', 'liver', 52, 'liver'), ('CHEBI_35455', '1-naphthyl isothiocyanate', 69, 'bisulphite'), ('GO_0006306', 'DNA methylation', 133, 'DNA methylation')]
PMC3877003	12/2013	S255-PMC3877003	['for each Animal group up to 6 Livers and 53 clones were sequenced using t3 sequencing Primer (see detail indataset s10).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 9, 'animal'), ('UBERON_0002107', 'liver', 30, 'livers'), ('SO_0000112', 'primer', 86, 'primer')]
PMC3888066	12/2012	S40-PMC3888066	['non-fortified foods\nLiver is the Food source with the highest quantity of Vitamin A by weight.']	N/A	N/A	[('UBERON_0002107', 'liver', 20, 'Liver'), ('CHEBI_33290', 'food', 33, 'food'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin A')]
PMC3897149	10/2013	S5-PMC3897149	['introduction\nthe pathway for the Catabolism Of Uracil and Thymine in Mammalian Livers consists of three consecutive steps [figure 1].']	N/A	N/A	[('GO_0019651', 'citrate catabolic process to diacetyl', 33, 'catabolism of uracil'), ('GO_0046903', 'secretion', 58, 'thymine'), ('NCBITaxon_40674', 'Mammalia', 69, 'mammalian'), ('UBERON_0002107', 'liver', 79, 'livers')]
PMC3907150	1/2014	S238-PMC3907150	['Dna Methylation in the Pparα Promoter decreased in the Liver of Rats Prenatally exposed to a protein-restricted diet.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 23, 'PPARα'), ('SO_0000167', 'promoter', 29, 'promoter'), ('UBERON_0002107', 'liver', 55, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 64, 'rats'), ('GO_0019230', 'proprioception', 69, 'prenatally')]
PMC3925765	9/2013	S71-PMC3925765	['f0 Serum and Liver Ros measurement at breeding at day 120\nf0 Serum and Tissue were frozen at −70°c until analyzed.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 3, 'serum'), ('UBERON_0002107', 'liver', 13, 'liver'), ('CHEBI_8756', 'RNA (poly(A))', 19, 'ROS'), ('UBERON_0001977', 'blood serum', 61, 'Serum'), ('UBERON_0000479', 'tissue', 71, 'tissue')]
PMC3925765	9/2013	S74-PMC3925765	['Liver data were normalized to protein concentration.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC3925765	9/2013	S86-PMC3925765	['Nitrotyrosine (nt) histology\n5 µm Liver paraffin sections were immunostained using methods that have been described previously in detail(25) with affinity-purified Mouse monoclonal Antibody anti-Nt (sc-101358) 1:1000 dilution, abc elite kit, vector laboratories and visualized using 2.5% Nickel Sulfate sith 0.02% dab Chromogen in 0.175 m Sodium Acetate.']	N/A	N/A	[('CHEBI_50692', 'mifepristone', 0, 'Nitrotyrosine'), ('UBERON_0002107', 'liver', 34, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 164, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 181, 'antibody'), ('PR_000011508', 'nuclear pore complex protein Nup153', 195, 'NT'), ('CHEBI_53001', 'nickel sulfate', 288, 'nickel sulfate'), ('CHEBI_76201', 'clonixin lysine salt', 318, 'chromogen'), ('CHEBI_32954', 'sodium acetate', 339, 'sodium acetate')]
PMC3925765	9/2013	S111-PMC3925765	['f0 oxidative stress before breeding\nbefore breeding, f0 Serum and Liver Mda and Ros, sod and gpx activities were increased in mo compared to c (fig 4).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 56, 'serum'), ('UBERON_0002107', 'liver', 66, 'liver'), ('CHEBI_34840', 'methyl methacrylate', 72, 'MDA'), ('CHEBI_8756', 'RNA (poly(A))', 80, 'ROS')]
PMC3925765	9/2013	S114-PMC3925765	['before breeding mo increased Liver nt.']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver')]
PMC3946277	3/2014	S9-PMC3946277	['early Gestational undernutrition induced lower Hepatic Expression of Gluconeogenic factors in fetuses and reduced in vivo Adipose Tissue Insulin sensitivity in Adulthood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 6, 'gestational'), ('UBERON_0002107', 'liver', 47, 'hepatic'), ('GO_0010467', 'gene expression', 55, 'expression'), ('GO_0006094', 'gluconeogenesis', 69, 'gluconeogenic'), ('UBERON_0001013', 'adipose tissue', 122, 'adipose tissue'), ('PR_000045358', 'insulin family protein', 137, 'insulin'), ('UBERON_0000113', 'post-juvenile adult stage', 160, 'adulthood')]
PMC3946277	3/2014	S10-PMC3946277	['in males, Undernutrition in early Gestation increased Adipose Tissue Lipid Handling mechanisms (lipoprotein lipase, Glucocorticoid receptor Expression) and Hepatic methylation within the Imprinted Control region of Insulin-Like Growth Factor 2 Receptor in Adulthood.']	N/A	N/A	[('GO_0019653', 'anaerobic purine nucleobase catabolic process', 10, 'undernutrition'), ('GO_0007565', 'female pregnancy', 34, 'gestation'), ('UBERON_0001013', 'adipose tissue', 54, 'adipose tissue'), ('CHEBI_18059', 'lipid', 69, 'lipid'), ('GO_0006629', 'lipid metabolic process', 69, 'lipid handling'), ('CHEBI_24261', 'glucocorticoid', 116, 'glucocorticoid'), ('GO_0010467', 'gene expression', 140, 'expression'), ('UBERON_0002107', 'liver', 156, 'hepatic'), ('GO_0071514', 'genetic imprinting', 187, 'imprinted'), ('GO_0065007', 'biological regulation', 197, 'control'), ('PR_000001364', 'interleukin-1 receptor type II', 215, 'insulin-like growth factor 2 receptor'), ('UBERON_0000113', 'post-juvenile adult stage', 256, 'adulthood')]
PMC3946277	3/2014	S100-PMC3946277	['real-time rt pcr (abl prism 7700 and 7500 sequence detection system, applied biosystems step one plus) was used to measure mrna Expression for ir in all Adult and fetal Tissues, Glut4 in Adult muscle and Adipose Tissue, gr in Adult Adipose Tissue and Adult and fetal Liver, Lpl and Ppar-γ in Adult Adipose Tissue, Pepck and g6pase in Adult and fetal Liver, igfii and Igf2R in the Left Lobe Of adult Liver.']	N/A	N/A	[('GO_0010467', 'gene expression', 128, 'expression'), ('UBERON_0007023', 'adult organism', 153, 'adult'), ('UBERON_0000479', 'tissue', 169, 'tissues'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 178, 'GLUT4'), ('UBERON_0007023', 'adult organism', 187, 'adult'), ('UBERON_0001013', 'adipose tissue', 204, 'adipose tissue'), ('UBERON_0007023', 'adult organism', 226, 'adult'), ('UBERON_0001013', 'adipose tissue', 232, 'adipose tissue'), ('UBERON_0007023', 'adult organism', 251, 'adult'), ('UBERON_0002107', 'liver', 267, 'liver'), ('PR_000009880', 'Lon protease, mitochondrial', 274, 'LPL'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 282, 'PPAR-'), ('UBERON_0007023', 'adult organism', 292, 'adult'), ('UBERON_0001013', 'adipose tissue', 298, 'adipose tissue'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 314, 'PEPCK'), ('UBERON_0007023', 'adult organism', 334, 'adult'), ('UBERON_0002107', 'liver', 350, 'liver'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 367, 'IGF2R'), ('UBERON_0001115', 'left lobe of liver', 380, 'left lobe of ... liver')]
PMC3946277	3/2014	S104-PMC3946277	['in Adult and fetal Liver, Gene Expression was normalised to the geometric mean of Glyceraldehyde 3-Phosphate dehydrogenase (gapdh), Ribosomal Protein 19 Large Subunit (Rpl-19) and Β-Actin mrna Expression, as determined using the genorm normalising kit.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 3, 'adult'), ('UBERON_0002107', 'liver', 19, 'liver'), ('GO_0010467', 'gene expression', 26, 'gene expression'), ('SO_0000704', 'gene', 26, 'gene'), ('CHEBI_17138', 'glyceraldehyde 3-phosphate', 82, 'glyceraldehyde 3-phosphate'), ('GO_0005840', 'ribosome', 132, 'ribosomal'), ('PR_000012989', 'DNA-directed RNA polymerase II subunit RPB3', 132, 'ribosomal protein 19 large subunit'), ('PR_000014339', 'radial spoke head 14 homolog', 168, 'RPL'), ('PR_000003676', 'actin, cytoplasmic 1', 180, 'β-actin'), ('GO_0010467', 'gene expression', 193, 'expression')]
PMC3946277	3/2014	S124-PMC3946277	['for Adult Liver, the same factors were examined using multifactorial analyses of variance for repeated measures (rm anova), with Liver Lobe as the repeated measure.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 4, 'adult'), ('UBERON_0002107', 'liver', 10, 'liver'), ('UBERON_0001113', 'lobe of liver', 129, 'liver lobe')]
PMC3946277	3/2014	S125-PMC3946277	['for fetal Liver, the main factors of maternal dietary group and fetal sex were used in a rm anova, with Liver Lobe as the repeated measure.']	N/A	N/A	[('UBERON_0002107', 'liver', 10, 'liver'), ('UBERON_0001113', 'lobe of liver', 104, 'liver lobe')]
PMC3946277	3/2014	S149-PMC3946277	['Adipose Tissue Lipid content was also reduced (p<0.05) in cu compared to cc females at 2.5 years (table 2).10.1371/journal.pone.0090994.t002\n\ncaption (table-Wrap): table 2\nGenes of interest in Liver and Adipose Tissue of mature (2.5 years) Adult male and female Sheep.malesfemalescccuucuucccuucuu n \u200a=\u200a13 n \u200a=\u200a7 n \u200a=\u200a8 n \u200a=\u200a11 n \u200a=\u200a9 n \u200a=\u200a7 n \u200a=\u200a9 n \u200a=\u200a11liver – left Lobe:gr mrnax,z3.41±0.492.85±0.403.41±0.403.35±0.492.73±0.372.20±0.292.32±0.142.37±0.24ir mrna0.187±0.0230.222±0.0660.304±0.0810.282±0.0560.268±0.0300.203±0.0250.276±0.0410.228±0.041pepck mrnay,z0.258±0.0490.190±0.0210.313±0.0330.294±0.0550.166±0.0360.194±0.0380.224±0.0410.140±0.027g6pase mrna0.485±0.0510.521±0.1160.463±0.0590.522±0.1000.536±0.0840.486±0.0780.471±0.0780.455±0.060gr methylation0.013±0.0040.021±0.0120.010±0.0020.018±0.0040.013±0.0040.011±0.0050.049±0.0430.013±0.004igfii mrna0.512±0.0760.523±0.0970.552±0.1360.513±0.0560.380±0.0590.405±0.0410.378±0.0670.426±0.041igf2r mrna0.015±0.0060.006±0.0020.023±0.0110.017±0.0060.062±0.0560.011±0.0030.017±0.0010.040±0.023liver – right Lobe:gr mrnax7.18±0.677.57±0.666.68±0.947.42±1.443.67±0.563.51±0.303.75±0.603.77±0.47ir mrna0.234±0.0410.302±0.0500.238±0.0640.266±0.0390.203±0.0170.217±0.0240.250±0.0510.242±0.019pepck mrna0.198±0.0290.219±0.0460.307±0.0720.182±0.0270.106±0.0080.150±0.0250.126±0.0170.141±0.021g6pase mrna0.512±0.0760.523±0.0970.552±0.1360.513±0.0560.380±0.0590.405±0.0410.378±0.0670.426±0.041gr Dna Methylation0.015±0.0060.006±0.0020.023±0.0110.017±0.0060.062±0.0560.011±0.0030.017±0.0010.040±0.023adipose Tissue:ir mrna1.63±0.151.75±0.251.56±0.171.29±0.101.55±0.241.37±0.191.54±0.191.35±0.18glut4 mrna1.55±0.161.66±0.121.38±0.181.51±0.131.06±0.181.28±0.181.42±0.151.49±0.32Pparγ mrna1.85±0.171.83±0.241.82±0.151.68±0.150.97±0.160.88±0.110.96±0.090.97±0.14lipid content (mmol.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 0, 'Adipose tissue'), ('CHEBI_18059', 'lipid', 15, 'lipid'), ('PR_000017453', 'protein Wnt-9b', 157, 'WRAP'), ('SO_0000704', 'gene', 172, 'Genes'), ('UBERON_0002107', 'liver', 193, 'liver'), ('UBERON_0001013', 'adipose tissue', 203, 'adipose tissue'), ('UBERON_0007023', 'adult organism', 240, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 262, 'sheep'), ('UBERON_0009912', 'anatomical lobe', 368, 'lobe'), ('UBERON_0009912', 'anatomical lobe', 1062, 'lobe'), ('GO_0006309', 'apoptotic DNA fragmentation', 1442, 'DNA methylation0'), ('UBERON_0000479', 'tissue', 1553, 'tissue'), ('PR_000010977', 'nucleosome assembly protein 1-like 3', 1719, '32PPARγ')]
PMC3946277	3/2014	S152-PMC3946277	['values given have arbitrary units and are normalised to geometric means of Β-Actin, gapdh and Rpl-19 (Liver) or Β Actin and gapdh (Adipose Tissue).']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 75, 'β-actin'), ('PR_000014170', 'replication protein A 70 kDa DNA-binding subunit', 94, 'RPL-19'), ('UBERON_0002107', 'liver', 102, 'liver'), ('PR_000003676', 'actin, cytoplasmic 1', 112, 'β actin'), ('UBERON_0001013', 'adipose tissue', 131, 'adipose tissue')]
PMC3946277	3/2014	S167-PMC3946277	['levels of gr (p<0.01) and g6pase (p<0.05) mrna in fetal Liver were also reduced by early Gestation undernutrition, but in a Lobe-specific manner.']	N/A	N/A	[('UBERON_0002107', 'liver', 56, 'liver'), ('GO_0007565', 'female pregnancy', 89, 'gestation'), ('UBERON_0009912', 'anatomical lobe', 124, 'lobe')]
PMC3946277	3/2014	S175-PMC3946277	['4), Adipose Tissue or Liver (table 2), or on Hepatic gr, Pepck or G6Pase mrna levels (fig.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 4, 'adipose tissue'), ('UBERON_0002107', 'liver', 22, 'liver'), ('UBERON_0002107', 'liver', 45, 'hepatic'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 57, 'PEPCK'), ('PR_000007897', 'glutamate--cysteine ligase catalytic subunit', 66, 'G6Pase')]
PMC3946277	3/2014	S182-PMC3946277	['Gluconeogenic Genes in Liver differs between the Lobes\nthere was differential Expression of Gluconeogenic Genes between the fetal Liver Lobes, with g6pase (p<0.01) and gr (p\u200a=\u200a0.065) Expression overall greater in the left (29.09±5.93 and 8.85±0.66, respectively) compared to the right (20.34±4.15 and 7.18±0.73 arbitrary units, respectively) Liver Lobe.']	N/A	N/A	[('GO_0046654', 'tetrahydrofolate biosynthetic process', 0, 'Gluconeogenic'), ('SO_0000704', 'gene', 14, 'genes'), ('UBERON_0002107', 'liver', 23, 'liver'), ('UBERON_0009912', 'anatomical lobe', 49, 'lobes'), ('GO_0010467', 'gene expression', 78, 'expression'), ('GO_0006094', 'gluconeogenesis', 92, 'gluconeogenic'), ('SO_0000704', 'gene', 106, 'genes'), ('UBERON_0002107', 'liver', 130, 'liver'), ('UBERON_0009912', 'anatomical lobe', 136, 'lobes'), ('GO_0010467', 'gene expression', 183, 'expression'), ('UBERON_0002107', 'liver', 342, 'liver'), ('UBERON_0009912', 'anatomical lobe', 348, 'lobe')]
PMC3946277	3/2014	S184-PMC3946277	['both gr and Pepck mrna levels overall were higher (p<0.001) in Adult male than female Liver, regardless of Lobe (5.19±0.22 vs. 2.93±0.26 and 0.24±0.02 vs. 0.14±0.02 arbitrary units, respectively) and in female twins compared to singletons (3.89±0.26 vs. 3.24±0.43 arbitrary units (right Liver Lobe) and 0.21±0.02 vs. 0.10±0.03 (left Liver Lobe), respectively, see alsotable 2).']	N/A	N/A	[('PR_000012564', 'peroxisomal biogenesis factor 3', 12, 'PEPCK'), ('UBERON_0007023', 'adult organism', 63, 'adult'), ('UBERON_0002107', 'liver', 86, 'liver'), ('UBERON_0009912', 'anatomical lobe', 107, 'lobe'), ('UBERON_0001113', 'lobe of liver', 287, 'liver lobe'), ('UBERON_0001113', 'lobe of liver', 333, 'liver lobe')]
PMC3946277	3/2014	S185-PMC3946277	['Dna Methylation within the gr Promoter region in Adult Liver was not affected by Lobe, nutrition, sex or offspring number (table 2).']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('SO_0000167', 'promoter', 30, 'promoter'), ('UBERON_0007023', 'adult organism', 49, 'adult'), ('UBERON_0002107', 'liver', 55, 'liver'), ('UBERON_0009912', 'anatomical lobe', 81, 'lobe')]
PMC3946277	3/2014	S190-PMC3946277	['post-weaning nutrition restriction had no effect in the Liver on ir, gr, Pepck or G6Pase mrna levels (table 2), except in the right Liver Lobe where Pepck mrna levels in singleton male Sheep were reduced by post-weaning undernutrition (cu and uu combined, 0.16±0.02 ( n \u200a=\u200a8) vs. cc and uc combined, 0.31±0.06 ( n \u200a=\u200a10) arbitrary units).']	N/A	N/A	[('UBERON_0002107', 'liver', 56, 'liver'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 73, 'PEPCK'), ('PR_000007897', 'glutamate--cysteine ligase catalytic subunit', 82, 'G6Pase'), ('UBERON_0002107', 'liver', 132, 'liver'), ('UBERON_0009912', 'anatomical lobe', 138, 'lobe'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 149, 'PEPCK'), ('NCBITaxon_10088', 'Mus <genus>', 185, 'sheep')]
PMC3946277	3/2014	S193-PMC3946277	['early Gestation undernutrition had no effect on methylation at the Igf2/h19 or Dlk/Meg3 loci in Adult Liver in either sex (fig.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 6, 'gestation'), ('PR_000008989', 'interleukin-1 family member 7', 67, 'IGF2'), ('PR_000006528', 'homeobox protein DLX-2', 79, 'DLK'), ('PR_000010330', 'talin rod domain-containing protein 1', 83, 'MEG3'), ('UBERON_0007023', 'adult organism', 96, 'adult'), ('UBERON_0002107', 'liver', 102, 'liver')]
PMC3946277	3/2014	S195-PMC3946277	['there were no effects of early Gestation undernutrition on igfii or Igf2R mrna levels in Adult Liver (table 2).10.1371/journal.pone.0090994.g005\n\ncaption (fig): figure 5\nepigenetic modification of Genes Regulating Metabolic Homeostasis and body composition in Liver of 2.5 year-old Sheep.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 31, 'gestation'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 68, 'IGF2R'), ('UBERON_0007023', 'adult organism', 89, 'adult'), ('UBERON_0002107', 'liver', 95, 'liver'), ('SO_0000704', 'gene', 197, 'genes'), ('GO_0065007', 'biological regulation', 203, 'regulating'), ('GO_0055064', 'chloride ion homeostasis', 214, 'metabolic homeostasis'), ('UBERON_0002107', 'liver', 260, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 282, 'sheep')]
PMC3946277	3/2014	S245-PMC3946277	['Nutrient restriction in both early and late Gestation reduced key Gluconeogenic enzymes in late Gestation Liver and there was differential Expression between the fetal Liver Lobes.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 0, 'Nutrient'), ('GO_0007565', 'female pregnancy', 44, 'gestation'), ('GO_0006094', 'gluconeogenesis', 66, 'gluconeogenic'), ('GO_0007565', 'female pregnancy', 96, 'gestation'), ('UBERON_0002107', 'liver', 106, 'liver'), ('GO_0010467', 'gene expression', 139, 'expression'), ('UBERON_0001113', 'lobe of liver', 168, 'liver lobes')]
PMC3953741	3/2014	S3-PMC3953741	['fetal predisposition to nafld involves numerous physiological reroutings that are initiated by increased Delivery Of Nonesterified Fatty Acids to the fetal Liver.']	N/A	N/A	[('GO_0015908', 'fatty acid transport', 105, 'delivery of ... fatty acids'), ('CHEBI_25509', 'neuraminosyl group', 117, 'nonesterified fatty acids'), ('UBERON_0002107', 'liver', 156, 'liver')]
PMC3953741	3/2014	S18-PMC3953741	['upon reaching the developing Liver, nefas diffuse into Hepatocytes and they are rapidly converted into Fatty Acyl-Coenzyme A (Coa).10primarily, fatty acyl-coas enter the Mitochondria for β-oxidation.']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver'), ('CL_0000182', 'hepatocyte', 55, 'hepatocytes'), ('CHEBI_39015', 'apolipoprotein', 103, 'fatty acyl-coenzyme A'), ('CHEBI_15346', 'coenzyme A', 126, 'CoA'), ('GO_0005739', 'mitochondrion', 170, 'mitochondria')]
PMC3953741	3/2014	S29-PMC3953741	['disruptions resulting from elevated β-oxidation\nin a study by bruce et al,17the Hepatic Metabolic capacities of four groups of Mice that received either a hf or control (c) Prenatal and Postnatal diet were analyzed.']	N/A	N/A	[('UBERON_0002107', 'liver', 80, 'hepatic'), ('GO_0008152', 'metabolic process', 88, 'metabolic'), ('NCBITaxon_10088', 'Mus <genus>', 127, 'mice'), ('GO_0007565', 'female pregnancy', 173, 'prenatal'), ('GO_0007567', 'parturition', 186, 'postnatal')]
PMC4002571	12/2013	S4-PMC4002571	['the Hypothalamus, Pituitary Gland and Liver were dissected for histological studies.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('UBERON_0000007', 'pituitary gland', 18, 'pituitary gland'), ('UBERON_0002107', 'liver', 38, 'liver')]
PMC4002571	12/2013	S11-PMC4002571	['introduction\nMetabolic syndrome (ms) is a collection of multiple conditions, including hypertension, hyperglycemia, dyslipidemia and obesity, that directly lead to fatty Liver and diabetes, as well as Cardiovascular and Cerebrovascular diseases.']	N/A	N/A	[('GO_0008152', 'metabolic process', 13, 'Metabolic'), ('UBERON_0002107', 'liver', 170, 'liver'), ('UBERON_0004535', 'cardiovascular system', 201, 'cardiovascular'), ('UBERON_0004086', 'brain ventricle', 220, 'cerebrovascular')]
PMC4002571	12/2013	S68-PMC4002571	['the Hypothalamus, Pituitary Gland and Liver were dissected and fixed in a 4% paraformaldehyde Solution for histological examination.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('UBERON_0000007', 'pituitary gland', 18, 'pituitary gland'), ('UBERON_0002107', 'liver', 38, 'liver'), ('CHEBI_75958', 'solution', 94, 'solution')]
PMC4002571	12/2013	S74-PMC4002571	['histological examination\nthe Hypothalamus, Pituitary Gland and Liver were fixed in a 4% paraformaldehyde Solution overnight and processed using the paraffin section technique.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 29, 'hypothalamus'), ('UBERON_0000007', 'pituitary gland', 43, 'pituitary gland'), ('UBERON_0002107', 'liver', 63, 'liver'), ('CHEBI_75958', 'solution', 105, 'solution')]
PMC4002571	12/2013	S101-PMC4002571	['pathological alterations\nthe normal architecture of the Hypothalamus, Pituitary Gland and Liver were observed in the male and female control Rats (figures 6a1–6a3and6c1–6c3).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 56, 'hypothalamus'), ('UBERON_0000007', 'pituitary gland', 70, 'pituitary gland'), ('UBERON_0002107', 'liver', 90, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 141, 'rats')]
PMC4018592	4/2014	S32-PMC4018592	['multiparous women as well as those with hypertension, mild and severe pre-eclampsia, Intrauterine growth retardation (iugr), intra-Uterine fetal death, Gestational diabetes mellitus (gdm), completed bed rest (cbr), history or evidence of rheumatoid arthritis, Thyroid, Parathyroid or Adrenal diseases, Hepatic or Renal failure and metabolic bone disease were not included in the current study.']	N/A	N/A	[('UBERON_0022293', 'reproductive gland secretion', 85, 'intrauterine'), ('UBERON_0000995', 'uterus', 131, 'uterine'), ('GO_0007565', 'female pregnancy', 152, 'gestational'), ('UBERON_0002046', 'thyroid gland', 260, 'thyroid'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid'), ('UBERON_0002369', 'adrenal gland', 284, 'adrenal'), ('UBERON_0002107', 'liver', 302, 'hepatic'), ('UBERON_0002113', 'kidney', 313, 'renal')]
PMC4026129	1/2014	S63-PMC4026129	['iasvis reduced to iasiiimainly in the Blood or Liver by one of several Mammalian enzymes that utilize Glutathione (Gssh) or Dithiothreitol (Dtt) as reductants.']	N/A	N/A	[('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0002107', 'liver', 47, 'liver'), ('NCBITaxon_40674', 'Mammalia', 71, 'mammalian'), ('CHEBI_16856', 'glutathione', 102, 'glutathione'), ('CHEBI_86624', 'G b1-G', 115, 'GSSH'), ('CHEBI_18320', '1,4-dithiothreitol', 124, 'dithiothreitol'), ('CHEBI_18320', '1,4-dithiothreitol', 140, 'DTT')]
PMC4026129	1/2014	S64-PMC4026129	['the remaining steps of ias Biotransformation, which involve alternating Oxidative Methylation and reduction steps, occur mainly in the Liver.']	N/A	N/A	[('GO_0046225', 'bacteriocin catabolic process', 27, 'biotransformation'), ('GO_0035514', 'DNA demethylase activity', 72, 'oxidative methylation'), ('UBERON_0002107', 'liver', 135, 'liver')]
PMC4026129	1/2014	S151-PMC4026129	['long-term (6\xa0months) exposure to Ias resulted in the downregulation of P16 mrna in the Livers of c57bl/6 Mice, which was accompanied by an increase of the transcription-restrictive ptm H3K9Me2 in the P16 Promoter region but no change in Promoter Dna Methylation status [65•].']	N/A	N/A	[('CHEBI_24870', 'ion', 33, 'iAs'), ('PR_000001245', 'rhodopsin', 71, 'p16'), ('UBERON_0002107', 'liver', 87, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 105, 'mice'), ('SO_0001707', 'H3K9_trimethylation_site', 185, 'H3K9me2'), ('PR_000001245', 'rhodopsin', 200, 'p16'), ('SO_0000167', 'promoter', 204, 'promoter'), ('SO_0000167', 'promoter', 237, 'promoter'), ('GO_0006306', 'DNA methylation', 246, 'DNA methylation')]
PMC4048511	5/2014	S34-PMC4048511	['un-married women and married women having Fertility problems or any history of Gynecological problem like fibroids, menorrhagia, amenorrhoea and Pelvic inflammatory disease were excluded from the study.']	N/A	N/A	[('GO_0009566', 'fertilization', 42, 'fertility'), ('UBERON_0001155', 'colon', 79, 'gynecological'), ('UBERON_0002107', 'liver', 145, 'Pelvic')]
PMC4051754	6/2014	S95-PMC4051754	['Liver has a great flexibility to adapt to the Metabolic changes occurring during the transition period[30].']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('GO_0008152', 'metabolic process', 46, 'metabolic')]
PMC4051754	6/2014	S100-PMC4051754	['in a previous experiment, Liver from Cows Fed ad-libitum vs. restricted before Parturition had only numerically higher Glycogen concentration[5].']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'liver'), ('NCBITaxon_33208', 'Metazoa', 37, 'cows'), ('GO_0007631', 'feeding behavior', 42, 'fed'), ('GO_0019230', 'proprioception', 79, 'parturition'), ('CHEBI_24384', 'glycogens', 119, 'glycogen')]
PMC4051754	6/2014	S104-PMC4051754	['the Liver of re Cows had a higher activation both pre- and post-Partum of energy production through the ‘Oxidative Phosphorylation’ pathway (figure 5).']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('NCBITaxon_33208', 'Metazoa', 16, 'cows'), ('GO_0007567', 'parturition', 64, 'partum'), ('GO_0006119', 'oxidative phosphorylation', 105, 'Oxidative phosphorylation')]
PMC4051754	6/2014	S153-PMC4051754	['there was no detectable lower Plasma concentration of negative App in re vs. of (figure s1) or in their mrna abundance in Liver (figure s2).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 30, 'plasma'), ('PR_000004168', 'amyloid-beta precursor protein', 63, 'APP'), ('UBERON_0002107', 'liver', 122, 'liver')]
PMC4051754	6/2014	S180-PMC4051754	['Ethanol-induced steatosis in Liver of Rats increased Hepatocyte Proliferation as a mechanism to reduce the injury due to the large degree of Lipid infiltration[56].']	N/A	N/A	[('CHEBI_16236', 'ethanol', 0, 'Ethanol'), ('UBERON_0002107', 'liver', 29, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 38, 'rats'), ('CL_0000182', 'hepatocyte', 53, 'hepatocyte'), ('GO_0008283', 'cell proliferation', 64, 'proliferation'), ('CHEBI_18059', 'lipid', 141, 'lipid')]
PMC4051754	6/2014	S241-PMC4051754	['the Liver biopsies were harvested on day −65, −30, −14, +1, +14, +28, +49 relative to Parturition.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('GO_0019230', 'proprioception', 86, 'parturition')]
PMC4051754	6/2014	S287-PMC4051754	['caption (supplementary-material): figure s3\n\ningenuity pathway upstream network analysis of differentially Expressed Genes (deg) between Liver of Cows Fed restricted (re) energy and protein or receiving a higher energy and protein diet (of) Prepartum at +1 d. up-stream regulators are located at the center of the network and down-stream Genes are located in the periphery.']	N/A	N/A	[('GO_0010467', 'gene expression', 107, 'expressed'), ('SO_0000704', 'gene', 117, 'genes'), ('UBERON_0002107', 'liver', 137, 'liver'), ('NCBITaxon_33208', 'Metazoa', 146, 'cows'), ('GO_0007631', 'feeding behavior', 151, 'fed'), ('GO_0007565', 'female pregnancy', 241, 'prepartum'), ('SO_0000704', 'gene', 338, 'genes')]
PMC4051754	6/2014	S290-PMC4051754	['caption (supplementary-material): figure s4\n\ningenuity pathway upstream network analysis of differentially Expressed Genes (deg) between Liver of Cows Fed restricted (re) energy and protein or receiving a higher energy and protein diet (of) Prepartum at +14 d. up-stream regulators are located at the center of the network and down-stream Genes are located in the periphery.']	N/A	N/A	[('GO_0010467', 'gene expression', 107, 'expressed'), ('SO_0000704', 'gene', 117, 'genes'), ('UBERON_0002107', 'liver', 137, 'liver'), ('NCBITaxon_33208', 'Metazoa', 146, 'cows'), ('GO_0007631', 'feeding behavior', 151, 'fed'), ('GO_0007565', 'female pregnancy', 241, 'prepartum'), ('SO_0000704', 'gene', 339, 'genes')]
PMC4051754	6/2014	S304-PMC4051754	['caption (supplementary-material): file s5\n\ncomplete results from database for annotation, visualization and integrated discovery (david) of deg between Liver of Cows Fed restricted (re) energy and protein or receiving a higher energy and protein diet (of) prepaprtum.']	N/A	N/A	[('UBERON_0002107', 'liver', 152, 'liver'), ('NCBITaxon_33208', 'Metazoa', 161, 'cows'), ('GO_0007631', 'feeding behavior', 166, 'fed')]
PMC4100392	6/2014	S51-PMC4100392	['pups from Rats on hfd during Pregnancy and Lactation, for instance, were shown to be heavier, fatter, and more hyperglycemic and moreover had higher Hepatic Lipid content at weaning than pups from Rats Fed a control diet [54].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 10, 'rats'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy'), ('GO_0007595', 'lactation', 43, 'lactation'), ('UBERON_0002107', 'liver', 149, 'hepatic'), ('CHEBI_18059', 'lipid', 157, 'lipid'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 197, 'rats'), ('GO_0007631', 'feeding behavior', 202, 'fed')]
PMC4100392	6/2014	S88-PMC4100392	['ir is defined as a pathophysiological condition of underresponsiveness to normal Insulin concentrations in target Tissues such as Adipose, muscle, Liver, or Cardiovascular Tissues.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 81, 'insulin'), ('UBERON_0000479', 'tissue', 114, 'tissues'), ('UBERON_2000251', 'adipose fin', 130, 'adipose'), ('UBERON_0002107', 'liver', 147, 'liver'), ('UBERON_0004535', 'cardiovascular system', 157, 'cardiovascular tissues')]
PMC4100392	6/2014	S128-PMC4100392	['moreover, Liver Cells exposed to Pharmacological triggers of Er stress response show ir profiles characterized by serine phosphorylation of Irs-1 and suppression of Insulin-induced Akt phosphorylation.']	N/A	N/A	[('CL_0000592', 'large luteal cell', 10, 'liver cells'), ('UBERON_0002107', 'liver', 10, 'liver'), ('CHEBI_52217', 'pharmaceutical', 33, 'pharmacological'), ('GO_0005783', 'endoplasmic reticulum', 61, 'ER'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 140, 'IRS-1'), ('PR_000045358', 'insulin family protein', 165, 'insulin'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 181, 'Akt')]
PMC4113768	7/2014	S291-PMC4113768	['Liver or Renal failure was considered exclusion criteria.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0002113', 'kidney', 9, 'renal')]
PMC4113768	7/2014	S727-PMC4113768	['Vitamin D3Is mainly Metabolized in the Liver and Kidney.']	N/A	N/A	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3is'), ('GO_0008152', 'metabolic process', 20, 'metabolized'), ('UBERON_0002107', 'liver', 39, 'liver'), ('UBERON_0002113', 'kidney', 49, 'kidney')]
PMC4113768	7/2014	S1091-PMC4113768	['exclusion criteria: previous hypocalcaemic seizure or an underlying condition causing secondary vdd (e.g., Renal & Liver disease).']	N/A	N/A	[('UBERON_0002113', 'kidney', 107, 'renal'), ('UBERON_0002107', 'liver', 115, 'liver')]
PMC4113768	7/2014	S1385-PMC4113768	['conclusions: using gold standard techniques this cross-sectional analysis did not reveal a significant association between Vitamin D and measures of Whole-Body, Peripheral or Hepatic Insulin resistance in healthy overweight Individuals at high risk of Cardiovascular disease.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('UBERON_0000468', 'multicellular organism', 149, 'whole-body'), ('UBERON_0003060', 'pronephric duct', 161, 'peripheral ...'), ('UBERON_0002107', 'liver', 175, 'hepatic'), ('PR_000045358', 'insulin family protein', 183, 'insulin'), ('NCBITaxon_1', 'root', 224, 'individuals'), ('UBERON_0004535', 'cardiovascular system', 252, 'cardiovascular')]
PMC4113768	7/2014	S1697-PMC4113768	['Renal and Liver function test was done for screening any pseudo cause of hypovitaminosis.']	N/A	N/A	[('UBERON_0002113', 'kidney', 0, 'Renal'), ('UBERON_0002107', 'liver', 10, 'liver')]
PMC4113768	7/2014	S2619-PMC4113768	['secondary outcome measures included Blood pressure, body mass index, waist circumference, Fructosamine, Lipid and Apolipoprotein levels, Liver function tests, c-reactive protein level and safety of supplementation.']	N/A	N/A	[('UBERON_0000178', 'blood', 36, 'blood'), ('CHEBI_24111', 'fructoside', 90, 'fructosamine'), ('CHEBI_18059', 'lipid', 104, 'lipid'), ('CHEBI_39015', 'apolipoprotein', 114, 'apolipoprotein'), ('UBERON_0002107', 'liver', 137, 'liver')]
PMC4120194	7/2014	S91-PMC4120194	['caption (table-wrap): table 7\n\nconsiderations for baseline laboratory investigations (as needed based on patient’s presenting symptoms)basic lab tests • complete blood count• fasting Glucose• fasting Lipid profile (tc, vldl, ldl, hdl, tg)• Thyroid-Stimulating Hormone• electrolytes• Liver enzymes if warranted • Urine toxicology for substance use\nadapted from references [32,53].']	N/A	N/A	[('CHEBI_17234', 'glucose', 183, 'glucose'), ('CHEBI_18059', 'lipid', 200, 'lipid'), ('CHEBI_81565', 'resolvin D2', 240, 'Thyroid-stimulating hormone'), ('UBERON_0002107', 'liver', 283, 'Liver'), ('UBERON_0001088', 'urine', 312, 'Urine')]
PMC4143239	8/2014	S38-PMC4143239	['kwashiorkor refers to a form of oedematous malnutrition, the fulminant syndrome including enlarged fatty Liver, mental changes as well as skin and Hair changes[20].']	N/A	N/A	[('UBERON_0002107', 'liver', 105, 'liver'), ('UBERON_0001037', 'strand of hair', 147, 'hair')]
PMC4143239	8/2014	S157-PMC4143239	['complement\nthe complement system consists of Plasma proteins Secreted by the Liver that, upon activation, react to recruit Immune Cells, Opsonize and kill pathogens[24].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 45, 'plasma'), ('GO_0046903', 'secretion', 61, 'secreted'), ('UBERON_0002107', 'liver', 77, 'liver'), ('CL_0000738', 'leukocyte', 123, 'immune cells'), ('UBERON_0002405', 'immune system', 123, 'immune'), ('GO_0007608', 'sensory perception of smell', 137, 'opsonize')]
PMC4143751	8/2014	S82-PMC4143751	['combined exposure of Mouse fetuses to Arsenic and maternal ms, in the form of Folate, led to more pronounced Dna Methylation changes in the Liver and corresponding impaired Fetal development and body weight gain (tsang et al.,2012).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 21, 'mouse'), ('CHEBI_27563', 'arsenic atom', 38, 'arsenic'), ('CHEBI_30863', '5-azaorotic acid', 78, 'folate'), ('GO_0006306', 'DNA methylation', 109, 'DNA methylation'), ('UBERON_0002107', 'liver', 140, 'liver'), ('GO_0007631', 'feeding behavior', 173, 'fetal')]
PMC4160835	9/2014	S48-PMC4160835	['the form has 5 check-off boxes relevant to pre-eclampsia: haemolysis, elevated Liver enzymes and low Platelet count (hellp syndrome); eclampsia; early pre-eclampsia (diagnosed before 34\u2005weeks); mild pre-eclampsia and severe pre-eclampsia.']	N/A	N/A	[('UBERON_0002107', 'liver', 79, 'liver'), ('CL_0000233', 'platelet', 101, 'platelet')]
PMC4160835	9/2014	S113-PMC4160835	['§severe pre-eclampsia including eclampsia and hellp syndrome (haemolysis, elevated Liver enzymes and low Platelet count).']	N/A	N/A	[('UBERON_0002107', 'liver', 83, 'liver'), ('CL_0000233', 'platelet', 105, 'platelet')]
PMC4161853	8/2014	S206-PMC4161853	['once bacteria have penetrated the Mucosal barrier, the invading Micro-Organism translocates to the Intestinal Lymph Follicles and the draining Mesenteric Lymph Nodes (Mlns), and some pass on to the Reticulo-Endothelial Cells of the Liver and Spleen [113].']	N/A	N/A	[('UBERON_0000344', 'mucosa', 34, 'mucosal'), ('NCBITaxon_10088', 'Mus <genus>', 64, 'micro'), ('NCBITaxon_1', 'root', 70, 'organism'), ('UBERON_0001241', 'crypt of Lieberkuhn of small intestine', 99, 'intestinal lymph follicles'), ('UBERON_0002509', 'mesenteric lymph node', 143, 'mesenteric lymph nodes'), ('UBERON_0001791', 'inner nuclear layer of retina', 167, 'MLNs'), ('CL_0000432', 'reticular cell', 198, 'reticulo-'), ('CL_0000115', 'endothelial cell', 207, 'endothelial cells'), ('UBERON_0001986', 'endothelium', 207, 'endothelial'), ('UBERON_0002107', 'liver', 232, 'liver'), ('UBERON_0002106', 'spleen', 242, 'spleen')]
PMC4161944	9/2014	S21-PMC4161944	['Hscs migrate from the Yolk Sac and Aorta-Gonad-Mesonephros region into the fetal Liver, to ultimately reside in the Bone Marrow in Adults where they constantly self-renew and differentiate to replace the rapid turn over of Circulating Immune Cells.']	N/A	N/A	[('CL_0000545', 'T-helper 1 cell', 0, 'HSCs'), ('UBERON_0001040', 'yolk sac', 22, 'yolk sac'), ('UBERON_0000947', 'aorta', 35, 'aorta'), ('UBERON_0000991', 'gonad', 41, 'gonad'), ('UBERON_0000080', 'mesonephros', 47, 'mesonephros'), ('UBERON_0002107', 'liver', 81, 'liver'), ('UBERON_0002371', 'bone marrow', 116, 'bone marrow'), ('UBERON_0007023', 'adult organism', 131, 'adults'), ('CL_0000080', 'circulating cell', 223, 'circulating'), ('CL_0000738', 'leukocyte', 235, 'immune cells'), ('UBERON_0002405', 'immune system', 235, 'immune')]
PMC4166817	10/2014	S17-PMC4166817	['although L-Arginine is a direct substrate used in the Synthesis Of Nitric Oxide (No) in the No Cycle, it is easily Metabolized in the small Intestine and Liver when administered orally.']	N/A	N/A	[('CHEBI_16977', 'L-alanine', 9, 'L-arginine'), ('GO_0030474', 'spindle pole body duplication', 54, 'synthesis of nitric oxide'), ('CHEBI_16480', 'nitric oxide', 67, 'nitric oxide'), ('CHEBI_16382', 'iodide', 81, 'NO'), ('CHEBI_16382', 'iodide', 92, 'NO'), ('GO_0006097', 'glyoxylate cycle', 92, 'NO cycle'), ('GO_0008152', 'metabolic process', 115, 'metabolized'), ('UBERON_0000160', 'intestine', 140, 'intestine'), ('UBERON_0002107', 'liver', 154, 'liver')]
PMC4169453	9/2014	S38-PMC4169453	['the exclusion criteria were: maternal and neonatal Endocrine disorders (e.g., diabetes mellitus, Thyroid disease, disturbed Calcium-Phosphorus Homeostasis), Renal and Hepatic insufficiency, Anticonvulsant treatment, and congenital malformations of the newborn infant.']	N/A	N/A	[('GO_0006397', 'mRNA processing', 51, 'endocrine'), ('UBERON_0002046', 'thyroid gland', 97, 'thyroid'), ('CHEBI_22313', 'alkaline earth metal atom', 124, 'calcium'), ('GO_0055073', 'cadmium ion homeostasis', 124, 'calcium- ... homeostasis'), ('CHEBI_35885', 'secondary phosphine', 132, 'phosphorus'), ('UBERON_0002113', 'kidney', 157, 'renal'), ('UBERON_0002107', 'liver', 167, 'hepatic'), ('CHEBI_35624', 'azaspiro compound', 190, 'anticonvulsant')]
PMC4188019	1/2010	S15-PMC4188019	['in the Liver, Vitamin D is hydroxylated to 25-Hydroxyvitamin D. subsequent hydroxylation in the Kidney forms the active Metabolite, 1,25-Oh vitamin D.\nin Pregnancy, there is a 2-fold higher concentration of 1,25-Oh Vitamin D in maternal Serum due to activity of Placental 1-α-hydroxylase (novakovic et al., 2009).']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 43, '25-hydroxyvitamin D'), ('UBERON_0002113', 'kidney', 96, 'kidney'), ('CHEBI_39382', 'flufenoxuron', 120, 'metabolite'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 134, '25-OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 148, 'D'), ('GO_0007565', 'female pregnancy', 154, 'pregnancy'), ('CHEBI_72639', '13-HODE', 207, '1,25-OH'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('UBERON_0001987', 'placenta', 262, 'placental')]
PMC4210519	10/2014	S203-PMC4210519	['in this setting, any excess Glucose would be utilised for increased Hepatic de Novo Synthesis Of Fatty Acids.']	N/A	N/A	[('CHEBI_17234', 'glucose', 28, 'glucose'), ('UBERON_0002107', 'liver', 68, 'hepatic'), ('GO_0007567', 'parturition', 79, 'novo'), ('GO_0019626', 'short-chain fatty acid catabolic process', 84, 'synthesis of fatty acids'), ('CHEBI_35366', 'fatty acid', 97, 'fatty acids')]
PMC4210909	10/2014	S17-PMC4210909	['Absorption Of Iron is primarily Regulated within the Intestine, and once iron has been absorbed, there is no mechanism of Excretion from the Kidneys or Liver [9].']	N/A	N/A	[('GO_0006754', 'ATP biosynthetic process', 0, 'Absorption of iron'), ('GO_0065007', 'biological regulation', 32, 'regulated'), ('UBERON_0000160', 'intestine', 53, 'intestine'), ('GO_0007588', 'excretion', 122, 'excretion'), ('UBERON_0002113', 'kidney', 141, 'kidneys'), ('UBERON_0002107', 'liver', 152, 'liver')]
PMC4210909	10/2014	S29-PMC4210909	['transferrin-bound iron is imported with the help of the Transferrin receptor into the Liver, Heart and other storage areas, where it is stored within ferritin.']	N/A	N/A	[('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 56, 'transferrin'), ('UBERON_0002107', 'liver', 86, 'liver'), ('UBERON_0000948', 'heart', 93, 'heart')]
PMC4210909	10/2014	S30-PMC4210909	['Hepcidin, produced by the Liver, helps to Regulate Iron Metabolism by binding to ferroportin and, thus, inhibiting iron export.']	N/A	N/A	[('PR_000008450', 'hyaluronan synthase 2', 0, 'Hepcidin'), ('UBERON_0002107', 'liver', 26, 'liver'), ('GO_0065007', 'biological regulation', 42, 'regulate'), ('GO_1901523', 'icosanoid catabolic process', 51, 'iron metabolism')]
PMC4231606	10/2013	S79-PMC4231606	['Liver, Eggs, fish, fortified Orange Juice) were not significantly associated with higher mean 25(Oh)D levels (data not shown).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'liver'), ('CL_0000025', 'egg cell', 7, 'eggs'), ('CHEBI_52254', 'apatite', 29, 'orange juice'), ('CHEBI_71657', 'versiconol acetate', 94, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 94, '25(OH)D')]
PMC4237823	8/2014	S42-PMC4237823	['however, Fa consumed in fortified foods/supplements is reduced primarly to Dihydrofolate by the enzyme Dihydrofolate reductase in the Liver and finally converted to the Tetrahydrofolate (thf), the substrate for polyglutamate synthetase.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 9, 'FA'), ('CHEBI_36263', 'hydrogenmolybdate', 75, 'dihydrofolate'), ('CHEBI_36263', 'hydrogenmolybdate', 103, 'dihydrofolate'), ('UBERON_0002107', 'liver', 134, 'liver'), ('CHEBI_67016', 'tetrahydrofolate', 169, 'tetrahydrofolate')]
PMC4249952	12/2014	S15-PMC4249952	['lead is absorbed and spread through the Blood, resulting in long-term accumulation in the Liver, Kidney, Spleen, Lung, and Brain.']	N/A	N/A	[('UBERON_0000178', 'blood', 40, 'blood'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0002113', 'kidney', 97, 'kidney'), ('UBERON_0002106', 'spleen', 105, 'spleen'), ('UBERON_0002048', 'lung', 113, 'lung'), ('UBERON_0000955', 'brain', 123, 'brain')]
PMC4251419	12/2014	S18-PMC4251419	['the Synthesis Of Vitamin D following uvb irradiation Of The Skin\nuvb Photons are absorbed by 7-Dehydrocholestrol in the Epidermis and are converted into pre-Vitamin D which undergoes a thermal isomerisation to Formvitamin D. this then undergoes two Hydroxylation reactions, first in the Liver to form 25-Hydroxyvitamin D (25(Oh)D) and then in the Kidney to form the active Metabolite, 1,25-Dihydroxyvitamin D (1,25(Oh)2D).']	N/A	N/A	[('GO_0030474', 'spindle pole body duplication', 4, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0001554', 'luteolysis', 53, 'of     skin'), ('CHEBI_30212', 'photon', 69, 'photons'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 93, '7-dehydrocholestrol'), ('UBERON_0007376', 'outer epithelium', 120, 'epidermis'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_72459', 'Dig-Cy5', 210, 'formvitamin D'), ('GO_0044444', 'cytoplasmic part', 249, 'hydroxylation'), ('UBERON_0002107', 'liver', 287, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 301, '25-hydroxyvitamin D'), ('CHEBI_63056', 'zinc cation', 322, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 328, 'D'), ('UBERON_0002113', 'kidney', 347, 'kidney'), ('CHEBI_39382', 'flufenoxuron', 373, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 385, '1,25-dihydroxyvitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 410, '1,25(OH)2D')]
PMC4271720	12/2014	S203-PMC4271720	['other clinical manifestations involve Parenchymal Organs such as the Kidney, Lung, and Liver (mavragani and moutsopoulos, 2014).']	N/A	N/A	[('UBERON_0001804', 'capsule of lens', 38, 'parenchymal'), ('UBERON_0000062', 'organ', 50, 'organs'), ('UBERON_0002113', 'kidney', 69, 'kidney'), ('UBERON_0002048', 'lung', 77, 'lung'), ('UBERON_0002107', 'liver', 87, 'liver')]
PMC4275593	9/2014	S51-PMC4275593	['the symptoms of ‘tropical macrocytic anaemia’ closely resembled those of pernicious anaemia, established by 1934 as a disease curable by Liver extract (wailoo, 1999, pp.']	N/A	N/A	[('UBERON_0002107', 'liver', 137, 'liver')]
PMC4275593	9/2014	S54-PMC4275593	['she observed that Macrocytic anaemia could be treated effectively with both crude Liver and yeast extract supplied by the marmite Food extract company.']	N/A	N/A	[('CL_0000025', 'egg cell', 18, 'macrocytic'), ('UBERON_0002107', 'liver', 82, 'liver'), ('CHEBI_33290', 'food', 130, 'Food')]
PMC4275595	9/2014	S17-PMC4275595	['in 1942 the vitamin welfare scheme was extended to include expectant and nursing mothers (and children under five), allowing them free or inexpensive orange juice, cod Liver oil or Vitamin A and d tablets.']	N/A	N/A	[('UBERON_0002107', 'liver', 168, 'liver'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin A')]
PMC4275595	9/2014	S225-PMC4275595	['for example the provision of orange Juice and cod Liver oil was maintained after the war, responsibility for their distribution being transferred from the ministry of Food to the local health authorities.79the number of hospital Births also continued to Grow.']	N/A	N/A	[('CHEBI_37958', 'dye', 36, 'juice'), ('UBERON_0002107', 'liver', 50, 'liver'), ('CHEBI_33290', 'food', 167, 'Food'), ('GO_0007567', 'parturition', 229, 'births'), ('GO_0040007', 'growth', 254, 'grow')]
PMC4292443	1/2015	S51-PMC4292443	['these and Liver Triglycerides were later determined using calorimetric enzymatic gpo-pap assays (roche diagnostics, in, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 10, 'liver'), ('CHEBI_17855', 'triglyceride', 16, 'triglycerides')]
PMC4292443	1/2015	S60-PMC4292443	['thus, we removed Livers and male Epididymal or female Perirenal Fat Pads.']	N/A	N/A	[('UBERON_0002107', 'liver', 17, 'livers'), ('UBERON_0001301', 'epididymis', 33, 'epididymal'), ('UBERON_0010412', 'epididymal fat pad', 54, 'perirenal fat pads')]
PMC4292443	1/2015	S67-PMC4292443	['we isolated rna from our snap-frozen Liver and fat samples using qiazol and an rneasy purification kit (qiagen, valencia, ca, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 37, 'liver')]
PMC4292443	1/2015	S73-PMC4292443	["Liver samples were Lysed using bio-plex Cell Lysis kit (bio-rad) according to the manufacturer's instructions."]	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('GO_0019835', 'cytolysis', 19, 'lysed'), ('GO_0019835', 'cytolysis', 40, 'cell lysis')]
PMC4292443	1/2015	S144-PMC4292443	['(d,h) Liver Triglycerides in male (d) and female (h) Rats.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'Liver'), ('CHEBI_17855', 'triglyceride', 12, 'triglycerides'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 53, 'rats')]
PMC4292443	1/2015	S156-PMC4292443	['in the Liver there was an increase in Tlr4 mrna after 3d high fat diet in both cl and sl males compared with their Chow-Fed counterparts.']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('PR_000001155', 'Toll-like receptor 4', 38, 'TLR4'), ('CHEBI_33290', 'food', 115, 'chow'), ('GO_0007631', 'feeding behavior', 120, 'fed')]
PMC4292443	1/2015	S160-PMC4292443	['Liver and fat Tlr4 (a–d) , Nfκ B (e–h) , Interleukin (Il)-10 (i–l) , tnfα (m–p) , Il-1Β (q–t) and Il-6 (u–x) after 3 day (3d) and 3 week (3w) high fat diet or Chow (Ch) in male and female Adult Rats that were raised in control (cl) and small (sl) litters.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('PR_000001155', 'Toll-like receptor 4', 14, 'TLR4'), ('GO_0005883', 'neurofilament', 27, 'NFκ'), ('PR_000011159', 'nexilin', 27, 'NFκ B'), ('PR_000001470', 'interleukin-28B', 41, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 54, 'IL)-10'), ('PR_000001383', 'interleukin-22', 82, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 98, 'IL-6'), ('CHEBI_33290', 'food', 159, 'chow'), ('CHEBI_17996', 'chloride', 165, 'CH'), ('UBERON_0007023', 'adult organism', 188, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 194, 'rats')]
PMC4292443	1/2015	S171-PMC4292443	['there were no differences between the groups in Liver tnfα mrna and Il-6 was undetectable in this Tissue (figure5).']	N/A	N/A	[('UBERON_0002107', 'liver', 48, 'liver'), ('PR_000001470', 'interleukin-28B', 68, 'IL-6'), ('UBERON_0000479', 'tissue', 98, 'tissue')]
PMC4292443	1/2015	S176-PMC4292443	['Lps significantly increased Liver Il-1Α, Il-1Β, Il-6, and tnfα across the groups, but there were no significant differences with the post - hoc tests except in Il-1Α cl after 3d high fat diet.']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 0, 'LPS'), ('UBERON_0002107', 'liver', 28, 'liver'), ('PR_000001388', 'interleukin-32', 34, 'IL-1α'), ('PR_000001383', 'interleukin-22', 41, 'IL-1β'), ('PR_000001470', 'interleukin-28B', 48, 'IL-6'), ('PR_000001388', 'interleukin-32', 160, 'IL-1α')]
PMC4292443	1/2015	S241-PMC4292443	['neonatally overfed Rats had an overall increase in Plasma and Liver Triglyceride content on a high fat diet compared with cl Rats.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 19, 'rats'), ('UBERON_0001969', 'blood plasma', 51, 'plasma'), ('UBERON_0002107', 'liver', 62, 'liver'), ('CHEBI_17855', 'triglyceride', 68, 'triglyceride'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 125, 'rats')]
PMC4292443	1/2015	S244-PMC4292443	['they also had no differences in inflammatory Gene Expression in the Liver or fat or in Liver cytokine concentrations.']	N/A	N/A	[('GO_0010467', 'gene expression', 45, 'gene expression'), ('SO_0000704', 'gene', 45, 'gene'), ('UBERON_0002107', 'liver', 68, 'liver'), ('UBERON_0002107', 'liver', 87, 'liver')]
PMC4302093	1/2015	S136-PMC4302093	['ectopic activation of Hepatic mtorc1 in Liver-specific Tsc1 knockout Mice resulted in enhanced Expression of Fgf21 [131].']	N/A	N/A	[('UBERON_0002107', 'liver', 22, 'hepatic'), ('UBERON_0002107', 'liver', 40, 'liver'), ('PR_000016677', 'N(2),N(2)-dimethylguanosine tRNA methyltransferase', 55, 'Tsc1'), ('NCBITaxon_10088', 'Mus <genus>', 69, 'mice'), ('GO_0010467', 'gene expression', 95, 'expression'), ('PR_000007483', 'fibroblast growth factor 13', 109, 'FGF21')]
PMC4302388	1/2015	S61-PMC4302388	['dietary factors\nthe ffq containing eighteen items was based on the epic-norfolk ffq(21), and was designed to collect information on the Consumption of the following Se- and Iodine-rich Foods: seafood (white, oily and shellfish, fish Fingers, and fish roe); meat (beef, beef burgers, pork and Lamb, bacon, Ham, sausages, and corned beef); poultry; brazil nuts; offal (Liver and Liver products); dairy products (grouped as one item in the questionnaire); Milk.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 136, 'consumption'), ('CHEBI_37972', 'phosphorus-32 atom', 165, 'Se'), ('CHEBI_24859', 'iodine atom', 173, 'iodine'), ('CHEBI_33290', 'food', 185, 'foods'), ('UBERON_0002389', 'manual digit', 233, 'fingers'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 292, 'lamb'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 305, 'ham'), ('UBERON_0002107', 'liver', 367, 'liver'), ('UBERON_0002107', 'liver', 377, 'liver'), ('UBERON_0001913', 'milk', 453, 'milk')]
PMC4302388	1/2015	S101-PMC4302388	["caption (table-wrap): table 2\n\npredictors of Selenium status (number of women; median values and interquartile ranges)12-week whole-Blood se (μmol/l)toenail se (μg/g)women ( n )medianinterquartile range p adjusted p *women ( n )medianinterquartile range p adjusted p *demographic factorssocial classmiddle and above1011·331·22–1·480·027na†980·630·59–0·690·004na†lower middle and below1281·301·14–1·451200·600·55–0·65smoking statusnever smoked1561·321·19–1·470·529na†1480·610·57–0·670·261na†ex-smoker731·301·18–1·46700·610·54–0·66ethnicitycaucasian2131·311·18–1·470·438na†2020·610·56–0·670·869na†other161·341·25–1·48160·620·55–0·63bmi<\xa025\xa0kg/m21381·351·19–1·480·183na†1310·610·56–0·670·841na†≥\xa025\xa0kg/m2911·291·16–1·44870·610·56–0·68dietary factorsseafood<\xa02 portions/week981·271·14–1·410·0100·054950·590·54–0·650·0120·078≥\xa02 portions/week1211·361·21–1·481180·630·57–0·69meat<\xa07 portions/week1081·331·19–1·470·5400·2991070·610·56–0·660·7290·610≥\xa07 portions/week1111·301·16–1·461060·610·56–0·68brazil nutsnon-consumer1931·301·16–1·460·0050·0401870·600·56–0·660·0340·147consumer261·401·31–1·61260·660·60–0·72offal (Liver)non-consumer1821·311·18–1·470·5830·7651760·610·56–0·660·7020·804consumer371·351·22–1·45370·620·56–0·72dairy products≤\xa01 portion/d1101·301·16–1·450·4230·6721070·610·56–0·670·9160·112>1 portion/d1091·321·19–1·481060·610·57–0·67cows' Milk<\xa0280\xa0ml/d1461·321·18–1·460·9200·9831440·600·56–0·660·0160·083≥\xa0280\xa0ml/d731·321·21–1·46690·630·57–0·70\nna, not applicable."]	N/A	N/A	[('CHEBI_27568', 'selenium atom', 45, 'selenium'), ('UBERON_0000178', 'blood', 132, 'blood'), ('UBERON_0002107', 'liver', 1111, 'liver'), ('UBERON_0001913', 'milk', 1348, 'milk')]
PMC4302388	1/2015	S106-PMC4302388	['Intake of dairy products, meat and poultry, or Liver did not significantly affect se status (whole Blood and Toenails).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 0, 'Intake'), ('UBERON_0002107', 'liver', 47, 'liver'), ('UBERON_0000178', 'blood', 99, 'blood'), ('UBERON_0009567', 'nail of pedal digit', 109, 'toenails')]
PMC4303849	1/2015	S12-PMC4303849	['once formed in the skin or absorbed in the Intestine, vd is released into the circulation and transported by the Vd-Binding Protein (Dbp) to the Liver, where it is converted by the vd-25-hydroxylase (Cyp2R1) into 25-Hydroxyvitamin D (Calcidiol, 25Ohd).']	N/A	N/A	[('UBERON_0000160', 'intestine', 43, 'intestine'), ('PR_000017314', 'vascular non-inflammatory molecule 2', 113, 'VD-binding protein'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 133, 'DBP'), ('UBERON_0002107', 'liver', 145, 'liver'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 200, 'CYP2R1'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 213, '25-hydroxyvitamin D'), ('CHEBI_17933', 'calcidiol', 234, 'calcidiol'), ('CHEBI_72652', "7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation", 245, '25OHD')]
PMC4311629	1/2015	S3-PMC4311629	['Endocrine factors, such as Fibroblast Growth Factor 21 (Fgf21) and Bone Morphogenic Protein Factor-9 (Bmp-9), predominantly produced in the Liver, were shown to lead to activation of Bat Thermogenesis, as well as to “browning” of Wat.']	N/A	N/A	[('GO_0009790', 'embryo development', 0, 'Endocrine'), ('CL_0000057', 'fibroblast', 27, 'fibroblast'), ('PR_000007481', 'fibroblast growth factor 11', 27, 'fibroblast growth factor 21'), ('PR_000007483', 'fibroblast growth factor 13', 56, 'FGF21'), ('GO_0060349', 'bone morphogenesis', 67, 'bone morphogenic'), ('PR_000004622', 'BAG family molecular chaperone regulator 4', 67, 'bone morphogenic protein factor-9'), ('PR_000000168', 'BMP7', 102, 'BMP-9'), ('UBERON_0002107', 'liver', 140, 'liver'), ('UBERON_0001348', 'brown adipose tissue', 183, 'BAT'), ('GO_0031649', 'heat generation', 187, 'thermogenesis'), ('UBERON_0006337', 'distal early tubule', 230, 'WAT')]
PMC4311629	1/2015	S83-PMC4311629	['it is Expressed in Bat and Wat, although its main production site is the Liver (nishimura et al.,2000; muise et al.,2008; schulz et al.,2013; zafrir,2013).']	N/A	N/A	[('GO_0010467', 'gene expression', 6, 'expressed'), ('UBERON_0001348', 'brown adipose tissue', 19, 'BAT'), ('UBERON_0006337', 'distal early tubule', 27, 'WAT'), ('UBERON_0002107', 'liver', 73, 'liver')]
PMC4311629	1/2015	S85-PMC4311629	['under this condition, Fgf21 Expression was indeed decreased in the Liver, but enhanced in Bat, as well as in Wat, where it acted to markedly increase Ucp1 Expression and the “browning” of subcutaneous Tissue (fisher et al.,2012).']	N/A	N/A	[('PR_000007483', 'fibroblast growth factor 13', 22, 'FGF21'), ('GO_0010467', 'gene expression', 28, 'expression'), ('UBERON_0002107', 'liver', 67, 'liver'), ('UBERON_0001348', 'brown adipose tissue', 90, 'BAT'), ('UBERON_0006337', 'distal early tubule', 109, 'WAT'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 150, 'UCP1'), ('GO_0010467', 'gene expression', 155, 'expression'), ('UBERON_0000479', 'tissue', 201, 'tissue')]
PMC4311629	1/2015	S143-PMC4311629	['in addition, specific deletion of Pten in the Liver in lptenko Mice induces a strong Hepatic steatosis (stiles et al.,2004; peyrou et al.,2015), but improves the overall Insulin sensitivity, and decreases the fat mass.']	N/A	N/A	[('PR_000012582', 'ATP-dependent 6-phosphofructokinase, liver type', 34, 'Pten'), ('UBERON_0002107', 'liver', 46, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 63, 'mice'), ('UBERON_0002107', 'liver', 85, 'hepatic'), ('PR_000045358', 'insulin family protein', 170, 'insulin')]
PMC4314531	11/2014	S16-PMC4314531	['Hscs first emerge in the Early Embryo and go on to rapidly expand in the fetal Liver before transitioning to the Bone Marrow late during Gestation[13].']	N/A	N/A	[('CL_0000545', 'T-helper 1 cell', 0, 'HSCs'), ('UBERON_0019248', 'early embryo', 25, 'early embryo'), ('UBERON_0002107', 'liver', 79, 'liver'), ('UBERON_0002371', 'bone marrow', 113, 'bone marrow'), ('GO_0007565', 'female pregnancy', 137, 'gestation')]
PMC4314531	11/2014	S27-PMC4314531	['Pregnancies were timed using the Vaginal Plug method; fetuses were harvested at day 14.5 of Gestation and Livers were dissected and prepared in single cell suspensions by pipetting.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnancies'), ('UBERON_0010148', 'mating plug', 33, 'vaginal plug'), ('GO_0007565', 'female pregnancy', 92, 'gestation'), ('UBERON_0002107', 'liver', 106, 'livers')]
PMC4314531	11/2014	S30-PMC4314531	["cell culture\nunfractionated fetal Liver Cells were plated in Mouse Methylcellulose complete media (r&d systems, minneapolis, mn) at 20,000\xa0cells/ml and performed according to manufacturer's instructions."]	N/A	N/A	[('UBERON_0002107', 'liver', 34, 'liver'), ('CL_0000573', 'retinal cone cell', 40, 'cells'), ('NCBITaxon_10088', 'Mus <genus>', 61, 'mouse'), ('CHEBI_53448', 'methyl cellulose', 67, 'methylcellulose')]
PMC4314531	11/2014	S31-PMC4314531	['flow cytometry\ncells were prepared from fetal Liver and Adult Bone Marrow.']	N/A	N/A	[('UBERON_0002107', 'liver', 46, 'liver'), ('UBERON_0007023', 'adult organism', 56, 'adult'), ('UBERON_0002371', 'bone marrow', 62, 'bone marrow')]
PMC4314531	11/2014	S35-PMC4314531	['quantitative real-time pcr\nfor qrt-pcr, hfd or control fetal Liver cells were immunomagnetically enriched using the Sca-1 Antibody conjugated to pe (clone e13-161.7; bd, franklin lakes, nj) and the easysep pe positive selection kit (stemcell technologies, vancouver, bc)[15].']	N/A	N/A	[('UBERON_0002107', 'liver', 61, 'liver'), ('PR_000014662', 'selenoprotein W', 116, 'Sca-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 122, 'antibody')]
PMC4314531	11/2014	S43-PMC4314531	['rna-sequencing and analysis\na cohort of dams were Fed hfd or control diet for 12–14 weeks, and their offspring were harvested at 15\xa0±\xa00.5\xa0dpc; whole Livers from 6 control and 6 hfd male fetuses were frozen in rnalater (qiagen).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 50, 'fed'), ('UBERON_0002107', 'liver', 149, 'livers')]
PMC4314531	11/2014	S63-PMC4314531	['shepherd) with 750\xa0cgy and approximately 7\xa0h later, were each injected with 1\xa0×\xa0106whole fetal Liver Cells.']	N/A	N/A	[('CL_0000592', 'large luteal cell', 95, 'liver cells'), ('UBERON_0002107', 'liver', 95, 'liver')]
PMC4314531	11/2014	S64-PMC4314531	['each recipient received a different fetal Liver, for a total of 5 chronic hfd and 5 control grafts.']	N/A	N/A	[('UBERON_0002107', 'liver', 42, 'liver')]
PMC4314531	11/2014	S67-PMC4314531	["donor fetal Livers were harvested at 14.5\xa0dpc and single-cell suspensions were cryopreserved in iscove's modified dulbecco's medium (invitrogen, carlsbad, ca) with 10% fbs, 1% Penicillin/Streptomycin, and 10% Dmso."]	N/A	N/A	[('UBERON_0002107', 'liver', 12, 'livers'), ('CHEBI_17334', 'penicillin', 176, 'penicillin'), ('CHEBI_17076', 'streptomycin', 187, 'streptomycin'), ('CHEBI_34018', '(S)-AMPA', 209, 'DMSO')]
PMC4314531	11/2014	S69-PMC4314531	['for each graft, fetal Liver Cells were thawed, washed, and 2.5\xa0×\xa0105hfd fetal Liver Cells were mixed with an equivalent number of control fetal Liver Cells, for a total of 10 different pairs of grafts prepared in duplicate, and were transplanted via Tail Vein injection into pairs of sex-matched Mice on differential diets (also maintained post-transplant).']	N/A	N/A	[('CL_0000592', 'large luteal cell', 22, 'liver cells'), ('UBERON_0002107', 'liver', 22, 'liver'), ('CL_0000592', 'large luteal cell', 78, 'liver cells'), ('UBERON_0002107', 'liver', 78, 'liver'), ('CL_0000592', 'large luteal cell', 144, 'liver cells'), ('UBERON_0002107', 'liver', 144, 'liver'), ('UBERON_0003481', 'tail vein', 250, 'tail vein'), ('NCBITaxon_10088', 'Mus <genus>', 296, 'mice')]
PMC4314531	11/2014	S79-PMC4314531	['both the body mass and Liver cellularity of hfd fetuses were significantly increased relative to controls, while the Placental masses of hfd fetuses were approximately equivalent to controls (figure\xa01b–d).']	N/A	N/A	[('UBERON_0002107', 'liver', 23, 'liver'), ('UBERON_0001987', 'placenta', 117, 'placental')]
PMC4314531	11/2014	S81-PMC4314531	['within more differentiated cell subsets, acute hfd fetal Livers were comparatively enriched in both Lymphoid (cd3+/B220+) and Myeloid (Gr1+/ter119+) Cells, relative to controls (figure\xa01h–i).']	N/A	N/A	[('UBERON_0002107', 'liver', 57, 'livers'), ('CL_0000542', 'lymphocyte', 100, 'lymphoid ...'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 115, 'B220'), ('CL_0000766', 'myeloid leukocyte', 126, 'myeloid ...'), ('PR_000008220', 'GRB2-related adapter protein 2', 135, 'Gr1'), ('CL_0000573', 'retinal cone cell', 149, 'cells')]
PMC4314531	11/2014	S82-PMC4314531	['in sum, acute hfd is sufficient to increase fetal body mass, Liver cellularity, and expansion of the asl hspc population as well as the lymphoid and Myeloid lineages in the fetal Liver.']	N/A	N/A	[('UBERON_0002107', 'liver', 61, 'liver'), ('CL_0000763', 'myeloid cell', 149, 'myeloid'), ('UBERON_0002107', 'liver', 179, 'liver')]
PMC4314531	11/2014	S86-PMC4314531	['the cellularity of chronic hfd fetal Livers was diminished by 21%, compared to controls (figure\xa02e).']	N/A	N/A	[('UBERON_0002107', 'liver', 37, 'livers')]
PMC4314531	11/2014	S94-PMC4314531	['in sum, chronic hfd-Fed, obese dams were less fertile and their offspring exhibited multiple indications of adverse Metabolic programming, including growth retardation at day 14.5\xa0dpc, a decrease in Hspc content in fetal Livers, and a concomitant increase in differentiated Blood Cells.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 20, 'fed'), ('GO_0008152', 'metabolic process', 116, 'metabolic'), ('CL_0000037', 'hematopoietic stem cell', 199, 'HSPC'), ('UBERON_0002107', 'liver', 221, 'livers'), ('CL_0000081', 'blood cell', 274, 'blood cells'), ('UBERON_0000178', 'blood', 274, 'blood')]
PMC4314531	11/2014	S99-PMC4314531	['there were no significant increases in lymphoid and Myeloid populations in dr Livers (figure\xa0a.2a–b).']	N/A	N/A	[('CL_0000763', 'myeloid cell', 52, 'myeloid'), ('UBERON_0002107', 'liver', 78, 'livers')]
PMC4314531	11/2014	S103-PMC4314531	['transplantation of Cd45.2 chronic hfd or control 14.5\xa0dpc Fetal Liver Cells into irradiated Cd45.1 Adult male recipients (figure\xa04a) yielded comparable levels of engraftment for hfd and control fetal Liver cells (figure\xa04b).']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 19, 'CD45'), ('CL_0000521', 'fungal cell', 58, 'fetal'), ('CL_0000592', 'large luteal cell', 64, 'liver cells'), ('UBERON_0002107', 'liver', 64, 'liver'), ('PR_000001309', 'CD70 molecule', 92, 'CD45'), ('UBERON_0007023', 'adult organism', 99, 'adult'), ('UBERON_0002107', 'liver', 200, 'liver')]
PMC4314531	11/2014	S106-PMC4314531	['each graft was prepared in duplicate, with a mix of 2.5\xa0×\xa0105each of hfd- and control-programmed fetal Liver Cells, and given to a pair of recipient Mice of the same sex, conditioned on different diets (figure\xa04c).']	N/A	N/A	[('CL_0000592', 'large luteal cell', 103, 'liver cells'), ('UBERON_0002107', 'liver', 103, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice')]
PMC4314531	11/2014	S111-PMC4314531	['by contrast, the male hfd group showed a greater proportion of hfd fetal Liver-derived Mac-1+/Gr-1+Myeloid Cells than in female hfd or male controls (figure\xa04j).']	N/A	N/A	[('UBERON_0002107', 'liver', 73, 'liver'), ('PR_000010123', 'microtubule-associated protein 1S', 87, 'Mac-1'), ('PR_000008224', 'growth factor receptor-bound protein 2', 94, 'Gr-1'), ('CL_0000763', 'myeloid cell', 99, 'myeloid cells')]
PMC4314531	11/2014	S117-PMC4314531	['six Transcripts involved in Complement Activation were among the upregulated Transcripts in hfd fetal Livers; this process is also activated in nonalcoholic fatty Liver disease (nafld)[33].']	N/A	N/A	[('SO_0000673', 'transcript', 4, 'transcripts'), ('GO_0006956', 'complement activation', 28, 'complement activation'), ('SO_0000673', 'transcript', 77, 'transcripts'), ('UBERON_0002107', 'liver', 102, 'livers'), ('UBERON_0002107', 'liver', 163, 'liver')]
PMC4329745	10/2014	S20-PMC4329745	['exclusion criteria included chronic illness, history of cancer, Pregnancy or Lactation, malabsorption syndrome or gastric disorders, Metabolic bone disease, Renal or Hepatic failure, recent history of therapeutic Vitamin D consumption or osteoporosis treatment.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007595', 'lactation', 77, 'lactation'), ('GO_0008152', 'metabolic process', 133, 'metabolic'), ('UBERON_0002113', 'kidney', 157, 'renal'), ('UBERON_0002107', 'liver', 166, 'hepatic'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]
PMC4349447	3/2015	S85-PMC4349447	['Eating offal —the Eating of Liver, Heart, Kidney or Liver pate with five responses ranging from never or rarely to more than once per day .']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('GO_0051318', 'G1 phase', 18, 'eating'), ('UBERON_0002107', 'liver', 28, 'liver'), ('UBERON_0000948', 'heart', 35, 'heart'), ('UBERON_0002113', 'kidney', 42, 'kidney'), ('UBERON_0002107', 'liver', 52, 'liver')]
PMC4360220	2/2015	S23-PMC4360220	['we observed higher levels of tumor necrosis factor alpha (Tnfa) and Interleukin 6 (Il6) in Placentas and Fetal Livers and lower levels in Brains.']	N/A	N/A	[('PR_000000134', 'tumor necrosis factor alpha', 58, 'TNFA'), ('PR_000008988', 'interleukin-1 family member 5', 68, 'Interleukin 6'), ('PR_000008989', 'interleukin-1 family member 7', 83, 'IL6'), ('UBERON_0001987', 'placenta', 91, 'placentas'), ('UBERON_0000922', 'embryo', 105, 'fetal'), ('UBERON_0002107', 'liver', 111, 'livers'), ('UBERON_0000955', 'brain', 138, 'brains')]
PMC4383546	4/2015	S21-PMC4383546	['sl rodents remain overweight and hyperinsulinemic into Adulthood [16–18], and also develop more pronounced Insulin resistance and Hepatic steatosis when Fed a high-fat diet (hfd) [16,19,20].']	N/A	N/A	[('UBERON_0000113', 'post-juvenile adult stage', 55, 'adulthood'), ('PR_000045358', 'insulin family protein', 107, 'insulin'), ('UBERON_0002107', 'liver', 130, 'hepatic'), ('GO_0007631', 'feeding behavior', 153, 'fed')]
PMC4383546	4/2015	S47-PMC4383546	['total Triglyceride (tg) content was assayed in the Liver of 17-week-old Mice (n = 5–11 per group from ≥ 5 litters) using a Triglyceride assay kit (sigma) as previously described [29].']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 6, 'triglyceride'), ('UBERON_0002107', 'liver', 51, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 72, 'mice'), ('CHEBI_17855', 'triglyceride', 123, 'Triglyceride')]
PMC4383546	4/2015	S128-PMC4383546	['in addition, sl Animals exposed to hfd displayed a 2-fold increase in the mean Hepatic Triglyceride content and enhanced Hepatic steatosis compared to nl-hfd Mice ( p<0.01;fig 3 e –3 f ).10.1371/journal.pone.0121954.g003\n\ncaption (fig): fig 3\nneonatal overnutrition perturbs Glucose Homeostasis and causes Hepatic steatosis in diet-induced obesity.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 16, 'animals'), ('UBERON_0002107', 'liver', 79, 'hepatic'), ('CHEBI_17855', 'triglyceride', 87, 'triglyceride'), ('UBERON_0002107', 'liver', 121, 'hepatic'), ('NCBITaxon_10088', 'Mus <genus>', 158, 'mice'), ('CHEBI_17234', 'glucose', 275, 'glucose'), ('GO_0042593', 'glucose homeostasis', 275, 'glucose homeostasis'), ('UBERON_0002107', 'liver', 306, 'hepatic')]
PMC4383546	4/2015	S130-PMC4383546	['c-e : Plasma levels of Glucose ( c ), Insulin ( d ), and Hepatic Triglyceride content ( e ) of Adult sl and nl Mice Fed a Chow or a hfd ( n = 5–11 per group from ≥ 5 litters).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 6, 'Plasma'), ('CHEBI_17234', 'glucose', 23, 'glucose'), ('PR_000045358', 'insulin family protein', 38, 'insulin'), ('UBERON_0002107', 'liver', 57, 'hepatic'), ('CHEBI_17855', 'triglyceride', 65, 'triglyceride'), ('UBERON_0007023', 'adult organism', 95, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 111, 'mice'), ('GO_0007631', 'feeding behavior', 116, 'fed'), ('CHEBI_33290', 'food', 122, 'chow')]
PMC4383546	4/2015	S131-PMC4383546	['f : representative images showing oil red-o stain in the Liver of Adult sl and nl Mice Fed a Chow or a hfd.']	N/A	N/A	[('UBERON_0002107', 'liver', 57, 'liver'), ('UBERON_0007023', 'adult organism', 66, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 82, 'mice'), ('GO_0007631', 'feeding behavior', 87, 'fed'), ('CHEBI_33290', 'food', 93, 'chow')]
PMC4388824	4/2015	S189-PMC4388824	['moreover, treatment of obese and diabetic Mice with Er stress Inhibitors improved Insulin sensitivity in the Liver, Muscles and Adipose Tissues [15].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 42, 'mice'), ('GO_0005783', 'endoplasmic reticulum', 52, 'ER'), ('CHEBI_35222', 'inhibitor', 62, 'inhibitors'), ('PR_000045358', 'insulin family protein', 82, 'insulin'), ('UBERON_0002107', 'liver', 109, 'liver'), ('UBERON_0005090', 'muscle structure', 116, 'muscles'), ('UBERON_0001013', 'adipose tissue', 128, 'adipose tissues')]
PMC4390789	1/2015	S83-PMC4390789	['Metabolically, Fa (pteroylmonoglutamate) consumed through supplementation or fortified foods is reduced by the enzyme Dihydrofolate reductase primarily to Dihydrofolate, and chemically reduced to Tetrahydrofolate in the Liver, where it collects a Formyl Group which is reduced to methyl to form 5-Methyl-Tetrahydrofolate [5].']	N/A	N/A	[('GO_0008152', 'metabolic process', 0, 'Metabolically'), ('CHEBI_30751', 'formic acid', 15, 'FA'), ('CHEBI_36263', 'hydrogenmolybdate', 118, 'dihydrofolate'), ('CHEBI_36263', 'hydrogenmolybdate', 155, 'dihydrofolate'), ('CHEBI_67016', 'tetrahydrofolate', 196, 'tetrahydrofolate'), ('UBERON_0002107', 'liver', 220, 'liver'), ('CHEBI_42485', 'formyl group', 247, 'formyl group'), ('CHEBI_17837', 'D-tagatose 6-phosphate', 295, '5-methyl-tetrahydrofolate')]
PMC4392553	3/2015	S44-PMC4392553	["[156] cyp enzyme dysfunction impairs the Liver's ability to Detoxify Xenobiotics."]	N/A	N/A	[('UBERON_0002107', 'liver', 41, 'liver'), ('GO_0098754', 'detoxification', 60, 'detoxify'), ('CHEBI_35703', 'xenobiotic', 69, 'xenobiotics')]
PMC4392553	3/2015	S92-PMC4392553	['[98139140]\nsprague-dawley Rats Fed a Mn-deficient diet had significantly reduced concentrations of Mn in Liver, Kidney, Heart, and Pancreas, compared with controls.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 26, 'rats'), ('GO_0007631', 'feeding behavior', 31, 'fed'), ('CHEBI_25614', 'nylons', 37, 'Mn'), ('CHEBI_25614', 'nylons', 99, 'Mn'), ('UBERON_0002107', 'liver', 105, 'liver'), ('UBERON_0002113', 'kidney', 112, 'kidney'), ('UBERON_0000948', 'heart', 120, 'heart'), ('UBERON_0001264', 'pancreas', 131, 'pancreas')]
PMC4392553	3/2015	S162-PMC4392553	['Arsenic is normally disposed of by the Liver through Biliary Excretion.']	N/A	N/A	[('CHEBI_85195', '9,10-epoxyoctadecanoate', 0, 'Arsenic'), ('UBERON_0002107', 'liver', 39, 'liver'), ('UBERON_0002294', 'biliary system', 53, 'biliary'), ('GO_0007588', 'excretion', 61, 'excretion')]
PMC4392553	3/2015	S200-PMC4392553	['[173]\nthe Liver Regulates the amount of Mn in the general vascular circulation, by incorporating any excess into Bile Acids, which gives the Gut bacteria repeated chances to take it up.']	N/A	N/A	[('UBERON_0002107', 'liver', 10, 'liver'), ('GO_0065007', 'biological regulation', 16, 'regulates'), ('CHEBI_25614', 'nylons', 40, 'Mn'), ('CHEBI_3098', 'bile acid', 113, 'bile acids'), ('UBERON_0001970', 'bile', 113, 'bile'), ('UBERON_0001555', 'digestive tract', 141, 'gut')]
PMC4392553	3/2015	S232-PMC4392553	['[174] several Metabolites were measured from the Liver, Kidney, and Brain.']	N/A	N/A	[('CHEBI_25212', 'metabolite', 14, 'metabolites'), ('UBERON_0002107', 'liver', 49, 'liver'), ('UBERON_0002113', 'kidney', 56, 'kidney'), ('UBERON_0000955', 'brain', 68, 'brain')]
PMC4392553	3/2015	S267-PMC4392553	['[50] furthermore, gamma-glutamyl carboxylase, a Liver enzyme that Metabolizes Oxalate, is catalyzed by Vitamin K, which depends on the shikimate pathway.']	N/A	N/A	[('UBERON_0002107', 'liver', 48, 'liver'), ('GO_0008152', 'metabolic process', 66, 'metabolizes'), ('CHEBI_16162', 'o-orsellinate', 78, 'oxalate'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin K')]
PMC4392553	3/2015	S324-PMC4392553	['a mn-deficient diet administered to Rats induced a reduction in Hepatic arginase activity ( p< 0.01), along with a significant rise in Plasma Ammonia ( p< 0.01).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rats'), ('UBERON_0002107', 'liver', 64, 'hepatic'), ('UBERON_0001969', 'blood plasma', 135, 'plasma'), ('CHEBI_16134', 'ammonia', 142, 'ammonia')]
PMC4392553	3/2015	S333-PMC4392553	['People with a defective Cyp7A1 Gene have significantly elevated total and ldl Cholesterol levels, as well as substantial accumulation of Cholesterol in the Liver and a markedly decreased rate of Bile Acid Excretion.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'People'), ('PR_000006111', '25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial', 24, 'CYP7A1'), ('SO_0000704', 'gene', 31, 'gene'), ('CHEBI_16113', 'cholesterol', 78, 'cholesterol'), ('CHEBI_16113', 'cholesterol', 137, 'cholesterol'), ('UBERON_0002107', 'liver', 156, 'liver'), ('CHEBI_3098', 'bile acid', 195, 'bile acid'), ('GO_0030153', 'bacteriocin immunity', 195, 'bile acid excretion'), ('UBERON_0001970', 'bile', 195, 'bile')]
PMC4392553	3/2015	S338-PMC4392553	['[114] impaired Bile Salt deconjugation by Gut bacteria results in significant weight gain along with elevated Plasma Cholesterol and Liver Triglycerides in Mice.']	N/A	N/A	[('CHEBI_22868', 'bile salt', 15, 'bile salt'), ('UBERON_0001970', 'bile', 15, 'bile'), ('UBERON_0001555', 'digestive tract', 42, 'gut'), ('UBERON_0001969', 'blood plasma', 110, 'plasma'), ('CHEBI_16113', 'cholesterol', 117, 'cholesterol'), ('UBERON_0002107', 'liver', 133, 'liver'), ('CHEBI_17855', 'triglyceride', 139, 'triglycerides'), ('NCBITaxon_10088', 'Mus <genus>', 156, 'mice')]
PMC4392553	3/2015	S373-PMC4392553	['the accumulation of Bile Acids in the cholestatic Liver induces oxidative stress and Apoptosis, resulting in damage to the Liver Parenchyma, and, ultimately, Extrahepatic Tissues as well.']	N/A	N/A	[('CHEBI_3098', 'bile acid', 20, 'bile acids'), ('UBERON_0001970', 'bile', 20, 'bile'), ('UBERON_0002107', 'liver', 50, 'liver'), ('GO_0006915', 'apoptotic process', 85, 'apoptosis'), ('UBERON_0001280', 'liver parenchyma', 123, 'liver parenchyma'), ('UBERON_0005292', 'extraembryonic tissue', 158, 'extrahepatic tissues')]
PMC4392553	3/2015	S478-PMC4392553	['[30] mri abnormalities indicative of Mn toxicity in the globi pallidi and substantia Nigra were noted in three cases of patients with Liver disease.']	N/A	N/A	[('CHEBI_25614', 'nylons', 37, 'Mn'), ('UBERON_0001756', 'middle ear', 85, 'nigra'), ('UBERON_0002107', 'liver', 134, 'liver')]
PMC4392553	3/2015	S495-PMC4392553	['[33] there was also considerable Liver damage, especially in the marmosets, including hemosiderosis, congestion, and Hepatic necrosis.']	N/A	N/A	[('UBERON_0002107', 'liver', 33, 'liver'), ('UBERON_0002107', 'liver', 117, 'hepatic')]
PMC4392553	3/2015	S534-PMC4392553	['they exhibit a marked dilated cardiomyopathy, neurodegeneration and fatty Liver disease.']	N/A	N/A	[('UBERON_0002107', 'liver', 74, 'liver')]
PMC4405493	4/2015	S132-PMC4405493	['the Liver converts both forms of Vitamin D to 25-Oh Vitamin D, which is the specific Metabolite measured to determine Vitamin D status.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 46, '25-OH'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 85, 'metabolite'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
PMC4417995	4/2015	S16-PMC4417995	['Vitamin D3 is transported to the Liver and is converted to 25-Hydroxyvitamin D (25(Oh)D).']	N/A	N/A	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('UBERON_0002107', 'liver', 33, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 59, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D')]
PMC4425955	4/2015	S116-PMC4425955	['ovariectomy resulted in decrease of absolute weight of right (Sham 0.97\xa0±\xa00.02 vs. ovx 0.88\xa0±\xa00.02) and left (Sham 0.91\xa0±\xa00.02 vs. ovx 0.85\xa0±\xa00.02) Kidneys and the Liver (Sham 9.6\xa0±\xa00.2 vs. ovx 8.8\xa0±\xa00.2), p \xa0<\xa00.001.']	N/A	N/A	[('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 62, 'SHAM'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 110, 'SHAM'), ('UBERON_0002113', 'kidney', 148, 'kidneys'), ('UBERON_0002107', 'liver', 164, 'liver'), ('PR_000014833', 'SH3 and multiple ankyrin repeat domains protein 3', 171, 'SHAM')]
PMC4441812	6/2015	S52-PMC4441812	['data were collected on Consumption of seafood (white fish, oily and shellfish, fish Fingers, and fish roe), meat (beef, beefburgers, pork and Lamb, bacon, Ham, sausages, and corned beef), and poultry, brazil nuts, offal (Liver and Liver products), dairy products (grouped as 1 item in the questionnaire), and milk.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 23, 'consumption'), ('UBERON_0002389', 'manual digit', 84, 'fingers'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 142, 'lamb'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 155, 'ham'), ('UBERON_0002107', 'liver', 221, 'liver'), ('UBERON_0002107', 'liver', 231, 'liver')]
PMC4441812	6/2015	S57-PMC4441812	['for Liver products and brazil nuts, the participants were dichotomized into either “consumers” (any frequency of Consumption) or “nonconsumers” (those who answered as “never/rarely” Consuming the products) because of the low numbers of consumers.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('GO_0007631', 'feeding behavior', 113, 'consumption'), ('GO_0007631', 'feeding behavior', 182, 'consuming')]
PMC4441812	6/2015	S116-PMC4441812	['caption (table-wrap): table 2\n\npredictors of Urinary Iodine-to-Creatinine ratio measured at ∼12 wk Gestation1N median (iqr) p2adjusted p3demographic factors\u2003smoking status\u2003\u2003nonsmoker155104 (72–172)0.160.30\u2003\u2003ex-smoker73102 (60–163)\u2003ethnicity\u2003\u2003caucasian212104 (67–170)0.72na\u2003\u2003other1692 (67–147)\u2003social class\u2003\u2003middle and above100107 (69–182)0.41na\u2003\u2003lower middle and below128102 (64–157)dietary factors\u2003daily milk Intake\u2003\u2003<140 ml6172 (48–99)<0.001<0.001\u2003\u2003140–280 ml84104 (76–175)\u2003\u2003>280 ml73150 (96–219)\u2003dairy products\u2003\u2003≤1 portion/d10993 (64–163)0.190.59\u2003\u2003>1 portion/d109116 (72–175)\u2003seafood\u2003\u2003<2 portions/wk97107 (69–173)0.62na\u2003\u2003\u2003≥2 portions/wk12199 (65–164)\u2003meat/poultry\u2003\u2003<7 portions/wk10898 (65–162)0.40na\u2003\u2003\u2003≥7 portions/wk110107 (69–178)\u2003Iodized Salt\u2003\u2003nonconsumer205104 (68–172)0.28na\u2003\u2003consumer1394 (66–127)\u2003brazil nuts\u2003\u2003nonconsumer19299 (65–164)0.070.12\u2003\u2003consumer26129 (92–186)\u2003Liver\u2003\u2003nonconsumer181102 (67–173)0.98na\u2003\u2003consumer37107 (75–157)\nvalues are Iodine-to-Creatinine ratio, μg/g.']	N/A	N/A	[('UBERON_0001088', 'urine', 45, 'urinary'), ('CHEBI_24859', 'iodine atom', 53, 'iodine'), ('CHEBI_16737', 'creatinine', 63, 'creatinine'), ('GO_0007565', 'female pregnancy', 99, 'gestation1n'), ('GO_0007631', 'feeding behavior', 410, 'intake'), ('CHEBI_31721', 'Irsogladine maleate', 735, 'Iodized salt'), ('UBERON_0002107', 'liver', 876, 'Liver'), ('CHEBI_24859', 'iodine atom', 951, 'iodine'), ('CHEBI_16737', 'creatinine', 961, 'creatinine')]
PMC4448820	5/2015	S41-PMC4448820	['cytokines then stimulate Hepatocytes in the Liver to produce the Acute Phase proteins (see working group 1) (21–23).']	N/A	N/A	[('CL_0000182', 'hepatocyte', 25, 'hepatocytes'), ('UBERON_0002107', 'liver', 44, 'liver'), ('GO_0006953', 'acute-phase response', 65, 'acute phase')]
PMC4448820	5/2015	S348-PMC4448820	['Hypomethylation Of Hepatic Dna occurs in response to Vitamin A treatment in Rats (204), and hypermethylation of long Interspersed Element (line) 1 is found in peripheral Blood White Cells of Vitamin A–deficient children (205).']	N/A	N/A	[('GO_0033526', 'tetrapyrrole biosynthetic process from glutamate', 0, 'Hypomethylation of ... DNA'), ('UBERON_0002107', 'liver', 19, 'hepatic'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin A'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 76, 'rats'), ('SO_0002006', 'zinc_repressed_element', 117, 'interspersed element'), ('CL_0000081', 'blood cell', 170, 'blood white cells'), ('UBERON_0000178', 'blood', 170, 'blood'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 199, 'A')]
PMC4448820	5/2015	S554-PMC4448820	['● more quantitative assessment techniques include the following:\n○ dose-response tests that indicate the adequacy of Liver stores and isotope-dilution tests that reflect the amount of Vitamin A stored in the Liver.']	N/A	N/A	[('UBERON_0002107', 'liver', 117, 'liver'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin A'), ('UBERON_0002107', 'liver', 208, 'liver')]
PMC4448820	5/2015	S661-PMC4448820	['● id is diagnosed by using a combination of indicators of iron nutrition, including Serum iron, percentage of saturation of Transferrin (the principal Serum transport protein for iron) with iron, and Serum concentration of ferritin, the soluble Serum form of the iron storage protein primarily found in the Liver and other Tissues where iron is stored (397).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 84, 'serum'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 124, 'transferrin'), ('UBERON_0001977', 'blood serum', 151, 'serum'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('UBERON_0001977', 'blood serum', 245, 'serum'), ('UBERON_0002107', 'liver', 307, 'liver'), ('UBERON_0000479', 'tissue', 323, 'tissues')]
PMC4448820	5/2015	S764-PMC4448820	['closely mimicking Human obesity, Mice with diet-induced obesity developed Insulin resistance, elevated leptin, and elevated Lipid tgs leading to fatty Liver and increased inflammatory markers (448–450).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 18, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 33, 'mice'), ('PR_000045358', 'insulin family protein', 74, 'insulin'), ('CHEBI_18059', 'lipid', 124, 'lipid'), ('UBERON_0002107', 'liver', 151, 'liver')]
PMC4448820	5/2015	S1449-PMC4448820	['○ Retinol is Homeostatically Regulated and is not a good indicator of status when there are adequate Liver stores of Vitamin A (770).']	N/A	N/A	[('CHEBI_27810', 'resorcinol', 2, 'Retinol'), ('GO_0048872', 'homeostasis of number of cells', 13, 'homeostatically'), ('GO_0065007', 'biological regulation', 29, 'regulated'), ('UBERON_0002107', 'liver', 101, 'liver'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin A')]
PMC4466139	6/2015	S24-PMC4466139	['maternal exclusion criteria were: Gestational diabetes, presence of any psychiatric or organic disease (Renal failure, Liver failure, other endocrine diseases) and any particular Pharmacological treatment (Corticosteroids, Antiepileptic Drugs, immunosuppressants) (s1 strobe checklist).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 34, 'gestational'), ('UBERON_0002113', 'kidney', 104, 'renal'), ('UBERON_0002107', 'liver', 119, 'liver'), ('CHEBI_52217', 'pharmaceutical', 179, 'pharmacological'), ('CHEBI_50850', 'etabonate ester', 206, 'corticosteroids'), ('CHEBI_35473', 'tranquilizing drug', 223, 'antiepileptic drugs')]
PMC4466850	4/2015	S115-PMC4466850	['during stress, the woman preferentially holds Choline in her own Liver, which lowers the levels observed in the Serum that is available to the fetus.']	N/A	N/A	[('CHEBI_15354', 'choline', 46, 'choline'), ('UBERON_0002107', 'liver', 65, 'liver'), ('UBERON_0001977', 'blood serum', 112, 'serum')]
PMC4473145	12/2014	S65-PMC4473145	['Tag and Glycogen analyses\nfor Tag analysis, Liver Tissue (100\xa0mg) and Muscle Tissue (40–50\xa0mg) were homogenised in 50 volumes or for Muscle Tissue in 20 volumes of 10\xa0mm-Sodium Phosphate buffer, ph 7·4, containing 1\xa0mm-edta and 1 % Polyoxyethylene-10-Tridecyl Ether using an ultra-turrax (ika-werke).']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 0, 'TAG'), ('CHEBI_24384', 'glycogens', 8, 'glycogen'), ('CHEBI_17855', 'triglyceride', 30, 'TAG'), ('UBERON_0002107', 'liver', 44, 'liver'), ('UBERON_0000479', 'tissue', 50, 'tissue'), ('UBERON_0005090', 'muscle structure', 70, 'muscle'), ('UBERON_0000479', 'tissue', 77, 'tissue'), ('UBERON_0005090', 'muscle structure', 133, 'muscle'), ('UBERON_0000479', 'tissue', 140, 'tissue'), ('CHEBI_37586', 'sodium phosphate', 170, 'sodium phosphate'), ('CHEBI_53427', 'poly(vinylcarbazole) macromolecule', 232, 'polyoxyethylene-'), ('CHEBI_46865', 'isocinchomeronic acid', 251, 'tridecyl ether')]
PMC4473145	12/2014	S69-PMC4473145	['for Glycogen analysis, 50\xa0mg of ground Liver or muscle Tissue were homogenised in 1\xa0ml of 0·1m-Naoh using an ultra-turrax.']	N/A	N/A	[('CHEBI_24384', 'glycogens', 4, 'glycogen'), ('UBERON_0002107', 'liver', 39, 'liver'), ('UBERON_0000479', 'tissue', 55, 'tissue'), ('CHEBI_32145', 'sodium hydroxide', 95, 'NaOH')]
PMC4473145	12/2014	S139-PMC4473145	['Livers of mhfd offspring were 10 % heavier compared with Liver mass of the mlfd group ( p \xa0<\xa00·001;fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers'), ('UBERON_0002107', 'liver', 57, 'liver')]
PMC4473145	12/2014	S154-PMC4473145	['Liver mass (a), Liver Tag content (b), Liver Glycogen content (c), muscle mass (d), muscle Tag content (e), muscle Glycogen content (f) and Epididymal White Adipose Tissue (Ewat) mass of maternal low-fat diet (mlfd; □) and mhfd male offspring.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0002107', 'liver', 16, 'liver'), ('CHEBI_17855', 'triglyceride', 22, 'TAG'), ('UBERON_0002107', 'liver', 39, 'liver'), ('CHEBI_24384', 'glycogens', 45, 'glycogen'), ('CHEBI_17855', 'triglyceride', 91, 'TAG'), ('CHEBI_24384', 'glycogens', 115, 'glycogen'), ('UBERON_0004360', 'cauda epididymis', 140, 'epididymal white adipose tissue'), ('UBERON_0007376', 'outer epithelium', 173, 'eWAT')]
PMC4488777	5/2015	S34-PMC4488777	['Vitamin D uptake in the common diet is of minor significance, although Cholecalciferol can be found in sea fish fat and Liver oil, while Ergocalciferol in green Plants and Mushrooms.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_52550', 'theopalauamide', 71, 'cholecalciferol'), ('UBERON_0002107', 'liver', 120, 'liver'), ('CHEBI_4910', 'etomidate', 137, 'ergocalciferol'), ('NCBITaxon_10088', 'Mus <genus>', 161, 'plants'), ('NCBITaxon_10088', 'Mus <genus>', 172, 'mushrooms')]
PMC4488777	5/2015	S35-PMC4488777	['in Serum, Vitamin D is transported by Vitamin D-Binding Protein (Vdbp) to the Liver and Metabolized to an active form of 25-Hydroxycalciferol (25[Oh] D) [9].']	N/A	N/A	[('UBERON_0001977', 'blood serum', 3, 'serum'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 38, 'vitamin D-binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 65, 'VDBP'), ('UBERON_0002107', 'liver', 78, 'liver'), ('GO_0008152', 'metabolic process', 88, 'metabolized'), ('CHEBI_69445', '1-methyluracil', 121, '25-hydroxycalciferol'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 143, '25[OH] D')]
PMC4490503	6/2015	S42-PMC4490503	['adipokines are proteins Secreted by Adipose Tissue that act as paracrine factors in Adipose Tissue and as endocrine hormones in Liver, Muscles and the Central Nervous System [15].']	N/A	N/A	[('GO_0046903', 'secretion', 24, 'secreted'), ('UBERON_0001013', 'adipose tissue', 36, 'adipose tissue'), ('UBERON_0001013', 'adipose tissue', 84, 'adipose tissue'), ('UBERON_0002107', 'liver', 128, 'liver'), ('UBERON_0005090', 'muscle structure', 135, 'muscles'), ('UBERON_0001017', 'central nervous system', 151, 'central nervous system')]
PMC4490503	6/2015	S44-PMC4490503	['in obesity, adipokines Secreted by Adipocytes and Macrophages also act in an autocrine fashion to further exacerbate Adipose Tissue inflammation, and decrease muscle and Liver Insulin sensitivity [17].']	N/A	N/A	[('GO_0046903', 'secretion', 23, 'secreted'), ('CL_0000136', 'fat cell', 35, 'adipocytes'), ('CL_0000235', 'macrophage', 50, 'macrophages'), ('UBERON_0001013', 'adipose tissue', 117, 'adipose tissue'), ('UBERON_0002107', 'liver', 170, 'liver'), ('PR_000045358', 'insulin family protein', 176, 'insulin')]
PMC4490503	6/2015	S193-PMC4490503	['Adiponectin is an Insulin-sensitizing, anti-inflammatory and anti-atherogenic adipokine that stimulates Glucose Uptake in Skeletal muscle and reduces Hepatic Glucose Production through amp-activated protein kinases [26,42,95].']	N/A	N/A	[('PR_000004070', 'anthrax toxin receptor-like', 0, 'Adiponectin'), ('PR_000045358', 'insulin family protein', 18, 'insulin'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('GO_0046323', 'glucose import', 104, 'glucose uptake'), ('UBERON_0004288', 'skeleton', 122, 'skeletal'), ('UBERON_0002107', 'liver', 150, 'hepatic'), ('CHEBI_17234', 'glucose', 158, 'glucose'), ('GO_0006094', 'gluconeogenesis', 158, 'glucose production')]
PMC4512131	8/2015	S55-PMC4512131	['nafld is a general term used to describe a broad spectrum of Liver abnormalities, ranging from simple, uncomplicated Hepatic steatosis to nonalcoholic steatohepatitis (nash), with different degrees of inflammation and fibrosis.']	N/A	N/A	[('UBERON_0002107', 'liver', 61, 'liver'), ('UBERON_0002107', 'liver', 117, 'hepatic')]
PMC4512131	8/2015	S58-PMC4512131	['when we performed cesarean sections in the early third trimester (g130) in mothers Fed a wsd, we discovered the fetuses had a dramatic increase in Liver Lipids (fig.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 83, 'fed'), ('UBERON_0002107', 'liver', 147, 'liver'), ('CHEBI_18059', 'lipid', 153, 'lipids')]
PMC4512131	8/2015	S63-PMC4512131	['caption (fig): figure 1\n\nLiver steatosis in the fetal Liver during the early third trimester of nph on a high-fat diet.']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'Liver'), ('UBERON_0002107', 'liver', 54, 'liver')]
PMC4512131	8/2015	S66-PMC4512131	['Livers were stained for neutral Lipid (oil-red-o) and 4-Hydroxynonenal (4-Hne), a marker of oxidative stress (data are from mccurdy et al.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Livers'), ('CHEBI_18059', 'lipid', 32, 'lipid'), ('CHEBI_5445', 'glyceraldehyde', 54, '4-hydroxynonenal'), ('CHEBI_72639', '13-HODE', 72, '4-HNE')]
PMC4512131	8/2015	S72-PMC4512131	['at 12–14 months of age, the Livers from the juvenile Animals showed increased Tgs and increased Liver Macrophage Cell numbers and the Liver Macrophages were hyperresponsive to Fatty Acids in vitro, producing high levels of cytokines (36).']	N/A	N/A	[('UBERON_0002107', 'liver', 28, 'livers'), ('NCBITaxon_33208', 'Metazoa', 53, 'animals'), ('CL_0002488', 'trophoblast giant cell', 78, 'TGs'), ('CL_0000596', 'sexual spore', 96, 'liver macrophage cell'), ('UBERON_0002107', 'liver', 96, 'liver'), ('CL_0000091', 'Kupffer cell', 134, 'liver macrophages'), ('UBERON_0002107', 'liver', 134, 'liver'), ('CHEBI_35366', 'fatty acid', 176, 'fatty acids')]
PMC4512131	8/2015	S79-PMC4512131	['caption (fig): figure 2\n\nconsequences of maternal overfeeding on Fetal Liver and the evolution of nafld .']	N/A	N/A	[('UBERON_0000922', 'embryo', 65, 'fetal'), ('UBERON_0002107', 'liver', 71, 'liver')]
PMC4512131	8/2015	S80-PMC4512131	['exposure to excess Lipids triggers Placental inflammation, oxidative stress, and Liver steatosis prior to Birth.']	N/A	N/A	[('CHEBI_18059', 'lipid', 19, 'lipids'), ('UBERON_0001987', 'placenta', 35, 'placental'), ('UBERON_0002107', 'liver', 81, 'liver'), ('GO_0007567', 'parturition', 106, 'birth')]
PMC4512131	8/2015	S135-PMC4512131	['the major product of Microbial Fermentation, acetate, is a substrate for Hepatic Cholesterol and Tg Synthesis and increases Hepatic Expression of Genes involved in Fatty Acid Metabolism and Lipogenesis (68).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 21, 'microbial'), ('GO_0006113', 'fermentation', 31, 'fermentation'), ('UBERON_0002107', 'liver', 73, 'hepatic'), ('CHEBI_16113', 'cholesterol', 81, 'cholesterol'), ('GO_0030509', 'BMP signaling pathway', 81, 'cholesterol ...'), ('CHEBI_17855', 'triglyceride', 97, 'TG'), ('GO_0046049', 'UMP metabolic process', 97, 'TG synthesis'), ('UBERON_0002107', 'liver', 124, 'hepatic'), ('GO_0010467', 'gene expression', 132, 'expression'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_35366', 'fatty acid', 164, 'fatty acid'), ('GO_0006631', 'fatty acid metabolic process', 164, 'fatty acid metabolism'), ('GO_0008610', 'lipid biosynthetic process', 190, 'lipogenesis')]
PMC4512131	8/2015	S171-PMC4512131	['newborns show increased Hepatic Lipids, subcutaneous fat, and Adipogenesis in infant-derived Umbilical Cord Mscs.']	N/A	N/A	[('UBERON_0002107', 'liver', 24, 'hepatic'), ('CHEBI_18059', 'lipid', 32, 'lipids'), ('GO_0060612', 'adipose tissue development', 62, 'adipogenesis'), ('UBERON_0002331', 'umbilical cord', 93, 'umbilical cord'), ('CL_0000186', 'myofibroblast cell', 108, 'MSCs')]
PMC4528901	9/2014	S4-PMC4528901	['she initially presented with nausea, vomiting, and Abdominal pain and was found to have acute hepatocellular Liver injury and a systemic inflammatory response syndrome.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 51, 'abdominal'), ('UBERON_0002107', 'liver', 109, 'liver')]
PMC4528901	9/2014	S6-PMC4528901	['Liver biopsy, Serum dna polymerase chain reaction (pcr) as well as a Labial ulcer culture and pcr were all positive for Hsv 2.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0001977', 'blood serum', 14, 'serum'), ('UBERON_0004341', 'primitive streak', 69, 'labial'), ('NCBITaxon_10088', 'Mus <genus>', 120, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 120, 'HSV 2')]
PMC4528901	9/2014	S25-PMC4528901	['Liver tests revealed a total Bilirubin 0.5 mg/dl, aspartate aminotransferase (ast) 701 iu/l, alanine aminotransferase (alt) 284 iu/l, and alkaline phosphatase 103 iu/l.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_16990', 'bilirubin IXalpha', 29, 'bilirubin'), ('UBERON_0004058', 'biliary ductule', 29, 'bilirubin')]
PMC4528901	9/2014	S42-PMC4528901	['Liver histology revealed multifocal geographic areas of necrosis with associated Neutrophils (figure 1a).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CL_0000775', 'neutrophil', 81, 'neutrophils')]
PMC4528901	9/2014	S50-PMC4528901	['Hepatic histology (Hematoxylin and eosin).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_51686', 'haematoxylin', 19, 'hematoxylin')]
PMC4528901	9/2014	S52-PMC4528901	['in (b) is shown a high magnification image of Hematoxylin and eosin–stained Liver; several Nuclei with Intranuclear Inclusions, and a characteristic (of herpes simplex virus) “ground glass Nucleus” with margination of the Chromatin are shown, a classic example of a ground glass Nucleus is shown in the center (arrow).']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 46, 'hematoxylin'), ('UBERON_0002107', 'liver', 76, 'liver'), ('GO_0005634', 'nucleus', 91, 'nuclei'), ('GO_0005622', 'intracellular anatomical structure', 103, 'intranuclear'), ('GO_0016234', 'inclusion body', 116, 'inclusions'), ('GO_0005634', 'nucleus', 189, 'nucleus'), ('GO_0000785', 'chromatin', 222, 'chromatin'), ('GO_0005634', 'nucleus', 279, 'nucleus')]
PMC4528901	9/2014	S56-PMC4528901	['the Liver specimen shown infigure 1was fixed and labeled with anti-Hsv-2 Antibody.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 67, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 67, 'HSV-2'), ('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibody')]
PMC4528901	9/2014	S87-PMC4528901	['abbreviations: inr, international normalized ratio; Aflp, acute fatty Liver of Pregnancy; hellp, Hemolysis, elevated Liver enzymes, and low Platelets; iv, Intravenous; bp, Blood pressure; Nac, N -Acetylcysteine.']	N/A	N/A	[('SO_0001830', 'AFLP_fragment', 52, 'AFLP'), ('UBERON_0002107', 'liver', 70, 'liver'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('GO_0030097', 'hemopoiesis', 97, 'hemolysis'), ('UBERON_0002107', 'liver', 117, 'liver'), ('CL_0000233', 'platelet', 140, 'platelets'), ('UBERON_0034986', 'sacral nerve plexus', 155, 'intravenous'), ('UBERON_0000178', 'blood', 172, 'blood'), ('CHEBI_7421', 'NAC', 188, 'NAC'), ('CHEBI_70981', '6-formylpterin', 193, 'N -acetylcysteine')]
PMC4528901	9/2014	S88-PMC4528901	['acute fatty Liver of Pregnancy and hellp syndrome are 2 medical and obstetric emergencies that typically occur during the third Trimester.']	N/A	N/A	[('UBERON_0002107', 'liver', 12, 'liver'), ('GO_0007565', 'female pregnancy', 21, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 128, 'trimester')]
PMC4528901	9/2014	S99-PMC4528901	['maternal and fetal mortality are 5% and 30%, respectively.15\nLiver diseases not unique to Pregnancy can also present at any time in expectant mothers.']	N/A	N/A	[('UBERON_0002107', 'liver', 61, 'Liver'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy')]
PMC4539881	7/2015	S23-PMC4539881	['microsomal Liver enzymes get induced by circulating Steroids, and there is Biliary stasis.']	N/A	N/A	[('UBERON_0002107', 'liver', 11, 'liver'), ('CHEBI_35341', 'steroid', 52, 'steroids'), ('UBERON_0002294', 'biliary system', 75, 'biliary')]
PMC4539881	7/2015	S26-PMC4539881	['vulnerability factors for the fetus include small total Plasma volume, decreased albumin with increased levels of free Drugs, decreased Hepatic enzyme formation, decreased gfr, and immature Blood-Brain Barrier.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 56, 'plasma'), ('CHEBI_23888', 'drug', 119, 'drugs'), ('UBERON_0002107', 'liver', 136, 'hepatic'), ('UBERON_0000178', 'blood', 190, 'blood-'), ('UBERON_0000052', 'fornix of brain', 196, 'brain barrier')]
PMC4549107	8/2015	S140-PMC4549107	['Eating the right kinds of Food – fruit and vegetables, fish, Chicken, and meat such as Liver were listed – was frequently mentioned as desirable, often without prompting.']	N/A	N/A	[('GO_0007568', 'aging', 0, 'Eating'), ('CHEBI_33290', 'food', 26, 'food'), ('NCBITaxon_33208', 'Metazoa', 61, 'chicken'), ('UBERON_0002107', 'liver', 87, 'liver')]
PMC4586532	8/2015	S0-PMC4586532	['high fat diet exposure during Fetal Life enhances Plasma and Hepatic omega-6 Fatty Acid profiles in fetal wistar Rats\n\nabstract\nPregnant Rats were Fed a high fat diet (hfd) for the first (hf1), second (hf2), third (hf3) or all three weeks (hfg) of Gestation.']	N/A	N/A	[('GO_0008618', '7-methylguanosine metabolic process', 30, 'Fetal'), ('UBERON_0000104', 'life cycle', 36, 'Life'), ('UBERON_0001969', 'blood plasma', 50, 'Plasma'), ('UBERON_0002107', 'liver', 61, 'Hepatic'), ('CHEBI_35366', 'fatty acid', 77, 'Fatty Acid'), ('NCBITaxon_10088', 'Mus <genus>', 113, 'Rats'), ('GO_0007565', 'female pregnancy', 128, 'Pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 137, 'rats'), ('GO_0007631', 'feeding behavior', 147, 'fed'), ('GO_0007565', 'female pregnancy', 248, 'gestation')]
PMC4586532	8/2015	S2-PMC4586532	['at day 20 of Gestation, fetal Plasma and Hepatic Fa profiles were determined by gas chromatography; body weight, fasting glycemia, Insulinemia and the Homeostasis model assessment (homa-Insulin resistance) were also determined.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestation'), ('UBERON_0001969', 'blood plasma', 30, 'plasma'), ('UBERON_0002107', 'liver', 41, 'hepatic'), ('CHEBI_30751', 'formic acid', 49, 'FA'), ('PR_000008917', 'interferon alpha-4', 131, 'insulinemia'), ('GO_0042592', 'homeostatic process', 151, 'Homeostasis'), ('PR_000045358', 'insulin family protein', 186, 'insulin')]
PMC4586532	8/2015	S5-PMC4586532	['in the Liver, hf3 fetuses displayed elevated Linoleic, Eicosatrienoic (20:3 n -6) and arachidonic acid proportions ( p< 0.05).']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('CHEBI_6409', 'Lentiginosine', 45, 'linoleic'), ('CHEBI_64372', 'emericellamide', 55, 'eicosatrienoic')]
PMC4586532	8/2015	S6-PMC4586532	['hfg fetuses had reduced Hepatic Docosatrienoic Acid (22:5 n -3) proportions ( p< 0.05).']	N/A	N/A	[('UBERON_0002107', 'liver', 24, 'hepatic'), ('CHEBI_82846', 'docosatrienoic acid', 32, 'docosatrienoic acid')]
PMC4586532	8/2015	S7-PMC4586532	['high fat maintenance during the final week of fetal Life enhances Hepatic Omega-6 Fa profiles in fetuses concomitant with hyperglycemia and Insulin resistance thereby presenting a Metabolically compromised phenotype.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 52, 'life'), ('UBERON_0002107', 'liver', 66, 'hepatic'), ('CHEBI_79370', 'ibho#10', 74, 'omega-6'), ('CHEBI_30751', 'formic acid', 82, 'FA'), ('PR_000045358', 'insulin family protein', 140, 'insulin'), ('GO_0008152', 'metabolic process', 180, 'metabolically')]
PMC4586532	8/2015	S37-PMC4586532	['whole Liver was collected, weighed and stored at −80 °c until analysis.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver')]
PMC4586532	8/2015	S42-PMC4586532	['for Fa analysis, Nonadecenoic Acid (19:1; sigma-aldrich, madrid, spain) was added as the internal standard to fresh aliquots of frozen Plasma and Liver which were used for Lipid extraction and purification [9].']	N/A	N/A	[('CHEBI_30751', 'formic acid', 4, 'FA'), ('CHEBI_39251', '12-methyltetradecanoic acid', 17, 'nonadecenoic acid'), ('UBERON_0001969', 'blood plasma', 135, 'plasma'), ('UBERON_0002107', 'liver', 146, 'liver'), ('CHEBI_18059', 'lipid', 172, 'lipid')]
PMC4586532	8/2015	S74-PMC4586532	['as shown intable 3, the proportion of different Fas in fetal Liver remained relatively constant.']	N/A	N/A	[('CHEBI_33290', 'food', 48, 'FAs'), ('UBERON_0002107', 'liver', 61, 'liver')]
PMC4586532	8/2015	S76-PMC4586532	['further, Hepatic Docosapentaenoic Acid (Dpa; 22:5 n -3) was lower in hfg fetuses compared to control and hf3 fetuses (table 3).nutrients-07-05337-t003_table 3\n\ncaption (table-wrap): table 3\n\nHepatic Fatty Acid profiles (%) of 20-day-old Rat fetuses exposed to a maternal high fat diet.Fatty Acidcontrolhf1Hf2Hf3Hfgsaturated14:01.03 ± 0.200.93 ± 0.091.00 ± 0.071.39 ± 0.161.22 ± 0.1516:024.46 ± 0.9223.15 ± 0.4323.62 ± 0.5924.20 ± 0.9023.75 ± 0.5018:015.40 ± 0.4015.57 ± 0.3714.85 ± 0.1715.20 ± 0.4314.55 ± 0.2120:00.31 ± 0.050.30 ± 0.040.26 ± 0.010.28 ± 0.020.32 ± 0.04monounsaturated15:10.49 ± 0.050.33 ± 0.090.34 ± 0.070.36 ± 0.060.36 ± 0.0616:1 ( n -7)4.20 ± 0.373.82 ± 0.313.93 ± 0.133.43 ± 0.234.03 ± 0.1118:1 ( n -9)21.01 ± 0.7020.09 ± 0.7721.35 ± 0.7919.03 ± 1.3122.44 ± 0.6720:1 ( n -9)0.21 ± 0.070.24 ± 0.030.24 ± 0.010.23 ± 0.030.23 ± 0.03omega-320:5 ( n -3)0.83 ± 0.100.70 ± 0.080.57 ± 0.030.65 ± 0.090.69 ± 0.1022:5 ( n -3)0.40 ± 0.030.37 ± 0.060.34 ± 0.030.41 ± 0.040.24 ± 0.01 *,§22:6 ( n -3)12.64 ± 0.9113.00 ± 0.9612.01 ± 0.569.99 ± 1.218.81 ± 0.51omega-618:2 ( n -6)7.24 ± 0.307.86 ± 0.538.06 ± 0.2510.16 ± 0.79 *,‡8.79 ± 0.3020:2 ( n -6)0.22 ± 0.030.25 ± 0.050.24 ± 0.020.25 ± 0.010.23 ± 0.0220:3 ( n -6)0.83 ± 0.030.79 ± 0.030.87 ± 0.061.03 ± 0.03†0.99 ± 0.0520:4 ( n -6)8.68 ± 0.3310.53 ± 0.4610.21 ± 0.2610.95 ± 0.52*10.65 ± 0.7222:4 ( n -6)0.40 ± 0.010.43 ± 0.010.47 ± 0.020.50 ± 0.050.48 ± 0.04\nthe fetuses were maintained (through their mothers’ nutrition) on a high fat diet (hfd) for either the first week (hf1), second week (hf2), third week (hf3) or all 3 weeks (hfg) of fetal Life.']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'hepatic'), ('CHEBI_61205', 'docosatetraenoic acid', 17, 'docosapentaenoic acid'), ('CHEBI_49168', 'dopa', 40, 'DPA'), ('UBERON_0002107', 'liver', 191, 'Hepatic'), ('CHEBI_35366', 'fatty acid', 199, 'fatty acid'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 237, 'rat'), ('CHEBI_83932', '(R,R)-tubulozole', 285, 'Fatty AcidControlHF1HF2HF3HFGSaturated14'), ('UBERON_0000104', 'life cycle', 1605, 'life')]
PMC4586532	8/2015	S84-PMC4586532	['discussion\nthe hyperglycemia and Insulin resistance in fetuses maintained on a hfd for the final week of fetal Life concomitant with increased Hepatic Omega-6 Fa proportions were the main findings.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 33, 'insulin'), ('UBERON_0000104', 'life cycle', 111, 'life'), ('UBERON_0002107', 'liver', 143, 'hepatic'), ('CHEBI_79370', 'ibho#10', 151, 'omega-6'), ('CHEBI_30751', 'formic acid', 159, 'FA')]
PMC4586532	8/2015	S93-PMC4586532	['with an increase of the precursor, Linoleic Acid, in the hf3 fetal Livers, more substrate was available for conversion into arachidonic acid to help meet the fetal growth demands.']	N/A	N/A	[('CHEBI_30881', 'xanthine-8-carboxylic acid', 35, 'linoleic acid'), ('UBERON_0002107', 'liver', 67, 'livers')]
PMC4586532	8/2015	S116-PMC4586532	['Liver mass and its later function are essentially set during Fetal development which is Regulated by the Intrauterine environment [27].']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('GO_0007631', 'feeding behavior', 61, 'fetal'), ('GO_0065007', 'biological regulation', 88, 'regulated'), ('UBERON_0022293', 'reproductive gland secretion', 105, 'intrauterine')]
PMC4586532	8/2015	S119-PMC4586532	['from e8–14 Hepatic fate is specified, followed by Gut Tube Formation, the Liver domain relocating to the mid-Gut followed by the Liver diverticulum expanding into a Liver Bud [12,13].']	N/A	N/A	[('UBERON_0002107', 'liver', 11, 'hepatic'), ('GO_1901070', 'guanosine-containing compound biosynthetic process', 50, 'gut tube formation'), ('UBERON_0001555', 'digestive tract', 50, 'gut'), ('UBERON_0000025', 'tube', 54, 'tube'), ('UBERON_0002107', 'liver', 74, 'liver'), ('UBERON_0001555', 'digestive tract', 109, 'gut'), ('UBERON_0002107', 'liver', 129, 'liver'), ('UBERON_0008836', 'liver bud', 165, 'liver bud')]
PMC4586532	8/2015	S131-PMC4586532	['conclusions\nfetuses maintained on a hfd solely for the final week of fetal Life were hyperglycemic and Insulin resistant concomitant with enhanced Hepatic Omega-6 Fa proportions, viz., Linoleic, Eicosatrienoic and arachidonic acid.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 75, 'life'), ('PR_000045358', 'insulin family protein', 103, 'insulin'), ('UBERON_0002107', 'liver', 147, 'hepatic'), ('CHEBI_79370', 'ibho#10', 155, 'omega-6'), ('CHEBI_30751', 'formic acid', 163, 'FA'), ('CHEBI_6409', 'Lentiginosine', 185, 'linoleic'), ('CHEBI_64372', 'emericellamide', 195, 'eicosatrienoic')]
PMC4619070	10/2015	S46-PMC4619070	['the following Maternal Pregnancy outcomes were recorded: Gestational hypertension (Blood pressure\u2009≥\u2009140/90\xa0mmhg), Preeclampsia [hypertension with proteinuria or in combination with reduced fetal growth or the ‘Hemolysis elevated Liver enzymes and low Platelets’ (helpp)-syndrome], Preterm Delivery (<37\xa0weeks of Gestation) and cesarean section (planned\u2009+\u2009emergency sections combined).']	N/A	N/A	[('GO_0007618', 'mating', 14, 'maternal'), ('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('GO_0007565', 'female pregnancy', 57, 'gestational'), ('UBERON_0000178', 'blood', 83, 'blood'), ('GO_0007128', 'meiotic prophase I', 114, 'preeclampsia'), ('GO_0030097', 'hemopoiesis', 210, 'Hemolysis'), ('UBERON_0002107', 'liver', 229, 'Liver'), ('CL_0000233', 'platelet', 251, 'Platelets'), ('GO_0007565', 'female pregnancy', 281, 'preterm'), ('GO_0007567', 'parturition', 289, 'delivery'), ('GO_0007565', 'female pregnancy', 312, 'gestation')]
PMC4619070	10/2015	S51-PMC4619070	['as a secondary measure of Insulin sensitivity (largely Hepatic), we also calculated the reciprocal of the Homeostasis model assessment of Insulin resistance (1/homa-ir) [17].']	N/A	N/A	[('PR_000045358', 'insulin family protein', 26, 'insulin'), ('UBERON_0002107', 'liver', 55, 'hepatic'), ('GO_0042592', 'homeostatic process', 106, 'homeostasis'), ('PR_000045358', 'insulin family protein', 138, 'insulin')]
PMC4661500	11/2014	S237-PMC4661500	['additional collateral clinical observations: Liver function, tendinitis, Learn stress and side effects of supplementation with Magnesium Citrate\nsince alteration in Liver function parameters can be seen during initial phases of hyperthyroidism we followed-up 4 cases who presented initially elevated levels of transaminases.']	N/A	N/A	[('UBERON_0002107', 'liver', 45, 'liver'), ('GO_0007612', 'learning', 73, 'learn'), ('CHEBI_63006', 'magnesium formate dihydrate', 127, 'magnesium citrate'), ('UBERON_0002107', 'liver', 165, 'liver')]
PMC4661500	11/2014	S398-PMC4661500	['in the experiments with magnesium deficiency, Cardiac muscle was more sensitive than Kidney and Liver showing a decrease in oxphos.']	N/A	N/A	[('UBERON_0000948', 'heart', 46, 'cardiac'), ('UBERON_0002113', 'kidney', 85, 'kidney'), ('UBERON_0002107', 'liver', 96, 'liver')]
PMC4661500	11/2014	S618-PMC4661500	['the Chickens presented high levels of Selenium in Blood while Liver selenoproteins were low.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'chickens'), ('CHEBI_27568', 'selenium atom', 38, 'selenium'), ('UBERON_0000178', 'blood', 50, 'blood'), ('UBERON_0002107', 'liver', 62, 'liver')]
PMC4663580	11/2015	S253-PMC4663580	['Synthesis Of Pc through the Hepatic de novo pathway by Phosphatidylethanolamine n-methyltransferase (pemt), using S-Adenosylmethionine (sam) as substrate, results in pc that is enriched in Long-Chain polyunsaturated Fatty Acids such as Dha.']	N/A	N/A	[('GO_0007416', 'synapse assembly', 0, 'Synthesis of PC'), ('UBERON_0002107', 'liver', 28, 'hepatic'), ('CHEBI_16038', 'phosphatidylethanolamine', 55, 'phosphatidylethanolamine'), ('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 114, 'S-adenosylmethionine'), ('CHEBI_28911', 'cob(III)alamin', 189, 'long-chain'), ('CHEBI_35366', 'fatty acid', 216, 'fatty acids'), ('CHEBI_17874', 'dihydrozeatin', 236, 'DHA')]
PMC4663588	11/2015	S156-PMC4663588	['protein restricted offspring given the casein based Chow had a higher body weight, a higher percent of Carcass fat, and a higher amount of Liver fat.']	N/A	N/A	[('CHEBI_33290', 'food', 52, 'chow'), ('UBERON_0008979', 'carcass', 103, 'carcass'), ('UBERON_0002107', 'liver', 139, 'liver')]
PMC4663588	11/2015	S157-PMC4663588	['protein restricted offspring that were switched to the corn and soybean protein based Chow showed a decrease in Adult body weight, a lower body fat percentage, and exhibited a loss in Liver fat after the dietary intervention.']	N/A	N/A	[('CHEBI_33290', 'food', 86, 'chow'), ('UBERON_0007023', 'adult organism', 112, 'adult'), ('UBERON_0002107', 'liver', 184, 'liver')]
PMC4663588	11/2015	S195-PMC4663588	['moreover, no significant alteration in Regulation Of Metabolic Pathways were observed in Porcine fetal Livers when a high protein diet Fed during Pregnancy [89].']	N/A	N/A	[('GO_0001969', 'regulation of activation of membrane attack complex', 39, 'regulation of metabolic pathways'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'porcine'), ('UBERON_0002107', 'liver', 103, 'livers'), ('GO_0007631', 'feeding behavior', 135, 'fed'), ('GO_0007565', 'female pregnancy', 146, 'pregnancy')]
PMC4663588	11/2015	S199-PMC4663588	['evaluated Hepatic and muscular Gene Expression profiles of the progeny of sow Fed either an isoenergetic maternal low protein/high Carbohydrate (lp) diet, a high protein/low Carbohydrate (hp) diet, or an adequate protein (ap) diet throughout Pregnancy.']	N/A	N/A	[('UBERON_0002107', 'liver', 10, 'hepatic'), ('GO_0010467', 'gene expression', 31, 'gene expression'), ('SO_0000704', 'gene', 31, 'gene'), ('GO_0007631', 'feeding behavior', 78, 'fed'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 131, 'carbohydrate'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 174, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 242, 'pregnancy')]
PMC4663588	11/2015	S272-PMC4663588	['in offspring Born to sows Fed a high protein/low Carbohydrate Gestational diet, increased Hepatic Transcript concentrations of Pck1 were observed when compared with controls.']	N/A	N/A	[('GO_0007567', 'parturition', 13, 'born'), ('GO_0007631', 'feeding behavior', 26, 'fed'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 49, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 62, 'gestational'), ('UBERON_0002107', 'liver', 90, 'hepatic'), ('SO_0000673', 'transcript', 98, 'transcript'), ('PR_000012422', 'PEST proteolytic signal-containing nuclear protein', 127, 'PCK1')]
PMC4663588	11/2015	S318-PMC4663588	['neonatal Hepatic pro-inflammatory cytokine Expression was also down regulated following maternal Taurine supplementation.']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'hepatic'), ('GO_0010467', 'gene expression', 43, 'expression'), ('CHEBI_15891', 'taurine', 97, 'taurine')]
PMC4663588	11/2015	S460-PMC4663588	['a post-weaning low protein diet reduced the growth rate in male offspring and presented with lower Liver, Pancreas and Kidney weight.']	N/A	N/A	[('UBERON_0002107', 'liver', 99, 'liver'), ('UBERON_0001264', 'pancreas', 106, 'pancreas'), ('UBERON_0002113', 'kidney', 119, 'kidney')]
PMC4663588	11/2015	S461-PMC4663588	['Plasma Igf-1 concentrations at 8 and 25 weeks, the incidence of Hepatic Lipidosis at 25 weeks and body fat were also higher in offspring Fed a low protein post-weaning diet compared with those Fed a post-weaning normal protein diet.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('PR_000008929', 'interferon-related developmental regulator 1', 7, 'IGF-1'), ('UBERON_0002107', 'liver', 64, 'hepatic'), ('GO_0008610', 'lipid biosynthetic process', 72, 'lipidosis'), ('GO_0007631', 'feeding behavior', 137, 'fed'), ('GO_0007631', 'feeding behavior', 193, 'fed')]
PMC4663588	11/2015	S521-PMC4663588	['maternal low protein diet did not affect Liver Cholesterol content in females at any age.']	N/A	N/A	[('UBERON_0002107', 'liver', 41, 'liver'), ('CHEBI_16113', 'cholesterol', 47, 'cholesterol')]
PMC4663595	11/2015	S96-PMC4663595	['additionally, deficiencies in Folate and Vitamin B12 during Gestation and Lactation produced manifestations of Fetal Programming, with decreased Birth weight, increased central fat mass, Liver steatosis and Myocardium hypertrophy in pups from deficient Rat mothers [16].']	N/A	N/A	[('CHEBI_30863', '5-azaorotic acid', 30, 'folate'), ('CHEBI_33279', 'vitamin D5', 41, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 49, 'B12'), ('GO_0007565', 'female pregnancy', 60, 'gestation'), ('GO_0007595', 'lactation', 74, 'lactation'), ('GO_0001553', 'luteinization', 111, 'fetal programming'), ('GO_0007567', 'parturition', 145, 'birth'), ('UBERON_0002107', 'liver', 187, 'liver'), ('UBERON_0002349', 'myocardium', 207, 'myocardium'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 253, 'rat')]
PMC4663595	11/2015	S101-PMC4663595	['additionally, levels of H3K9Me2 and h3k27me3 (repressed) were upregulated in the fetal Liver and Brain by maternal Choline supplementation, whereas levels of H3K4Me2 (active) were highest in Choline-deficient Rats.']	N/A	N/A	[('SO_0001707', 'H3K9_trimethylation_site', 24, 'H3K9me2'), ('UBERON_0002107', 'liver', 87, 'liver'), ('UBERON_0000955', 'brain', 97, 'brain'), ('CHEBI_15354', 'choline', 115, 'choline'), ('SO_0001734', 'H3K4_methylation_site', 158, 'H3K4me2'), ('CHEBI_15354', 'choline', 191, 'choline'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 209, 'rats')]
PMC4663595	11/2015	S144-PMC4663595	['lp diet during fetal development resulted in Dna Hypermethylation of the h19/Igf2 locus with increased Expressions of Dnmt1, Dnmt3A and Methyl Cpg Binding Domain Protein 2 in Liver of male offspring [49].']	N/A	N/A	[('GO_0044026', 'DNA hypermethylation', 45, 'DNA hypermethylation'), ('PR_000008989', 'interleukin-1 family member 7', 77, 'IGF2'), ('GO_0010467', 'gene expression', 103, 'expressions'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 118, 'DNMT1'), ('PR_000006609', 'DNA (cytosine-5)-methyltransferase 3-like', 125, 'DNMT3a'), ('PR_000010050', 'transcription factor MafG', 136, 'methyl CpG binding domain protein 2'), ('SO_0000417', 'polypeptide_domain', 155, 'domain'), ('UBERON_0002107', 'liver', 175, 'liver')]
PMC4666222	11/2015	S59-PMC4666222	['Pelvic ultrasound showed no signs of retained products of Conception.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Pelvic'), ('GO_0007620', 'copulation', 58, 'conception')]
PMC4670104	12/2015	S133-PMC4670104	['color depicts representative Tissue origins or subcellular localization of proteins: black-Intracellular Space; green-Hepatic origin and Secreted into Plasma; red-Extracellular Matrix; blue-Extracellular Matrix Membrane binding.']	N/A	N/A	[('UBERON_0000479', 'tissue', 29, 'tissue'), ('GO_0005622', 'intracellular anatomical structure', 91, 'intracellular'), ('GO_0045202', 'synapse', 105, 'space'), ('UBERON_0002107', 'liver', 118, 'hepatic'), ('GO_0046903', 'secretion', 137, 'secreted'), ('GO_0005886', 'plasma membrane', 151, 'plasma'), ('UBERON_0001969', 'blood plasma', 151, 'plasma'), ('GO_0031012', 'extracellular matrix', 163, 'extracellular matrix'), ('GO_0010008', 'endosome membrane', 190, 'extracellular matrix membrane')]
PMC4670104	12/2015	S140-PMC4670104	['proteins in pc2 are known to be mainly produced by the Liver and Secreted into the Bloodstream (green) and proteins in pc3 are largely produced by extra-Hepatic Tissues and localized in Extracellular Matrix Regions (red and blue).']	N/A	N/A	[('UBERON_0002107', 'liver', 55, 'liver'), ('GO_0046903', 'secretion', 65, 'secreted'), ('UBERON_0001969', 'blood plasma', 83, 'bloodstream'), ('UBERON_0002529', 'limb segment', 153, 'hepatic tissues'), ('GO_0005576', 'extracellular region', 186, 'extracellular matrix regions')]
PMC4673623	11/2015	S18-PMC4673623	['for example, reduction of Folic Acid to Tetrahydrofolate (thf; the active form of Folate) by Dihydrofolate reductase in the Human Liver occurs at less than 2% the rate observed in Rat Liver (bailey and ayling2009).']	N/A	N/A	[('CHEBI_30751', 'formic acid', 26, 'folic acid'), ('CHEBI_67016', 'tetrahydrofolate', 40, 'tetrahydrofolate'), ('CHEBI_30863', '5-azaorotic acid', 82, 'folate'), ('CHEBI_36263', 'hydrogenmolybdate', 93, 'dihydrofolate'), ('NCBITaxon_9606', 'Homo sapiens', 124, 'human'), ('UBERON_0002107', 'liver', 130, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 180, 'rat'), ('UBERON_0002107', 'liver', 184, 'liver')]
PMC4673623	11/2015	S79-PMC4673623	['caption (table-wrap): table 1\n\nPlacental and fetal morphometric characteristics at cesarean section (0.9\xa0Gestation) in control ( n \xa0=\xa020–22) and hf-hed ( n \xa0=\xa05) group*controlhf-hedplacenta measures\u2003weight (g)210\xa0±\xa09214\xa0±\xa09\u2003efficiency (g fetus/g Placenta)3.9\xa0±\xa00.13.2\xa0±\xa00.2†\u2003volume (cm3)159\xa0±\xa018111\xa0±\xa026fetal measures\u2003body weight (g)806\xa0±\xa024675\xa0±\xa036†\u2003length (cm)38\xa0±\xa00.637\xa0±\xa01\u2003bmi (kg/m2)5.7\xa0±\xa00.15.1\xa0±\xa00.4‡\u2003ponderal index (kg/m3)15\xa0±\xa00.514\xa0±\xa01\u2003Brain (g)82\xa0±\xa0280\xa0±\xa02\u2003Heart (g)4.9\xa0±\xa00.24.2\xa0±\xa00.2\u2003Kidneys (g)4.5\xa0±\xa00.24.0\xa0±\xa00.2\u2003Liver (g)24\xa0±\xa00.920\xa0±\xa01.2‡\u2003Lung (g)17\xa0±\xa00.617\xa0±\xa01.5\u2003Pancreas (g)0.56\xa0±\xa00.060.44\xa0±\xa00.05\u2003Thymus (g)3.4\xa0±\xa00.203.4\xa0±\xa00.46fetal measures as percent fetal weight\u2003Placenta26\xa0±\xa00.832\xa0±\xa02.5†\u2003Brain11\xa0±\xa00.312\xa0±\xa00.6†\u2003Heart0.61\xa0±\xa00.020.63\xa0±\xa00.04\u2003Kidneys0.56\xa0±\xa00.020.59\xa0±\xa00.03\u2003Liver3.0\xa0±\xa00.063.0\xa0±\xa00.125\u2003Lungs2.2\xa0±\xa00.072.4\xa0±\xa00.12‡\u2003Pancreas0.07\xa0±\xa00.010.07\xa0±\xa00.01\u2003Thymus0.42\xa0±\xa00.020.52\xa0±\xa00.05†fetal measures as percent maternal weight\u2003fetal weight4.3\xa0±\xa00.13.5\xa0±\xa00.2†\u2003Placenta1.13\xa0±\xa00.041.09\xa0±\xa00.05\ndata are mean\xa0±\xa0sem.']	N/A	N/A	[('UBERON_0001987', 'placenta', 31, 'Placental'), ('GO_0007565', 'female pregnancy', 105, 'gestation'), ('UBERON_0001987', 'placenta', 246, 'placenta'), ('UBERON_0000955', 'brain', 445, 'Brain'), ('UBERON_0000948', 'heart', 467, 'Heart'), ('UBERON_0002113', 'kidney', 495, 'Kidneys'), ('UBERON_0002107', 'liver', 525, 'Liver'), ('UBERON_0002048', 'lung', 552, 'Lung'), ('UBERON_0001264', 'pancreas', 577, 'Pancreas'), ('UBERON_0002370', 'thymus', 612, 'Thymus'), ('UBERON_0001950', 'neocortex', 681, 'Placenta26'), ('UBERON_0009747', 'tail fold of embryonic disc', 707, 'Brain11'), ('UBERON_0000948', 'heart', 730, 'Heart0'), ('UBERON_0000975', 'sternum', 758, 'Kidneys0'), ('UBERON_0006009', 'cusp of cardiac valve', 788, 'Liver3'), ('UBERON_0000170', 'pair of lungs', 815, 'Lungs2'), ('UBERON_0001272', 'innominate bone', 842, 'Pancreas0'), ('UBERON_0002370', 'thymus', 873, 'Thymus0'), ('UBERON_0001987', 'placenta', 976, 'Placenta1')]
PMC4673623	11/2015	S117-PMC4673623	['by providing Methyl Groups for de novo Synthesis Of Phosphatidylcholine, lipotropes facilitate Vldl Biosynthesis and Hepatic Lipid Export (lamaziere et\xa0al.2012) (fig.1).']	N/A	N/A	[('CHEBI_33961', 'mu4-sulfido-quadro-tetracopper(5+)', 13, 'methyl groups'), ('GO_0006550', 'isoleucine catabolic process', 39, 'synthesis of phosphatidylcholine'), ('CHEBI_36710', 'interferon inducer', 52, 'phosphatidylcholine'), ('GO_0045210', 'FasL biosynthetic process', 95, 'VLDL biosynthesis'), ('UBERON_0002107', 'liver', 117, 'hepatic'), ('CHEBI_18059', 'lipid', 125, 'lipid'), ('GO_0016132', 'brassinosteroid biosynthetic process', 125, 'lipid export')]
PMC4682815	12/2015	S99-PMC4682815	['Alanine Aminotransferase 1, Liver Isoform Of Glutaminase, Eaat1 , Eaat4 and Eaat5 mrna Expression was not detected in Human Placenta.']	N/A	N/A	[('PR_000003892', 'A-kinase anchor protein 5', 0, 'Alanine aminotransferase 1'), ('PR_000025622', 'E3 ubiquitin-protein ligase SIAH1 isoform 1', 28, 'liver isoform of glutaminase'), ('UBERON_0002107', 'liver', 28, 'liver'), ('SO_0001060', 'sequence_variant', 34, 'isoform'), ('PR_000006874', 'endothelin-converting enzyme 1', 58, 'EAAT1'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 66, 'EAAT4'), ('PR_000006890', 'enhancer of mRNA-decapping protein 3', 76, 'EAAT5'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 118, 'human'), ('UBERON_0001987', 'placenta', 124, 'placenta')]
PMC4683322	11/2015	S2-PMC4683322	['Liver samples were obtained and rna was isolated.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC4683322	11/2015	S7-PMC4683322	['among all the predicted Mirnas, 4 Mirnas targeting gr were quantitated by real-time pcr and Mirna-124A, which has been identified to target gr 3′Utr[2],[3], was more highly Expressed in betaine-exposed neonatal Livers.']	N/A	N/A	[('SO_0000276', 'miRNA', 24, 'miRNAs'), ('SO_0000276', 'miRNA', 34, 'miRNAs'), ('PR_000010200', 'MEF2-activating motif and SAP domain-containing transcriptional regulator', 92, 'miRNA-124a'), ('SO_0000243', 'internal_ribosome_entry_site', 144, '′UTR'), ('GO_0010467', 'gene expression', 173, 'expressed'), ('UBERON_0002107', 'liver', 211, 'livers')]
PMC4683322	11/2015	S11-PMC4683322	['data, experimental design, materials and methods\n\nLiver samples\nsows were divided randomly into control and betaine groups (8 per group) while sows were Fed basal diet and received betaine-supplemented (3\xa0g/kg) diet respectively throughout the Pregnancy.']	N/A	N/A	[('UBERON_0002107', 'liver', 50, 'Liver'), ('GO_0007631', 'feeding behavior', 153, 'fed'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy')]
PMC4683322	11/2015	S14-PMC4683322	['Liver samples were collected immediately, snap-frozen in liquid nitrogen and stored at −80\xa0°c.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC4683322	11/2015	S23-PMC4683322	['Microrna rt-pcr quantification\ntotal rna was extracted from Liver samples using the trizol Reagent (invitrogen) and subsequently purified with the rnase-free dnase kit (promega) according to the manufacturer׳s instructions.']	N/A	N/A	[('SO_0000383', 'MicF_RNA', 0, 'MicroRNA'), ('UBERON_0002107', 'liver', 60, 'liver'), ('CHEBI_33893', 'reagent', 91, 'reagent')]
PMC4683322	11/2015	S38-PMC4683322	['as shown intable 2, among the 4 Mirnas targeting gr, Mir-124A, which has been identified to target gr 3′Utr[2],[3], was significantly higher Expression in the Liver of betaine-exposed piglets, compared to that of control group.']	N/A	N/A	[('SO_0000276', 'miRNA', 32, 'miRNAs'), ('PR_000001443', 'cadherin-2', 53, 'miR-124a'), ('SO_0000205', 'three_prime_UTR', 102, '3′UTR'), ('GO_0010467', 'gene expression', 141, 'expression'), ('UBERON_0002107', 'liver', 159, 'liver')]
PMC4690060	12/2015	S69-PMC4690060	['Liver, Brain, Heart, Left and Right Kidney weights of offspring, which were culled at Birth and at the end of Lactation, were measured (table 2).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000955', 'brain', 7, 'brain'), ('UBERON_0000948', 'heart', 14, 'heart'), ('UBERON_0002079', 'left cardiac atrium', 21, 'left ...'), ('UBERON_0004539', 'right kidney', 30, 'right kidney'), ('GO_0007567', 'parturition', 86, 'birth'), ('GO_0007595', 'lactation', 110, 'lactation')]
PMC4728639	1/2016	S4-PMC4728639	['at day 20 of Gestation, maternal Plasma, Liver, Adipose Tissue, and Placenta Fa profiles were determined.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 13, 'gestation'), ('UBERON_0001969', 'blood plasma', 33, 'plasma'), ('UBERON_0002107', 'liver', 41, 'liver'), ('UBERON_0001013', 'adipose tissue', 48, 'adipose tissue'), ('UBERON_0001987', 'placenta', 68, 'placenta'), ('CHEBI_30751', 'formic acid', 77, 'FA')]
PMC4728639	1/2016	S53-PMC4728639	['after the last Blood collection (e20), mothers were maintained under anesthesia and whole Liver, lumbar adipose tissue, and Placenta were collected and stored at −80 °c until analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 15, 'blood'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0001987', 'placenta', 124, 'placenta')]
PMC4728639	1/2016	S128-PMC4728639	['Hepatic la proportions were also reduced in hf2 mothers compared to control mothers (figure 5).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic')]
PMC4728639	1/2016	S135-PMC4728639	['caption (fig): figure 5\n\nHepatic Fatty Acids (g/100 g Fatty Acids).']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'Hepatic'), ('CHEBI_35366', 'fatty acid', 33, 'fatty acids'), ('CHEBI_35366', 'fatty acid', 54, 'fatty acids')]
PMC4728639	1/2016	S150-PMC4728639	['the main fate of Plasma nefa is the Liver [17,18] for partial re-esterification in the Synthesis Of Tag which are released back into the circulation, and this pathway is also known to be enhanced in late Pregnancy in the Rat [19,20].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 17, 'plasma'), ('UBERON_0002107', 'liver', 36, 'liver'), ('GO_0034205', 'amyloid-beta formation', 87, 'synthesis of TAG'), ('CHEBI_17855', 'triglyceride', 100, 'TAG'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 221, 'rat')]
PMC4728639	1/2016	S160-PMC4728639	['a different scenario presents with the proportion of la in the Liver which was decreased near-term virtually in all the Rats (apart from hf1 mothers) maintained on the hfd for any of the three weeks of Gestation.']	N/A	N/A	[('UBERON_0002107', 'liver', 63, 'liver'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 120, 'rats'), ('GO_0007565', 'female pregnancy', 202, 'gestation')]
PMC4728639	1/2016	S161-PMC4728639	['however, the main Pufa derived from la, aa, did not differ amongst the groups in either Plasma or Liver.']	N/A	N/A	[('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 18, 'PUFA'), ('UBERON_0001969', 'blood plasma', 88, 'plasma'), ('UBERON_0002107', 'liver', 98, 'liver')]
PMC4728639	1/2016	S181-PMC4728639	['the reduced Dha in mothers maintained on a hfd for the third week of Gestation or throughout Gestation in the Plasma, Liver, Adipose Tissue, and Placenta may predispose their offspring to Metabolic disease.']	N/A	N/A	[('CHEBI_17874', 'dihydrozeatin', 12, 'DHA'), ('GO_0007565', 'female pregnancy', 69, 'gestation'), ('GO_0007565', 'female pregnancy', 93, 'gestation'), ('UBERON_0001969', 'blood plasma', 110, 'plasma'), ('UBERON_0002107', 'liver', 118, 'liver'), ('UBERON_0001013', 'adipose tissue', 125, 'adipose tissue'), ('UBERON_0001987', 'placenta', 145, 'placenta'), ('GO_0008152', 'metabolic process', 188, 'metabolic')]
PMC4728639	1/2016	S196-PMC4728639	['conclusions\nmothers maintained on a hfd for the final week of Gestation or throughout Gestation had reduced Dha in Plasma, Liver, Adipose Tissue, and Placenta.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 62, 'gestation'), ('GO_0007565', 'female pregnancy', 86, 'gestation'), ('CHEBI_17874', 'dihydrozeatin', 108, 'DHA'), ('UBERON_0001969', 'blood plasma', 115, 'plasma'), ('UBERON_0002107', 'liver', 123, 'liver'), ('UBERON_0001013', 'adipose tissue', 130, 'adipose tissue'), ('UBERON_0001987', 'placenta', 150, 'placenta')]
PMC4728659	1/2016	S67-PMC4728659	['the Stomach, Small Intestine, Cecum, Colon and Liver were measured and a sample of each was snap frozen in liquid nitrogen and stored at −80 °c.']	N/A	N/A	[('UBERON_0000945', 'stomach', 4, 'stomach'), ('UBERON_0002108', 'small intestine', 13, 'small intestine'), ('UBERON_0001153', 'caecum', 30, 'cecum'), ('UBERON_0001155', 'colon', 37, 'colon'), ('UBERON_0002107', 'liver', 47, 'liver')]
PMC4728659	1/2016	S75-PMC4728659	['Hepatic Triglyceride analysis\nTriglyceride content of the Liver was quantified using 25 mg of Tissue according to the manufacturer guidelines of the gpo Reagent set (pointe scientific inc., lincoln park, mi, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_17855', 'triglyceride', 8, 'Triglyceride'), ('CHEBI_17855', 'triglyceride', 30, 'Triglyceride'), ('UBERON_0002107', 'liver', 58, 'liver'), ('UBERON_0000479', 'tissue', 94, 'tissue'), ('CHEBI_33893', 'reagent', 153, 'reagent')]
PMC4728659	1/2016	S77-PMC4728659	['rna extraction and real-time pcr\ntotal rna was extracted from the Liver using trizol Reagent (invitrogen, carlsbad, ca, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 66, 'liver'), ('CHEBI_33893', 'reagent', 85, 'reagent')]
PMC4728659	1/2016	S136-PMC4728659	['Liver Triglycerides were higher in males than females, and lower in hf1 than c1 and hp1 Rats at 28 weeks of age (table 3).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_17855', 'triglyceride', 6, 'triglycerides'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 88, 'rats')]
PMC4728659	1/2016	S172-PMC4728659	['hp1 Animals in addition to having greater Hepatic Triglyceride levels also demonstrated increased Gene Expression of the Lipogenic enzymes Acetyl Co-A carboxylase (acc), Fatty Acid synthase (fas) and Sterol Regulatory Element-Binding Protein-1c (Srebp1C) in the Liver.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'animals'), ('UBERON_0002107', 'liver', 42, 'hepatic'), ('CHEBI_17855', 'triglyceride', 50, 'triglyceride'), ('GO_0010467', 'gene expression', 98, 'gene expression'), ('SO_0000704', 'gene', 98, 'gene'), ('GO_0008610', 'lipid biosynthetic process', 121, 'lipogenic'), ('CHEBI_83151', 'glycyl-AMP(1-) residue', 139, 'acetyl Co-A'), ('CHEBI_35366', 'fatty acid', 170, 'fatty acid'), ('CHEBI_15889', 'sterol', 200, 'sterol'), ('PR_000015699', 'alpha-2,8-sialyltransferase 8E', 200, 'sterol regulatory element-binding protein'), ('SO_0001861', 'sterol_regulatory_element', 200, 'sterol regulatory element'), ('GO_0065007', 'biological regulation', 207, 'regulatory'), ('PR_000015696', 'alpha-2,8-sialyltransferase 8B', 246, 'SREBP1c'), ('UBERON_0002107', 'liver', 262, 'liver')]
PMC4729160	1/2016	S36-PMC4729160	['we excluded participants with a history of Kidney disease or chronic Liver disease.']	N/A	N/A	[('UBERON_0002113', 'kidney', 43, 'kidney'), ('UBERON_0002107', 'liver', 69, 'liver')]
PMC4740094	2/2016	S5-PMC4740094	['Hepatic Gene Expression changes and the global methylation and Histone Acetylation levels were also evaluated.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010467', 'gene expression', 8, 'gene expression'), ('SO_0000704', 'gene', 8, 'gene'), ('CHEBI_15358', 'histone', 63, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 63, 'histone acetylation'), ('PR_000043452', 'core histone', 63, 'histone')]
PMC4740094	2/2016	S61-PMC4740094	["dna/rna isolation\ndna and rna were extracted from Liver Tissues using the zr-duet™ dna/rna miniprep (zymo research, irvine, ca, usa) according to the manufacturer's instructions."]	N/A	N/A	[('UBERON_0002107', 'liver', 50, 'liver'), ('UBERON_0000479', 'tissue', 56, 'tissues')]
PMC4740094	2/2016	S145-PMC4740094	['Hepatic mrna levels\nthe Expression of the Insulin Promoter Factor-1 Gene was lowest in the hfd group in comparison with the other groups in mothers (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010467', 'gene expression', 24, 'expression'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 42, 'Insulin Promoter Factor-1'), ('SO_0000167', 'promoter', 50, 'Promoter'), ('SO_0000704', 'gene', 68, 'gene')]
PMC4740094	2/2016	S149-PMC4740094	['Hepatic Glut2 Expression was lowest in the hfd and geld groups in the mothers (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 8, 'GLUT2'), ('GO_0010467', 'gene expression', 14, 'expression')]
PMC4740094	2/2016	S153-PMC4740094	['5\n\nHepatic mrna levels of Insulin Promoter Factor-1 (Ipf1) in mothers (a) and offsprings (b), and Hepatic mrna levels of Glucose transporter 2 in mothers (c) and offsprings (d).']	N/A	N/A	[('UBERON_0002107', 'liver', 3, 'Hepatic'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 26, 'insulin promoter factor-1'), ('SO_0000167', 'promoter', 34, 'promoter'), ('PR_000009020', "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase", 53, 'IPF1'), ('UBERON_0002107', 'liver', 98, 'Hepatic'), ('CHEBI_17234', 'glucose', 121, 'glucose')]
PMC4740094	2/2016	S164-PMC4740094	['6\n\nfold changes in Hepatic global Dna Methylation in mothers (a) and offspring (b).']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'hepatic'), ('GO_0006306', 'DNA methylation', 34, 'DNA methylation')]
PMC4740094	2/2016	S165-PMC4740094	['Hepatic total H3 Histone Acetylation in mothers (c) and offspring (d).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0070932', 'histone H3 deacetylation', 14, 'H3 histone acetylation'), ('PR_000027594', 'histone H3', 14, 'H3'), ('CHEBI_15358', 'histone', 17, 'histone'), ('PR_000043452', 'core histone', 17, 'histone')]
PMC4740094	2/2016	S166-PMC4740094	['Hepatic total H4 Histone Acetylation in mothers (e) and offspring (f).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0000724', 'double-strand break repair via homologous recombination', 14, 'H4'), ('PR_000027547', 'histone H2A', 14, 'H4'), ('CHEBI_15358', 'histone', 17, 'histone'), ('GO_0043974', 'histone H3-K27 acetylation', 17, 'histone acetylation'), ('PR_000043452', 'core histone', 17, 'histone')]
PMC4752899	11/2015	S79-PMC4752899	['safety outcomes included toxicity to maternal Bone Marrow, Kidney, and Liver as measured by laboratory parameters collected just before, and 24 hours after dosing, maternal seizures, immediate toxicity to the fetus as assessed by abortion (fetal demise before 20 weeks Gestation), Live Birth rate, and newborn congenital anomalies.']	N/A	N/A	[('UBERON_0002371', 'bone marrow', 46, 'bone marrow'), ('UBERON_0002113', 'kidney', 59, 'kidney'), ('UBERON_0002107', 'liver', 71, 'liver'), ('GO_0007565', 'female pregnancy', 269, 'gestation'), ('GO_0008610', 'lipid biosynthetic process', 281, 'live birth')]
PMC4754476	2/2016	S38-PMC4754476	["Pelvic ultrasound confirmed a Pregnancy at 8 weeks' Gestation."]	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Pelvic'), ('GO_0007565', 'female pregnancy', 30, 'pregnancy'), ('GO_0007565', 'female pregnancy', 52, 'gestation')]
PMC4754476	2/2016	S57-PMC4754476	["she was subsequently admitted to the hospital at 33 weeks' Gestation due to worsening hypertension (sbp, 170\u2009s\u2009mmhg) and elevated Liver enzymes."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 59, 'gestation'), ('UBERON_0002107', 'liver', 130, 'liver')]
PMC4763449	2/2016	S50-PMC4763449	['Liver function tests and Platelet counts remained within the normal range throughout the Peri-Partum Period.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CL_0000233', 'platelet', 25, 'platelet'), ('UBERON_0001789', 'outer nuclear layer of retina', 89, 'peri'), ('UBERON_0001699', 'sensory root of facial nerve', 94, 'partum period')]
PMC4764298	2/2016	S39-PMC4764298	['pe was defined as a Blood pressure greater than 140/90 mmhg on two occasions six hours apart and proteinuria greater than 2+ on dipstick or greater than 300 mg in 24 hour Urine collection, supplemented by clinical symptoms and lab test results such as hellp (hemolysis, elevated Liver enzymes, and low Platelet count), thrombocytopenia, Renal insufficiency, impaired Liver function, Pulmonary edema, Cerebral or Visual symptoms, and elevated Uric Acid levels, in the absence of proteinuria.']	N/A	N/A	[('UBERON_0000178', 'blood', 20, 'blood'), ('UBERON_0001088', 'urine', 171, 'urine'), ('UBERON_0002107', 'liver', 279, 'liver'), ('CL_0000233', 'platelet', 302, 'platelet'), ('UBERON_0002113', 'kidney', 337, 'renal'), ('UBERON_0002107', 'liver', 367, 'liver'), ('UBERON_0002048', 'lung', 383, 'pulmonary'), ('UBERON_0001893', 'telencephalon', 400, 'cerebral'), ('GO_0007601', 'visual perception', 412, 'visual'), ('CHEBI_27226', 'uric acid', 442, 'uric acid')]
PMC4811441	3/2016	S20-PMC4811441	['Pulmonary edema, eclampsia, Renal or Liver failure and stroke [3].']	N/A	N/A	[('UBERON_0002048', 'lung', 0, 'pulmonary'), ('UBERON_0002113', 'kidney', 28, 'renal'), ('UBERON_0002107', 'liver', 37, 'liver')]
PMC4825102	2/2016	S120-PMC4825102	['Mirna profile Expression was evaluated in the Livers of wild-type (c57b6/j) Mice or apoe–/– Mice Fed diets supplemented with different Polyphenols (including Quercetin, Hesperidin, naringenin, Proanthocyanidin, Caffeic Acid, Curcumin)(88,106).']	N/A	N/A	[('SO_0000276', 'miRNA', 0, 'MiRNA'), ('GO_0010467', 'gene expression', 14, 'expression'), ('UBERON_0002107', 'liver', 46, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 76, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 92, 'mice'), ('GO_0007631', 'feeding behavior', 97, 'fed'), ('CHEBI_26196', 'polyphenylpropanoid', 135, 'polyphenols'), ('CHEBI_16243', 'quercetin', 158, 'quercetin'), ('CHEBI_28304', 'heparin', 169, 'hesperidin'), ('CHEBI_26267', 'proanthocyanidin', 193, 'proanthocyanidin'), ('CHEBI_28616', 'carbamic acid', 211, 'caffeic acid'), ('CHEBI_3962', 'curcumin', 225, 'curcumin')]
PMC4825102	2/2016	S139-PMC4825102	['the activation of these pathways results in Fa Oxidation (fao) and Glucose Uptake in Skeletal muscle, and in the inhibition of Gluconeogenesis in the Liver(121).']	N/A	N/A	[('CHEBI_30751', 'formic acid', 44, 'FA'), ('GO_0019395', 'fatty acid oxidation', 44, 'FA oxidation'), ('CHEBI_17234', 'glucose', 67, 'glucose'), ('GO_0046323', 'glucose import', 67, 'glucose uptake'), ('UBERON_0004288', 'skeleton', 85, 'skeletal'), ('GO_0006094', 'gluconeogenesis', 127, 'gluconeogenesis'), ('UBERON_0002107', 'liver', 150, 'liver')]
PMC4825102	2/2016	S141-PMC4825102	['adiponectin Gene Expression, processing and secretion is up-regulated by Ppar Γ Agonist; ppar γ activation results in increased Insulin sensitivity, in Skeletal muscle and Liver, by inducing the Release of Insulin-Sensitising Adipokines including adiponectin(123).']	N/A	N/A	[('GO_0010467', 'gene expression', 12, 'gene expression'), ('SO_0000704', 'gene', 12, 'gene'), ('CHEBI_73730', 'PPARbeta/delta agonist', 73, 'PPAR γ agonist'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 73, 'PPAR'), ('PR_000045358', 'insulin family protein', 128, 'insulin'), ('UBERON_0004288', 'skeleton', 152, 'skeletal'), ('UBERON_0002107', 'liver', 172, 'liver'), ('GO_0006260', 'DNA replication', 195, 'release'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 206, 'insulin-sensitising adipokines'), ('PR_000045358', 'insulin family protein', 206, 'insulin')]
PMC4848989	4/2016	S8-PMC4848989	['Liver Insulin Receptor and Adenosine Monophosphate-activated protein kinase mrna Expressions and protein levels were lower in the Dhf group.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('PR_000001365', 'interleukin-10 receptor subunit alpha', 6, 'insulin receptor'), ('CHEBI_22251', 'adenosine bisphosphate', 27, 'adenosine monophosphate'), ('GO_0010467', 'gene expression', 81, 'expressions'), ('CHEBI_42098', 'digoxigenin', 130, 'DHF')]
PMC4848989	4/2016	S10-PMC4848989	['“programming” of Liver or Epididymal Adipose Tissue resulted from Prenatal events.']	N/A	N/A	[('UBERON_0002107', 'liver', 17, 'liver'), ('UBERON_0004360', 'cauda epididymis', 26, 'epididymal adipose tissue'), ('GO_0007565', 'female pregnancy', 66, 'prenatal')]
PMC4848989	4/2016	S56-PMC4848989	['Glucocorticoids can promote Gluconeogenesis in the Liver and decrease Glucose Uptake and Utilization in the Skeletal muscle and White Adipose Tissue.']	N/A	N/A	[('CHEBI_5439', 'Glutethimide', 0, 'Glucocorticoids'), ('GO_0006094', 'gluconeogenesis', 28, 'gluconeogenesis'), ('UBERON_0002107', 'liver', 51, 'liver'), ('CHEBI_17234', 'glucose', 70, 'glucose'), ('GO_0046323', 'glucose import', 70, 'glucose uptake'), ('GO_0008355', 'olfactory learning', 89, 'utilization'), ('UBERON_0004288', 'skeleton', 108, 'skeletal'), ('UBERON_0001347', 'white adipose tissue', 128, 'white adipose tissue')]
PMC4848989	4/2016	S57-PMC4848989	['excess Glucocorticoid exposure causes hyperglycemia by inducing Gluconeogenic enzyme Genes in the Liver.']	N/A	N/A	[('CHEBI_24261', 'glucocorticoid', 7, 'glucocorticoid'), ('GO_0006094', 'gluconeogenesis', 64, 'gluconeogenic'), ('SO_0000704', 'gene', 85, 'genes'), ('UBERON_0002107', 'liver', 98, 'liver')]
PMC4848989	4/2016	S62-PMC4848989	['[16] reported that after maternal injection with Dexamethasone, offspring showed higher Phosphoenolpyruvate carboxykinase activity in the Liver than in controls both at Birth and weanlings.']	N/A	N/A	[('CHEBI_41879', 'dexamethasone', 49, 'dexamethasone'), ('CHEBI_18021', 'phosphoenolpyruvate', 88, 'phosphoenolpyruvate'), ('UBERON_0002107', 'liver', 138, 'liver'), ('GO_0007567', 'parturition', 169, 'birth')]
PMC4848989	4/2016	S75-PMC4848989	['the Expression of Adiponectin in the Liver is downregulated in morbidly obese patients with non-alcoholic steatohepatitis compared to that in patients with simple steatosis [22].']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'expression'), ('PR_000004104', 'AP-3 complex subunit beta-1', 18, 'adiponectin'), ('UBERON_0002107', 'liver', 37, 'liver')]
PMC4848989	4/2016	S79-PMC4848989	['next, we observed increased Igf-1 mrna levels in the Liver of the dhf group than in the vhf group and increased Igf1-r mrna Expression in the Gastrocnemius Muscle in the Dhf group compared to that in the other three groups.']	N/A	N/A	[('PR_000008929', 'interferon-related developmental regulator 1', 28, 'IGF-1'), ('UBERON_0002107', 'liver', 53, 'liver'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 112, 'IGF1'), ('GO_0010467', 'gene expression', 124, 'expression'), ('UBERON_0001388', 'gastrocnemius', 142, 'gastrocnemius muscle'), ('CHEBI_42098', 'digoxigenin', 170, 'DHF')]
PMC4848989	4/2016	S80-PMC4848989	['Igf-1 Gene Expression was reported to be downregulated in Liver Tissues and progressively decreased with the severity and duration of diabetic state [23].']	N/A	N/A	[('PR_000008929', 'interferon-related developmental regulator 1', 0, 'IGF-1'), ('GO_0010467', 'gene expression', 6, 'gene expression'), ('SO_0000704', 'gene', 6, 'gene'), ('UBERON_0002107', 'liver', 58, 'liver'), ('UBERON_0000479', 'tissue', 64, 'tissues')]
PMC4848989	4/2016	S97-PMC4848989	['in addition, Insulin Signaling is required for Insulin to act both, directly and indirectly, on Hepatic Glucose Production.']	N/A	N/A	[('GO_0031129', 'inductive cell-cell signaling', 13, 'insulin signaling'), ('PR_000045358', 'insulin family protein', 13, 'insulin'), ('PR_000045358', 'insulin family protein', 47, 'insulin'), ('UBERON_0002107', 'liver', 96, 'hepatic'), ('CHEBI_17234', 'glucose', 104, 'glucose'), ('GO_0006094', 'gluconeogenesis', 104, 'glucose production')]
PMC4848989	4/2016	S98-PMC4848989	['lower Liver ir was also observed in the Dhf group.']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('CHEBI_42098', 'digoxigenin', 40, 'DHF')]
PMC4865387	5/2016	S81-PMC4865387	['these women display worsened Insulin resistance in Skeletal muscle (75), Liver, and Adipose Tissue (2,3,76,77) by the third trimester.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 29, 'insulin'), ('UBERON_0004288', 'skeleton', 51, 'skeletal'), ('UBERON_0002107', 'liver', 73, 'liver'), ('UBERON_0001013', 'adipose tissue', 84, 'adipose tissue')]
PMC4865392	5/2016	S79-PMC4865392	['all patients in the intervention group received education from a nurse educator regarding the risk factors for gdm and general nutrition and exercise in Pregnancy, including Carbohydrate awareness and the Metabolic benefits of exercise (e.g., improvement of Glucose utilization and decrease in Hepatic Glucose output) (17).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 153, 'pregnancy'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 174, 'carbohydrate'), ('GO_0008152', 'metabolic process', 205, 'metabolic'), ('CHEBI_17234', 'glucose', 258, 'glucose'), ('UBERON_0002107', 'liver', 294, 'hepatic'), ('CHEBI_17234', 'glucose', 302, 'glucose')]
PMC4873529	3/2016	S95-PMC4873529	['both maternal and offspring Obesogenic Feeding significantly increased their Hepatic Gene Expression ( p \u2009<\u20090.05 and <0.01, respectively) (fig.']	N/A	N/A	[('GO_0001503', 'ossification', 28, 'obesogenic'), ('GO_0007631', 'feeding behavior', 39, 'feeding'), ('UBERON_0002107', 'liver', 77, 'hepatic'), ('GO_0010467', 'gene expression', 85, 'gene expression'), ('SO_0000704', 'gene', 85, 'gene')]
PMC4873529	3/2016	S97-PMC4873529	['indeed, the “double hit” of Obesogenic Feeding in mother and offspring resulted in significantly increased ob-ob Liver Atf4 and Chop messenger rna (mrna) Expressions in comparison with all other experimental groups ( p from <0.05 to <0.01 and from 157 to 217\xa0% for Atf4 and p from <0.01 to <0.001 and from 99 to 147\xa0% for Chop).']	N/A	N/A	[('GO_0001503', 'ossification', 28, 'obesogenic'), ('GO_0007631', 'feeding behavior', 39, 'feeding'), ('UBERON_0002107', 'liver', 113, 'liver'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 119, 'ATF4'), ('CHEBI_63057', 'EHNA', 128, 'CHOP'), ('PR_000005439', 'charged multivesicular body protein 5', 128, 'CHOP'), ('GO_0010467', 'gene expression', 154, 'expressions'), ('PR_000004405', 'activating transcription factor 7-interacting protein 1', 265, 'ATF4'), ('CHEBI_63057', 'EHNA', 322, 'CHOP')]
PMC4873529	3/2016	S106-PMC4873529	['finally, Hepatic Insulin Expression was increased due to obesogenic Feeding in both mother and offspring (208\xa0%, p \u2009<\u20090.05 and 491\xa0%, p \u2009<\u20090.001, respectively) (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 9, 'hepatic'), ('PR_000045358', 'insulin family protein', 17, 'insulin'), ('GO_0010467', 'gene expression', 25, 'expression'), ('GO_0007631', 'feeding behavior', 68, 'feeding')]
PMC4892656	6/2016	S95-PMC4892656	['compared to males, female Sheep had higher ( p< 0.05 for all unless otherwise stated, seetable 1ands2 table) bcs (3.2±0.05 vs. 2.8±0.05; p< 0.0001), reduced size (% of body weight) of Liver and m. Longissimus Dorsii , and increased contents (% of body weight; >2-fold higher) of all fats.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 26, 'sheep'), ('UBERON_0002107', 'liver', 184, 'liver'), ('UBERON_0001401', 'longissimus thoracis muscle', 197, 'longissimus dorsii')]
PMC4892656	6/2016	S184-PMC4892656	['the low-hchf Sheep in addition to hypercholesterolaemia also developed hyperuraemia, hypercreatinaemia and hyperlactaemia, of which the two first were indicators of alterations in Hepatic and/or Renal function.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 13, 'sheep'), ('UBERON_0002107', 'liver', 180, 'hepatic'), ('UBERON_0002113', 'kidney', 195, 'renal')]
PMC4896250	4/2016	S807-PMC4896250	['Blood chemistries, Liver and Kidney function tests, inflammatory markers (esr and crp) and Immunoglobulin levels were within the normal ranges in all patients.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002107', 'liver', 19, 'liver'), ('UBERON_0002113', 'kidney', 29, 'kidney'), ('GO_0019814', 'immunoglobulin complex', 91, 'immunoglobulin')]
PMC4896250	4/2016	S1327-PMC4896250	['co-morbidities consisted of hypertension (29.5%), Renal insufficiency (13.6%), diabetes (9.1%), dyslipidemia (5.7%), Cardiac diseases (4.5%) and Liver diseases (4.5%).']	N/A	N/A	[('UBERON_0002113', 'kidney', 50, 'renal'), ('UBERON_0000948', 'heart', 117, 'cardiac'), ('UBERON_0002107', 'liver', 145, 'liver')]
PMC4896250	4/2016	S4416-PMC4896250	['Mannose-Binding Lectin (Mbl) is a protein, which contains lectin and collagen Domains, synthesized in the Liver.']	N/A	N/A	[('CHEBI_31005', 'manninotriose', 0, 'Mannose'), ('PR_000010046', 'repressor of RNA polymerase III transcription MAF1', 0, 'Mannose-binding lectin'), ('PR_000010220', 'mannose-binding protein C', 24, 'MBL'), ('SO_0000417', 'polypeptide_domain', 78, 'domains'), ('UBERON_0002107', 'liver', 106, 'liver')]
PMC4896250	4/2016	S6356-PMC4896250	['Liver involvement is the most common Visceral manifestation.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0002075', 'viscus', 37, 'visceral')]
PMC4896250	4/2016	S6362-PMC4896250	['skin rash, fever, Eosinophilia, and elevations of Liver enzymes improved with conservative treatment and discontinuation of the causative Drugs.']	N/A	N/A	[('CL_0000771', 'eosinophil', 18, 'eosinophilia'), ('UBERON_0002107', 'liver', 50, 'liver'), ('CHEBI_23888', 'drug', 138, 'drugs')]
PMC4896250	4/2016	S6494-PMC4896250	['eosinophilia in peripheral Blood and Hepatic involvement was more frequently noted in period ii, while enlarged Lymph Nodes in period i significantly.']	N/A	N/A	[('UBERON_0000178', 'blood', 27, 'blood'), ('UBERON_0002107', 'liver', 37, 'hepatic'), ('UBERON_0000029', 'lymph node', 112, 'lymph nodes')]
PMC4896250	4/2016	S7479-PMC4896250	['from the laboratory examination, there were anaemia, with a small increased of the Erythrocyte sedimentation rate (esr), but C-Reactive Protein (Crp), Liver and Kidney function were within normal limits.']	N/A	N/A	[('CL_0000232', 'erythrocyte', 83, 'erythrocyte'), ('PR_000005890', 'crooked neck-like protein 1', 125, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 145, 'CRP'), ('UBERON_0002107', 'liver', 151, 'liver'), ('UBERON_0002113', 'kidney', 161, 'kidney')]
PMC4903143	5/2016	S51-PMC4903143	['the fetal Liver is immature and incapable of efficient Detoxification of contaminants.']	N/A	N/A	[('UBERON_0002107', 'liver', 10, 'liver'), ('GO_0098754', 'detoxification', 55, 'detoxification')]
PMC4905827	1/2016	S1-PMC4905827	['233 Animals were diagnosed with a fl, based on fat deposition of >10% into the Hepatic Parenchyma obtained from Liver biopsy, and were eventually cured of the fl.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 4, 'animals'), ('UBERON_0001280', 'liver parenchyma', 79, 'hepatic parenchyma'), ('UBERON_0002107', 'liver', 112, 'liver')]
PMC4905827	1/2016	S2-PMC4905827	['these 233 Animals were classified into mild group (n=99: Hepatic fat deposition rates ranging from 10 to <30%), moderate group (n=56: Hepatic fat deposition rates ranging from 30 to <60%) and severe group (n=78: Hepatic fat deposition rates of >60%).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 10, 'animals'), ('UBERON_0002107', 'liver', 57, 'hepatic'), ('UBERON_0002107', 'liver', 134, 'hepatic'), ('UBERON_0002107', 'liver', 212, 'hepatic')]
PMC4905827	1/2016	S8-PMC4905827	['in a Perinatal neb state, the Liver Triglyceride (tg) and Blood free Fatty Acid (nefa) levels increase [19,26] to compensate for the insufficient energy by degrading the fat accumulated in Adipose Tissues and mobilizing it to the Liver.']	N/A	N/A	[('GO_0036268', 'swimming', 5, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 5, 'perinatal'), ('UBERON_0002107', 'liver', 30, 'liver'), ('CHEBI_17855', 'triglyceride', 36, 'triglyceride'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_35366', 'fatty acid', 69, 'fatty acid'), ('UBERON_0001013', 'adipose tissue', 189, 'adipose tissues'), ('UBERON_0002107', 'liver', 230, 'liver')]
PMC4905827	1/2016	S14-PMC4905827	['based on the amount of fat deposited, the condition of the Liver can be categorized as normal (mild), moderate or severe fl.']	N/A	N/A	[('UBERON_0002107', 'liver', 59, 'liver')]
PMC4905827	1/2016	S20-PMC4905827	['these Animals were then examined for the presence of a fl and its severity by Liver biopsy, for which the specimens were blindly collected using a puncture device for cattle Liver (fujihira co., tokyo, japan).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 6, 'animals'), ('UBERON_0002107', 'liver', 78, 'liver'), ('UBERON_0002107', 'liver', 174, 'liver')]
PMC4905827	1/2016	S22-PMC4905827	['these Animals were divided into four groups based on the severity of the fl as follows: no-fl group (n=133) had Hepatic fat deposition rates of <10%; mild fl group (n=99) had Hepatic fat deposition rates ranging from 10 to <30%; moderate fl group (n=56) had Hepatic fat deposition rates ranging from 30 to <60%; and severe fl group (n=78) had Hepatic fat deposition rates of >60% [6].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 6, 'animals'), ('UBERON_0002107', 'liver', 112, 'hepatic'), ('UBERON_0002107', 'liver', 175, 'hepatic'), ('UBERON_0002107', 'liver', 258, 'hepatic'), ('UBERON_0002107', 'liver', 343, 'hepatic')]
PMC4905827	1/2016	S25-PMC4905827	['systemic diseases, including Liver disorders, mastitis, displacement of the Abomasums, Uterine diseases and others, were recorded in 49.5% (49/99) of the mild fl cases, 57.2% (32/56) of the moderate fl cases and 57.7% (45/78) of the severe fl cases.']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver'), ('UBERON_0007358', 'abomasum', 76, 'abomasums'), ('UBERON_0000995', 'uterus', 87, 'uterine')]
PMC4905827	1/2016	S46-PMC4905827	['case information in three severity groups of fatty Liversmild (n=99)moderate (n=56)severe (n=78)age (years)5.3 ± 0.44.8 ± 0.45.2 ± 0.5number of parities (times)3.4 ± 0.43.4 ± 0.43.4 ± 0.3body weight (kg)658.2 ± 14.3636.2 ± 20.2670.1 ± 22.3interval between Deliveries (days)437.4 ± 23.7416.7 ± 20.3455.4 ± 21.3postpartum day on first onset of Ketosis (days)9.7 ± 2.75.2 ± 2.69.2 ± 3.0frequency of treatment (days)9.0 ± 0.910.5 ± 1.212.9 ± 1.6duration of cure (days)11.5 ± 1.512.3 ± 1.215.9 ± 2.0\nfatty Liver has been categorized into three classes: a mild fatty Liver (mild) with a fat deposition rate of 10–30%; moderate fatty Liver (moderate) with a fat deposition rate of 30–60%; and severe fatty Liver (severe) with a fat deposition rate of 60% or more.).']	N/A	N/A	[('UBERON_0001173', 'biliary tree', 51, 'liversMild'), ('GO_0007567', 'parturition', 256, 'deliveries'), ('GO_0001818', 'negative regulation of cytokine production', 342, 'ketosis'), ('UBERON_0002107', 'liver', 501, 'liver'), ('UBERON_0002107', 'liver', 561, 'liver'), ('UBERON_0002107', 'liver', 627, 'liver'), ('UBERON_0002107', 'liver', 699, 'liver')]
PMC4905827	1/2016	S48-PMC4905827	['Blood chemistry in three severity groups of fatty Liversmild (n=12)moderate (n=20)severe (n=28)bun (mg/d l )13.5 ± 2.113.2 ± 1.113.1 ± 0.6ast (iu/ l )114.3 ± 12.3171.4 ± 21.2135.5 ± 21.4Alt (iu/ l )15.5 ± 2.320.2 ± 3.416.2 ± 1.6alp (u/ l )4.6 ± 0.65.1 ± 0.65.3 ± 0.6γ-gtp (u/ l )28.8 ± 3.622.1 ± 2.350.0 ± 13.5t-Bili (mg/d l )0.8 ± 0.20.8 ± 0.10.8 ± 0.1glu (mg/d l )72.7 ± 8.5a)50.2 ± 3.5b)49.2 ± 3.1b)Tg (mg/d l )18.1 ± 3.218.8 ± 1.328.0 ± 6.6nefa ( µ eq/ l )1,005.5 ± 141.9a)1,047.5 ± 88.9a)1,428.5 ± 108.7b)t-Cho (mg/d l )127.8 ± 23.789.1 ± 8.199.7 ± 10.9tp (g/m l )8.3 ± 0.47.7 ± 0.27.7 ± 0.2\nfatty Liver has been categorized into three classes: a mild fatty Liver (mild) with a fat deposition rate of 10–30%; moderate fatty Liver (moderate) with a fat deposition rate of 30–60%; and severe fatty Liver (severe) with a fat deposition rate of 60% or more.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0001173', 'biliary tree', 50, 'liversMild'), ('UBERON_0001464', 'hip', 185, '4ALT'), ('CHEBI_17097', 'biphenyl', 312, 'Bili'), ('CHEBI_17855', 'triglyceride', 402, 'TG'), ('CHEBI_33290', 'food', 512, 'Cho'), ('UBERON_0002107', 'liver', 603, 'liver'), ('UBERON_0002107', 'liver', 663, 'liver'), ('UBERON_0002107', 'liver', 729, 'liver'), ('UBERON_0002107', 'liver', 801, 'liver')]
PMC4905827	1/2016	S55-PMC4905827	['rate of culling and secondary Ovarian diseases in the three groups of Cows with fatty Livermild (n=99)moderate (n=56)severe (n=78)c group1)rate of culling (%)3)53.1 (26/49)**a)75.0 (24/32)**b)88.9 (40/45)*b)nc group2)Ovulation failure (%)8.0 (4/50)25.0 (6/24)30.3 (10/33)follicular cyst (%)6.0 (3/50)25.0 (6/24)27.3 (9/33)subestrus (%)14.0 (7/50)12.5 (3/24)21.2 (7/33)Ovarian Quiescence (%)8.0 (4/50)16.7 (4/24)18.2 (6/33)retained Corpus Luteum (%)4.0 (2/50)8.3 (2/24)15.2 (5/33)total Ovarian diseases (%)40.0 (20/50)a)58.3 (14/24)4) a)84.9 (28/33)5) b)rate of culling (%)10.0 (5/50)a)37.5 (9/24)b)69.7 (23/33)c)\nfatty Liver has been categorized into three classes: a mild fatty Liver (mild) with a fat deposition rate of 10–30%; moderate fatty Liver (moderate) with a fat deposition rate of 30–60%; and severe fatty Liver (severe) with a fat deposition rate of 60% or more.']	N/A	N/A	[('UBERON_0000992', 'ovary', 30, 'ovarian'), ('NCBITaxon_33208', 'Metazoa', 70, 'cows'), ('UBERON_0008836', 'liver bud', 86, 'liverMild'), ('GO_0030728', 'ovulation', 217, 'Ovulation'), ('GO_0007601', 'visual perception', 368, 'Ovarian'), ('UBERON_0000992', 'ovary', 368, 'Ovarian'), ('GO_0090444', 'regulation of nematode larval development, heterochronic', 376, 'quiescence'), ('UBERON_0002512', 'corpus luteum', 431, 'corpus luteum'), ('UBERON_0000992', 'ovary', 485, 'ovarian'), ('UBERON_0002107', 'liver', 619, 'liver'), ('UBERON_0002107', 'liver', 679, 'liver'), ('UBERON_0002107', 'liver', 745, 'liver'), ('UBERON_0002107', 'liver', 817, 'liver')]
PMC4905827	1/2016	S56-PMC4905827	['1) the c group included the Cows that developed secondary systemic diseases, such as Liver disorders, mastitis, displacement of the Abomasums and Uterine diseases; 2) the nc group included the Cows that did not develop systemic diseases; 3) includes cases of death too; *and **: asterisks indicate statistically significant differences between the rates of culling of groups c and nc ( p<0.05 and p<0.01, respectively); 4) of the 14 Cow (21 episodes in total) developed Ovarian disease; 5) of the 28 Cow (37 episodes in total) developed Ovarian disease; a, b, c) the rates with different superscripts in each row are significantly different ( p<0.05 or p<0.01).).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 28, 'cows'), ('UBERON_0002107', 'liver', 85, 'liver'), ('UBERON_0007358', 'abomasum', 132, 'abomasums'), ('UBERON_0000995', 'uterus', 146, 'uterine'), ('NCBITaxon_33208', 'Metazoa', 193, 'cows'), ('NCBITaxon_33208', 'Metazoa', 433, 'cow'), ('UBERON_0000992', 'ovary', 470, 'ovarian'), ('NCBITaxon_33208', 'Metazoa', 500, 'cow'), ('UBERON_0000992', 'ovary', 537, 'ovarian')]
PMC4905827	1/2016	S64-PMC4905827	['discussion\nthe Liver biopsy of 366 Cows diagnosed with Ketosis after calving revealed that >10% fat was deposited within the Livers of more than half of the Cows (233 Cows, 63.7%).']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'liver'), ('NCBITaxon_33208', 'Metazoa', 35, 'cows'), ('GO_0001818', 'negative regulation of cytokine production', 55, 'ketosis'), ('UBERON_0002107', 'liver', 125, 'livers'), ('NCBITaxon_33208', 'Metazoa', 157, 'cows'), ('NCBITaxon_33208', 'Metazoa', 167, 'cows')]
PMC4905827	1/2016	S91-PMC4905827	['the Igf-1 is mainly produced in the Liver, and, apart from the other Tissues, its receptors are also present in the follicles and the corpus Luteum [16,43].']	N/A	N/A	[('PR_000008929', 'interferon-related developmental regulator 1', 4, 'IGF-1'), ('UBERON_0002107', 'liver', 36, 'liver'), ('UBERON_0000479', 'tissue', 69, 'tissues'), ('UBERON_0007365', 'rumen', 141, 'luteum')]
PMC4905827	1/2016	S101-PMC4905827	['the Liver fat content can then be used to identify the stage of the Fl, which enables the distinction between several risk groups.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('UBERON_0004288', 'skeleton', 68, 'FL')]
PMC4910734	6/2015	S47-PMC4910734	['endogenous Aldehydes involved in alcoholism\nas shown infigure 2, the Liver forms of adh convert Ethanol into a toxic Acetaldehyde intermediate, and subsequently, aldh2 converts the toxic Acetaldehyde into a Water-soluble, nontoxic Acid, which is Excreted in the Urine.']	N/A	N/A	[('CHEBI_17478', 'aldehyde', 11, 'aldehydes'), ('UBERON_0002107', 'liver', 69, 'liver'), ('CHEBI_16236', 'ethanol', 96, 'ethanol'), ('CHEBI_15343', 'acetaldehyde', 117, 'acetaldehyde'), ('CHEBI_15343', 'acetaldehyde', 187, 'acetaldehyde'), ('CHEBI_15377', 'water', 207, 'water'), ('CHEBI_37527', 'acid', 231, 'acid'), ('GO_0007588', 'excretion', 246, 'excreted'), ('UBERON_0001088', 'urine', 262, 'urine')]
PMC4910734	6/2015	S246-PMC4910734	['finally, the dietary reference intake for Retinol, in the form of mercury-free cod Liver oil that also includes essential Fatty Acids and Vitamin D, should be included for most.']	N/A	N/A	[('CHEBI_26536', 'retinoic acid', 42, 'retinol'), ('UBERON_0002107', 'liver', 83, 'liver'), ('CHEBI_35366', 'fatty acid', 122, 'fatty acids'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
PMC4930210	7/2016	S130-PMC4930210	['there are few natural sources of Vitamin D in the Food supply: primarily fatty fish, beef Liver, and Egg Yolk [7].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_33290', 'food', 50, 'food'), ('UBERON_0002107', 'liver', 90, 'liver'), ('UBERON_0007378', 'egg yolk', 101, 'egg yolk')]
PMC4934634	11/2015	S26-PMC4934634	['previtamin D3Isomerizes into Vitamin D3(Cholecalciferol) and is subsequently Metabolized by 25-Hydroxylase (Cyp2R1) to 25-Hydroxyvitamin D3(25(Oh)D) in the Liver.']	N/A	N/A	[('CHEBI_47858', '1-piperideine', 11, 'D3isomerizes'), ('PR_000022471', 'transcriptional regulatory protein DpiA', 11, 'D3isomerizes'), ('CHEBI_33279', 'vitamin D5', 29, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 29, 'vitamin D3'), ('CHEBI_52550', 'theopalauamide', 40, 'cholecalciferol'), ('GO_0008152', 'metabolic process', 77, 'metabolized'), ('CHEBI_24689', 'hydroxycinnamic acid', 95, 'hydroxylase'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 108, 'CYP2R1'), ('CHEBI_63991', '15-epi-lipoxin B4', 119, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 137, 'D3'), ('CHEBI_71657', 'versiconol acetate', 140, '25(OH)D'), ('UBERON_0002107', 'liver', 156, 'liver')]
PMC4939564	8/2015	S121-PMC4939564	['Oxidation Of Fatty Acids generates Ketones that can be used as fuel by Skeletal and Cardiac Muscle, Liver, Kidney, and Adipose Tissue, thus sparing Glucose for continued utilization by Brain and Erythrocytes [64].']	N/A	N/A	[('GO_0035193', 'larval central nervous system remodeling', 0, 'Oxidation of fatty acids'), ('CHEBI_35366', 'fatty acid', 13, 'fatty acids'), ('CHEBI_17087', 'ketone', 35, 'ketones'), ('UBERON_0001442', 'skeleton of manus', 71, 'skeletal ...'), ('UBERON_0001133', 'cardiac muscle tissue', 84, 'cardiac muscle'), ('UBERON_0002107', 'liver', 100, 'liver'), ('UBERON_0002113', 'kidney', 107, 'kidney'), ('UBERON_0001013', 'adipose tissue', 119, 'adipose tissue'), ('CHEBI_17234', 'glucose', 148, 'glucose'), ('UBERON_0000955', 'brain', 185, 'brain'), ('CL_0000232', 'erythrocyte', 195, 'erythrocytes')]
PMC4944244	7/2016	S38-PMC4944244	['the exclusion criteria were mothers with pre-existing type i or type ii diabetes, pre-existing hypertension, pre-existing Parathyroid disease or uncontrolled Thyroid disease, rheumatoid arthritis, Metabolic bone disease, malabsorption, Kidney disease, Liver disease or treatment with Antiepileptic Drugs or Antituberculous.']	N/A	N/A	[('UBERON_0001132', 'parathyroid gland', 122, 'parathyroid'), ('UBERON_0002046', 'thyroid gland', 158, 'thyroid'), ('GO_0008152', 'metabolic process', 197, 'metabolic'), ('UBERON_0002113', 'kidney', 236, 'kidney'), ('UBERON_0002107', 'liver', 252, 'liver'), ('CHEBI_35473', 'tranquilizing drug', 284, 'antiepileptic drugs'), ('CHEBI_35494', 'D-cystine', 307, 'antituberculous')]
PMC4975560	7/2016	S34-PMC4975560	['a total of 3.5% of the women who had serious non-obstetric problems (e.g., lupus, type 1 or 2 diabetes, seizure disorders, malignancies, acute or chronic Liver disease, Drug or alcohol abuse and psychiatric problems) were not eligible.']	N/A	N/A	[('UBERON_0002107', 'liver', 154, 'liver'), ('CHEBI_23888', 'drug', 169, 'drug')]
PMC4975765	1/2016	S13-PMC4975765	['apart from main synthesis in the Liver, Hepcidin messenger rna (mrna) is also Expressed in the Lung, Heart, Brain, and Placenta Tissue.']	N/A	N/A	[('UBERON_0002107', 'liver', 33, 'liver'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 40, 'hepcidin'), ('GO_0010467', 'gene expression', 78, 'expressed'), ('UBERON_0002048', 'lung', 95, 'lung'), ('UBERON_0000948', 'heart', 101, 'heart'), ('UBERON_0000955', 'brain', 108, 'brain'), ('UBERON_0001987', 'placenta', 119, 'placenta'), ('UBERON_0000479', 'tissue', 128, 'tissue')]
PMC4975765	1/2016	S116-PMC4975765	['Animal models demonstrate that increasing Reactive Oxygen Species, especially H2O2, reduced Expression of Hepcidin mrna as well as Hepatic iron concentration [39,40].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_26523', 'reactive oxygen species', 42, 'reactive oxygen species'), ('CHEBI_16240', 'hydrogen peroxide', 78, 'H2O2'), ('GO_0010467', 'gene expression', 92, 'expression'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 106, 'hepcidin'), ('UBERON_0002107', 'liver', 131, 'hepatic')]
PMC4989298	8/2016	S339-PMC4989298	['notes on Vitamin D Metabolism\nexposure to sunlight is the main source of Vitamin D: ultraviolet b rays induce the production of Cholecalciferol (Vitamin D3) in the skin, and it is then hydroxylated to 25-Hydroxyvitamin D3 (25 [Oh] D) in the Liver.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0008152', 'metabolic process', 19, 'metabolism'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 128, 'cholecalciferol'), ('CHEBI_33279', 'vitamin D5', 145, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 145, 'vitamin D3'), ('CHEBI_63991', '15-epi-lipoxin B4', 201, '25-hydroxyvitamin D3'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 223, '25 [OH] D'), ('UBERON_0002107', 'liver', 241, 'liver')]
PMC4992225	8/2016	S33-PMC4992225	['following the first Hydroxylation in the Liver, 25-Hydroxyvitamin D is produced.']	N/A	N/A	[('GO_0044444', 'cytoplasmic part', 20, 'hydroxylation'), ('UBERON_0002107', 'liver', 41, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 48, '25-hydroxyvitamin D')]
PMC4993554	8/2016	S103-PMC4993554	['the majority of women (62%, n=248) did not identify Liver as a high source of Vitamin A, among a list including cheese and sweet potato.']	N/A	N/A	[('UBERON_0002107', 'liver', 52, 'liver'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin A')]
PMC4995781	8/2016	S5-PMC4995781	['the Fatty Acid composition of Phospholipids was determined in samples of Liver and two Skeletal Muscles (Soleus and red Quadriceps).']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 4, 'fatty acid'), ('CHEBI_16247', 'phospholipid', 30, 'phospholipids'), ('UBERON_0002107', 'liver', 73, 'liver'), ('UBERON_0004833', 'lip skeletal muscle', 87, 'skeletal muscles'), ('UBERON_0001389', 'soleus muscle', 105, 'soleus'), ('UBERON_0001377', 'quadriceps femoris', 120, 'quadriceps')]
PMC4995781	8/2016	S47-PMC4995781	['samples of Skeletal muscle and Liver were snap frozen and stored at -80\xa0°c for subsequent analysis.']	N/A	N/A	[('UBERON_0004288', 'skeleton', 11, 'skeletal'), ('UBERON_0002107', 'liver', 31, 'liver')]
PMC4995781	8/2016	S49-PMC4995781	['the extraction and derivatization of the Fatty Acids in muscle and Liver Phospholipids have been described elsewhere [18,19].']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 41, 'fatty acids'), ('UBERON_0002107', 'liver', 67, 'liver'), ('CHEBI_16247', 'phospholipid', 73, 'phospholipids')]
PMC4995781	8/2016	S55-PMC4995781	['Liver Triglycerides were analyzed as above except the dried Triglycerides were re-dissolved in 200\xa0μl of 95\xa0% (v/v) Ethanol.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_17855', 'triglyceride', 6, 'triglycerides'), ('CHEBI_17855', 'triglyceride', 60, 'triglycerides'), ('CHEBI_16236', 'ethanol', 116, 'ethanol')]
PMC4995781	8/2016	S77-PMC4995781	['caption (table-wrap): table 1\n\nbody weight and biochemical analyses ( n \u2009=\u20097–8 per group)chown-3n-6 p -valuenon-Pregnantpregnantnon-Pregnantpregnantnon-Pregnantpregnantpregnancydietinteractionbefore dietary interventions\u2003weight [g]241\u2009±\u20093242\u2009±\u20092245\u2009±\u20093242\u2009±\u20091246\u2009±\u20093246\u2009±\u20094nsnsnsafter dietary interventions\u2003weight [g]265\u2009±\u20093303\u2009±\u20095284\u2009±\u20092319\u2009±\u20094287\u2009±\u20093319\u2009±\u20092<0.001< 0.001ns\u2003fasting Glucose [mmol/l]5.78\u2009±\u20090.254.41\u2009±\u20090.126.54\u2009±\u20090.523.91\u2009±\u20090.336.83\u2009±\u20090.536.01\u2009±\u20090.34< 0.001< 0.01ns\u2003fasting Insulin [pmol/l]161\u2009±\u200926280\u2009±\u200952189\u2009±\u200936116\u2009±\u200919162\u2009±\u200928305\u2009±\u200945< 0.05ns< 0.01\u2003Ivgtt Glucose auc[min*mmol/l]a270\u2009±\u200920183\u2009±\u20096300\u2009±\u200923219\u2009±\u200912325\u2009±\u200918260\u2009±\u200912< 0.001< 0.01ns\u2003Ivgtt Insulin auc[min*nmol/l]a11.9\u2009±\u20091.427.2\u2009±\u20093.910.3\u2009±\u20090.79.4\u2009±\u20091.117.0\u2009±\u20092.718.9\u2009±\u20092.9< 0.01< 0.001< 0.01\u2003Liver Triglycerides [mmol/mg]8.30\u2009±\u20090.697.79\u2009±\u20090.566.45\u2009±\u20090.896.13\u2009±\u20090.7010.7\u2009±\u20090.898.31\u2009±\u20091.00ns< 0.001ns\naivgtt Intravenous Glucose tolerance test, auc area under the curve\n\nGlucose Homeostasis\nfasting circulating levels of Glucose and Insulin did not differ between diet groups in non-Pregnant Rats (fig.']	N/A	N/A	[('GO_0006412', 'translation', 112, 'pregnantPregnantNon'), ('GO_0006412', 'translation', 132, 'pregnantPregnantNon'), ('GO_0048206', 'vesicle targeting, cis-Golgi to rough endoplasmic reticulum', 152, 'pregnantPregnantPregnancyDietInteractionBefore'), ('CHEBI_17234', 'glucose', 383, 'glucose'), ('PR_000045358', 'insulin family protein', 489, 'insulin'), ('GO_0080088', 'spermidine hydroxycinnamate conjugate biosynthetic process', 568, 'IVGTT'), ('CHEBI_17234', 'glucose', 574, 'glucose'), ('GO_0080088', 'spermidine hydroxycinnamate conjugate biosynthetic process', 661, 'IVGTT'), ('PR_000045358', 'insulin family protein', 667, 'insulin'), ('UBERON_0002107', 'liver', 770, 'Liver'), ('CHEBI_17855', 'triglyceride', 776, 'triglycerides'), ('UBERON_0034986', 'sacral nerve plexus', 884, 'intravenous'), ('CHEBI_17234', 'glucose', 896, 'glucose'), ('CHEBI_17234', 'glucose', 946, 'Glucose'), ('GO_0043062', 'extracellular structure organization', 946, 'Glucose homeostasis'), ('CHEBI_17234', 'glucose', 996, 'glucose'), ('PR_000045358', 'insulin family protein', 1008, 'insulin'), ('GO_0007565', 'female pregnancy', 1058, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 1067, 'rats')]
PMC4995781	8/2016	S104-PMC4995781	['1\n\nMembrane Lipid composition\nthe Fatty Acid compositions of red Quadriceps and Soleus Skeletal Muscles and Liver were profiled.']	N/A	N/A	[('GO_0016020', 'membrane', 3, 'Membrane'), ('CHEBI_18059', 'lipid', 12, 'lipid'), ('CHEBI_35366', 'fatty acid', 34, 'fatty acid'), ('UBERON_0001377', 'quadriceps femoris', 65, 'quadriceps'), ('UBERON_0001134', 'skeletal muscle tissue', 80, 'soleus skeletal muscles'), ('UBERON_0002107', 'liver', 108, 'liver')]
PMC4995781	8/2016	S107-PMC4995781	['as a result, the n-3 group had a higher total n-3/n-6 ratio, and vice versa for the n-6 group (Fatty Acid profiles of muscle and Liver in individual Animal were included in additional file1: table s1).']	N/A	N/A	[('PR_000000035', 'BMP receptor type-1A', 47, '-3'), ('CHEBI_35366', 'fatty acid', 95, 'fatty acid'), ('UBERON_0002107', 'liver', 129, 'liver'), ('NCBITaxon_33208', 'Metazoa', 149, 'animal')]
PMC4995781	8/2016	S114-PMC4995781	['1\nPregnancy had no major effects on the pufas in muscle and Liver in the chow group, except a significant reduction in n-3 pufas (14.6\u2009±\u20090.5 vs 17.9\u2009±\u20090.2\xa0% for non-Pregnant; p \u2009<\u20090.001) and an almost reciprocal increase in n-6 Pufas (41.3\u2009±\u20090.6 vs 38.0\u2009±\u20090.8\xa0% for non-Pregnant; p \u2009<\u20090.001) in the Soleus Muscle.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 2, 'Pregnancy'), ('UBERON_0002107', 'liver', 60, 'liver'), ('GO_0007565', 'female pregnancy', 165, 'pregnant'), ('CHEBI_86926', 'S a S b S', 228, 'PUFAs'), ('GO_0007565', 'female pregnancy', 270, 'pregnant'), ('UBERON_0001389', 'soleus muscle', 299, 'soleus muscle')]
PMC4995781	8/2016	S127-PMC4995781	['a - c : correlations between the abundance of N-3 polyunsaturated Fatty Acids in Liver (a), red Quadriceps ( b ) and Soleus ( c ) muscle with the Insulin sensitivity index (s).']	N/A	N/A	[('CHEBI_30256', 'thiocarbonyl group', 46, 'n-3'), ('CHEBI_35366', 'fatty acid', 66, 'fatty acids'), ('UBERON_0002107', 'liver', 81, 'liver'), ('UBERON_0001377', 'quadriceps femoris', 96, 'quadriceps'), ('UBERON_0001389', 'soleus muscle', 117, 'soleus'), ('PR_000045358', 'insulin family protein', 146, 'insulin')]
PMC4995781	8/2016	S128-PMC4995781	['d - f : correlations between the abundance of N-6 polyunsaturated Fatty Acids in Liver ( d ), red Quadriceps ( e ) and Soleus ( f ) Muscles with s. Rats from all diet and Pregnancy groups were included in this analyses.']	N/A	N/A	[('CHEBI_70674', 'erythro-carolignan E', 46, 'n-'), ('CHEBI_35366', 'fatty acid', 66, 'fatty acids'), ('UBERON_0002107', 'liver', 81, 'liver'), ('UBERON_0001377', 'quadriceps femoris', 98, 'quadriceps'), ('UBERON_0001389', 'soleus muscle', 119, 'soleus'), ('UBERON_0005090', 'muscle structure', 132, 'muscles'), ('NCBITaxon_10088', 'Mus <genus>', 148, 'Rats'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
PMC4995781	8/2016	S141-PMC4995781	['correlations between the ratio of the abundance of Arachidonic and Linoleic Acids in Liver ( a ), red Quadriceps ( b ) and Soleus ( c ) Muscles with the Insulin sensitivity index.']	N/A	N/A	[('CHEBI_33282', 'antibacterial agent', 51, 'arachidonic'), ('CHEBI_25048', 'linolenic acid', 67, 'linoleic acids'), ('UBERON_0002107', 'liver', 85, 'liver'), ('UBERON_0001377', 'quadriceps femoris', 102, 'quadriceps'), ('UBERON_0001389', 'soleus muscle', 123, 'soleus'), ('UBERON_0005090', 'muscle structure', 136, 'muscles'), ('PR_000045358', 'insulin family protein', 153, 'insulin')]
PMC4995781	8/2016	S145-PMC4995781	['there was no effect of Pregnancy on Liver Triglycerides in any of the diet groups.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('UBERON_0002107', 'liver', 36, 'liver'), ('CHEBI_17855', 'triglyceride', 42, 'triglycerides')]
PMC4995781	8/2016	S181-PMC4995781	['certainly in Humans, during Pregnancy, and especially during the last Trimester, secretion of very-low-density-lipoprotein (Triglycerides) from the Liver is markedly increased [35].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 13, 'humans'), ('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 70, 'trimester'), ('CHEBI_17855', 'triglyceride', 124, 'triglycerides'), ('UBERON_0002107', 'liver', 148, 'liver')]
PMC4997411	8/2016	S57-PMC4997411	['the weight of Liver and Spleen of the offspring gilts was recorded.']	N/A	N/A	[('UBERON_0002107', 'liver', 14, 'liver'), ('UBERON_0002106', 'spleen', 24, 'spleen')]
PMC4997411	8/2016	S104-PMC4997411	['the Liver weight of the offspring was significantly reduced ( p< 0.05) in the hfd group at d160, but Spleen weight was not significantly influenced by maternal fat treatments.table 5shows that bf was significantly increased ( p< 0.05) in the hfd group ( p< 0.05) compared to the con group at d160 and upon puberty.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('UBERON_0002106', 'spleen', 101, 'spleen')]
PMC4997567	8/2016	S19-PMC4997567	['inclusion criteria\nthe cases were children between 2 - 4 years of age with history, clinical, laboratory, and radiographic findings of Vitamin D deficiency rickets causing bow Legs or Genu Varus, not receiving therapeutic doses of Vitamin D, with no history of prematurity, and not suffering any form of Renal, Liver, Cardiac, bone (excluding rickets) disease or any form of chronic infection.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('UBERON_0000978', 'leg', 176, 'legs'), ('UBERON_0004084', 'genital labium', 184, 'genu varus'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('UBERON_0002113', 'kidney', 304, 'renal'), ('UBERON_0002107', 'liver', 311, 'liver'), ('UBERON_0000948', 'heart', 318, 'cardiac')]
PMC4997567	8/2016	S21-PMC4997567	['exclusion criteria\nchildren younger than 2 years and older than 4 years of age, with no history, clinical, laboratory, and radiographic findings of Vitamin D deficiency rickets, or rachitic but with no Bow Legs or Genu varus, receiving therapeutic doses of Vitamin D, history of prematurity, and suffering any form of Renal, Liver, Cardiac, bone (excluding rickets) disease or any form of chronic infection were rejected.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('UBERON_0000160', 'intestine', 202, 'bow legs'), ('UBERON_2001304', 'vagal ganglion 3', 214, 'genu'), ('CHEBI_27300', 'vitamin D', 257, 'vitamin D'), ('UBERON_0002113', 'kidney', 318, 'renal'), ('UBERON_0002107', 'liver', 325, 'liver'), ('UBERON_0000948', 'heart', 332, 'cardiac')]
PMC4997567	8/2016	S31-PMC4997567	['1,25(Oh)2D is the product of both Liver and Renal Hydroxylation of Vitamin D3Which is the most active Metabolite of Vitamin D. its standard Serum level ranges from 20 - 60 ng/dl.']	N/A	N/A	[('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 2, '25(OH)2D'), ('UBERON_0002107', 'liver', 34, 'liver'), ('UBERON_0002113', 'kidney', 44, 'renal'), ('GO_0044444', 'cytoplasmic part', 50, 'hydroxylation'), ('CHEBI_83360', 'N-lignoceroylsphingosine-1-phosphocholine', 67, 'vitamin D3which'), ('CHEBI_39382', 'flufenoxuron', 102, 'metabolite'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0001977', 'blood serum', 140, 'serum')]
PMC5019390	9/2016	S166-PMC5019390	['d) fas activity (in mu per mg of protein) in the Liver, Epididymal (Ewat) and Inguinal (Iwat) White Adipose Tissues.']	N/A	N/A	[('UBERON_0002107', 'liver', 49, 'liver'), ('UBERON_0004360', 'cauda epididymis', 56, 'epididymal ...'), ('UBERON_0001301', 'epididymis', 68, 'eWAT ...'), ('UBERON_0008337', 'inguinal part of abdomen', 78, 'inguinal ...'), ('UBERON_0013629', 'hallical pad', 88, 'iWAT ...'), ('UBERON_0001347', 'white adipose tissue', 94, 'white adipose tissues')]
PMC5025983	8/2015	S70-PMC5025983	['upon transfer to the fetus, they bind to alpha-fetoproteins and enter the fetal Liver for the Synthesis Of Triglycerides [32].']	N/A	N/A	[('UBERON_0002107', 'liver', 80, 'liver'), ('GO_0007416', 'synapse assembly', 94, 'synthesis of triglycerides'), ('CHEBI_17855', 'triglyceride', 107, 'triglycerides')]
PMC5025983	8/2015	S117-PMC5025983	['inappropriate Metabolic and Endocrine Responses occur in Organs like Brain, Adipose Tissue, muscle, Liver, and Pancreas [14].']	N/A	N/A	[('GO_0008152', 'metabolic process', 14, 'metabolic ...'), ('GO_0006897', 'endocytosis', 28, 'endocrine responses'), ('UBERON_0000062', 'organ', 57, 'organs'), ('UBERON_0000955', 'brain', 69, 'brain'), ('UBERON_0001013', 'adipose tissue', 76, 'adipose tissue'), ('UBERON_0002107', 'liver', 100, 'liver'), ('UBERON_0001264', 'pancreas', 111, 'pancreas')]
PMC5025983	8/2015	S184-PMC5025983	['high fat maternal diet and maternal obesity cause fetal and neonatal Liver lipotoxicity [8,76].']	N/A	N/A	[('UBERON_0002107', 'liver', 69, 'liver')]
PMC5025983	8/2015	S218-PMC5025983	['in the Liver, Fatty Acids Regulate the Expression of key Lipogenic, Lipolytic and Glycolytic Genes [21].']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver'), ('CHEBI_35366', 'fatty acid', 14, 'fatty acids'), ('GO_0065007', 'biological regulation', 26, 'regulate'), ('GO_0010467', 'gene expression', 39, 'expression'), ('GO_0008610', 'lipid biosynthetic process', 57, 'lipogenic'), ('GO_0008610', 'lipid biosynthetic process', 68, 'lipolytic'), ('GO_0006096', 'glycolytic process', 82, 'glycolytic'), ('SO_0000704', 'gene', 93, 'genes')]
PMC5030620	9/2016	S230-PMC5030620	['(2009)*\u20022,3,7,8-Tetrachloro-Dibenzo- \u2002P-Dioxin (tcdd)Mouse ratinjection (ip) (50\u2009µg/kg) oral (gavage) (1\u2009µg/kg/d) in utero early Adulthood in utero Neonatal Adolescence/early \u2002Adulthood Adulthood f0-f1generations↓Gonado-tropins and Gonadal \u2002Steroid-Genesis mammary and Hepatic \u2002abnormalitieshistone modification Dna Methylation epigenetic machinery mirnaspapoutsis et\xa0al.']	N/A	N/A	[('CHEBI_34249', '2,6-dichlorobiphenyl', 8, '2,3,7,8-tetrachloro-dibenzo-  p-dioxin'), ('NCBITaxon_10088', 'Mus <genus>', 53, 'Mouse'), ('UBERON_0000113', 'post-juvenile adult stage', 129, 'adulthood'), ('GO_0007569', 'cell aging', 148, 'Neonatal'), ('GO_0044808', 'oncostatin M production', 157, 'Adolescence'), ('UBERON_0000113', 'post-juvenile adult stage', 176, 'adulthood'), ('UBERON_0000113', 'post-juvenile adult stage', 186, 'Adulthood'), ('UBERON_0000991', 'gonad', 213, 'gonado'), ('UBERON_0000991', 'gonad', 232, 'gonadal'), ('CHEBI_35341', 'steroid', 241, 'steroid'), ('SO_0000704', 'gene', 249, 'genesis'), ('UBERON_0002107', 'liver', 269, 'hepatic'), ('GO_0006306', 'DNA methylation', 312, 'DNA methylation')]
PMC5058640	11/2016	S6-PMC5058640	['adjustment for preeclampsia (464, 47.3%) did not negate the relationship between severe hypertension and the chips primary outcome ( p<0.001), Birth weight <10th percentile ( p =0.005), Delivery at <37 ( p<0.001) or <34 weeks ( p<0.001), or elevated Liver enzymes with symptoms ( p =0.02).']	N/A	N/A	[('GO_0007567', 'parturition', 143, 'birth'), ('GO_0007567', 'parturition', 186, 'delivery'), ('UBERON_0002107', 'liver', 250, 'liver')]
PMC5062906	10/2016	S9-PMC5062906	['there was no change in total Expression of Genes adjacent to methylation changes in neonatal Liver.']	N/A	N/A	[('GO_0010467', 'gene expression', 29, 'expression'), ('SO_0000704', 'gene', 43, 'genes'), ('UBERON_0002107', 'liver', 93, 'liver')]
PMC5062906	10/2016	S10-PMC5062906	['methylation changes were cell type specific such that changes at ig-dmr were present in Sperm but not in Liver.']	N/A	N/A	[('CL_0000019', 'sperm', 88, 'sperm'), ('UBERON_0002107', 'liver', 105, 'liver')]
PMC5062906	10/2016	S11-PMC5062906	['some methylation changes were distinct between generations such that methylation changes at the h19icr in second-generation Liver were not present in first-generation Sperm or Liver.']	N/A	N/A	[('UBERON_0002107', 'liver', 124, 'liver'), ('CL_0000019', 'sperm', 167, 'sperm'), ('UBERON_0002107', 'liver', 176, 'liver')]
PMC5062906	10/2016	S28-PMC5062906	['dietary Vitamin D is converted in the Liver to the inactive Metabolite 25-Hydroxyvitamin D, 25(Oh)D, before being converted in the Kidney to the active Metabolite 1,25(Oh)2D.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0002107', 'liver', 38, 'liver'), ('CHEBI_39382', 'flufenoxuron', 60, 'metabolite'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 71, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 92, '25(OH)D'), ('UBERON_0002113', 'kidney', 131, 'kidney'), ('CHEBI_39382', 'flufenoxuron', 152, 'metabolite'), ('CHEBI_66212', "5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone", 165, '25(OH)2D')]
PMC5062906	10/2016	S161-PMC5062906	['4\n\nmaternal Vitamin D deficiency perturbs Dna Methylation at Imprinted regions in Adult g1 Soma (Liver) and germline (Sperm).']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0006306', 'DNA methylation', 42, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 61, 'imprinted'), ('UBERON_0007023', 'adult organism', 82, 'adult'), ('GO_0044297', 'cell body', 91, 'soma'), ('UBERON_0002107', 'liver', 97, 'liver'), ('CL_0000019', 'sperm', 118, 'sperm')]
PMC5062906	10/2016	S164-PMC5062906	['location of lollipop and location of arrows indicates parental methylation or Expression from maternal Alleles (above Gene) and paternal Allele (below Gene); b – cbar graphs depict average Dna Methylation across samples in the respective treatment group assayed in Adult g1 Liver ( b) and Sperm ( c) for each sample analyzed (in order from left to right n \u2009=\u200910, 11, 10, 9 for all loci except Grb10 n \u2009=\u200910, 10, 9, 8 and n \u2009=\u200910, 10, 10, 9 Liver and Sperm, respectively).']	N/A	N/A	[('GO_0010467', 'gene expression', 78, 'expression'), ('SO_0001023', 'allele', 103, 'alleles'), ('SO_0000704', 'gene', 118, 'gene'), ('SO_0001023', 'allele', 137, 'allele'), ('SO_0000704', 'gene', 151, 'gene'), ('GO_0006306', 'DNA methylation', 189, 'DNA methylation'), ('UBERON_0007023', 'adult organism', 265, 'adult'), ('UBERON_0002107', 'liver', 274, 'liver'), ('CL_0000019', 'sperm', 289, 'sperm'), ('PR_000008210', 'glutathione peroxidase 1', 393, 'Grb10'), ('UBERON_0002107', 'liver', 440, 'liver'), ('CL_0000019', 'sperm', 450, 'sperm')]
PMC5062906	10/2016	S171-PMC5062906	['cross 1 lvd Liver had significantly lower methylation compared with controls at the h19/igf2 icr ( h19cbs2 , 2.63\xa0% by mean, p \u2009=\u20090.039), h19pp (0.68\xa0%, p \u2009=\u20090.035), and Grb10Dmr (6.23\xa0%, p \u2009=\u20090.004) (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 12, 'liver'), ('PR_000008211', 'glutathione peroxidase 2', 170, 'Grb10DMR')]
PMC5062906	10/2016	S176-PMC5062906	['g1adult Sperm showed fewer affected loci and smaller methylation changes compared to Liver samples.']	N/A	N/A	[('CL_0000019', 'sperm', 8, 'sperm'), ('UBERON_0002107', 'liver', 85, 'liver')]
PMC5062906	10/2016	S194-PMC5062906	['5\n\nGrandmaternal Vitamin D deficiency perturbs Dna Methylation at Imprinted regions in Adult g2male Soma (Liver) and germline (Sperm).']	N/A	N/A	[('GO_0000050', 'urea cycle', 3, 'Grandmaternal'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0006306', 'DNA methylation', 47, 'DNA methylation'), ('GO_0071514', 'genetic imprinting', 66, 'imprinted'), ('UBERON_0007023', 'adult organism', 87, 'adult'), ('GO_0044297', 'cell body', 100, 'soma'), ('UBERON_0002107', 'liver', 106, 'liver'), ('CL_0000019', 'sperm', 127, 'sperm')]
PMC5062906	10/2016	S201-PMC5062906	['not significant\n\nVitamin D-dependent epimutations are unstable in the Soma and do not reflect transcriptional state\nto determine the developmental timing of Vitamin D-dependent Dna Methylation changes in g2adult Liver, and thus investigate the mode of inheritance, we assayed Dna Methylation levels at the h19/igf2 , Dlk1/Meg3 , snrpn , and Grb10 Domains in g2neonatal (pnd9) Liver.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 17, 'Vitamin D'), ('GO_0044297', 'cell body', 70, 'soma'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('GO_0006306', 'DNA methylation', 177, 'DNA methylation'), ('UBERON_0002107', 'liver', 212, 'liver'), ('GO_0006306', 'DNA methylation', 276, 'DNA methylation'), ('PR_000006549', 'doublesex- and mab-3-related transcription factor C2', 317, 'Dlk1'), ('PR_000010229', 'membrane-bound transcription factor site-1 protease', 322, 'Meg3'), ('PR_000008210', 'glutathione peroxidase 1', 341, 'Grb10'), ('SO_0000417', 'polypeptide_domain', 347, 'domains'), ('UBERON_0002107', 'liver', 376, 'liver')]
PMC5062906	10/2016	S202-PMC5062906	['similar to g2adult Liver, g2neonatal lvd Liver samples exhibited significantly lower methylation at h19cbs4 compared with controls independently for cross 2 and when data from both crosses were combined (4.00\xa0%, p \u2009=\u20090.015, and 3.41\xa0%, p \u2009=\u20090.002, fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'liver'), ('UBERON_0002107', 'liver', 41, 'liver')]
PMC5062906	10/2016	S204-PMC5062906	['for cross 1 neonatal lvd Liver, methylation levels at Grb10Dmr were also significantly lower compared with controls (3.46\xa0%, p \u2009=\u20090.044, fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('PR_000008211', 'glutathione peroxidase 2', 54, 'Grb10DMR')]
PMC5062906	10/2016	S206-PMC5062906	['this effect at Grb10Dmr was not present in Adult Liver (fig.']	N/A	N/A	[('PR_000008211', 'glutathione peroxidase 2', 15, 'Grb10DMR'), ('UBERON_0007023', 'adult organism', 43, 'adult'), ('UBERON_0002107', 'liver', 49, 'liver')]
PMC5062906	10/2016	S220-PMC5062906	['there was no significant grandmaternal dietary effect on total mrna levels for these Imprinted Genes in g2neonatal Liver (fig.']	N/A	N/A	[('GO_0071514', 'genetic imprinting', 85, 'imprinted'), ('SO_0000704', 'gene', 95, 'genes'), ('UBERON_0002107', 'liver', 115, 'liver')]
PMC5062906	10/2016	S229-PMC5062906	['Grb10Dmr exhibited diet-dependent methylation changes in g1adult and g2neonatal Livers.']	N/A	N/A	[('PR_000008211', 'glutathione peroxidase 2', 0, 'Grb10DMR'), ('UBERON_0002107', 'liver', 80, 'livers')]
PMC5062906	10/2016	S233-PMC5062906	['therefore, we assayed relative Gene Expression of dna methyltransferases, Dnmt1 , Dnmt3A , and dnmt3b in g2neonatal Liver.']	N/A	N/A	[('GO_0010467', 'gene expression', 31, 'gene expression'), ('SO_0000704', 'gene', 31, 'gene'), ('PR_000006543', 'doublesex- and mab-3-related transcription factor 2', 74, 'Dnmt1'), ('PR_000006564', 'dynein heavy chain 5, axonemal', 82, 'Dnmt3a'), ('UBERON_0002107', 'liver', 116, 'liver')]
PMC5062906	10/2016	S286-PMC5062906	['7\n\ndiet-dependent Dna Methylation profile in Liver and Sperm of g1and g2.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 18, 'DNA methylation'), ('UBERON_0002107', 'liver', 45, 'liver'), ('CL_0000019', 'sperm', 55, 'sperm')]
PMC5062906	10/2016	S345-PMC5062906	['Dna Methylation measured by pyrosequencing\nLiver and Sperm samples were harvested immediately after euthanasia and snap-frozen in liquid nitrogen and stored at −80\xa0°c.']	N/A	N/A	[('GO_0006306', 'DNA methylation', 0, 'DNA methylation'), ('UBERON_0002107', 'liver', 43, 'Liver'), ('CL_0000019', 'sperm', 53, 'sperm')]
PMC5062906	10/2016	S357-PMC5062906	['quantitative real-time pcr (qrt-pcr)\ntotal rna was extracted from Liver using trizol Reagent according to the manufacturer’s protocol (#155960926, life technologies, ny).']	N/A	N/A	[('UBERON_0002107', 'liver', 66, 'liver'), ('CHEBI_33893', 'reagent', 85, 'reagent')]
PMC5062906	10/2016	S377-PMC5062906	['1); litter sizes at Birth and litter sizes at weaning (square root transformed) (table\xa01); body weight (log10 transformed), Testes weight, Testes weight/square root of body weight, percent fat mass (fat mass/body weight), percent lean mass (lean mass/body weight), Sperm count, Dna Methylation levels for Igf2Dmr1 , h19cbs2 , h19cbs4 , h19pp , ig-dmr , snrpn icr, and Grb10Dmr in Sperm, Adult Liver, and neonatal Liver; and Gene Expression levels for igf2 , H19 , snrpn , Grb10 , Dnmta , Dnmtb , and Dnmt1 (table\xa01, figs.']	N/A	N/A	[('GO_0007567', 'parturition', 20, 'birth'), ('UBERON_0000473', 'testis', 124, 'testes'), ('UBERON_0000473', 'testis', 139, 'testes'), ('CL_0000019', 'sperm', 265, 'sperm'), ('GO_0006306', 'DNA methylation', 278, 'DNA methylation'), ('PR_000008897', 'radiation-inducible immediate-early gene IEX-1', 305, 'Igf2DMR1'), ('PR_000008211', 'glutathione peroxidase 2', 368, 'Grb10DMR'), ('CL_0000019', 'sperm', 380, 'sperm'), ('UBERON_0007023', 'adult organism', 387, 'adult'), ('UBERON_0002107', 'liver', 393, 'liver'), ('UBERON_0002107', 'liver', 413, 'liver'), ('GO_0010467', 'gene expression', 424, 'gene expression'), ('SO_0000704', 'gene', 424, 'gene'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 458, 'H19'), ('PR_000008210', 'glutathione peroxidase 1', 472, 'Grb10'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 480, 'Dnmta'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 488, 'Dnmtb'), ('PR_000006543', 'doublesex- and mab-3-related transcription factor 2', 500, 'Dnmt1')]
PMC5070159	10/2016	S55-PMC5070159	['caption (table-wrap): table 2\n\nAbdominal ectopic case reportsauthor (year)age/parityinfertility etiologyother pertinent historypriorectopicstimulation protocolegg #et no./timingfresh/frozen etmax Hcg level (miu/ml)location (e/h)stage at diagnosisrupture?interventionoutcomeoehniger (1988) [23]35 yog0p0endometriosislaparotomy x 2, left Salpingectomy, frozen Pelvis; right Hydrosalpinx with partial obstructionnofsh/pergonal (hmg/hcg), hcg trigger4442–44 hfreshnasigmoid Mesentery (e)~41\xa0days ptnoexploratory laparotomyremoval of Pregnancy Tissue by laparotomybassil (1991) [24]33 yonamale factornanaclomid/hmg, hcg trigger64nafreshnaposterior Uterus, Broad Ligament (h)19\xa0weeks Gestationnolaparotomy, right Adnexectomydelivery of viable twins at 34\xa0weeksferland (1991) [25]32 yog4p0030des exposure, secondary infertilityright Salpingectomy, left Hydrosalpinxtubal ectopiclong protocol w/Gnrh Agonist73Day 2 etfresh19,450retroperitoneal (e)37\xa0days ptyeslaparotomy, left Salpingectomyragni (1991) [26]32 yog1p0010pelvic adhesive diseaseright Adnexectomy, hysteropexytubal ectopiclong protocol w/Gnrh Agonist43Day 2 etfreshnaright Adnexa (h)12\xa0weeks Gestationnoselective reduction of Abdominal Pregnancy, laparotomylaparotomy for resorbing Abdominal Pregnancy, sab of iup at 16\xa0weeksbalmaceda (1993) [27]33 yog3p1021tubalright Salpingectomy, left Salpingostomytubal ectopic x 2short protocol, w/Gnrh agonist154day 4 etfresh4651abdominal - Broad Ligament (E)30\xa0days ptnolaparoscopy, salpingectomylaparoscopic removal of Abdominal ectopic, left Salpingectomyfisch (1995) [28]32 yog2p0020tubalbilateral Salpingectomytubal ectopic x 2long protocol w/Gnrh Agonist53Nafreshnaileum, Left Uterine Cornua (h)10\xa0weeks Gestationyesgastrostoscopy, sigmoidoscopy, tc scan, angiography, d&c, tagged Rbc scan, laparotomylaparotomy for Abdominal ectopic, d&c for incomplete ab of iupdelrosario (1996) [29]33 yog1p1001tubalbreast cancernonana4nafrozen563bladder (e)75\xa0days ptyesmethotrexate, laparoscopylaparoscopic removal of Pregnancy Tissuefisch (1996) [11]38 yog2p0020tuballaparoscopic Salpingectomy x 2, 8th Ivf cycletubal ectopic x 2long protocol w/Gnrh agonist144day 3 etfresh1730broad Ligament (e)21\xa0days ptyesexploratory laparotomyremoval of Pregnancy Tissue by laparotomymoonen-delarue (1996) [30]23 yog2p0020pelvic adhesive diseaseright Salpingectomytubal and Abdominal ectopicnanananafreshnaabdominal - Uterine Fundus (e)28\xa0weeksplacental abruptionlaparotomyfetal demise of Abdominal ectopic @ 28\xa0weekspisarska (1998) [31]35 yog2p0020unexplainednanolong protocol w/Gnrh agonist96nafresh6004bladder Serosa (h)6\xa0weeks Gestationnodiagnostic laparoscopylaparoscopic removal of ectopic Pregnancy (Bladder), term Delivery of iupdeshpande (1999) [32]33 yog1p0010endometriosisendometriosis, left Salpingectomy, patent right Tubenolong protocol w/Gnrh agonist82day 3 etfresh55,560twin Pregnancy in Broad Ligament (h)7\xa0weeks ptnolaparotomyremoval of twin ectopic Pregnancy by laparotomy at 7\xa0weeksscheiber (1999) [33]37 yog3p0030tubal factor endometriosisdorsalpingostomy, donor Oocytestubal ectopicnana2day 3 etfrozennaabdominal (h)8.5\xa0weeks ptnokcl selective reduction of Abdominal Pregnancyselective reduction of Abdominal Pregnancy, full term viable iupdmowski (2002) [34]34 yog0p0tubalbilateral Salpingectomynolong protocol w/Gnrh agonist153day 3 etfresh38,635retroperitoneal Pancreatic (e)41\xa0days ptyeslaparotomyretroperitoneal Subpancreatic ectopic removed by laparotomyjain (2002) [35]29 yog0p0unexplainednanonana2nananapouch of douglas (h)9\xa0weeks ptnalaparotomy at 4w weeks (no iup seen), selective reduction of ectopic at 13\xa0weeksselective reduction of Abdominal ectopic, removal by laparotomy, sab of iupcormio (2003) [36]30 yog2p0020tubalbilateral Salpingectomytubal ectopic x 2menotropins, Hcg trigger74day 3 etfresh256,400omentum, Uterine Fundus (h)13\xa0weeks Gestationnolaparotomylaparotomy for Abdominal ectopic; live iup Delivered at 36\xa0weeksreid (2003) [37]28 yog5p1041tubalbilateral Salpingectomytubal ectopic x3nana3nana5500retroperitoneal, Iliac bifurcation (e)63\xa0days ptnalaparotomyremoval of ectopic via laparotomykitade (2005) [38]37 yog0p0unexplainednanolong protocol w/Gnrh Agonist123Day 3 etfresh45,896splenic and Tubal (h)34\xa0days pt (Tubal), 46\xa0day pt (Splenic)tubal - no, Splenic - yes1) laparoscopic Salpingectomy 2) exploratory laparotomyremoval of Tubal ectopic by laparoscopy, removal of Splenic ectopic by laparotomy (12\xa0days later)ali (2006) [39]35natubalpelvic adhesionsnona111nafresh1524tube with omental/Peritoneal trophoblastic Tissue (h)3\xa0weeks pt - Tubal ectopic; 5\xa0weeks pt – Omental Tissuenolaparoscopic Salpingectomy; laparocopic removal of Omental/Peritoneal Trophoblastic Tissueremoval of Tubal and Peritoneal/Omental Pregnancy Tissue by 2 laparoscopiesapantaku (2006) [40]33g3p1021tubalbilateral Salpingectomytubal ectopic x 2nana2nafreshnaright Adnexa (e)6\xa0weeks ptnolaparoscopylaparoscopic removal of Pregnancy Tissueknopman (2007) [41]37 yog4p0040unexplainednanognrh antagonist92day 5 etfresh1023posterior Cul-De-Sac (h)7\xa0weeks, nonviable iup; 9\xa0weeks ectopicyeslaparoscopyd&c for non-viable iup; laparoscopy for Abdominal ectopicshih (2007) [42]33 yog0p0male factorpatent tubesnolong protocol w/Gnrh Agonist4Nanafresh901Cul-de-Sac(e)28\xa0days ptnolaparoscopy converted to laparotomyremoval of Pregnancy Tissue by laparotomyshojai (2007) [43]35 yog0p0structural, des exposurenanonana3nananaabdominal - Uterine Fundus (h)21\xa0weeks Gestationnolaparotomydelivery of viable twins at 32\xa0weeksiwama (2008) [44]31 yog1p0010tubalright Salpingectomy for Tubal ectopic after ivf, left Salpingectomy for Hydrosalpinxtubal ectopicnana3day 3 etfresh45, 369inferior Vena Cava/Retroperitoneal (e)32\xa0days pt: pul; 53\xa0days pt: Retroperitoneal ectopicyesd&c, mtx, diagnostic laparoscopy, repeat mtx, exploratory laparotomyruptured Retroperitoneal ectopic, removed by laparotomyhyvarinen (2009) [45]nananananananananananaabdominal (e)30\xa0weeks Gestationnolaparotomydelivery of viable fetus at 30\xa0weekszacche (2011) [46]36g1p1tubalbilateral Salpingectomy, pidnonana2nafreshnaabdominal (h)32\xa0weeks at cesarean deliverynolaparotomy, hysterectomyviable twin Pregnancies at 32\xa0weeks; hysterectomyangelova (2015) [47]33namale factorobturated left tubenashort protocol, w/Gnrh antagonistna2day 3 etfreshnaabdominal - Vesicouterine junction (e)23\xa0days ptnolaparoscopylaparoscopic removal of Pregnancy Tissuedalmia (2015) [48]37g1p0010endometriosistubal factorbilateral Salpingectomy for hydrosalpinxnananananana21,730left Adnexa (e)2\xa0weeks ptnomini-laparotomyremoval of ectopic via laparotomykoyama (2015) [49]32g5p1male factornanonana1nafrozen14,800retroperitoneal (e)10\xa0weeks Gestationnalaparoscopylaparoscopic removal of Pregnancy Tissue\nabbreviations : ab Abortion, d&c dilation and curettage, des Diethylstilbestrol, e ectopic, fsh follicle Stimulating Hormone, gnrh gonadotropin-Releasing Hormone, h heterotopic, hcg Human Chorionic Gonadotropin, hmg Human menopausal gonadotropin, hsg Hysterosalpingogram, iup Intrauterine Pregnancy, ivf in vitro Fertilization, Kcl Potassium Chloride, mtx Methotrexate, na not available, pid Pelvic inflammatory disease, pt post transfer, Rbc Red Blood Cell, tc technetium, sab spontaneous Abortion\n\nresults\na total of 28 cases of Abdominal ectopic Pregnancy after Ivf were identified.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 31, 'Abdominal'), ('CHEBI_17883', 'hydrogen chloride', 196, 'HCG'), ('UBERON_0001220', 'quadratus lumborum', 336, 'salpingectomy'), ('UBERON_0002355', 'pelvic region of trunk', 358, 'pelvis'), ('UBERON_0011601', 'gingiva of upper jaw', 372, 'hydrosalpinx'), ('UBERON_0002095', 'mesentery', 470, 'mesentery'), ('GO_0007565', 'female pregnancy', 529, 'pregnancy'), ('UBERON_0000479', 'tissue', 539, 'tissue'), ('UBERON_0000995', 'uterus', 643, 'uterus'), ('UBERON_0006472', 'Brodmann (1909) area 6', 651, 'broad ligament'), ('GO_0007538', 'primary sex determination', 678, 'gestationNoLaparotomy'), ('UBERON_0007646', 'endomeninx', 707, 'adnexectomyDelivery'), ('UBERON_0001220', 'quadratus lumborum', 826, 'salpingectomy'), ('UBERON_0010896', 'piston cartilage', 846, 'hydrosalpinxTubal'), ('PR_000008293', 'glutathione synthetase', 887, 'GnRH'), ('CHEBI_35845', 'gout suppressant', 892, 'agonist73Day'), ('UBERON_0010233', 'stroma of thyroid gland', 969, 'salpingectomyRagni'), ('UBERON_0002223', 'endolymphatic sac', 1040, 'adnexectomy'), ('CHEBI_72469', 'alpha-Neup5Gc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc', 1093, 'GnRH agonist43Day'), ('PR_000008293', 'glutathione synthetase', 1093, 'GnRH'), ('UBERON_0004742', 'dentary', 1128, 'adnexa'), ('GO_0051294', 'establishment of spindle orientation', 1147, 'gestationNoSelective'), ('UBERON_0000916', 'abdomen', 1181, 'abdominal'), ('GO_0007565', 'female pregnancy', 1191, 'pregnancy'), ('UBERON_0000916', 'abdomen', 1237, 'abdominal'), ('GO_0007565', 'female pregnancy', 1247, 'pregnancy'), ('UBERON_0001220', 'quadratus lumborum', 1324, 'salpingectomy'), ('UBERON_0010749', 'middle pharyngeal constrictor', 1344, 'salpingostomyTubal'), ('PR_000008293', 'glutathione synthetase', 1392, 'GnRH'), ('UBERON_0006472', 'Brodmann (1909) area 6', 1436, 'broad ligament'), ('UBERON_0000922', 'embryo', 1452, 'E'), ('UBERON_0000916', 'abdomen', 1516, 'abdominal'), ('UBERON_2001425', 'basal plate cartilage', 1540, 'salpingectomyFisch'), ('UBERON_0010749', 'middle pharyngeal constrictor', 1597, 'salpingectomyTubal'), ('PR_000008293', 'glutathione synthetase', 1643, 'GnRH'), ('CHEBI_64432', '2-diazoniobenzoate', 1648, 'agonist53NAFreshNAIleum'), ('UBERON_0005457', 'left thymus lobe', 1673, 'left uterine cornua'), ('GO_0009873', 'ethylene-activated signaling pathway', 1705, 'gestationYesGastrostoscopy'), ('CL_0000232', 'erythrocyte', 1782, 'RBC'), ('UBERON_0000916', 'abdomen', 1817, 'abdominal'), ('GO_0007565', 'female pregnancy', 2007, 'pregnancy'), ('UBERON_0001277', 'intestinal epithelium', 2017, 'tissueFisch'), ('UBERON_0002207', 'xiphoid process', 2070, 'Salpingectomy'), ('UBERON_0001137', 'dorsum', 2093, 'IVF'), ('PR_000008293', 'glutathione synthetase', 2135, 'GnRH'), ('UBERON_0000211', 'ligament', 2173, 'Ligament'), ('GO_0007565', 'female pregnancy', 2231, 'pregnancy'), ('UBERON_0000479', 'tissue', 2241, 'tissue'), ('UBERON_0010749', 'middle pharyngeal constrictor', 2328, 'salpingectomyTubal'), ('UBERON_0000916', 'abdomen', 2351, 'abdominal'), ('UBERON_0000995', 'uterus', 2395, 'uterine'), ('UBERON_0003951', 'ocular fundus', 2403, 'fundus'), ('UBERON_0000916', 'abdomen', 2466, 'abdominal'), ('PR_000008293', 'glutathione synthetase', 2557, 'GnRH'), ('UBERON_0000043', 'tendon', 2590, 'serosa'), ('GO_0002007', 'detection of hypoxic conditions in blood by chemoreceptor signaling', 2608, 'gestationNoDiagnostic'), ('GO_0007565', 'female pregnancy', 2673, 'pregnancy'), ('UBERON_0018707', 'bladder organ', 2684, 'bladder'), ('GO_0007567', 'parturition', 2699, 'delivery'), ('UBERON_0001220', 'quadratus lumborum', 2780, 'salpingectomy'), ('UBERON_0016925', 'juxtaductal region of aortic arch', 2808, 'tubeNoLong'), ('CHEBI_63559', 'HBOA', 2830, 'GNRH'), ('GO_0007565', 'female pregnancy', 2868, 'pregnancy'), ('UBERON_0002185', 'bronchus', 2881, 'broad'), ('UBERON_0000211', 'ligament', 2887, 'ligament'), ('GO_0007565', 'female pregnancy', 2945, 'pregnancy'), ('CL_0000024', 'oogonial cell', 3061, 'oocytesTubal'), ('UBERON_0000916', 'abdomen', 3156, 'abdominal'), ('GO_0000050', 'urea cycle', 3166, 'pregnancySelective'), ('UBERON_0000916', 'abdomen', 3198, 'abdominal'), ('GO_0007565', 'female pregnancy', 3208, 'pregnancy'), ('UBERON_3000432', 'pila metoptica', 3282, 'SalpingectomyNoLong'), ('PR_000008293', 'glutathione synthetase', 3313, 'GnRH'), ('UBERON_0001264', 'pancreas', 3363, 'pancreatic'), ('UBERON_0001161', 'body of stomach', 3416, 'subpancreatic'), ('UBERON_0000916', 'abdomen', 3645, 'abdominal'), ('UBERON_0010749', 'middle pharyngeal constrictor', 3742, 'salpingectomyTubal'), ('PR_000006060', 'CWF19-like protein 1', 3785, 'hCG'), ('UBERON_0000995', 'uterus', 3827, 'uterine'), ('UBERON_0003951', 'ocular fundus', 3835, 'fundus'), ('GO_0007539', 'primary sex determination, soma', 3854, 'gestationNoLaparotomyLaparotomy'), ('UBERON_0000916', 'abdomen', 3890, 'abdominal'), ('GO_0007567', 'parturition', 3918, 'delivered'), ('UBERON_0010749', 'middle pharyngeal constrictor', 3982, 'salpingectomyTubal'), ('UBERON_0001273', 'ilium', 4041, 'iliac'), ('CHEBI_5533', 'granaticin', 4175, 'GnRH agonist123Day'), ('PR_000008293', 'glutathione synthetase', 4175, 'GnRH'), ('UBERON_0000025', 'tube', 4221, 'Tubal'), ('UBERON_0000025', 'tube', 4242, 'tubal'), ('UBERON_0002106', 'spleen', 4261, 'splenic'), ('UBERON_0002106', 'spleen', 4281, 'Splenic'), ('UBERON_0001220', 'quadratus lumborum', 4310, 'salpingectomy'), ('UBERON_0000025', 'tube', 4360, 'tubal'), ('UBERON_0002106', 'spleen', 4401, 'splenic'), ('UBERON_0001179', 'peritoneal cavity', 4522, 'peritoneal'), ('UBERON_0000479', 'tissue', 4547, 'tissue'), ('UBERON_0000025', 'tube', 4570, 'tubal'), ('UBERON_0001091', 'calcareous tooth', 4598, 'omental'), ('UBERON_0004273', 'cartilaginous joint suture', 4606, 'tissueNoLaparoscopic'), ('UBERON_0001220', 'quadratus lumborum', 4627, 'salpingectomy'), ('UBERON_0001091', 'calcareous tooth', 4665, 'omental'), ('UBERON_0001179', 'peritoneal cavity', 4673, 'peritoneal'), ('UBERON_0000088', 'trophoblast', 4684, 'trophoblastic'), ('UBERON_0004910', 'epithelium of male gonad', 4698, 'tissueRemoval'), ('UBERON_0000025', 'tube', 4715, 'tubal'), ('UBERON_0001179', 'peritoneal cavity', 4725, 'peritoneal'), ('UBERON_0001091', 'calcareous tooth', 4736, 'omental'), ('GO_0007565', 'female pregnancy', 4744, 'pregnancy'), ('UBERON_0000479', 'tissue', 4754, 'tissue'), ('UBERON_0010749', 'middle pharyngeal constrictor', 4823, 'salpingectomyTubal'), ('UBERON_0004742', 'dentary', 4873, 'adnexa'), ('GO_0007565', 'female pregnancy', 4930, 'pregnancy'), ('UBERON_0003335', 'serosa of colon', 4940, 'tissueKnopman'), ('UBERON_0003978', 'valve', 5036, 'cul'), ('UBERON_0003062', 'primitive knot', 5040, 'de'), ('UBERON_0009856', 'sac', 5043, 'sac'), ('UBERON_0000916', 'abdomen', 5143, 'abdominal'), ('CHEBI_67721', 'Officinoic acid B', 5226, 'GnRH agonist4NANAFresh901Cul'), ('PR_000008293', 'glutathione synthetase', 5226, 'GnRH'), ('UBERON_0009856', 'sac', 5258, 'sac'), ('GO_0007565', 'female pregnancy', 5322, 'pregnancy'), ('UBERON_0000479', 'tissue', 5332, 'tissue'), ('UBERON_0005203', 'trachea gland', 5430, 'uterine fundus'), ('GO_0007281', 'germ cell development', 5457, 'gestationNoLaparotomyDelivery'), ('UBERON_0002207', 'xiphoid process', 5554, 'Salpingectomy'), ('UBERON_0000025', 'tube', 5572, 'tubal'), ('UBERON_0001220', 'quadratus lumborum', 5602, 'salpingectomy'), ('UBERON_0010896', 'piston cartilage', 5620, 'hydrosalpinxTubal'), ('UBERON_0001681', 'nasal bone', 5679, 'Vena Cava'), ('UBERON_0003693', 'retroperitoneal space', 5689, 'Retroperitoneal'), ('UBERON_0003693', 'retroperitoneal space', 5737, 'retroperitoneal'), ('UBERON_0003693', 'retroperitoneal space', 5840, 'retroperitoneal'), ('GO_0007281', 'germ cell development', 5951, 'gestationNoLaparotomyDelivery'), ('UBERON_0002207', 'xiphoid process', 6047, 'Salpingectomy'), ('GO_0007565', 'female pregnancy', 6161, 'pregnancies'), ('PR_000008293', 'glutathione synthetase', 6272, 'GnRH'), ('UBERON_0003957', "Bruch's membrane", 6317, 'vesicouterine'), ('GO_0007565', 'female pregnancy', 6390, 'pregnancy'), ('UBERON_0000479', 'tissue', 6400, 'tissueDalmia'), ('UBERON_0001220', 'quadratus lumborum', 6468, 'salpingectomy'), ('UBERON_0004742', 'dentary', 6521, 'adnexa'), ('GO_0006309', 'apoptotic DNA fragmentation', 6677, 'gestationNALaparoscopyLaparoscopic'), ('GO_0007565', 'female pregnancy', 6723, 'pregnancy'), ('UBERON_0000479', 'tissue', 6733, 'tissue'), ('GO_0007602', 'phototransduction', 6759, 'Abortion'), ('CHEBI_34713', 'dimepiperate', 6801, 'Diethylstilbestrol'), ('PR_000015909', 'synaptotagmin-7', 6845, 'stimulating hormone'), ('PR_000004759', 'Bloom syndrome protein', 6883, '-releasing hormone'), ('NCBITaxon_10088', 'Mus <genus>', 6922, 'Human'), ('UBERON_0003124', 'chorion', 6928, 'chorionic'), ('PR_000001220', 'encephalopsin', 6938, 'gonadotropin'), ('NCBITaxon_10088', 'Mus <genus>', 6956, 'Human'), ('UBERON_0014762', 'fused metapodial bones 2-4', 6991, 'Hysterosalpingogram'), ('UBERON_0035108', 'temporalis fascia', 7016, 'Intrauterine'), ('GO_0007565', 'female pregnancy', 7029, 'pregnancy'), ('GO_0009566', 'fertilization', 7053, 'fertilization'), ('CHEBI_32588', 'potassium chloride', 7068, 'KCl'), ('CHEBI_8349', 'pradimicin A', 7072, 'Potassium chloride'), ('CHEBI_44185', 'methotrexate', 7096, 'Methotrexate'), ('UBERON_0002107', 'liver', 7132, 'Pelvic'), ('CL_0000232', 'erythrocyte', 7179, 'RBC'), ('CL_0000232', 'erythrocyte', 7183, 'Red blood cell'), ('UBERON_0000178', 'blood', 7187, 'blood'), ('GO_0007569', 'cell aging', 7230, 'abortion'), ('UBERON_0000916', 'abdomen', 7271, 'abdominal'), ('GO_0007565', 'female pregnancy', 7289, 'pregnancy'), ('GO_0002006', 'vasoconstriction by vasopressin involved in systemic arterial blood pressure control', 7305, 'IVF')]
PMC5084009	10/2016	S12-PMC5084009	['Homocysteine is remethylated to methionine by the ubiquitous Folate and cobalamin-dependent methionine synthase (mtr; ec 2.1.1.13) and by betaine:Homocysteine methyltransferase (bhmt; ec 2.1.1.5) that occurs mainly in the Kidney and Liver [1].']	N/A	N/A	[('CHEBI_5759', 'Honokiol', 0, 'Homocysteine'), ('CHEBI_30863', '5-azaorotic acid', 61, 'folate'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 146, 'homocysteine'), ('UBERON_0002113', 'kidney', 222, 'kidney'), ('UBERON_0002107', 'liver', 233, 'liver')]
PMC5084009	10/2016	S123-PMC5084009	['Liver Bhmt Expression was reported to be lower in the offspring of Rat dams supplemented with Folic Acid during Pregnancy [41] but was unaffected by excessive Folic Acid Intake in Mice [40].']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('GO_0036260', 'RNA capping', 6, 'BHMT'), ('GO_0010467', 'gene expression', 11, 'expression'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 67, 'rat'), ('CHEBI_30751', 'formic acid', 94, 'folic acid'), ('GO_0007565', 'female pregnancy', 112, 'pregnancy'), ('CHEBI_30751', 'formic acid', 159, 'folic acid'), ('GO_0007631', 'feeding behavior', 170, 'intake'), ('NCBITaxon_10088', 'Mus <genus>', 180, 'mice')]
PMC5084016	10/2016	S124-PMC5084016	['high amounts of Vitamin D are contained in cod Liver oil.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0002107', 'liver', 47, 'liver')]
PMC5085625	9/2016	S17-PMC5085625	['Vitamin D3 is transported to the Liver from the skin and Intestines by Vitamin D-Binding Protein (Dbp) [7].']	N/A	N/A	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('UBERON_0002107', 'liver', 33, 'liver'), ('UBERON_0000160', 'intestine', 57, 'intestines'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 71, 'vitamin D-binding protein'), ('PR_000006317', 'mRNA-decapping enzyme 1A', 98, 'DBP')]
PMC5091916	11/2016	S73-PMC5091916	['additionally, the whole Brain, Plasma and samples from Perirenal Fat and Liver were collected for further analysis (fig 1).']	N/A	N/A	[('UBERON_0000955', 'brain', 24, 'brain'), ('UBERON_0001969', 'blood plasma', 31, 'plasma'), ('UBERON_0001845', 'perilymph', 55, 'perirenal fat'), ('UBERON_0002107', 'liver', 73, 'liver')]
PMC5091916	11/2016	S80-PMC5091916	['additionally, the characterization of the ecs, Lipid Metabolism and ppars Gene Expression was evaluated in Metabolically-relevant Tissues (Hypothalamus, Liver and Pat).']	N/A	N/A	[('CHEBI_18059', 'lipid', 47, 'lipid'), ('GO_0006629', 'lipid metabolic process', 47, 'lipid metabolism'), ('GO_0010467', 'gene expression', 74, 'gene expression'), ('SO_0000704', 'gene', 74, 'gene'), ('GO_0008152', 'metabolic process', 107, 'metabolically'), ('UBERON_0000479', 'tissue', 130, 'tissues'), ('UBERON_0001898', 'hypothalamus', 139, 'hypothalamus'), ('UBERON_0002107', 'liver', 153, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 163, 'PAT')]
PMC5091916	11/2016	S119-PMC5091916	['additionally, samples from Perirenal Adipose Tissue (Pat) and Liver were dissected and immediately frozen at −80°c until rt-qpcr analysis.']	N/A	N/A	[('UBERON_0001745', 'secondary nodular lymphoid tissue', 27, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 53, 'PAT'), ('UBERON_0002107', 'liver', 62, 'liver')]
PMC5091916	11/2016	S120-PMC5091916	['measurement of Metabolites, Hepatic enzymes and leptin in Plasma\nthe following Plasma Metabolites were measured: basal Glucose, Triglycerides, total Cholesterol, high-density lipoprotein (hdl), Urea, Bilirubin, alkaline phosphatase (alkp), and the Hepatic enzymes alanine aminotransferase (alt), aspartate aminotransferase (ast) and gamma-glutamyltranspeptidase (γgt).']	N/A	N/A	[('CHEBI_25212', 'metabolite', 15, 'metabolites'), ('UBERON_0002107', 'liver', 28, 'hepatic'), ('UBERON_0001969', 'blood plasma', 58, 'plasma'), ('UBERON_0001969', 'blood plasma', 79, 'plasma'), ('CHEBI_25212', 'metabolite', 86, 'metabolites'), ('CHEBI_17234', 'glucose', 119, 'glucose'), ('CHEBI_17855', 'triglyceride', 128, 'triglycerides'), ('CHEBI_16113', 'cholesterol', 149, 'cholesterol'), ('CHEBI_16199', 'urea', 194, 'urea'), ('CHEBI_16990', 'bilirubin IXalpha', 200, 'bilirubin'), ('UBERON_0002107', 'liver', 248, 'hepatic')]
PMC5091916	11/2016	S131-PMC5091916	['Tissue portions (100–300 mg) of the Liver, Pat and the whole Hypothalamus were homogenized.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('UBERON_0002107', 'liver', 36, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 43, 'PAT'), ('UBERON_0001898', 'hypothalamus', 61, 'hypothalamus')]
PMC5091916	11/2016	S415-PMC5091916	['001 ) (table 1).10.1371/journal.pone.0165432.t001\n\ncaption (table-wrap): table 1\nPlasma leptin, Metabolites and Hepatic transaminases at 5thpostnatal montha.malefemaletwo-way anovacc (n = 6)pc (n = 5)cc (n = 5)pc (n = 5)interactionperinatal dietsex leptin (μg/ml) 5.829±0.88 11.21 ±1.69* 6.07±2.17 4.15±0.89#f1,16= 6.817, p = 0.0189ns f1,16= 5.94, p = 0.0269 Glucose (mg/dl) 187.33±12.11211.40±17.04169.60±15.65 154.80±15.57#nsns f1,17= 7.60, p = 0.013 Triglycerides (mg/dl) 79.50±3.12105.40±9.8482.60±15.96110.40±10.87ns f1,17= 8.241, p = 0.011ns Tcholesterol (mg/dl) 39.00±5.4938.60±2.6137.20±2.53 26.40±4.04#nsnsns hdl (mg/dl) 26.67±3.04 13.80±7.73* 21.60±2.91 2.20±0.82$ $ns f1,17= 17.304, p = 0.001f1,17= 4.617, p = 0.046 ldl (mg/dl) 12.37±2.79 37.36±11.80* 17.01±8.4 40.29±4.76$ns f1,17= 13.144, p = 0.002ns vldl (mg/dl) 15.90±0.6221.08±1.9716.52±3.1922.08±2.17ns f1,17= 8.241, p = 0.011ns Urea (mg/dl) 27.50±2.8926.80±1.2930.40±2.0228.80±4.33nsnsns Bilirubin (mg/dl) 0.13±0.02 0.50±0.19** 0.20±0.050.24±0.06nsf1,17= 5.512, p = 0.031ns Alkp (ui) 73.83±4.5764.60±2.6663.20±7.7968.40±2.08nsnsns γgt (ui) 10.50±1.018.80±1.7812.20±0.9611.40±0.57nsnsns ast (ui) 162.50±33.02108.80±18.26145.00±20.39172.60±27.22nsnsf1,17= 5.152, p = 0.037 alt (ui) 55.00±3.9659.80±6.2670.40±8.3774.60±10.56nsnsns ast/alt 0.39±0.060.57±0.38 4.05±0.24***3.97±0.42###nsns f1,17= 290.791, p<0.001\navalues are expressed as means ± s.e.m.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 81, 'Plasma'), ('CHEBI_25212', 'metabolite', 96, 'metabolites'), ('UBERON_0002107', 'liver', 112, 'hepatic'), ('CHEBI_17234', 'glucose', 359, 'Glucose'), ('CHEBI_17855', 'triglyceride', 453, 'Triglycerides'), ('CHEBI_17027', 'allysine', 548, 'tCholesterol'), ('CHEBI_16199', 'urea', 896, 'Urea'), ('UBERON_0000978', 'leg', 896, 'Urea'), ('CHEBI_16990', 'bilirubin IXalpha', 956, 'Bilirubin'), ('PR_000003939', 'GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase', 1042, 'ALKP')]
PMC5091916	11/2016	S443-PMC5091916	['effect of maternal diet on Endocannabinoid Metabolism Gene Expression on the Hypothalamus, Liver and Pat of offspring at Adulthood\nGene Expression levels of several ecs components ( cnr1 , Cnr2 , Napepld , faah , Daglα , Daglβ , mgll ) were evaluated in male and female offspring from Rat dams Fed either a standard Chow (cc) or a high caloric diet (pc) in the Hypothalamus, Liver and Perirenal Adipose Tissue (Pat).']	N/A	N/A	[('CHEBI_67198', 'retinoic acid receptor agonist', 27, 'endocannabinoid'), ('GO_0046584', 'enniatin metabolic process', 27, 'endocannabinoid metabolism'), ('GO_0010467', 'gene expression', 54, 'gene expression'), ('SO_0000704', 'gene', 54, 'gene'), ('UBERON_0001898', 'hypothalamus', 77, 'hypothalamus'), ('UBERON_0002107', 'liver', 91, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 101, 'PAT'), ('UBERON_0000113', 'post-juvenile adult stage', 121, 'adulthood'), ('GO_0010467', 'gene expression', 131, 'Gene expression'), ('SO_0000704', 'gene', 131, 'Gene'), ('PR_000004968', 'calretinin', 189, 'Cnr2'), ('PR_000011593', 'ovarian cancer-related protein 1', 196, 'Napepld'), ('PR_000006490', 'solute carrier family 49 member 4', 213, 'Daglα'), ('PR_000006447', 'diacylglycerol kinase eta', 221, 'Daglβ'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 285, 'rat'), ('GO_0007631', 'feeding behavior', 294, 'fed'), ('CHEBI_33290', 'food', 316, 'chow'), ('UBERON_0001898', 'hypothalamus', 361, 'hypothalamus'), ('UBERON_0002107', 'liver', 375, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 385, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 411, 'PAT')]
PMC5091916	11/2016	S461-PMC5091916	['concerning the Liver, a two-way anova did not show any effect or interaction on the Gene Expression of cnr1 and Daglα (fig 7a and 7e).']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'liver'), ('GO_0010467', 'gene expression', 84, 'gene expression'), ('SO_0000704', 'gene', 84, 'gene'), ('PR_000006490', 'solute carrier family 49 member 4', 112, 'Daglα')]
PMC5091916	11/2016	S485-PMC5091916	['01 ) (fig 7g).10.1371/journal.pone.0165432.g007\n\ncaption (fig): fig 7\nlevels of Endocannabinoid Metabolism Gene Expression in Liver.']	N/A	N/A	[('CHEBI_67198', 'retinoic acid receptor agonist', 80, 'endocannabinoid'), ('GO_0046584', 'enniatin metabolic process', 80, 'endocannabinoid metabolism'), ('GO_0010467', 'gene expression', 107, 'gene expression'), ('SO_0000704', 'gene', 107, 'gene'), ('UBERON_0002107', 'liver', 126, 'liver')]
PMC5091916	11/2016	S536-PMC5091916	['these alterations include modifications in the Hypothalamus, Liver and Pat.']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 47, 'hypothalamus'), ('UBERON_0002107', 'liver', 61, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 71, 'PAT')]
PMC5091916	11/2016	S541-PMC5091916	['additionally, female offspring had an increased Expression of Cnr2 in the Liver and Pat, that was significantly different from the Cnr2 Expression of pc males in Pat.']	N/A	N/A	[('GO_0010467', 'gene expression', 48, 'expression'), ('PR_000004968', 'calretinin', 62, 'Cnr2'), ('UBERON_0002107', 'liver', 74, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 84, 'PAT'), ('PR_000004968', 'calretinin', 131, 'Cnr2'), ('GO_0010467', 'gene expression', 136, 'expression'), ('UBERON_0004363', 'pharyngeal arch artery', 162, 'PAT')]
PMC5091916	11/2016	S542-PMC5091916	['effect of maternal diet on Fatty Acid Metabolism and Ppars Gene Expression on the Liver and Pat of offspring at Adulthood\nthe Gene Expression of selected key Metabolic enzymes regulating Lipogenesis ( Acaca/Scd1 ) and β-oxidation ( cpt1a , cpt1b ) in the Liver and Pat was evaluated in the offspring of Rats Fed with either a high caloric or a standard Chow diet (fig 9).']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 27, 'fatty acid'), ('GO_0006631', 'fatty acid metabolic process', 27, 'fatty acid metabolism'), ('PR_000013349', 'pregnancy-specific beta-1-glycoprotein 11', 53, 'Ppars'), ('GO_0010467', 'gene expression', 59, 'gene expression'), ('SO_0000704', 'gene', 59, 'gene'), ('UBERON_0002107', 'liver', 82, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 92, 'PAT'), ('UBERON_0000113', 'post-juvenile adult stage', 112, 'adulthood'), ('GO_0010467', 'gene expression', 126, 'gene expression'), ('SO_0000704', 'gene', 126, 'gene'), ('GO_0008152', 'metabolic process', 158, 'metabolic'), ('GO_0008610', 'lipid biosynthetic process', 187, 'lipogenesis'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 201, 'Acaca'), ('PR_000014869', 'sialic acid-binding Ig-like lectin 9', 207, 'Scd1'), ('UBERON_0002107', 'liver', 255, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 265, 'PAT'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 303, 'rats'), ('GO_0007631', 'feeding behavior', 308, 'fed'), ('CHEBI_33290', 'food', 353, 'chow')]
PMC5091916	11/2016	S560-PMC5091916	['Acaca , acetilcoenzyme a carboxilase; Scd1 , Stearoylconzyme A Desaturase 1; cpt1a/B , Carnitine Palmitoyltrasnferase 1 Liver/muscle Isoforms.']	N/A	N/A	[('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 0, 'Acaca'), ('PR_000014869', 'sialic acid-binding Ig-like lectin 9', 38, 'Scd1'), ('CHEBI_26625', 'selenides', 45, 'stearoylconzyme'), ('PR_000014600', 'translocation protein SEC63', 45, 'stearoylconzyme A desaturase 1'), ('PR_000006000', 'carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2', 83, 'b'), ('CHEBI_17126', 'carnitine', 87, 'carnitine'), ('PR_000005349', 'centrosomal protein of 290 kDa', 87, 'carnitine palmitoyltrasnferase 1'), ('UBERON_0002107', 'liver', 120, 'liver'), ('SO_0001060', 'sequence_variant', 133, 'isoforms')]
PMC5091916	11/2016	S563-PMC5091916	['additionally, the Gene Expression of pparα and pparγ was also analyzed in the Liver and Pat (fig 10).']	N/A	N/A	[('GO_0010467', 'gene expression', 18, 'gene expression'), ('SO_0000704', 'gene', 18, 'gene'), ('UBERON_0002107', 'liver', 78, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 88, 'PAT')]
PMC5091916	11/2016	S568-PMC5091916	['0048) in the Gene Expression of pparα in the Liver.']	N/A	N/A	[('GO_0010467', 'gene expression', 13, 'gene expression'), ('SO_0000704', 'gene', 13, 'gene'), ('UBERON_0002107', 'liver', 45, 'liver')]
PMC5091916	11/2016	S589-PMC5091916	['01) (fig 10d).10.1371/journal.pone.0165432.g010\n\ncaption (fig): fig 10\nlevels of pparα and pparγ Gene Expression in Liver (a,b) and Pat (c,d).']	N/A	N/A	[('GO_0010467', 'gene expression', 97, 'gene expression'), ('SO_0000704', 'gene', 97, 'gene'), ('UBERON_0002107', 'liver', 116, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 132, 'PAT')]
PMC5091916	11/2016	S599-PMC5091916	['furthermore, the offspring exposed to this diet during the Perinatal Period showed reduced Gene Expression of pparγ , especially in the Liver but also in Pat.']	N/A	N/A	[('GO_0036268', 'swimming', 59, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 59, 'perinatal period'), ('GO_0010467', 'gene expression', 91, 'gene expression'), ('SO_0000704', 'gene', 91, 'gene'), ('UBERON_0002107', 'liver', 136, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 154, 'PAT')]
PMC5091916	11/2016	S737-PMC5091916	['they exhibited hyperphagia during part of their Life, increased Perigonadal adiposity but not Abdominal adiposity, alterations in lipoproteins including strong reduction of hdl and higher cnr1 Expression in Hypothalamus and Pat, along with lower Expression of Endocannabinoid-Degrading enzymes in the Liver.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 48, 'life'), ('UBERON_0001179', 'peritoneal cavity', 64, 'perigonadal'), ('UBERON_0000916', 'abdomen', 94, 'abdominal'), ('GO_0010467', 'gene expression', 193, 'expression'), ('UBERON_0001898', 'hypothalamus', 207, 'hypothalamus'), ('UBERON_0004363', 'pharyngeal arch artery', 224, 'PAT'), ('GO_0010467', 'gene expression', 246, 'expression'), ('CHEBI_67198', 'retinoic acid receptor agonist', 260, 'endocannabinoid'), ('GO_0048313', 'Golgi inheritance', 260, 'endocannabinoid-degrading'), ('UBERON_0002107', 'liver', 301, 'liver')]
PMC5096291	11/2016	S21-PMC5096291	['in Rats, Intake of N-3 Lcpufas during Pregnancy was shown to change Dna Methylation levels in the Fatty Acid desaturase Promoter in the Liver of the offspring [18].']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 3, 'rats'), ('GO_0007631', 'feeding behavior', 9, 'intake'), ('CHEBI_73863', '(7Z,10Z,13Z,16Z,19Z)-3-oxodocosapentaenoyl-CoA(4-)', 19, 'n-3 LCPUFAs'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0006306', 'DNA methylation', 68, 'DNA methylation'), ('CHEBI_35366', 'fatty acid', 98, 'fatty acid'), ('SO_0000167', 'promoter', 120, 'promoter'), ('UBERON_0002107', 'liver', 136, 'liver')]
PMC5100627	10/2016	S42-PMC5100627	['the nmr metabolomics platform has been extensively applied for biomarker profiling in epidemiological studies20,21,23–25,34,35and details of the experimentation have been described elsewhere.19,36in addition to the nmr metabolomics measures, 10 Metabolic markers related to inflammation, Liver function and hormone balance, assayed in two or more of the cohorts, were analysed as part of the comprehensive Metabolic profile (supplementary methods).25mean (standard deviation; sd) concentrations of the Metabolic measures in each cohort are listed in table s2, available assupplementary dataat ije online.']	N/A	N/A	[('GO_0008152', 'metabolic process', 245, 'metabolic'), ('UBERON_0002107', 'liver', 288, 'liver'), ('GO_0008152', 'metabolic process', 406, 'metabolic'), ('GO_0008152', 'metabolic process', 502, 'metabolic')]
PMC5117700	11/2016	S29-PMC5117700	['Metformin inhibits both Gluconeogenesis and Glycogenolysis, thereby reducing Hepatic Glucose Production, [18] while increasing Insulin mediated Skeletal muscle and Adipocyte Glucose utilisation [19].']	N/A	N/A	[('CHEBI_6801', 'metformin', 0, 'Metformin'), ('GO_0006094', 'gluconeogenesis', 24, 'gluconeogenesis'), ('GO_0005981', 'regulation of glycogen catabolic process', 44, 'glycogenolysis'), ('UBERON_0002107', 'liver', 77, 'hepatic'), ('CHEBI_17234', 'glucose', 85, 'glucose'), ('GO_0006094', 'gluconeogenesis', 85, 'glucose production'), ('PR_000045358', 'insulin family protein', 127, 'insulin'), ('UBERON_0004288', 'skeleton', 144, 'skeletal'), ('CL_0000136', 'fat cell', 164, 'adipocyte'), ('CHEBI_17234', 'glucose', 174, 'glucose')]
PMC5117700	11/2016	S38-PMC5117700	['exclusion criteria\nwomen with a multiple Pregnancy, type 1 or 2 diabetes diagnosed prior to Pregnancy, or with significant Renal or Hepatic impairment such that Metformin would be contraindicated will be excluded from participation.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('UBERON_0002113', 'kidney', 123, 'renal'), ('UBERON_0002107', 'liver', 132, 'hepatic'), ('CHEBI_6801', 'metformin', 161, 'metformin')]
PMC5118969	11/2016	S37-PMC5118969	['Liver function tests showed transaminitis and hyperbilirubinemia.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC5133057	10/2016	S24-PMC5133057	['inclusion criteria were that participants were Pregnant adolescents who initiated Prenatal care at 20 weeks or less of Gestation; that they did not receive vitamin supplements containing Vitamin a up to 5 months before Conception and during Pregnancy; that they were not carriers of disease clinically proven to start pre-Pregnancy (i.e., diabetes, Liver disease, Heart disease, and others), that they were nonsmokers, and that they were experiencing single-fetus Pregnancies.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 47, 'pregnant'), ('GO_0007565', 'female pregnancy', 82, 'prenatal'), ('GO_0007565', 'female pregnancy', 119, 'gestation'), ('CHEBI_33229', 'vitamin (role)', 187, 'vitamin'), ('GO_0007620', 'copulation', 219, 'conception'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy'), ('GO_0007565', 'female pregnancy', 322, 'pregnancy'), ('UBERON_0002107', 'liver', 349, 'liver'), ('UBERON_0000948', 'heart', 364, 'heart'), ('GO_0007565', 'female pregnancy', 464, 'pregnancies')]
PMC5133065	10/2016	S29-PMC5133065	['exclusion criteria were: (a) pre-existing clinical conditions such as diabetes, hypertension, Autoimmune diseases, asthma, allergies, Renal or Hepatic diseases, Viral, bacterial or Protozoan infection, anemia (hemoglobin, hb < 10 g/l); (b) twin Pregnancies; (c) Pregnancy disease and preterm Deliveries; (d) smoking more than 10 cigarettes per day; (e) use of other Probiotics during the study protocol.']	N/A	N/A	[('UBERON_0001442', 'skeleton of manus', 94, 'autoimmune'), ('UBERON_0002113', 'kidney', 134, 'renal'), ('UBERON_0002107', 'liver', 143, 'hepatic'), ('NCBITaxon_1', 'root', 161, 'viral'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 181, 'protozoan'), ('GO_0007565', 'female pregnancy', 245, 'pregnancies'), ('GO_0007565', 'female pregnancy', 262, 'pregnancy'), ('GO_0007567', 'parturition', 292, 'deliveries'), ('CHEBI_26346', 'prostaglandins J', 366, 'probiotics')]
PMC5139761	4/2011	S34-PMC5139761	['her basic Metabolic profile, Liver function tests were within normal limits.']	N/A	N/A	[('GO_0008152', 'metabolic process', 10, 'metabolic'), ('UBERON_0002107', 'liver', 29, 'liver')]
PMC5139761	4/2011	S35-PMC5139761	['an Abdominal ultrasound revealed an unremarkable Gallbladder, fatty Liver and the Pancreas could not be adequately visualized.']	N/A	N/A	[('UBERON_0000916', 'abdomen', 3, 'abdominal'), ('UBERON_0002110', 'gall bladder', 49, 'gallbladder'), ('UBERON_0002107', 'liver', 68, 'liver'), ('UBERON_0001264', 'pancreas', 82, 'pancreas')]
PMC5153572	11/2016	S21-PMC5153572	['the mechanism for this increase in tbg involves both increased Hepatic Synthesis Of Tbg and Estrogen mediated perpetuation in sialylation of tbg that increases the half-life from 15 min to 3 days to fully sialylated tbg (6).']	N/A	N/A	[('GO_0007568', 'aging', 63, 'hepatic'), ('UBERON_0002107', 'liver', 63, 'hepatic'), ('GO_0034205', 'amyloid-beta formation', 71, 'synthesis of TBG'), ('CHEBI_50114', 'estrogen', 92, 'estrogen')]
PMC5187359	12/2016	S6-PMC5187359	['their Liver showed a decreased Gene Expression of cnr1, ppar α, ppar γ, the ecbs-degrading enzymes faah and mgll , the de novo Lipogenic enzymes Acaca and Fasn , and the Liver-specific Cholesterol Biosynthesis regulators insig1 and hmgcr .']	N/A	N/A	[('UBERON_0002107', 'liver', 6, 'liver'), ('GO_0010467', 'gene expression', 31, 'gene expression'), ('SO_0000704', 'gene', 31, 'gene'), ('GO_0008610', 'lipid biosynthetic process', 127, 'lipogenic'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 145, 'Acaca'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 155, 'Fasn'), ('UBERON_0002107', 'liver', 170, 'liver'), ('CHEBI_16113', 'cholesterol', 185, 'cholesterol'), ('GO_0006695', 'cholesterol biosynthetic process', 185, 'cholesterol biosynthesis')]
PMC5187359	12/2016	S33-PMC5187359	['particularly, we evaluated the Gene Expression of relevant components of the Endocannabinoid system, and key enzymes and regulators of the Lipid and Cholesterol Metabolism in Metabolically relevant Tissues, such as the Hypothalamus, the Liver, and the Perirenal Adipose Tissue (Pat), of male and female Adult offspring.']	N/A	N/A	[('GO_0010467', 'gene expression', 31, 'gene expression'), ('SO_0000704', 'gene', 31, 'gene'), ('CHEBI_67198', 'retinoic acid receptor agonist', 77, 'endocannabinoid'), ('CHEBI_18059', 'lipid', 139, 'lipid'), ('GO_0006266', 'DNA ligation', 139, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 149, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 149, 'cholesterol metabolism'), ('GO_0008152', 'metabolic process', 175, 'metabolically'), ('UBERON_0000479', 'tissue', 198, 'tissues'), ('UBERON_0001898', 'hypothalamus', 219, 'hypothalamus'), ('UBERON_0002107', 'liver', 237, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 252, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 278, 'PAT'), ('UBERON_0007023', 'adult organism', 303, 'adult')]
PMC5187359	12/2016	S88-PMC5187359	['Liver samples and the Brains were also collected, frozen and stored at −80°c.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000955', 'brain', 22, 'brains')]
PMC5187359	12/2016	S90-PMC5187359	['measurement of Metabolites, Hepatic enzymes, and leptin in Plasma\nthe following Plasma Metabolites and enzymes were measured: basal Glucose, Triglycerides, total Cholesterol, high-density lipoprotein (hdl), Urea, Bilirubin, alkaline phosphatase (alkp), and the Hepatic enzymes alanine aminotransferase (alt), aspartate aminotransferase (ast), and gamma-glutamyl transpeptidase (γgt).']	N/A	N/A	[('CHEBI_25212', 'metabolite', 15, 'metabolites'), ('UBERON_0002107', 'liver', 28, 'hepatic'), ('UBERON_0001969', 'blood plasma', 59, 'plasma'), ('UBERON_0001969', 'blood plasma', 80, 'plasma'), ('CHEBI_25212', 'metabolite', 87, 'metabolites'), ('CHEBI_17234', 'glucose', 132, 'glucose'), ('CHEBI_17855', 'triglyceride', 141, 'triglycerides'), ('CHEBI_16113', 'cholesterol', 162, 'cholesterol'), ('CHEBI_16199', 'urea', 207, 'urea'), ('CHEBI_16990', 'bilirubin IXalpha', 213, 'bilirubin'), ('UBERON_0002107', 'liver', 261, 'hepatic')]
PMC5187359	12/2016	S100-PMC5187359	["portions (100–300 mg) of Liver and Pat, and the whole Hypothalamus were homogenized in ice and rna was extracted using the trizol® method according to the manufacturer's instruction (gibco brl)."]	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 35, 'PAT'), ('UBERON_0001898', 'hypothalamus', 54, 'hypothalamus')]
PMC5187359	12/2016	S175-PMC5187359	['caption (table-wrap): table 1\n\nPlasma levels of leptin, Metabolites, alkaline phosphatase, and Hepatic transaminases in Adult Rat offspring at Postnatal weeks 21–23† .malefemaletwo-way anovacc ( n = 6)rc ( n = 7)cc ( n = 5)rc ( n = 7)interactionprenatal dietsex leptin (ng/ml)5.82 ± 0.8812.06 ± 2.13*6.07 ± 2.175.97 ± 1.36$$nsnsnsglucose (mg/dl)187.33 ± 12.11207.71 ± 19.27169.60 ± 15.65216.00 ± 10.86#ns f(1, 22)= 5.339, p = 0.031nstriglycerides (mg/dl)79.50 ± 3.12114.13 ± 9.66*82.60 ± 15.9696.50 ± 11.64ns f(1, 22)= 5.462, p = 0.029nscholesterol (mg/dl)39.00 ± 5.4944.86 ± 2.1337.20 ± 2.5331.13 ± 2.56$$$nsns f(1, 22)= 6.112, p = 0.022hdl (mg/dl)26.67 ± 3.044.43 ± 0.81***21.60 ± 2.912.12 ± 0.55###ns f(1, 22)= 147.457, p< 0.001 f(1, 22)= 4.603, p = 0.043ldl (mg/dl)12.37 ± 2.7955.67 ± 3.5***17.09 ± 8.3737.01 ± 7.55#,$ns f(1, 22)= 29.887, p< 0.001nsvldl (mg/dl)15.90 ± 0.6222.863 ± 1.93*16.52 ± 3.1919.30 ± 2.33ns f(1, 22)= 5.462, p = 0.029nsurea (mg/dl)27.50 ± 2.8931.25 ± 1.6630.40 ± 2.0234.75 ± 2.07ns f(1, 22)= 4.876, p = 0.038nsbilirubin (mg/dl)0.13 ± 0.020.30 ± 0.07*0.20 ± 0.050.16 ± 0.02$f(1, 22)= 5.733, p = 0.026nsnsalkp (ui)73.13 ± 3.3972.14 ± 3.4863.20 ± 7.7965.43 ± 2.30nsns f(1, 23)= 4.608, p = 0.043γgt (ui)10.50 ± 1.0110.86 ± 0.3412.20 ± 0.9611.50 ± 0.93nsnsnsast (ui)162.50 ± 33.02138.14 ± 18.33145.00 ± 20.39133.14 ± 1.21nsnsnsalt (ui)55.00 ± 3.9669.86 ± 6.8270.40 ± 8.3756.63 ± 7.27 f(1, 22)= 4.697, p = 0.041nsnsast/alt0.39 ± 0.060.52 ± 0.034.05 ± 0.24***4.84 ± 0.25$$$nsns f(1, 23)= 452.066, p< 0.001\ncc, offspring from control-Fed dams; rc, offspring from calorie-restricted dams.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 31, 'Plasma'), ('CHEBI_25212', 'metabolite', 56, 'metabolites'), ('UBERON_0002107', 'liver', 95, 'hepatic'), ('UBERON_0007023', 'adult organism', 120, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 126, 'rat'), ('GO_0007567', 'parturition', 143, 'postnatal'), ('GO_0007631', 'feeding behavior', 1553, 'fed')]
PMC5187359	12/2016	S189-PMC5187359	['long-term effect of Prenatal caloric restriction on the ecs Gene Expression in Hypothalamus, Liver, and Perirenal Adipose Tissue of Adult offspring\nGene Expression of relevant ecs components ( cnr1, Cnr2, Napepld, faah, Dagl Α, Dagl Β, mgll ) was evaluated in the Hypothalamus, the Liver and the Pat of male and female offspring from Rat dams which were exposed to an ad libitum access of a standard Chow (cc) or a 20%-restricted access of the same standard Chow (rc) during Pregestational (2 weeks) and Gestational periods (figure4).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'prenatal'), ('GO_0010467', 'gene expression', 60, 'gene expression'), ('SO_0000704', 'gene', 60, 'gene'), ('UBERON_0001898', 'hypothalamus', 79, 'hypothalamus'), ('UBERON_0002107', 'liver', 93, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 104, 'perirenal adipose tissue'), ('UBERON_0007023', 'adult organism', 132, 'adult'), ('GO_0010467', 'gene expression', 148, 'Gene expression'), ('SO_0000704', 'gene', 148, 'Gene'), ('PR_000004968', 'calretinin', 199, 'Cnr2'), ('PR_000011593', 'ovarian cancer-related protein 1', 205, 'Napepld'), ('PR_000006490', 'solute carrier family 49 member 4', 220, 'Dagl α'), ('PR_000006447', 'diacylglycerol kinase eta', 228, 'Dagl β'), ('UBERON_0001898', 'hypothalamus', 264, 'hypothalamus'), ('UBERON_0002107', 'liver', 282, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 296, 'PAT'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 334, 'rat'), ('CHEBI_33290', 'food', 400, 'chow'), ('CHEBI_33290', 'food', 458, 'chow'), ('GO_0007565', 'female pregnancy', 475, 'pregestational'), ('GO_0007565', 'female pregnancy', 504, 'gestational')]
PMC5187359	12/2016	S190-PMC5187359	['caption (fig): figure 4\n\neffect of Prenatal caloric restriction on the Gene Expression of components of the Endocannabinoid system ( cnr1 , Cnr2 , Napepld , faah , Dagl Α, Dagl Β, mgll ) in the Hypothalamus (a) , Liver (b) , and Perirenal Adipose Tissue (Pat, c ) of male and female offspring at Adulthood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'prenatal'), ('GO_0010467', 'gene expression', 71, 'gene expression'), ('SO_0000704', 'gene', 71, 'gene'), ('CHEBI_67198', 'retinoic acid receptor agonist', 108, 'endocannabinoid'), ('PR_000004968', 'calretinin', 140, 'Cnr2'), ('PR_000011593', 'ovarian cancer-related protein 1', 147, 'Napepld'), ('PR_000006490', 'solute carrier family 49 member 4', 164, 'Dagl α'), ('PR_000006447', 'diacylglycerol kinase eta', 172, 'Dagl β'), ('UBERON_0001898', 'hypothalamus', 194, 'hypothalamus'), ('UBERON_0002107', 'liver', 213, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 229, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 255, 'PAT'), ('UBERON_0000113', 'post-juvenile adult stage', 296, 'adulthood')]
PMC5187359	12/2016	S199-PMC5187359	['cc females showed an increase in the Gene Expression of cnr1, Cnr2 , and mgll in Liver, but a decrease in the Gene Expression of faah, dagl α, Dagl Β, and mgll in Pat (figures4b,c).']	N/A	N/A	[('GO_0010467', 'gene expression', 37, 'gene expression'), ('SO_0000704', 'gene', 37, 'gene'), ('PR_000004968', 'calretinin', 62, 'Cnr2'), ('UBERON_0002107', 'liver', 81, 'liver'), ('GO_0010467', 'gene expression', 110, 'gene expression'), ('SO_0000704', 'gene', 110, 'gene'), ('PR_000006447', 'diacylglycerol kinase eta', 143, 'Dagl β'), ('UBERON_0004363', 'pharyngeal arch artery', 163, 'PAT')]
PMC5187359	12/2016	S200-PMC5187359	['long-term effect of Prenatal caloric restriction on the Gene Expression of Lipid and Cholesterol Metabolism in Liver and Perirenal Adipose Tissue of Adult offspring\nGene Expression of relevant Metabolic enzymes Regulating de novo Lipogenesis ( Acaca, Fasn, Scd1 ) and Fatty-Acid Β-Oxidation ( cpt1a, cpt1b, acox1 ), and key regulators of Lipid and Cholesterol Metabolism ( chrebp, Srebp1/2, insig1/2, hmgcr ) and Mitochondrial Respiration ( Ucp1, Cox4I1 ) was also evaluated in the Liver and the Pat (figure5).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'prenatal'), ('GO_0010467', 'gene expression', 56, 'gene expression'), ('SO_0000704', 'gene', 56, 'gene'), ('CHEBI_18059', 'lipid', 75, 'lipid'), ('GO_0006266', 'DNA ligation', 75, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 85, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 85, 'cholesterol metabolism'), ('UBERON_0002107', 'liver', 111, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 121, 'perirenal adipose tissue'), ('UBERON_0007023', 'adult organism', 149, 'adult'), ('GO_0010467', 'gene expression', 165, 'Gene expression'), ('SO_0000704', 'gene', 165, 'Gene'), ('GO_0008152', 'metabolic process', 193, 'metabolic'), ('GO_0065007', 'biological regulation', 211, 'regulating'), ('GO_0008610', 'lipid biosynthetic process', 230, 'lipogenesis'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 244, 'Acaca'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 251, 'Fasn'), ('PR_000014869', 'sialic acid-binding Ig-like lectin 9', 257, 'Scd1'), ('CHEBI_35366', 'fatty acid', 268, 'fatty-acid'), ('GO_0006635', 'fatty acid beta-oxidation', 268, 'fatty-acid β-oxidation'), ('CHEBI_18059', 'lipid', 338, 'lipid'), ('GO_0006266', 'DNA ligation', 338, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 348, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 348, 'cholesterol metabolism'), ('PR_000015909', 'synaptotagmin-7', 381, 'Srebp1'), ('GO_0005739', 'mitochondrion', 413, 'mitochondrial'), ('GO_0045333', 'cellular respiration', 427, 'respiration'), ('PR_000016970', 'ubiquitin-conjugating enzyme E2 D4', 441, 'Ucp1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 447, 'Cox4i1'), ('UBERON_0002107', 'liver', 482, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 496, 'PAT')]
PMC5187359	12/2016	S201-PMC5187359	['caption (fig): figure 5\n\neffect of Prenatal caloric restriction on the Gene Expression of enzymes and regulators of the Lipogenesis ( chrebp , acaca , Fasn , Scd1 ), Fatty-Acid Β-Oxidation ( cpt1a/b , acox1 ), Cholesterol Metabolism ( srebf1/2 , insig1/2 , hmgcr ), and Thermogenesis/Mitochondria Respiration ( Ucp1 , Cox4I1 ) in the Liver (a,b) and/or Perirenal Adipose Tissue (Pat) (c,d) of male and female offspring at Adulthood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'prenatal'), ('GO_0010467', 'gene expression', 71, 'gene expression'), ('SO_0000704', 'gene', 71, 'gene'), ('GO_0008610', 'lipid biosynthetic process', 120, 'lipogenesis'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 151, 'Fasn'), ('PR_000014869', 'sialic acid-binding Ig-like lectin 9', 158, 'Scd1'), ('CHEBI_35366', 'fatty acid', 166, 'fatty-acid'), ('GO_0006635', 'fatty acid beta-oxidation', 166, 'fatty-acid β-oxidation'), ('CHEBI_16113', 'cholesterol', 210, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 210, 'cholesterol metabolism'), ('GO_0031649', 'heat generation', 270, 'thermogenesis'), ('GO_0000085', 'mitotic G2 phase', 284, 'mitochondria'), ('GO_0005739', 'mitochondrion', 284, 'mitochondria'), ('GO_0045333', 'cellular respiration', 297, 'respiration'), ('PR_000016970', 'ubiquitin-conjugating enzyme E2 D4', 311, 'Ucp1'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 318, 'Cox4i1'), ('UBERON_0002107', 'liver', 334, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 353, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 379, 'PAT'), ('UBERON_0000113', 'post-juvenile adult stage', 422, 'adulthood')]
PMC5187359	12/2016	S210-PMC5187359	['cc females showed an increase in the Gene Expression of Acaca and insig1 in Liver, and Scd1 in Pat, compared to cc males (figures5a–c).']	N/A	N/A	[('GO_0010467', 'gene expression', 37, 'gene expression'), ('SO_0000704', 'gene', 37, 'gene'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 56, 'Acaca'), ('UBERON_0002107', 'liver', 76, 'liver'), ('PR_000014869', 'sialic acid-binding Ig-like lectin 9', 87, 'Scd1'), ('UBERON_0004363', 'pharyngeal arch artery', 95, 'PAT')]
PMC5187359	12/2016	S212-PMC5187359	['long-term effect of Prenatal calorict restriction on the Gene Expression of ppar α and ppar γ in Liver and Perirenal Adipose Tissue of Adult offspring\nGene Expression of relevant transcription factors ( ppar α, ppar γ) Regulating the Expression of Genes implicated in Lipid and Carbohydrate Metabolism was also evaluated in the Liver and the Pat (figure6).']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'prenatal'), ('GO_0010467', 'gene expression', 57, 'gene expression'), ('SO_0000704', 'gene', 57, 'gene'), ('UBERON_0002107', 'liver', 97, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 107, 'perirenal adipose tissue'), ('UBERON_0007023', 'adult organism', 135, 'adult'), ('GO_0010467', 'gene expression', 151, 'Gene expression'), ('SO_0000704', 'gene', 151, 'Gene'), ('GO_0065007', 'biological regulation', 219, 'regulating'), ('GO_0010467', 'gene expression', 234, 'expression'), ('SO_0000704', 'gene', 248, 'genes'), ('CHEBI_18059', 'lipid', 268, 'lipid'), ('GO_0006266', 'DNA ligation', 268, 'lipid ...'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 278, 'carbohydrate'), ('GO_0005975', 'carbohydrate metabolic process', 278, 'carbohydrate metabolism'), ('UBERON_0002107', 'liver', 328, 'liver'), ('UBERON_0004363', 'pharyngeal arch artery', 342, 'PAT')]
PMC5187359	12/2016	S213-PMC5187359	['caption (fig): figure 6\n\neffect of Prenatal caloric restriction on the Gene Expression of the Lipid flux and Storage regulators ppar α and ppar γ in the Liver (a) and Perirenal Adipose Tissue (Pat) (b) of male and female offspring at Adulthood.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 35, 'prenatal'), ('GO_0010467', 'gene expression', 71, 'gene expression'), ('SO_0000704', 'gene', 71, 'gene'), ('CHEBI_18059', 'lipid', 94, 'lipid'), ('GO_0019076', 'viral release from host cell', 94, 'lipid ... storage'), ('UBERON_0002107', 'liver', 153, 'liver'), ('UBERON_0001745', 'secondary nodular lymphoid tissue', 167, 'perirenal adipose tissue'), ('UBERON_0004363', 'pharyngeal arch artery', 193, 'PAT'), ('UBERON_0000113', 'post-juvenile adult stage', 234, 'adulthood')]
PMC5187359	12/2016	S276-PMC5187359	['the Adult male offspring from calorie-restricted dams specifically exhibited an increased Gene Expression of the Cannabinoid receptors cnr1 and Cnr2 in the Hypothalamus, and showed a decreased Gene Expression of the ecbs-Metabolizing enzymes Napepld in Liver, and faah, Dagl Α, Dagl Β, and mgll in Pat.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 4, 'adult'), ('GO_0010467', 'gene expression', 90, 'gene expression'), ('SO_0000704', 'gene', 90, 'gene'), ('CHEBI_67194', 'cannabinoid', 113, 'cannabinoid'), ('PR_000004968', 'calretinin', 144, 'Cnr2'), ('UBERON_0001898', 'hypothalamus', 156, 'hypothalamus'), ('GO_0010467', 'gene expression', 193, 'gene expression'), ('SO_0000704', 'gene', 193, 'gene'), ('GO_0008152', 'metabolic process', 221, 'metabolizing'), ('PR_000011593', 'ovarian cancer-related protein 1', 242, 'Napepld'), ('UBERON_0002107', 'liver', 253, 'liver'), ('PR_000006490', 'solute carrier family 49 member 4', 270, 'Dagl α'), ('PR_000006447', 'diacylglycerol kinase eta', 278, 'Dagl β'), ('UBERON_0004363', 'pharyngeal arch artery', 298, 'PAT')]
PMC5187359	12/2016	S297-PMC5187359	['the Hypothalamus is able to cross-talk to other Metabolically relevant Tissues such as Liver and Adipose Tissue through Sympathetic Circuits and circulating signals (leptin, Insulin, Cck, Neurotrophins, Il-6) by the Homeostatic Regulation Of the Endocannabinoid Signaling system (das,2010; maccarrone et al.,2014; seoane-collazo et al.,2015).']	N/A	N/A	[('UBERON_0001898', 'hypothalamus', 4, 'hypothalamus'), ('GO_0008152', 'metabolic process', 48, 'metabolically'), ('UBERON_0000479', 'tissue', 71, 'tissues'), ('UBERON_0002107', 'liver', 87, 'liver'), ('UBERON_0001013', 'adipose tissue', 97, 'adipose tissue'), ('UBERON_0003929', 'digestive tract epithelium', 120, 'sympathetic circuits'), ('PR_000045358', 'insulin family protein', 174, 'insulin'), ('PR_000005255', 'cyclin-dependent kinase 2-associated protein 2', 183, 'CCK'), ('PR_000021998', 'neurotrophin', 188, 'neurotrophins'), ('PR_000001470', 'interleukin-28B', 203, 'IL-6'), ('GO_0042592', 'homeostatic process', 216, 'homeostatic'), ('GO_0065007', 'biological regulation', 228, 'regulation of ...'), ('CHEBI_67198', 'retinoic acid receptor agonist', 246, 'endocannabinoid'), ('GO_0038002', 'endocrine signaling', 246, 'endocannabinoid signaling')]
PMC5187359	12/2016	S309-PMC5187359	['the Liver of Adult female offspring from calorie-restricted dams specifically showed a decrease in the Gene Expression of ppar α and ppar γ.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('UBERON_0007023', 'adult organism', 13, 'adult'), ('GO_0010467', 'gene expression', 103, 'gene expression'), ('SO_0000704', 'gene', 103, 'gene')]
PMC5187359	12/2016	S311-PMC5187359	['the Liver of rc females also showed a decrease in the Gene Expression of the de novo Lipogenic enzyme Acaca and Fasn , which constitute rate-limit steps in the Fatty-Acid Synthesis, and the Liver-specific Cholesterol Biosynthesis regulators insig1 and hmgcr .']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('GO_0010467', 'gene expression', 54, 'gene expression'), ('SO_0000704', 'gene', 54, 'gene'), ('GO_0008610', 'lipid biosynthetic process', 85, 'lipogenic'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 102, 'Acaca'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 112, 'Fasn'), ('CHEBI_35366', 'fatty acid', 160, 'fatty-acid'), ('GO_0006633', 'fatty acid biosynthetic process', 160, 'fatty-acid synthesis'), ('UBERON_0002107', 'liver', 190, 'liver'), ('CHEBI_16113', 'cholesterol', 205, 'cholesterol'), ('GO_0006695', 'cholesterol biosynthetic process', 205, 'cholesterol biosynthesis')]
PMC5216338	1/2017	S0-PMC5216338	['in ovo injection of betaine alleviates Corticosterone-induced fatty Liver in Chickens through epigenetic modifications\n\nabstract\nbetaine alleviates high-fat diet-induced fatty Liver and Prenatal betaine programs offspring Hepatic Lipid Metabolism.']	N/A	N/A	[('CHEBI_16827', 'corticosterone', 39, 'corticosterone'), ('UBERON_0002107', 'liver', 68, 'liver'), ('NCBITaxon_33208', 'Metazoa', 77, 'chickens'), ('UBERON_0002107', 'liver', 176, 'liver'), ('GO_0007565', 'female pregnancy', 186, 'prenatal'), ('GO_0007568', 'aging', 222, 'hepatic'), ('UBERON_0002107', 'liver', 222, 'hepatic'), ('CHEBI_18059', 'lipid', 230, 'lipid'), ('GO_0006629', 'lipid metabolic process', 230, 'lipid metabolism')]
PMC5216338	1/2017	S3-PMC5216338	['cort-induced fatty Liver was less severe in betaine-treated Chickens, with significantly reduced oil-red staining and Hepatic Triglyceride content ( p \u2009<\u20090.05).']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'liver'), ('NCBITaxon_33208', 'Metazoa', 60, 'chickens'), ('UBERON_0002107', 'liver', 118, 'hepatic'), ('CHEBI_17855', 'triglyceride', 126, 'triglyceride')]
PMC5216338	1/2017	S11-PMC5216338	['exogenous Cort administration causes abnormal accumulation of fat in the Liver67, which is manifested with Mitochondrial dysfunction, Lipid Peroxidation and inflammation, thereby increasing the susceptibility of Liver to more severe damages68.']	N/A	N/A	[('CHEBI_15346', 'coenzyme A', 10, 'CORT'), ('UBERON_0001113', 'lobe of liver', 73, 'liver67'), ('GO_0005739', 'mitochondrion', 107, 'mitochondrial'), ('CHEBI_18059', 'lipid', 134, 'lipid'), ('GO_0032622', 'interleukin-19 production', 134, 'lipid peroxidation'), ('UBERON_0002107', 'liver', 212, 'liver')]
PMC5216338	1/2017	S12-PMC5216338	['Lipid Homeostasis in the Liver is maintained through highly coordinated and strictly Regulated Biological Processes including Lipid Biosynthesis, Lipolysis, as well as Fatty Acids Transport and β-oxidation91011.']	N/A	N/A	[('CHEBI_18059', 'lipid', 0, 'Lipid'), ('GO_0055089', 'fatty acid homeostasis', 0, 'Lipid homeostasis'), ('UBERON_0002107', 'liver', 25, 'liver'), ('GO_0065007', 'biological regulation', 85, 'regulated'), ('GO_0008150', 'biological_process', 95, 'biological processes'), ('CHEBI_18059', 'lipid', 126, 'lipid'), ('GO_0008610', 'lipid biosynthetic process', 126, 'lipid biosynthesis'), ('GO_0016042', 'lipid catabolic process', 146, 'lipolysis'), ('CHEBI_35366', 'fatty acid', 168, 'fatty acids'), ('GO_0015908', 'fatty acid transport', 168, 'fatty acids transport')]
PMC5216338	1/2017	S14-PMC5216338	['Fatty Acids Β-Oxidation in the Liver is Regulated by Carnitine Palmitoyl Transferase 1 (Cpt-1) that catalyzes the rate-limiting step of Fatty Acid oxidation210, and the key transcription factor Peroxiisome Proliferator-Activated Receptor Alpha (Pparα) that activates Mitochondrial β-Oxidation and Oxidative Phosphorylation (oxphos)14.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 0, 'Fatty acids'), ('GO_0019395', 'fatty acid oxidation', 0, 'Fatty acids β-oxidation'), ('UBERON_0002107', 'liver', 31, 'liver'), ('GO_0065007', 'biological regulation', 40, 'regulated'), ('CHEBI_48080', 'brefeldin A', 53, 'carnitine palmitoyl'), ('PR_000005448', 'chondroitin sulfate synthase 2', 53, 'carnitine palmitoyl transferase 1'), ('PR_000005855', 'cyclic AMP-responsive element-binding protein 3', 88, 'CPT-1'), ('CHEBI_35366', 'fatty acid', 136, 'fatty acid'), ('GO_0005777', 'peroxisome', 194, 'peroxiisome'), ('PR_000013354', 'pregnancy-specific beta-1-glycoprotein 6', 194, 'peroxiisome proliferator-activated receptor alpha'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 245, 'PPARα'), ('GO_0005739', 'mitochondrion', 267, 'mitochondrial'), ('GO_0006196', 'AMP catabolic process', 282, '-oxidation'), ('GO_0006119', 'oxidative phosphorylation', 297, 'oxidative phosphorylation')]
PMC5216338	1/2017	S40-PMC5216338	['chronic Cort exposure changed the Liver color from red to yellow in control group (fig.']	N/A	N/A	[('CHEBI_15346', 'coenzyme A', 8, 'CORT'), ('PR_000005866', 'cAMP-responsive element modulator', 8, 'CORT'), ('UBERON_0002107', 'liver', 34, 'liver')]
PMC5216338	1/2017	S43-PMC5216338	['the same phenomenon was seen in histological sections stained with oil-red to show Hepatic Lipid accumulation (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 83, 'hepatic'), ('CHEBI_18059', 'lipid', 91, 'lipid')]
PMC5216338	1/2017	S45-PMC5216338	['in ovo injection of betaine had no effect on Liver weight (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 45, 'liver')]
PMC5216338	1/2017	S46-PMC5216338	['2c) or Liver index (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 7, 'liver')]
PMC5216338	1/2017	S48-PMC5216338	['chronic Cort administration significantly increased ( p \u2009<\u20090.05) the Liver weight (fig.']	N/A	N/A	[('CHEBI_15346', 'coenzyme A', 8, 'CORT'), ('UBERON_0002107', 'liver', 69, 'liver')]
PMC5216338	1/2017	S49-PMC5216338	['2c) and the Liver index (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 12, 'liver')]
PMC5216338	1/2017	S56-PMC5216338	['2g) and Liver (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 8, 'liver')]
PMC5216338	1/2017	S59-PMC5216338	['2g) and Hepatic content (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 8, 'hepatic')]
PMC5216338	1/2017	S62-PMC5216338	['Hepatic Expression of methionine Cycle and methyl transfer Genes\nthe schematic diagram of Methionine Cycle is shown infig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010467', 'gene expression', 8, 'expression'), ('GO_0007049', 'cell cycle', 33, 'cycle'), ('SO_0000704', 'gene', 59, 'genes'), ('GO_0000080', 'mitotic G1 phase', 90, 'methionine cycle')]
PMC5216338	1/2017	S77-PMC5216338	['3h) content in the Liver under basal condition.']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'liver')]
PMC5216338	1/2017	S80-PMC5216338	['as a result, the cort-induced decrease in sam/sah ratio was completely restored in the Liver of betaine-treated Chickens (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 87, 'liver'), ('NCBITaxon_33208', 'Metazoa', 112, 'chickens')]
PMC5216338	1/2017	S84-PMC5216338	['also, betaine had no effect on the Hepatic Expression of Cort Metabolic enzymes, including 11Β-Hsd1 that coverts 11-Dehydrocorticosterone (11dhc) to Corticosterone (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 35, 'hepatic'), ('GO_0010467', 'gene expression', 43, 'expression'), ('PR_000005866', 'cAMP-responsive element modulator', 57, 'CORT'), ('GO_0008152', 'metabolic process', 62, 'metabolic'), ('PR_000008777', '17-beta-hydroxysteroid dehydrogenase 13', 91, '11β-HSD1'), ('CHEBI_16973', '11-deoxycorticosterone', 113, '11-dehydrocorticosterone'), ('CHEBI_16827', 'corticosterone', 149, 'corticosterone')]
PMC5216338	1/2017	S91-PMC5216338	['Cort challenge significantly down-regulated ( p \u2009<\u20090.05) Hepatic gr mrna (fig.']	N/A	N/A	[('PR_000005866', 'cAMP-responsive element modulator', 0, 'CORT'), ('UBERON_0002107', 'liver', 57, 'hepatic')]
PMC5216338	1/2017	S95-PMC5216338	['Hepatic Expression of Fatty Acid Β-Oxidation and oxphos related Genes\nHepatic mrna Expression of Cpt1Α (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010467', 'gene expression', 8, 'expression'), ('CHEBI_35366', 'fatty acid', 22, 'fatty acid'), ('GO_0006635', 'fatty acid beta-oxidation', 22, 'fatty acid β-oxidation'), ('SO_0000704', 'gene', 64, 'genes'), ('UBERON_0002107', 'liver', 70, 'Hepatic'), ('GO_0010467', 'gene expression', 83, 'expression'), ('PR_000005855', 'cyclic AMP-responsive element-binding protein 3', 97, 'CPT1α')]
PMC5216338	1/2017	S106-PMC5216338	['chronic Cort administration significantly decreased Hepatic mrna Expression of mtdna-encoded Genes ( p \u2009<\u20090.05) in both control and betaine groups.']	N/A	N/A	[('CHEBI_15346', 'coenzyme A', 8, 'CORT'), ('UBERON_0002107', 'liver', 52, 'hepatic'), ('GO_0010467', 'gene expression', 65, 'expression'), ('SO_0000704', 'gene', 93, 'genes')]
PMC5216338	1/2017	S155-PMC5216338	['furthermore, betaine was shown to attenuate the Liver injury and oxidative stress induced by Ethanol through improving Mitochondrial function in rats45.']	N/A	N/A	[('UBERON_0002107', 'liver', 48, 'liver'), ('CHEBI_16236', 'ethanol', 93, 'ethanol'), ('GO_0005739', 'mitochondrion', 119, 'mitochondrial')]
PMC5216338	1/2017	S168-PMC5216338	['also, the cort-induced decrease in sam/sah ratio in the Liver was completely rescued in betaine-treated Chickens.']	N/A	N/A	[('UBERON_0002107', 'liver', 56, 'liver'), ('NCBITaxon_33208', 'Metazoa', 104, 'chickens')]
PMC5216338	1/2017	S207-PMC5216338	['Liver (without the Gall Bladder) samples were rapidly frozen in liquid nitrogen and keep at −80\u2009°c for further analysis.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0002110', 'gall bladder', 19, 'gall bladder')]
PMC5216338	1/2017	S208-PMC5216338	['determination of Hepatic content of Triglyceride and Plasma concentration of Triglyceride and Corticosterone\nTriglyceride in Plasma and Liver was measured by using respectively commercial Triglyceride assay kit (e1003 and e1013) purchased from applygen technologies inc., china, following the manufacturer’s instructions.']	N/A	N/A	[('UBERON_0002107', 'liver', 17, 'hepatic'), ('CHEBI_17855', 'triglyceride', 36, 'triglyceride'), ('UBERON_0001969', 'blood plasma', 53, 'plasma'), ('CHEBI_17855', 'triglyceride', 77, 'triglyceride'), ('CHEBI_16827', 'corticosterone', 94, 'corticosterone'), ('CHEBI_17855', 'triglyceride', 109, 'Triglyceride'), ('UBERON_0001969', 'blood plasma', 125, 'plasma'), ('UBERON_0002107', 'liver', 136, 'liver'), ('CHEBI_17855', 'triglyceride', 188, 'triglyceride')]
PMC5216338	1/2017	S211-PMC5216338	['total rna isolation and real-time pcr\ntotal rna was isolated from Liver sample (30\u2009mg) using trizol Reagent (invitrogen, usa) and then treated with rnase-free dnase and Reverse-Transcribed to cdna using random hexamer Primers (promega, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 66, 'liver'), ('CHEBI_33893', 'reagent', 100, 'Reagent'), ('GO_0001171', 'reverse transcription', 169, 'reverse-transcribed'), ('SO_0000112', 'primer', 218, 'primers')]
PMC5216338	1/2017	S216-PMC5216338	['total protein extraction and western blotting\ntotal protein was extracted from 80\u2009mg frozen Liver sample as previously described51.']	N/A	N/A	[('UBERON_0002107', 'liver', 92, 'liver')]
PMC5216338	1/2017	S221-PMC5216338	['determination of mtdna copy number and cox enzyme activity\nhigh-quality Genomic dna was isolated from Liver Tissues and the mtdna copy number was determined using real-time pcr as previously described52.']	N/A	N/A	[('SO_0001026', 'genome', 72, 'genomic'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0000479', 'tissue', 108, 'tissues')]
PMC5216338	1/2017	S224-PMC5216338	['for measuring cox enzyme activity, Liver Mitochondria were isolated according to a previously described protocol53.']	N/A	N/A	[('UBERON_0002107', 'liver', 35, 'liver'), ('GO_0005739', 'mitochondrion', 41, 'mitochondria')]
PMC5216338	1/2017	S225-PMC5216338	['briefly, 100\u2009mg of frozen Liver samples (w:v =1:5) were homogenized in an isolation buffer (0.1\u2009m Tris-Mops, 0.1\u2009m egta/Tris, and 1\u2009m Sucrose) with a dounce homogenizer.']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'liver'), ('CHEBI_9754', 'tris', 98, 'Tris'), ('CHEBI_39074', 'MOPS', 103, 'MOPS'), ('CHEBI_9754', 'tris', 120, 'Tris'), ('CHEBI_17992', 'sucrose', 134, 'sucrose')]
PMC5216338	1/2017	S230-PMC5216338	['methylated dna immunoprecipitation (medip) analysis\nGenomic dna was isolated from the Liver Tissues and sonicated to produce small fragments ranging from 300 to 1000\u2009Bp.']	N/A	N/A	[('SO_0001026', 'genome', 52, 'Genomic'), ('UBERON_0002107', 'liver', 86, 'liver'), ('UBERON_0000479', 'tissue', 92, 'tissues'), ('SO_0000028', 'base_pair', 166, 'bp')]
PMC5216338	1/2017	S237-PMC5216338	['briefly, 300\u2009mg of frozen Liver Tissues were ground in liquid nitrogen, resuspended in pbs containing protease inhibitor Cocktail (no.11697498001, roche, usa) and cross-linked in 1% Formaldehyde for 10\u2009min, then the reaction was stopped with 2.5\u2009m glycine at room temperature for 10\u2009min.']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'liver'), ('UBERON_0000479', 'tissue', 32, 'tissues'), ('CHEBI_60004', 'mixture', 121, 'cocktail'), ('CHEBI_16842', 'formaldehyde', 182, 'formaldehyde')]
PMC5216338	1/2017	S253-PMC5216338	['in ovo injection of betaine alleviates Corticosterone-induced fatty Liver in Chickens through epigenetic modifications.']	N/A	N/A	[('CHEBI_16827', 'corticosterone', 39, 'corticosterone'), ('UBERON_0002107', 'liver', 68, 'liver'), ('NCBITaxon_33208', 'Metazoa', 77, 'chickens')]
PMC5264377	7/2016	S15-PMC5264377	['Cholecalciferol (Vitamin D3) and Ergocalciferol (Vitamin D2) are hydroxylated in the Liver, resulting in 25-Hidroxyvitamin D or 25(Oh)D3.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 0, 'Cholecalciferol'), ('CHEBI_33279', 'vitamin D5', 17, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 17, 'vitamin D3'), ('CHEBI_4910', 'etomidate', 33, 'ergocalciferol'), ('CHEBI_28934', 'vitamin D2', 49, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 49, 'vitamin D2'), ('UBERON_0002107', 'liver', 85, 'liver'), ('CHEBI_67462', '3-epi-caryoptin', 105, '25-hidroxyvitamin D'), ('CHEBI_62946', 'ammonium sulfate', 128, '25(OH)D3')]
PMC5273824	1/2017	S40-PMC5273824	['patients with medical history of bone Mineral Metabolic disease, Liver or Kidney dysfunction were excluded.']	N/A	N/A	[('CHEBI_46662', 'mineral', 38, 'mineral'), ('GO_0008152', 'metabolic process', 46, 'metabolic'), ('UBERON_0002107', 'liver', 65, 'liver'), ('UBERON_0002113', 'kidney', 74, 'kidney')]
PMC5273824	1/2017	S48-PMC5273824	['medical history of Liver disease; 3).']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'liver')]
PMC5273824	1/2017	S64-PMC5273824	['all participants have normal Liver and Kidney function.']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver'), ('UBERON_0002113', 'kidney', 39, 'kidney')]
PMC5273824	1/2017	S101-PMC5273824	['they Consume more eggs, dairy, fish and Animal Liver products and have a more balanced diet, based on dietary records.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 5, 'consume'), ('NCBITaxon_33208', 'Metazoa', 40, 'animal'), ('UBERON_0002107', 'liver', 47, 'liver')]
PMC5295525	6/2015	S46-PMC5295525	['further evaluation, with computed tomography and magnetic resonance imaging (mri) of the Chest and Abdomen, showed not only the presence of the Right Atrial mass but also multiple nodules scattered in both Lungs and Liver (fig.']	N/A	N/A	[('UBERON_0001443', 'chest', 89, 'chest'), ('UBERON_0000916', 'abdomen', 99, 'abdomen'), ('UBERON_0002078', 'right cardiac atrium', 144, 'right atrial'), ('UBERON_0002048', 'lung', 206, 'lungs'), ('UBERON_0002107', 'liver', 216, 'liver')]
PMC5295525	6/2015	S48-PMC5295525	['the patient underwent a biopsy of one Hepatic lesion that showed moderate to poorly differentiated as (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 38, 'hepatic')]
PMC5295525	6/2015	S55-PMC5295525	['caption (fig): figure 4\n\nLiver biopsy showing (a) photomicrograph of moderate to poorly differentiated angiosarcoma with dense clumps of plump and spindle shaped, Anaplastic cells focally showing slit-like vascular lumens (original magnification, × 200); (b) entrapped Hepatocytes (arrows) within the tumor (original magnification, × 400); (c) immunohistochemical staining for the Endothelial marker Cd34 demonstrating the Endothelial origin of the neoplastic cells.']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'Liver'), ('CL_0000236', 'B cell', 163, 'anaplastic'), ('CL_0000182', 'hepatocyte', 269, 'hepatocytes'), ('UBERON_0001986', 'endothelium', 381, 'endothelial'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 400, 'CD34'), ('UBERON_0001986', 'endothelium', 423, 'endothelial')]
PMC5295525	6/2015	S56-PMC5295525	['the final diagnosis was metastatic Cardiac as to the Lungs and Liver.']	N/A	N/A	[('UBERON_0000948', 'heart', 35, 'cardiac'), ('UBERON_0002048', 'lung', 53, 'lungs'), ('UBERON_0002107', 'liver', 63, 'liver')]
PMC5319084	2/2017	S19-PMC5319084	['these include the presence of tuberculous lesions in the infant with at least one of the following: lesions in the first week of Life, a primary Hepatic complex or caseating granulomas, tuberculous infection of the Placenta or Endometrium and exclusion of post-Natal transmission of tb by screening contacts [8–10].']	N/A	N/A	[('UBERON_0000104', 'life cycle', 129, 'life'), ('UBERON_0002107', 'liver', 145, 'hepatic'), ('UBERON_0001987', 'placenta', 215, 'placenta'), ('UBERON_0001852', 'endolymph', 227, 'endometrium'), ('GO_0007567', 'parturition', 261, 'natal')]
PMC5319084	2/2017	S55-PMC5319084	['his Eye examination and Liver function tests are normal.']	N/A	N/A	[('UBERON_0000970', 'eye', 4, 'eye'), ('UBERON_0002107', 'liver', 24, 'liver')]
PMC5322422	2/2017	S56-PMC5322422	['second, infant Liver reserve levels are substantially lower than Adult levels [2].']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'liver'), ('UBERON_0007023', 'adult organism', 65, 'adult')]
PMC5325607	2/2017	S71-PMC5325607	['Expression was calculated as ddct using Ribosomal Protein L13A ( rpl13a ) in Skeletal muscle and Beta-2-Microglobulin ( B2M ) in Liver for normalization; the con group (mlfd -rw lfd) was set to a value of 1.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('GO_0005840', 'ribosome', 40, 'ribosomal'), ('PR_000014229', '60S ribosomal protein L41', 40, 'ribosomal protein L13A'), ('UBERON_0004288', 'skeleton', 77, 'skeletal'), ('PR_000004591', 'beta-1,4-glucuronyltransferase 1', 97, 'beta-2-microglobulin'), ('PR_000004806', 'bromodomain-containing protein 2', 120, 'B2m'), ('UBERON_0002107', 'liver', 129, 'liver')]
PMC5325607	2/2017	S78-PMC5325607	['Triglyceride and Glycogen analysis\nTriglyceride concentrations were analyzed in M. Quadriceps and Liver as previously described [21].']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 0, 'Triglyceride'), ('CHEBI_24384', 'glycogens', 17, 'glycogen'), ('CHEBI_17855', 'triglyceride', 35, 'Triglyceride'), ('NCBITaxon_10088', 'Mus <genus>', 80, 'M.'), ('UBERON_0001377', 'quadriceps femoris', 83, 'quadriceps'), ('UBERON_0002107', 'liver', 98, 'liver')]
PMC5325607	2/2017	S79-PMC5325607	['briefly, 40 mg Tissue were homogenized in either 400 μl (muscle) or 800 μl (Liver) of 10 mm Sodium Hydrogen Phosphate buffer (ph 7.4; 1 mm edta, 1% Polyoxyetylene-10-Tridecyl Ether).']	N/A	N/A	[('UBERON_0000479', 'tissue', 15, 'tissue'), ('UBERON_0002107', 'liver', 76, 'liver'), ('CHEBI_37586', 'sodium phosphate', 92, 'sodium hydrogen phosphate'), ('CHEBI_53420', 'poly(N-vinylimidazole) macromolecule', 148, 'polyoxyetylene-10-tridecyl ether')]
PMC5325607	2/2017	S83-PMC5325607	['measurement of muscle and Liver Glycogen content was performed as described previously [15].']	N/A	N/A	[('UBERON_0002107', 'liver', 26, 'liver'), ('CHEBI_24384', 'glycogens', 32, 'glycogen')]
PMC5325607	2/2017	S84-PMC5325607	['briefly, 35 mg Liver and 50 mg muscle were homogenized in 750 μl and 1000 μl of 0.1 m Naoh, respectively.']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'liver'), ('CHEBI_32145', 'sodium hydroxide', 86, 'NaOH')]
PMC5325607	2/2017	S141-PMC5325607	['furthermore, Liver weight in the -rw groups did not correlate with the Triglyceride content (fig 3c) and Hepatic Gene Expression of Lipogenesis Genes ( acetyl-Coa carboxylase alpha ( acaca ), Elongation Of Very Long Chain Fatty Acids 6 ( Elovl6 ), Stearoyl-Coa Desaturase-1 ( Scd1 ) and Sterol Regulatory Element-Binding Transcription Factor 1 ( srebf1 )) was not altered (table 2).']	N/A	N/A	[('UBERON_0002107', 'liver', 13, 'liver'), ('CHEBI_17855', 'triglyceride', 71, 'triglyceride'), ('UBERON_0002107', 'liver', 105, 'hepatic'), ('GO_0010467', 'gene expression', 113, 'gene expression'), ('SO_0000704', 'gene', 113, 'gene'), ('GO_0008610', 'lipid biosynthetic process', 132, 'lipogenesis'), ('SO_0000704', 'gene', 144, 'genes'), ('CHEBI_15346', 'coenzyme A', 159, 'CoA'), ('GO_0001770', 'establishment of natural killer cell polarity', 192, 'elongation of ... fatty'), ('CHEBI_87200', 'dicarboximide antifungal agent', 206, 'very long chain fatty acids'), ('PR_000007000', 'eukaryotic translation initiation factor 4 gamma 3', 238, 'Elovl6'), ('CHEBI_15541', 'stearoyl-CoA', 248, 'stearoyl-CoA'), ('PR_000015699', 'alpha-2,8-sialyltransferase 8E', 248, 'stearoyl-CoA desaturase-1'), ('PR_000014869', 'sialic acid-binding Ig-like lectin 9', 276, 'Scd1'), ('CHEBI_15889', 'sterol', 287, 'sterol'), ('PR_000015393', 'suppressor of cytokine signaling 2', 287, 'sterol regulatory'), ('SO_0001861', 'sterol_regulatory_element', 287, 'sterol regulatory element'), ('GO_0065007', 'biological regulation', 294, 'regulatory'), ('PR_000009659', 'laminin subunit gamma-2', 312, '-binding transcription factor 1')]
PMC5325607	2/2017	S163-PMC5325607	['(c/e) spearman correlation analyses were performed with -rw Animals.10.1371/journal.pone.0173076.t002\n\ncaption (table-Wrap): table 2\nHepatic Gene Expression of enzymes involved in Lipogenesis.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 60, 'animals'), ('PR_000017453', 'protein Wnt-9b', 118, 'WRAP'), ('UBERON_0002107', 'liver', 133, 'Hepatic'), ('GO_0010467', 'gene expression', 141, 'gene expression'), ('SO_0000704', 'gene', 141, 'gene'), ('GO_0008610', 'lipid biosynthetic process', 180, 'lipogenesis')]
PMC5325607	2/2017	S175-PMC5325607	['furthermore, mhfd consumption increased Liver weight which was not affected by voluntary exercise training.']	N/A	N/A	[('UBERON_0002107', 'liver', 40, 'liver')]
PMC5332602	3/2017	S46-PMC5332602	['the clinical signs in the affected Piglets were consistent with hypoglycemia and septicemia in addition to extraintestinal (Liver, Kidney, Lung, and Peritoneal Cavity swabs) recovery of clostridium perfringens type a and Nonhemolytic, Avirulent escherichia coli (bacterial identification to the species level was conducted at the ohio department of agriculture).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 35, 'piglets'), ('UBERON_0002107', 'liver', 124, 'liver'), ('UBERON_0002113', 'kidney', 131, 'kidney'), ('UBERON_0002048', 'lung', 139, 'lung'), ('UBERON_0001179', 'peritoneal cavity', 149, 'peritoneal cavity'), ('GO_0001822', 'kidney development', 221, 'nonhemolytic'), ('NCBITaxon_33208', 'Metazoa', 235, 'avirulent')]
PMC5350159	3/2017	S74-PMC5350159	['Liver histology\nintact whole Livers were removed from Mice and fixed for 24\xa0h in 4% pfa and then stored in 70% Ethanol prior to being embedded in paraffin blocks.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0002107', 'liver', 29, 'livers'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'mice'), ('CHEBI_16236', 'ethanol', 111, 'ethanol')]
PMC5350159	3/2017	S76-PMC5350159	['sections were stained with Hematoxylin and eosin (H&e) for assessment of Liver steatosis differences between diet groups.']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 27, 'hematoxylin'), ('CHEBI_51686', 'haematoxylin', 50, 'H'), ('UBERON_0002107', 'liver', 73, 'liver')]
PMC5350159	3/2017	S138-PMC5350159	['H&e stained sections of Livers showed evidence of vacuolization in offspring weaned to hfd (fig.']	N/A	N/A	[('CHEBI_51686', 'haematoxylin', 0, 'H'), ('UBERON_0002107', 'liver', 24, 'livers')]
PMC5369775	3/2017	S62-PMC5369775	['secondary outcomes were early-onset preeclampsia (Delivery before 34+0weeks of Gestation), late-onset preeclampsia (Delivery at or after 34+0weeks of Gestation), preterm preeclampsia (Delivery before 37+0weeks of Gestation), term preeclampsia (Delivery at or after 37+0weeks of Gestation), intermediate preeclampsia (Delivery between 34+0–36+6weeks of Gestation), severe preeclampsia (Blood pressure ≥160 mmhg systolic and/or ≥110 mmhg diastolic and/or proteinuria ≥ 5 g/24hours), small for Gestational age (sga) (Birthweight <-2sd), Gestational diabetes (diet or insulin treated), chronic hypertension (≥140/90 mmhg or Medication for hypertension before 20 weeks of Gestation), hellp syndrome (hemolysis, elevated Liver enzymes, low Platelets) and fetal demise (fetal death after 22thgestational week or over 500g weight).']	N/A	N/A	[('GO_0007567', 'parturition', 50, 'delivery'), ('GO_0007565', 'female pregnancy', 79, 'gestation'), ('GO_0007567', 'parturition', 116, 'delivery'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0007567', 'parturition', 184, 'delivery'), ('GO_0007565', 'female pregnancy', 213, 'gestation'), ('GO_0007567', 'parturition', 244, 'delivery'), ('GO_0007565', 'female pregnancy', 278, 'gestation'), ('GO_0007567', 'parturition', 317, 'delivery'), ('GO_0007565', 'female pregnancy', 352, 'gestation'), ('UBERON_0000178', 'blood', 385, 'blood'), ('GO_0007565', 'female pregnancy', 491, 'gestational'), ('GO_0007596', 'blood coagulation', 514, 'birthweight'), ('GO_0007565', 'female pregnancy', 534, 'gestational'), ('CHEBI_60211', 'compound Z', 620, 'medication'), ('GO_0007565', 'female pregnancy', 667, 'gestation'), ('UBERON_0002107', 'liver', 715, 'liver'), ('CL_0000233', 'platelet', 734, 'platelets')]
PMC5369775	3/2017	S75-PMC5369775	['465 women (51.5%) did not meet any of the primary or secondary outcome criteria whereas 438 (48.5%) had one or more of these Pregnancy complications (table 3).10.1371/journal.pone.0174399.t003\n\ncaption (table-wrap): table 3\nconfirmed diagnoses in the cohort of high-risk women.diagnosesn%all preeclampsia869.5term preeclampsia596.5preterm preeclampsia273.0early preeclampsia101.1severe preeclampsia353.9gestational hypertension9610.6chronic hypertension17919.5gestational diabetes, diet-treated17118.9gestational diabetes, Insulin-treated424.7hellp syndrome*60.7eclampsia10.1small for Gestational age343.8fetal demise20.2normal pregnancy46551.4\n* hellp = hemolysis, elevated Liver enzymes and low Platelet count\nin the control group of 110 women without risk factors two developed Preeclampsia; one of them had severe and the other non-severe late-onset preeclampsia.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 125, 'pregnancy'), ('PR_000045358', 'insulin family protein', 523, 'insulin'), ('GO_0007565', 'female pregnancy', 585, 'gestational'), ('UBERON_0002107', 'liver', 675, 'liver'), ('CL_0000233', 'platelet', 697, 'platelet'), ('GO_0007128', 'meiotic prophase I', 781, 'preeclampsia')]
PMC5371292	3/2017	S105-PMC5371292	['Stomach Tissue samples (linear strips from the squamo-columnar junction through the proximal Duodenum) and Liver Tissue samples collected for dna and rna extraction were flash-frozen in liquid nitrogen and stored at -80°c.']	N/A	N/A	[('UBERON_0000945', 'stomach', 0, 'Stomach'), ('UBERON_0000479', 'tissue', 8, 'tissue'), ('UBERON_0002114', 'duodenum', 93, 'duodenum'), ('UBERON_0002107', 'liver', 107, 'liver'), ('UBERON_0000479', 'tissue', 113, 'tissue')]
PMC5371292	3/2017	S107-PMC5371292	['sections of Stomach and Liver were collected, trimmed, and fixed overnight in 10% neutral buffered Formalin.']	N/A	N/A	[('UBERON_0000945', 'stomach', 12, 'stomach'), ('UBERON_0002107', 'liver', 24, 'liver'), ('CHEBI_16842', 'formaldehyde', 99, 'formalin')]
PMC5371292	3/2017	S114-PMC5371292	['real time quantitative pcr\nmrna Expression for target Genes was assessed in both Gastric and Liver Tissues.']	N/A	N/A	[('GO_0010467', 'gene expression', 32, 'expression'), ('SO_0000704', 'gene', 54, 'genes'), ('UBERON_0001844', 'cochlea', 81, 'gastric'), ('UBERON_0002107', 'liver', 93, 'liver'), ('UBERON_0000479', 'tissue', 99, 'tissues')]
PMC5371292	3/2017	S116-PMC5371292	['total rna from Liver and Stomach was prepared using trizol Reagent (life technologies), according to the manufacturer’s instructions.']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'liver'), ('UBERON_0000945', 'stomach', 25, 'stomach'), ('CHEBI_33893', 'reagent', 59, 'reagent')]
PMC5371292	3/2017	S170-PMC5371292	['the Liver is the primary source of Hepcidin Antimicrobial peptide, the body’s master iron Regulatory protein.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 35, 'hepcidin'), ('CHEBI_65381', 'albizoside C', 44, 'antimicrobial'), ('GO_0065007', 'biological regulation', 90, 'regulatory')]
PMC5371292	3/2017	S171-PMC5371292	['no effect of treatment group was noted on Hepatic Gene Expression of Bone Morphogenic Protein 4 ( Bmp4) (data not shown).10.1371/journal.pone.0173108.g002\n\ncaption (fig): fig 2\n\n(a-c).']	N/A	N/A	[('UBERON_0002107', 'liver', 42, 'hepatic'), ('GO_0010467', 'gene expression', 50, 'gene expression'), ('SO_0000704', 'gene', 50, 'gene'), ('PR_000004770', 'Polycomb complex protein BMI-1', 69, 'bone morphogenic protein 4'), ('GO_0009653', 'anatomical structure morphogenesis', 74, 'morphogenic'), ('PR_000000165', 'BMP4', 98, 'Bmp4')]
PMC5371292	3/2017	S174-PMC5371292	['Hepatic Dmt1 Expression was upregulated and Hamp Expression was downregulated in h .']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 8, 'Dmt1'), ('GO_0010467', 'gene expression', 13, 'expression'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 44, 'Hamp'), ('GO_0010467', 'gene expression', 49, 'expression')]
PMC5371292	3/2017	S178-PMC5371292	['(b) Expression of Hamp in Hepatic Tissue was significantly downregulated in h .']	N/A	N/A	[('GO_0010467', 'gene expression', 4, 'Expression'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 18, 'Hamp'), ('UBERON_0002107', 'liver', 26, 'hepatic'), ('UBERON_0000479', 'tissue', 34, 'tissue')]
PMC5371292	3/2017	S299-PMC5371292	['pylori infection causes inflammation, which in turn upregulates Expression of Hepcidin, an Antimicrobial peptide produced by the Liver that Regulates systemic iron Metabolism [48].']	N/A	N/A	[('GO_0010467', 'gene expression', 64, 'expression'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 78, 'hepcidin'), ('CHEBI_65381', 'albizoside C', 91, 'antimicrobial'), ('UBERON_0002107', 'liver', 129, 'liver'), ('GO_0065007', 'biological regulation', 140, 'regulates'), ('GO_0008152', 'metabolic process', 164, 'metabolism')]
PMC5371292	3/2017	S334-PMC5371292	['Hepatic Expression of Hamp , which encodes the body’s master iron Regulatory protein, Hepcidin, was significantly lower in h .']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010467', 'gene expression', 8, 'expression'), ('PR_000008474', 'hematopoietic lineage cell-specific protein', 22, 'Hamp'), ('GO_0065007', 'biological regulation', 66, 'regulatory'), ('PR_000008563', 'histidine triad nucleotide-binding protein 3', 86, 'hepcidin')]
PMC5387697	2/2017	S102-PMC5387697	['Liver magnetic resonance imaging–estimated Proton density fat fraction (pdff) is more sensitive and favourably comparable to histopathology scores (72).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('CHEBI_24636', 'proton', 43, 'proton')]
PMC5387697	2/2017	S118-PMC5387697	['measurement of fasting Insulin concentrations are considered representative of Insulin Hepatic sensitivity (low concentrations) or resistance (high concentrations).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 23, 'insulin'), ('PR_000045358', 'insulin family protein', 79, 'insulin'), ('UBERON_0002107', 'liver', 87, 'hepatic')]
PMC5392925	4/2017	S42-PMC5392925	['exclusion criteria include multiple Gestations or any of the following conditions diagnosed prior to Conception: diabetes, cancer, hepatitis c, or Liver cirrhosis.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 36, 'gestations'), ('GO_0007620', 'copulation', 101, 'conception'), ('UBERON_0002107', 'liver', 147, 'liver')]
PMC5392925	4/2017	S134-PMC5392925	['Liver enzymes alanine aminotransferases (alt) and gamma-glutamyl transferase (ggt) are measured on a polychem analyser (polymedco inc., cortlandt manor, ny).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC5392925	4/2017	S143-PMC5392925	['caption (table-wrap): table 1\n\noverview of data collection for expected 3350 women in the Pregnancy and environment lifestyle study (petals)Pregnancydeliverydata source10–13 weeks16–19 weeks24–28 weeksmaternal variablesdemographics\u2003agexsurvey\u2003race/ethnicityxsurvey\u2003household sesxsurveymedical historyxxxxsurvey/ehrreproductive historyxsurvey/ehrbehavioral/lifestyle\u2003maternal diet by ffqxsurvey [14]\u2003physical activityxsurvey [16]\u2003sleepxsurvey\u2003smoking and alcoholxsurvey\u2003stress and depressionxsurvey [17,18]/ehranthropometry\u2003pre-Pregnancy weightxehr\u2003weightxcv\u2003heightxcv\u2003waist and hip circumferencesxcv\u2003Gestational weight gainxxxxehrself-reported products usexsurveybiospecimen collection\u2003fasting Bloodxx\u2003Urinexxgdm ascertainmentxehr\u200350-g, 1-h gctxehr\u2003100-g, 3-hour ogttxehrinfant variables\u2003estimated fetal sizexehr\u2003birth size (weight, length)xehr\u2003Gestational age at Deliveryxehr\u2003infant sexxehrmeasurements for the Phenols-gdm case control studya\u2003Urinary Bpa/Bp-3/Tcs levels\u2003Glucose, Insulin, homa-irxaxaserum\u2003total adiponectinxaxaserum\u2003Liver enzymes (alt and ggt)xaxaserum\nalt aminotransferases, Bpa Bisphenol-a, b p-3 Bisphenol-3, cv clinic visit, ehr electronic health record, ffq Food frequency questionnaire, gct Glucose challenge test, ggt gamma-glutamyl transferase, homa-ir Homeostatic model assessment-Insulin resistance, ogtt oral Glucose tolerance test, ses socioeconomic status, tcs triclosan\nameasured among 300 expected gdm cases and 600 controls\n\ninterim results\nbetween october 2013 and february 2016, 2,416 women who initiated Prenatal care with a Gestation age <11\xa0weeks at a kpnc medical center participating in the petals were deemed eligible via telephone interview and enrolled in the study.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 90, 'Pregnancy'), ('GO_0006412', 'translation', 140, 'PregnancyDeliveryData'), ('GO_0007565', 'female pregnancy', 527, 'pregnancy'), ('GO_0007565', 'female pregnancy', 600, 'Gestational'), ('UBERON_0001969', 'blood plasma', 694, 'bloodXX'), ('UBERON_0005906', 'serous sac', 702, 'UrineXXGDM'), ('GO_0007565', 'female pregnancy', 845, 'Gestational'), ('GO_0070983', 'dendrite guidance', 864, 'deliveryXEHR'), ('CHEBI_33853', 'phenols', 912, 'phenols'), ('UBERON_0001088', 'urine', 944, 'Urinary'), ('PR_000004792', 'bisphosphoglycerate mutase', 952, 'BPA'), ('PR_000004793', 'valacyclovir hydrolase', 956, 'BP-3'), ('CHEBI_17855', 'triglyceride', 961, 'TCS'), ('CHEBI_17234', 'glucose', 972, 'Glucose'), ('PR_000045358', 'insulin family protein', 981, 'insulin'), ('UBERON_0002107', 'liver', 1034, 'Liver'), ('CHEBI_34018', '(S)-AMPA', 1094, 'BPA'), ('CHEBI_22901', 'bisphenol', 1098, 'bisphenol'), ('CHEBI_37972', 'phosphorus-32 atom', 1115, '3'), ('CHEBI_22901', 'bisphenol', 1117, 'bisphenol'), ('CHEBI_33290', 'food', 1181, 'food'), ('CHEBI_17234', 'glucose', 1215, 'glucose'), ('GO_0042592', 'homeostatic process', 1279, 'homeostatic'), ('PR_000045358', 'insulin family protein', 1308, 'insulin'), ('CHEBI_17234', 'glucose', 1338, 'glucose'), ('GO_0007565', 'female pregnancy', 1541, 'prenatal'), ('GO_0007565', 'female pregnancy', 1562, 'gestation')]
PMC5420136	5/2017	S40-PMC5420136	['second, Pigs have limited Ketogenesis (the Production Of Acetoacetate and β-hydroxybutyrate from Fatty Acids) at any developmental stage due to their low Expression of Hepatic 3-Hydroxy-3-Methylglutaryl-Coa (Hmg-Coa) synthase [16,17].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 8, 'pigs'), ('GO_0001822', 'kidney development', 26, 'ketogenesis'), ('GO_0015628', 'protein secretion by the type II secretion system', 43, 'production of acetoacetate ... fatty acids'), ('CHEBI_35366', 'fatty acid', 97, 'fatty acids'), ('GO_0010467', 'gene expression', 154, 'expression'), ('UBERON_0002107', 'liver', 168, 'hepatic'), ('CHEBI_15485', '3-hydroxypimeloyl-CoA', 176, '3-hydroxy-3-methylglutaryl-CoA'), ('CHEBI_11814', '3-hydroxy-3-methylglutaryl-CoA', 208, 'HMG-CoA')]
PMC5420136	5/2017	S110-PMC5420136	['in addition, compared with adequate Protein Feeding, Birth weights as well as Brain and Liver weights are reduced and Bone Development is impaired, in the progeny of gilts Fed a protein-deficient diet throughout Gestation [44,49].']	N/A	N/A	[('GO_0006457', 'protein folding', 36, 'protein feeding'), ('GO_0007567', 'parturition', 53, 'birth'), ('UBERON_0000955', 'brain', 78, 'brain'), ('UBERON_0002107', 'liver', 88, 'liver'), ('GO_0048539', 'bone marrow development', 118, 'bone development'), ('GO_0007631', 'feeding behavior', 172, 'fed'), ('GO_0007565', 'female pregnancy', 212, 'gestation')]
PMC5420136	5/2017	S240-PMC5420136	['second, maternal protein restriction alters the Hepatic Lipid content in male offspring [106], as well as a high incidence of fatty Liver [107].']	N/A	N/A	[('UBERON_0002107', 'liver', 48, 'hepatic'), ('CHEBI_18059', 'lipid', 56, 'lipid'), ('UBERON_0002107', 'liver', 132, 'liver')]
PMC5420136	5/2017	S242-PMC5420136	['third, maternal protein deficiency during Gestation and Lactation alters Hepatic Cholesterol Metabolism in weanling Piglets via the epigenetic Regulation of Expression of Hmg-Coa reductase and Cholesterol-7alpha-hydroxylase (Cyp7Α1) [110].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 42, 'gestation'), ('GO_0007595', 'lactation', 56, 'lactation'), ('GO_0007568', 'aging', 73, 'hepatic'), ('UBERON_0002107', 'liver', 73, 'hepatic'), ('CHEBI_16113', 'cholesterol', 81, 'cholesterol'), ('GO_0008203', 'cholesterol metabolic process', 81, 'cholesterol metabolism'), ('NCBITaxon_33208', 'Metazoa', 116, 'piglets'), ('GO_0065007', 'biological regulation', 143, 'regulation'), ('GO_0010467', 'gene expression', 157, 'expression'), ('CHEBI_11814', '3-hydroxy-3-methylglutaryl-CoA', 171, 'HMG-CoA'), ('CHEBI_16113', 'cholesterol', 193, 'cholesterol'), ('PR_000006101', 'cytochrome P450 1A1', 225, 'CYP7α1')]
PMC5420151	5/2017	S5-PMC5420151	['three curricula ― Sexual and Reproductive health and Lifeskills, financial literacy, and nutrition ― guided the meetings.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 18, 'sexual ...'), ('GO_0000003', 'reproduction', 29, 'reproductive'), ('UBERON_0002107', 'liver', 53, 'lifeskills')]
PMC5439533	5/2017	S33-PMC5439533	['questionnaire\nthe questionnaire included demographic information (age, race, living environment, education level, type of fuel used for Cooking, number of persons in the household, Delivery hospital), Antenatal care (number of Antenatal visits, vaccinations received during Pregnancy, consumption of Antenatal Supplements), presence of medical conditions prior to Pregnancy (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), any complications during Pregnancy (hospitalization for any specific complication such as Preeclampsia, eclampsia, hemorrhage, sepsis, Urinary infection, diabetes, severe acute Respiratory infection, or influenza-like illness), other risk factors for adverse Pregnancy outcomes (Alcohol consumption and smoking before and during Pregnancy), obstetric characteristics of the mother (number of Parturitions, number of abortions, number of Livebirths and stillbirths, type of Delivery), and characteristics of the offspring (sex, weight, Gestational age at Delivery).']	N/A	N/A	[('GO_0065007', 'biological regulation', 136, 'cooking'), ('GO_0007567', 'parturition', 181, 'delivery'), ('GO_0007567', 'parturition', 201, 'antenatal'), ('GO_0007567', 'parturition', 227, 'antenatal'), ('GO_0007565', 'female pregnancy', 274, 'pregnancy'), ('GO_0007567', 'parturition', 300, 'antenatal'), ('CHEBI_33341', 'titanium atom', 310, 'supplements'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('UBERON_0002113', 'kidney', 402, 'renal'), ('UBERON_0002107', 'liver', 417, 'liver'), ('UBERON_0000178', 'blood', 432, 'blood'), ('UBERON_0001016', 'nervous system', 447, 'neurologic'), ('GO_0007565', 'female pregnancy', 493, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 558, 'preeclampsia'), ('UBERON_0001088', 'urine', 603, 'urinary'), ('UBERON_0001004', 'respiratory system', 645, 'respiratory'), ('GO_0007565', 'female pregnancy', 727, 'pregnancy'), ('CHEBI_30879', 'alcohol', 747, 'alcohol'), ('GO_0007565', 'female pregnancy', 797, 'pregnancy'), ('GO_0018989', 'apolysis', 860, 'parturitions'), ('GO_0008610', 'lipid biosynthetic process', 905, 'livebirths'), ('GO_0007567', 'parturition', 941, 'delivery'), ('GO_0007565', 'female pregnancy', 1003, 'gestational'), ('GO_0007567', 'parturition', 1022, 'delivery')]
PMC5439533	5/2017	S53-PMC5439533	['variables included in the psm model that could explain probability of receiving vaccination were selected a priori (age, race, education level, number of Antenatal visits, reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease) and because of a crude association with vaccination and/or Birth outcomes (type of fuel used for cooking, number of People in the household, reporting receiving at least one tetanus vaccine, iron and Vitamin B12 consumption during Pregnancy, Albendazole consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) calculated from height and weight measurements taken at first Antenatal visit, number of Parturitions).']	N/A	N/A	[('GO_0007567', 'parturition', 154, 'antenatal'), ('UBERON_0002113', 'kidney', 241, 'renal'), ('UBERON_0002107', 'liver', 256, 'liver'), ('UBERON_0000178', 'blood', 271, 'blood'), ('UBERON_0001016', 'nervous system', 286, 'neurologic'), ('GO_0007567', 'parturition', 365, 'birth'), ('NCBITaxon_10088', 'Mus <genus>', 422, 'people'), ('CHEBI_33279', 'vitamin D5', 506, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 506, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 537, 'pregnancy'), ('CHEBI_16664', 'albendazole', 548, 'albendazole'), ('GO_0007565', 'female pregnancy', 579, 'pregnancy'), ('GO_0007565', 'female pregnancy', 617, 'pregnancy'), ('CHEBI_2904', 'atenolol', 628, 'aspirin'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_30879', 'alcohol', 666, 'alcohol'), ('GO_0007565', 'female pregnancy', 693, 'pregnancy'), ('GO_0007567', 'parturition', 788, 'antenatal'), ('GO_0018989', 'apolysis', 815, 'parturitions')]
PMC5439533	5/2017	S82-PMC5439533	['at least one chronic condition of the following: obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease.']	N/A	N/A	[('UBERON_0002113', 'kidney', 76, 'renal'), ('UBERON_0002107', 'liver', 91, 'liver'), ('UBERON_0000178', 'blood', 106, 'blood'), ('UBERON_0001016', 'nervous system', 121, 'neurologic')]
PMC5439533	5/2017	S91-PMC5439533	['model adjusted for reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), age, race, calcium, Iron, and Folic Acid Consumption during Pregnancy, education level, number of Parturitions, body mass index (bmi) at first Antenatal visit, and sex of the baby.']	N/A	N/A	[('UBERON_0002113', 'kidney', 88, 'renal'), ('UBERON_0002107', 'liver', 103, 'liver'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0001016', 'nervous system', 133, 'neurologic'), ('CHEBI_24870', 'ion', 174, 'iron'), ('CHEBI_30751', 'formic acid', 184, 'folic acid'), ('GO_0007631', 'feeding behavior', 195, 'consumption'), ('GO_0007565', 'female pregnancy', 214, 'pregnancy'), ('GO_0018989', 'apolysis', 252, 'parturitions'), ('GO_0007567', 'parturition', 297, 'antenatal')]
PMC5439533	5/2017	S92-PMC5439533	['model adjusted for reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease), age, Albendazol and Aspirin consumption during Pregnancy, hospitalization during Pregnancy for any specific complication (Preeclampsia, eclampsia, hemorrhage, sepsis, Urinary infection, diabetes, severe acute Respiratory infection), Delivery hospital, number of Parturitions, body mass index (bmi) at first Antenatal visit, Alcohol consumption before Pregnancy, number of Antenatal visits, and sex of the baby.']	N/A	N/A	[('UBERON_0002113', 'kidney', 88, 'renal'), ('UBERON_0002107', 'liver', 103, 'liver'), ('UBERON_0000178', 'blood', 118, 'blood'), ('UBERON_0001016', 'nervous system', 133, 'neurologic'), ('CHEBI_31181', 'aklavinone', 159, 'albendazol'), ('CHEBI_2904', 'atenolol', 174, 'aspirin'), ('GO_0007565', 'female pregnancy', 201, 'pregnancy'), ('GO_0007565', 'female pregnancy', 235, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 276, 'preeclampsia'), ('UBERON_0001088', 'urine', 321, 'urinary'), ('UBERON_0001004', 'respiratory system', 363, 'respiratory'), ('GO_0007567', 'parturition', 387, 'delivery'), ('GO_0018989', 'apolysis', 416, 'parturitions'), ('GO_0007567', 'parturition', 461, 'antenatal'), ('CHEBI_30879', 'alcohol', 478, 'alcohol'), ('GO_0007565', 'female pregnancy', 505, 'pregnancy'), ('GO_0007567', 'parturition', 526, 'antenatal')]
PMC5439533	5/2017	S94-PMC5439533	['propensity score models adjusted for age, race, education level, type of fuel used for Cooking, number of people in the household, reporting receiving at least one tetanus vaccine, number of Antenatal visits, fe and Vitamin B12 consumption during Pregnancy, Albendazol consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) at first Antenatal visit, number of Parturitions, and reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease).']	N/A	N/A	[('GO_0065007', 'biological regulation', 87, 'cooking'), ('GO_0007567', 'parturition', 191, 'antenatal'), ('CHEBI_33279', 'vitamin D5', 216, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 216, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 247, 'pregnancy'), ('CHEBI_31181', 'aklavinone', 258, 'albendazol'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('CHEBI_2904', 'atenolol', 337, 'aspirin'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('CHEBI_30879', 'alcohol', 375, 'alcohol'), ('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007567', 'parturition', 444, 'antenatal'), ('GO_0018989', 'apolysis', 471, 'parturitions'), ('UBERON_0002113', 'kidney', 558, 'renal'), ('UBERON_0002107', 'liver', 573, 'liver'), ('UBERON_0000178', 'blood', 588, 'blood'), ('UBERON_0001016', 'nervous system', 603, 'neurologic')]
PMC5439533	5/2017	S105-PMC5439533	['models adjusted for race, education level, Iron and Folic Acid Consumption during Pregnancy, number of Parturitions, body mass index (bmi) at first Antenatal visit, number of Antenatal visits and sex of the baby for mothers vaccinated in the first trimester; age, race, education level, Iron and Folic Acid consumption during Pregnancy, number of Parturitions, body mass index (bmi) at first Antenatal visit, number of Antenatal visits, number of People in the household and sex of the baby for mothers vaccinated in the second trimester; number of Parturitions, body mass index (bmi) at first Antenatal visit, reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease) and sex of the baby for mothers vaccinated in the third trimester.']	N/A	N/A	[('CHEBI_24870', 'ion', 43, 'iron'), ('CHEBI_30751', 'formic acid', 52, 'folic acid'), ('GO_0007631', 'feeding behavior', 63, 'consumption'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0018989', 'apolysis', 103, 'parturitions'), ('GO_0007567', 'parturition', 148, 'antenatal'), ('GO_0007567', 'parturition', 175, 'antenatal'), ('CHEBI_24870', 'ion', 287, 'iron'), ('CHEBI_30751', 'formic acid', 296, 'folic acid'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('GO_0018989', 'apolysis', 347, 'parturitions'), ('GO_0007567', 'parturition', 392, 'antenatal'), ('GO_0007567', 'parturition', 419, 'antenatal'), ('NCBITaxon_10088', 'Mus <genus>', 447, 'people'), ('GO_0018989', 'apolysis', 549, 'parturitions'), ('GO_0007567', 'parturition', 594, 'antenatal'), ('UBERON_0002113', 'kidney', 680, 'renal'), ('UBERON_0002107', 'liver', 695, 'liver'), ('UBERON_0000178', 'blood', 710, 'blood'), ('UBERON_0001016', 'nervous system', 725, 'neurologic')]
PMC5439533	5/2017	S109-PMC5439533	['propensity score models adjusted for age, race, education level, type of fuel used for Cooking, number of people in the household, reporting receiving at least one tetanus vaccine, number of Antenatal visits, fe and Vitamin B12 consumption during Pregnancy, Albendazol consumption during Pregnancy, calcium consumption during Pregnancy, Aspirin consumption during Pregnancy, Alcohol consumption before Pregnancy, body mass index (bmi) at first Antenatal visit, number of Parturitions, and reporting at least one chronic condition (obesity, diabetes, asthma, Renal disease, Liver disease, Blood disease, Neurologic disease).']	N/A	N/A	[('GO_0065007', 'biological regulation', 87, 'cooking'), ('GO_0007567', 'parturition', 191, 'antenatal'), ('CHEBI_33279', 'vitamin D5', 216, 'vitamin B12'), ('PR_000004481', 'V-type proton ATPase subunit B, kidney isoform', 216, 'vitamin B12'), ('GO_0007565', 'female pregnancy', 247, 'pregnancy'), ('CHEBI_31181', 'aklavinone', 258, 'albendazol'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy'), ('GO_0007565', 'female pregnancy', 326, 'pregnancy'), ('CHEBI_2904', 'atenolol', 337, 'aspirin'), ('GO_0007565', 'female pregnancy', 364, 'pregnancy'), ('CHEBI_30879', 'alcohol', 375, 'alcohol'), ('GO_0007565', 'female pregnancy', 402, 'pregnancy'), ('GO_0007567', 'parturition', 444, 'antenatal'), ('GO_0018989', 'apolysis', 471, 'parturitions'), ('UBERON_0002113', 'kidney', 558, 'renal'), ('UBERON_0002107', 'liver', 573, 'liver'), ('UBERON_0000178', 'blood', 588, 'blood'), ('UBERON_0001016', 'nervous system', 603, 'neurologic')]
PMC5445052	4/2017	S71-PMC5445052	['results\n\nAdult offspring bodyweight, fat mass, Ovary weight, and Liver weight\nafter 5\xa0weeks of exposure to the diets before Mating, the mean body weight of dams was not significantly different between the two groups (262.6\xa0±\xa08\xa0g vs. 283.5\xa0±\xa07\xa0g for control and hf diet group, respectively; p \xa0=\xa00.200).']	N/A	N/A	[('UBERON_0007023', 'adult organism', 9, 'Adult'), ('UBERON_0000992', 'ovary', 47, 'ovary'), ('UBERON_0002107', 'liver', 65, 'liver'), ('GO_0007618', 'mating', 124, 'mating')]
PMC5445052	4/2017	S150-PMC5445052	['we chose a high-fat, high-Sucrose diet for 6\xa0months to induce more fat mass and Liver weight deposition in the female offspring.']	N/A	N/A	[('CHEBI_17992', 'sucrose', 26, 'sucrose'), ('UBERON_0002107', 'liver', 80, 'liver')]
PMC5445501	5/2017	S8-PMC5445501	['recommendation of fruits, traditional herbs, ugali (a dish made of Maize flour, Millet flour, or sorghum flour, sometimes mixed with cassava flour), Porridge and Liver, and restriction of avocadoes and oily Food were reported by more than 20% of the respondents.']	N/A	N/A	[('NCBITaxon_40674', 'Mammalia', 67, 'maize'), ('NCBITaxon_10088', 'Mus <genus>', 80, 'millet'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'porridge'), ('UBERON_0002107', 'liver', 162, 'liver'), ('CHEBI_33290', 'food', 207, 'food')]
PMC5445501	5/2017	S137-PMC5445501	['the Foods to be avoided by Pregnant women were Organ meat (with exception of Liver), mentioned by 96% of the respondents, meat (87%) and eggs (68%), oily Food (25%), Avocados ( persea americana) (20%), Alcohol and cigarettes (19%), Sugary Food (11%), soil and soft stones (11%) and moboriet (left over Ugali from the previous night commonly eaten as breakfast with other accompaniments) (10%).']	N/A	N/A	[('CHEBI_33290', 'food', 4, 'foods'), ('GO_0007565', 'female pregnancy', 27, 'pregnant'), ('UBERON_0000062', 'organ', 47, 'organ'), ('UBERON_0002107', 'liver', 77, 'liver'), ('CHEBI_33290', 'food', 154, 'food'), ('NCBITaxon_33208', 'Metazoa', 166, 'avocados'), ('CHEBI_30879', 'alcohol', 202, 'alcohol'), ('CHEBI_26822', 'sulfide', 232, 'sugary'), ('CHEBI_33290', 'food', 239, 'food'), ('UBERON_0000078', 'mixed ectoderm/mesoderm/endoderm-derived structure', 302, 'ugali')]
PMC5445501	5/2017	S291-PMC5445501	['whenever an Animal is Slaughtered in the village, Liver is specifically reserved for any Pregnant woman or children within that homestead.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 12, 'animal'), ('GO_0035106', 'operant conditioning', 22, 'slaughtered'), ('UBERON_0002107', 'liver', 50, 'liver'), ('GO_0007565', 'female pregnancy', 89, 'pregnant')]
PMC5445501	5/2017	S295-PMC5445501	['in addition, when an Animal is Slaughtered (mostly goat, Sheep, Cow or Chicken), its Liver is preserved for any Pregnant woman in the homestead.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 21, 'animal'), ('GO_0035106', 'operant conditioning', 31, 'slaughtered'), ('NCBITaxon_10088', 'Mus <genus>', 57, 'sheep'), ('NCBITaxon_33208', 'Metazoa', 64, 'cow'), ('NCBITaxon_33208', 'Metazoa', 71, 'chicken'), ('UBERON_0002107', 'liver', 85, 'liver'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
PMC5445501	5/2017	S329-PMC5445501	['according to many respondents, the prominent way of ensuring enough Blood is Consuming plenty of traditional vegetables, Liver, Animal Blood, fruits, Milk, beans, red Soil/stones and fish during the Pregnancy period.']	N/A	N/A	[('UBERON_0000178', 'blood', 68, 'blood'), ('GO_0007631', 'feeding behavior', 77, 'consuming'), ('UBERON_0002107', 'liver', 121, 'liver'), ('NCBITaxon_33208', 'Metazoa', 128, 'animal'), ('UBERON_0000178', 'blood', 135, 'blood'), ('UBERON_0001913', 'milk', 150, 'milk'), ('UBERON_0001913', 'milk', 167, 'soil'), ('GO_0007565', 'female pregnancy', 199, 'pregnancy')]
PMC5445501	5/2017	S376-PMC5445501	['some Food beliefs such as Eating traditional vegetables and milk, as well as restricting the Consumption of Organ meat (with exemption of Liver), meat and eggs, are subscribed to by more than 60% of the respondents.']	N/A	N/A	[('CHEBI_33290', 'food', 5, 'food'), ('GO_0051318', 'G1 phase', 26, 'eating'), ('GO_0007631', 'feeding behavior', 93, 'consumption'), ('UBERON_0000062', 'organ', 108, 'organ'), ('UBERON_0002107', 'liver', 138, 'liver')]
PMC5445501	5/2017	S377-PMC5445501	['consumption of fruits, traditional herbs, ugali, porridge and Liver, and restriction of avocadoes and oily Food was reported by more than 20% of the respondents.']	N/A	N/A	[('UBERON_0002107', 'liver', 62, 'liver'), ('CHEBI_33290', 'food', 107, 'food')]
PMC544881	12/2004	S93-PMC544881	['in late Gestation, Adipose Tissue Lipolysis is greatly augmented generating Ffa and Glycerol, for further Hepatic Vldl Production, contributing to the flux of circulating Tg-fatty acids in Pregnancy [18,19].']	N/A	N/A	[('GO_0007565', 'female pregnancy', 8, 'gestation'), ('GO_0070227', 'lymphocyte apoptotic process', 19, 'adipose tissue lipolysis'), ('UBERON_0001013', 'adipose tissue', 19, 'adipose tissue'), ('CHEBI_30751', 'formic acid', 76, 'FFA'), ('CHEBI_17754', 'glycerol', 84, 'glycerol'), ('GO_0007568', 'aging', 106, 'hepatic'), ('UBERON_0002107', 'liver', 106, 'hepatic'), ('GO_0034397', 'telomere localization', 114, 'VLDL production'), ('CHEBI_17855', 'triglyceride', 171, 'TG'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy')]
PMC5472316	6/2017	S68-PMC5472316	['basal vital Organs such as Liver, Heart, Lungs, Spleen, Stomach, Kidneys, and Brain were isolated and weighted.']	N/A	N/A	[('UBERON_0000062', 'organ', 12, 'organs'), ('UBERON_0002107', 'liver', 27, 'liver'), ('UBERON_0000948', 'heart', 34, 'heart'), ('UBERON_0002048', 'lung', 41, 'lungs'), ('UBERON_0002106', 'spleen', 48, 'spleen'), ('UBERON_0000945', 'stomach', 56, 'stomach'), ('UBERON_0002113', 'kidney', 65, 'kidneys'), ('UBERON_0000955', 'brain', 78, 'brain')]
PMC5472316	6/2017	S164-PMC5472316	['moreover, Hmb given to sows during Pregnancy increased the weight of the Liver, Lung, and Stomach.']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 10, 'HMB'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('UBERON_0002107', 'liver', 73, 'liver'), ('UBERON_0002048', 'lung', 80, 'lung'), ('UBERON_0000945', 'stomach', 90, 'stomach')]
PMC5472316	6/2017	S268-PMC5472316	['the supplementation with Hmb significantly increases the weight of Livers and Kidneys.']	N/A	N/A	[('CHEBI_17883', 'hydrogen chloride', 25, 'HMB'), ('UBERON_0002107', 'liver', 67, 'livers'), ('UBERON_0002113', 'kidney', 78, 'kidneys')]
PMC5474873	6/2017	S19-PMC5474873	['in order to convert 7-Dehydrocholesterol to pre-Vitamin D3, the skin is penetrated by solar ultraviolet b radiation (wavelength between 290 and 315\u2009nm), which then is isomerized by heat to Vitamin D3 before being carried, bound to Vitamin D-binding protein, to the Liver where it is converted into the main Metabolite 25-Hydroxyvitamin D3.']	N/A	N/A	[('CHEBI_17500', '7alpha-hydroxycholesterol', 20, '7-dehydrocholesterol'), ('CHEBI_33279', 'vitamin D5', 48, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 48, 'vitamin D3'), ('CHEBI_33279', 'vitamin D5', 189, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 189, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('UBERON_0002107', 'liver', 265, 'liver'), ('CHEBI_39382', 'flufenoxuron', 307, 'metabolite'), ('CHEBI_63991', '15-epi-lipoxin B4', 318, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 336, 'D3')]
PMC5485039	3/2017	S36-PMC5485039	['following Ingestion, all are converted to 5‐Methyl‐Tetrahydrofolate (5‐Methyl‐Thf) monoglutamate, mostly in the Mucosa Of the Small Intestine and to some degree in the Liver, before entering into the Peripheral Circulation (fig\xa02).']	N/A	N/A	[('GO_0007631', 'feeding behavior', 10, 'ingestion'), ('CHEBI_46882', 'primary amino group', 42, '5‐methyl'), ('CHEBI_67016', 'tetrahydrofolate', 51, 'tetrahydrofolate'), ('CHEBI_52071', 'dextran', 69, '5'), ('CHEBI_32875', 'methyl group', 71, 'methyl'), ('CHEBI_17038', 'fecosterol', 78, 'THF'), ('UBERON_0001204', 'mucosa of small intestine', 112, 'mucosa of ... small intestine'), ('UBERON_0002107', 'liver', 168, 'liver'), ('UBERON_0002409', 'pericardial fluid', 200, 'peripheral circulation')]
PMC5501061	2/2017	S4-PMC5501061	['the third section has 14 chapters and covers various diseases from Cardiovascular diseases to hiv/aids, osteoporosis, Liver diseases and Neurological disorders.']	N/A	N/A	[('UBERON_0004535', 'cardiovascular system', 67, 'cardiovascular'), ('UBERON_0002107', 'liver', 118, 'liver'), ('UBERON_0001016', 'nervous system', 137, 'neurological')]
PMC5504744	7/2017	S39-PMC5504744	['subsequently, Spleen, Kidneys, Heart, Lungs, Liver and Brain were removed and weighed.']	N/A	N/A	[('UBERON_0002106', 'spleen', 14, 'spleen'), ('UBERON_0002113', 'kidney', 22, 'kidneys'), ('UBERON_0000948', 'heart', 31, 'heart'), ('UBERON_0002048', 'lung', 38, 'lungs'), ('UBERON_0002107', 'liver', 45, 'liver'), ('UBERON_0000955', 'brain', 55, 'brain')]
PMC5504744	7/2017	S100-PMC5504744	['the piglets selected from the ol sows compared with those from the in sows were heavier ( p = 0.008) at Birth, and had greater ( p ≤ 0.033) stm, pm, Liver and Kidney weights.']	N/A	N/A	[('GO_0007567', 'parturition', 104, 'birth'), ('UBERON_0002107', 'liver', 149, 'liver'), ('UBERON_0002113', 'kidney', 159, 'kidney')]
PMC5504744	7/2017	S106-PMC5504744	['Birth weight had no effect on either absolute or relative stm, pm, Organ weights and Brain:Liver weight ratio.']	N/A	N/A	[('GO_0007567', 'parturition', 0, 'Birth'), ('UBERON_0000062', 'organ', 67, 'organ'), ('UBERON_0000955', 'brain', 85, 'brain'), ('UBERON_0002107', 'liver', 91, 'liver')]
PMC5504744	7/2017	S108-PMC5504744	['compared with l-Piglets, m-Piglets Born from sows Fed the arg, but not the ctrl diet, had heavier stm (l-arg = 2.679 vs. m-arg = 3.401 g), pm (l-arg = 2.840 vs. m-arg = 3.547 g), Hearts (l-arg = 8.387 vs. m-arg = 9.538 g), Livers (l-Arg = 33.87 vs. m-arg = 41.07 g), Spleens (l-arg = 1.07 vs. m-arg = 1.42 g), Lungs (l-arg = 17.00 vs. m-arg = 19.90 g) and Kidneys (l-arg = 9.66 vs. m-arg = 12.00 g).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 16, 'piglets'), ('NCBITaxon_33208', 'Metazoa', 27, 'piglets'), ('GO_0007567', 'parturition', 35, 'born'), ('GO_0007631', 'feeding behavior', 50, 'fed'), ('UBERON_0000948', 'heart', 179, 'hearts'), ('UBERON_0002107', 'liver', 223, 'livers'), ('UBERON_0001885', 'dentate gyrus of hippocampal formation', 233, 'ARG'), ('UBERON_0002367', 'prostate gland', 267, 'spleens'), ('UBERON_0002048', 'lung', 310, 'lungs'), ('UBERON_0002113', 'kidney', 356, 'kidneys')]
PMC5504744	7/2017	S113-PMC5504744	['finally, males and females differed ( p< 0.05) in absolute weights of Liver (34.18 vs. 36.73 g), Lung weight (18.80 vs. 17.82 g) and relative Heart weight (0.69 vs. 0.66 g/100 g btw).']	N/A	N/A	[('UBERON_0002107', 'liver', 70, 'liver'), ('UBERON_0002048', 'lung', 97, 'lung'), ('UBERON_0000948', 'heart', 142, 'heart')]
PMC5504744	7/2017	S114-PMC5504744	['caption (table-wrap): table 4\n\nBirth weight, absolute and relative muscle and Organ weights and Brain:Liver weight ratio of offspring Born from Oviduct Ligated (ol; non crowded) and intact (in; relatively crowded) Fed an unsupplemented (ctrl) orl-arginine supplemented diet (arg) from d 14 to 28 of Gestation1Inol p -value2itemctrlargctrlargsemiucdietbtwiuc×dietdiet×btwobservations19191715birth weight, kg1.061.211.581.590.1280.0080.0680.5640.137< 0.001weights, g\u2003 Semitendinosus muscle2.082.483.473.600.4170.0250.0740.5710.4260.009\u2003 Psoas Major Muscle2.152.363.864.020.3430.0010.2320.5430.8910.024\u2003heart8.34a10.54b8.35ab7.38ab1.6950.4180.1590.8060.0050.032\u2003Liver20.9127.3945.9847.555.8080.0040.0530.5290.2900.022\u2003Spleen1.051.001.451.500.1640.0630.9380.9180.5370.052\u2003Lungs16.4818.2419.8618.662.6550.5760.7500.4590.1520.010\u2003Kidneys7.688.9312.7712.731.5160.0330.3010.7710.3220.022\u2003Brain32.2233.0133.8534.320.7810.2350.1190.6210.6990.031brain:Liver weight ratio1.361.120.940.920.2220.2700.0770.1510.1820.001weights, g/100 g btw\u2003 Semitendinosus Muscle2.092.082.192.280.0950.3280.4150.7160.3410.511\u2003 Psoas Major muscle2.062.142.312.390.1400.2770.2760.3140.9870.483\u2003heart0.700.670.670.650.0230.4920.0300.7700.7200.338\u2003Liver2.212.472.782.770.1790.1280.1920.6290.1420.343\u2003Spleen0.10b0.09a0.09ab0.09ab0.0060.6650.1760.7340.0180.556\u2003Lung1.471.391.311.270.1090.3630.2500.2350.7620.655\u2003Kidney0.740.720.800.820.0430.2700.7640.6130.3960.627\u2003Brain2.872.532.472.500.3230.6160.1690.2040.114< 0.001\n1results are presented as least squares means of interactions between the two main factors extent of intra Uterine crowding and dietary treatment and pooled sem\n2probability values for the effects of extent of intra Uterine crowding (iuc), dietary treatment (diet), Birth weight (btw), and interactions iuc × diet and diet × btw\na,bwithin a row for the main factor treatment, least squares means without a common superscript differ ( p< 0.05)\n\nMyofiber characteristics of the Semitendinosus muscle\nexcept for the greater ( p = 0.078) area of the Stmdin ol compared with in offspring, the extent of iuc did not affect total muscle area, muscle area of the stmlnor stmdand stmlmyofiber number of selected offspring (table5).']	N/A	N/A	[('GO_0007567', 'parturition', 31, 'Birth'), ('UBERON_0000062', 'organ', 78, 'organ'), ('UBERON_0000955', 'brain', 96, 'brain'), ('UBERON_0002107', 'liver', 102, 'liver'), ('GO_0007567', 'parturition', 134, 'born'), ('UBERON_0000993', 'oviduct', 144, 'oviduct'), ('GO_0006266', 'DNA ligation', 152, 'ligated'), ('GO_0007631', 'feeding behavior', 214, 'fed'), ('GO_0034206', 'enhanceosome', 299, 'gestation1INOL'), ('UBERON_0001375', 'semitendinosus', 466, 'Semitendinosus'), ('PR_000002240', 'tyrosine-protein kinase Tec', 535, 'Psoas major muscle2'), ('UBERON_0007150', 'superior thyroid artery', 659, 'Liver20'), ('UBERON_0011635', 'splenial bone', 715, 'Spleen1'), ('UBERON_0000118', 'lung bud', 768, 'Lungs16'), ('UBERON_0000975', 'sternum', 824, 'Kidneys7'), ('UBERON_0003822', 'forelimb stylopod', 880, 'Brain32'), ('UBERON_0002107', 'liver', 941, 'liver'), ('UBERON_0010313', 'neural crest-derived structure', 1027, 'Semitendinosus muscle2'), ('UBERON_0001298', 'psoas major muscle', 1096, 'Psoas major'), ('UBERON_0006009', 'cusp of cardiac valve', 1213, 'Liver2'), ('UBERON_0002106', 'spleen', 1265, 'Spleen0'), ('UBERON_0000118', 'lung bud', 1324, 'Lung1'), ('UBERON_0002022', 'insula', 1375, 'Kidney0'), ('UBERON_0000955', 'brain', 1428, 'Brain2'), ('UBERON_0000995', 'uterus', 1589, 'uterine'), ('UBERON_0000995', 'uterus', 1698, 'uterine'), ('GO_0007567', 'parturition', 1748, 'birth'), ('CL_0000187', 'muscle cell', 1926, 'Myofiber'), ('UBERON_0001375', 'semitendinosus', 1958, 'Semitendinosus'), ('PR_000015699', 'alpha-2,8-sialyltransferase 8E', 2028, 'STMdin')]
PMC5513133	7/2017	S33-PMC5513133	['this is followed by two successive hydroxylations - first at the 25 position to form 25-Hydroxyvitamin D [25(Oh)D], which occurs in the Liver, and second to form the active hormonal Metabolite 1,25-Dihydroxyvitamin D [1,25(Oh)2D], also called Calcitriol, which is largely carried out in the Kidney.']	N/A	N/A	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 85, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 106, '25(OH)D'), ('UBERON_0002107', 'liver', 136, 'liver'), ('CHEBI_39382', 'flufenoxuron', 182, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 193, '1,25-dihydroxyvitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 218, '1,25(OH)2D'), ('CHEBI_17823', 'calcitriol', 243, 'calcitriol'), ('UBERON_0002113', 'kidney', 291, 'kidney')]
PMC5514114	7/2017	S50-PMC5514114	['the treatment oil was derived from Hoki ( macruronus novaezelandiae ) Liver (seadragon marine oils, nelson, new zealand).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 35, 'hoki'), ('UBERON_0002107', 'liver', 70, 'liver')]
PMC5514114	7/2017	S64-PMC5514114	['pups not allocated to litters were killed by decapitation, when Plasma, Red Blood Cells, Liver, and Heart were collected.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 64, 'plasma'), ('CL_0000232', 'erythrocyte', 72, 'red blood cells'), ('UBERON_0000178', 'blood', 76, 'blood'), ('UBERON_0002107', 'liver', 89, 'liver'), ('UBERON_0000948', 'heart', 100, 'heart')]
PMC5514114	7/2017	S82-PMC5514114	['Liver and the Retroperitoneal and Gonadal Fat Pads were harvested and weighed.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0013531', 'retrosplenial region', 14, 'retroperitoneal ...'), ('UBERON_0003428', 'gonadal fat pad', 34, 'gonadal fat pads')]
PMC5514114	7/2017	S124-PMC5514114	['caption (table-wrap): table 6\n\nconcentrations of polyunsaturated Fatty Acids in Liver Phospholipids of Rat pups culled at day 2, according to the maternal diet (control or high-fat) and the gavage treatment during Pregnancy [fish oil or control (Water)].maternal control dietmaternal high-fat dietcontrolfish oilcontrolfish oiln912178c16:0 (Palmitic Acid)24.49\u2009±\u20091.0624.41\u2009±\u20091.0823.21\u2009±\u20090.5824.13\u2009±\u20090.50c16:1n-7 (Palmitoleic Acid)1.32\u2009±\u20090.091.26\u2009±\u20090.070.70\u2009±\u20090.05††††0.65\u2009±\u20090.05c18:0 (Stearic Acid)16.61\u2009±\u20091.0416.19\u2009±\u20090.8817.06\u2009±\u20090.6115.53\u2009±\u20090.86c18:1n-7 (Cis-Vaccenic Acid)1.87\u2009±\u20090.161.95\u2009±\u20090.111.61\u2009±\u20090.101.33\u2009±\u20090.08c18:1n-9 (Oleic Acid)9.67\u2009±\u20090.589.60\u2009±\u20090.4810.47\u2009±\u20090.639.47\u2009±\u20091.00c18:2n-6 (Linoleic Acid)10.74\u2009±\u20090.4010.45\u2009±\u20090.6511.13\u2009±\u20090.3511.39\u2009±\u20090.39c18:3N-3 (Α-Linolenic Acid)0.23\u2009±\u20090.040.25\u2009±\u20090.030.19\u2009±\u20090.020.24\u2009±\u20090.02c18:3N-6 (Γ-Linolenic Acid)0.44\u2009±\u20090.060.35\u2009±\u20090.030.36\u2009±\u20090.030.43\u2009±\u20090.048c20:0 (Arachidic Acid)0.62\u2009±\u20090.070.52\u2009±\u20090.060.60\u2009±\u20090.050.61\u2009±\u20090.06c20:1n-9 (eicosenoic acid)0.21\u2009±\u20090.030.28\u2009±\u20090.030.20\u2009±\u20090.010.26\u2009±\u20090.03C20:2n-6 (Eicosadienoic Acid)0.73\u2009±\u20090.050.72\u2009±\u20090.040.60\u2009±\u20090.03†0.61\u2009±\u20090.06C20:3N-6 (Dihomo-Γ-Linolenic Acid)0.75\u2009±\u20090.090.71\u2009±\u20090.060.85\u2009±\u20090.060.81\u2009±\u20090.10c20:4n-6 (arachidonic acid)17.57\u2009±\u20090.9718.57\u2009±\u20091.2518.84\u2009±\u20090.7618.42\u2009±\u20090.60c20:5n-3 (Eicosapentaenoic Acid)0.65\u2009±\u20090.070.66\u2009±\u20090.050.51\u2009±\u20090.040.68\u2009±\u20090.05**c22:4n-6 (Adrenic Acid)4.06\u2009±\u20090.573.56\u2009±\u20090.463.37\u2009±\u20090.294.21\u2009±\u20090.23c22:5n-6 (n-6 Docosapentaenoic Acid)1.46\u2009±\u20090.291.39\u2009±\u20090.161.27\u2009±\u20090.110.19\u2009±\u20090.13C22:5N-3 (N-3 Docosapentaenoic Acid)4.71\u2009±\u20090.315.03\u2009±\u20090.284.77\u2009±\u20090.275.82\u2009±\u20090.53c22:6n-3 (Docosahexaenoic Acid)3.87\u2009±\u20090.334.18\u2009±\u20090.444.29\u2009±\u20090.254.23\u2009±\u20090.36\ndata are means\u2009±\u2009standard errors.†p\u2009<\u20090.05 and††††p\u2009<\u20090.0001 for a maternal diet effect among the offspring of dams that received control gavage; **p\u2009<\u20090.01 for an effect of the gavage treatment between groups exposed to the same maternal diet.']	N/A	N/A	[('CHEBI_35366', 'fatty acid', 65, 'fatty acids'), ('UBERON_0002107', 'liver', 80, 'liver'), ('CHEBI_16247', 'phospholipid', 86, 'phospholipids'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 103, 'rat'), ('GO_0007565', 'female pregnancy', 214, 'pregnancy'), ('CHEBI_15377', 'water', 246, 'water'), ('CHEBI_15756', 'hexadecanoic acid', 341, 'palmitic acid'), ('CHEBI_30751', 'formic acid', 410, '7'), ('CHEBI_28716', 'palmitoleic acid', 413, 'palmitoleic acid'), ('CHEBI_28842', 'octadecanoic acid', 485, 'stearic acid'), ('CHEBI_52098', 'JOJO-1 dye', 553, '7 ('), ('CHEBI_32805', 'cis-aconitic acid', 556, 'cis-vaccenic acid'), ('CHEBI_52029', 'dilC18(3) dye', 625, '9 ('), ('CHEBI_30814', 'digallic acid', 628, 'oleic acid'), ('CHEBI_30881', 'xanthine-8-carboxylic acid', 694, 'linoleic acid'), ('CHEBI_37958', 'dye', 760, '3n'), ('CHEBI_37972', 'phosphorus-32 atom', 763, '3 ('), ('CHEBI_86354', '2-hydroxyacrylic acid', 766, 'α-linolenic acid'), ('CHEBI_37958', 'dye', 831, '3n'), ('CHEBI_52026', 'amorpha-4,11-diene', 834, '6'), ('CHEBI_61716', 'alpha-Kdo-CH2OH-(2->4)-alpha-Kdo', 837, 'γ-linolenic'), ('CHEBI_37527', 'acid', 849, 'acid'), ('CHEBI_28822', 'icosanoic acid', 906, 'arachidic acid'), ('CHEBI_52029', 'dilC18(3) dye', 972, '9 ('), ('CHEBI_73165', 'elf18', 1033, '03C20'), ('CHEBI_28741', 'sodium fluoride', 1042, '6 ('), ('CHEBI_36003', 'decenoic acid', 1045, 'eicosadienoic acid'), ('CHEBI_35050', 'ZAPA', 1107, '06C20'), ('CHEBI_71008', '3-dehydrotetradecasphinganine(1+)', 1113, '3n-6 (dihomo-γ-linolenic acid'), ('30', 'ACAA1 (human)', 1196, '('), ('CHEBI_36003', 'decenoic acid', 1272, 'eicosapentaenoic acid'), ('CHEBI_18308', 'acrylic acid', 1350, 'adrenic acid'), ('CHEBI_61205', 'docosatetraenoic acid', 1421, 'docosapentaenoic acid'), ('CHEBI_73171', 'ancymidol', 1485, '13C22'), ('CHEBI_76372', "5'-CCTTTC-3", 1491, '5n-3'), ('CHEBI_30256', 'thiocarbonyl group', 1497, 'n-3'), ('CHEBI_61205', 'docosatetraenoic acid', 1501, 'docosapentaenoic acid'), ('CHEBI_37972', 'phosphorus-32 atom', 1574, '3 ('), ('CHEBI_36003', 'decenoic acid', 1577, 'docosahexaenoic acid')]
PMC5514114	7/2017	S126-PMC5514114	['2b), adiposity, or proportional Liver weight (table\xa04).']	N/A	N/A	[('UBERON_0002107', 'liver', 32, 'liver')]
PMC5519748	7/2017	S6-PMC5519748	['in Adulthood, as compared to aga, sga showed: (1) decreased body weight and length; (2) increased Serum Triglycerides; (3) down-regulated Hepatic Ampk-Α1 but up-regulated Srebp-1c and Acc-1; (4) a significant reduction in Histone H3 Acetylation at the Promoter of Ampk-Α1.']	N/A	N/A	[('UBERON_0000113', 'post-juvenile adult stage', 3, 'adulthood'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_17855', 'triglyceride', 104, 'triglycerides'), ('UBERON_0002107', 'liver', 138, 'hepatic'), ('PR_000004512', 'ataxin-8', 146, 'AMPK-α1'), ('PR_000015619', 'sorcin', 171, 'SREBP'), ('PR_000003566', 'ATP-binding cassette sub-family D member 2', 184, 'ACC-1'), ('CHEBI_15358', 'histone', 222, 'histone'), ('GO_0043970', 'histone H3-K9 acetylation', 222, 'histone H3 acetylation'), ('PR_000027594', 'histone H3', 222, 'histone H3'), ('SO_0000167', 'promoter', 252, 'promoter'), ('PR_000004512', 'ataxin-8', 264, 'AMPK-α1')]
PMC5519748	7/2017	S17-PMC5519748	['ampk could inhibit both Cholesterol and Fatty Acid Biosynthesis by inactivating Acetyl Coa carboxylase (acc) and 3-Hydroxy-3-Methylglutaryl Coa reductase in the form of short Regulation, and Regulate Hepatic lipogenic Gene expression by inhibiting Srebp-1c, Peroxisome Proliferator-Activated Receptors or Carbohydrate Responsive Element-Binding Protein in the form of long Regulation7,8.']	N/A	N/A	[('CHEBI_16113', 'cholesterol', 24, 'cholesterol'), ('GO_0030509', 'BMP signaling pathway', 24, 'cholesterol ...'), ('CHEBI_35366', 'fatty acid', 40, 'fatty acid'), ('GO_0006633', 'fatty acid biosynthetic process', 40, 'fatty acid biosynthesis'), ('CHEBI_15513', 'acryloyl-CoA', 80, 'acetyl CoA'), ('CHEBI_15489', '3-oxo-fatty acyl-CoA', 113, '3-hydroxy-3-methylglutaryl CoA'), ('GO_0065007', 'biological regulation', 175, 'regulation'), ('GO_0065007', 'biological regulation', 191, 'regulate'), ('UBERON_0002107', 'liver', 200, 'hepatic'), ('SO_0000704', 'gene', 218, 'gene'), ('PR_000015619', 'sorcin', 248, 'SREBP'), ('GO_0005777', 'peroxisome', 258, 'peroxisome'), ('PR_000001658', 'prostaglandin E2 receptor EP2 subtype', 258, 'peroxisome proliferator-activated receptors'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 305, 'carbohydrate'), ('PR_000005890', 'crooked neck-like protein 1', 305, 'carbohydrate responsive element-binding protein'), ('GO_0065007', 'biological regulation', 373, 'regulation7')]
PMC5519748	7/2017	S55-PMC5519748	['caption (fig): figure 3\n\nimmunoprecipitation/western blot analyses of Hepatic Ampk-Α1, Nsrebp-1c and Acc-1 protein Expression.']	N/A	N/A	[('UBERON_0002107', 'liver', 70, 'hepatic'), ('PR_000004512', 'ataxin-8', 78, 'AMPK-α1'), ('PR_000011509', 'nuclear pore complex protein Nup155', 87, 'nSREBP'), ('PR_000003566', 'ATP-binding cassette sub-family D member 2', 101, 'ACC-1'), ('GO_0010467', 'gene expression', 115, 'expression')]
PMC5519748	7/2017	S58-PMC5519748	['Hepatic Ampk-Α1 protein Expression before ( a ) and after ( d ) gh or ns treatment.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000004512', 'ataxin-8', 8, 'AMPK-α1'), ('GO_0010467', 'gene expression', 24, 'expression')]
PMC5519748	7/2017	S59-PMC5519748	['Hepatic Nsrebp-1c protein Expression before ( b ) and after ( e ) gh or ns treatment.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000011509', 'nuclear pore complex protein Nup155', 8, 'nSREBP'), ('GO_0010467', 'gene expression', 26, 'expression')]
PMC5519748	7/2017	S60-PMC5519748	['Hepatic Acc-1 protein Expression before ( c ) and after ( f ) gh or ns treatment.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('PR_000003566', 'ATP-binding cassette sub-family D member 2', 8, 'ACC-1'), ('GO_0010467', 'gene expression', 22, 'expression')]
PMC5519748	7/2017	S64-PMC5519748	['exogenous Gh administration significantly increased Hepatic Ampk-Α1 mrna Expression ( p \u2009<\u20090.05) and decreased Srebp-1c and Acc-1 mrna Expression (all p \u2009<\u20090.05) in the sga\u2009+\u2009gh group compared with the sga\u2009+\u2009ns group (shown in fig.']	N/A	N/A	[('CHEBI_16382', 'iodide', 10, 'GH'), ('UBERON_0002107', 'liver', 52, 'hepatic'), ('PR_000004512', 'ataxin-8', 60, 'AMPK-α1'), ('GO_0010467', 'gene expression', 73, 'expression'), ('PR_000015619', 'sorcin', 111, 'SREBP'), ('PR_000003566', 'ATP-binding cassette sub-family D member 2', 124, 'ACC-1'), ('GO_0010467', 'gene expression', 135, 'expression')]
PMC5519748	7/2017	S66-PMC5519748	['caption (fig): figure 4\n\nreal-time rt-pcr analysis of Hepatic Ampk-Α1, Nsrebp-1c and Acc-1 mrna Expression.']	N/A	N/A	[('UBERON_0002107', 'liver', 54, 'hepatic'), ('PR_000004512', 'ataxin-8', 62, 'AMPK-α1'), ('PR_000011509', 'nuclear pore complex protein Nup155', 71, 'nSREBP'), ('PR_000003566', 'ATP-binding cassette sub-family D member 2', 85, 'ACC-1'), ('GO_0010467', 'gene expression', 96, 'expression')]
PMC5519748	7/2017	S68-PMC5519748	['Hepatic mrna Expression at neonatal ( a ) adolescent ( b ) and Adult ( c ) periods.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('GO_0010467', 'gene expression', 13, 'expression'), ('UBERON_0007023', 'adult organism', 63, 'adult')]
PMC5519748	7/2017	S75-PMC5519748	['at 21 days of age, there were significant reductions in Histone H3 Acetylation at the Promoter of Ampk-Α1 in sga Liver Tissue compared with aga Rats.']	N/A	N/A	[('CHEBI_15358', 'histone', 56, 'histone'), ('GO_0043970', 'histone H3-K9 acetylation', 56, 'histone H3 acetylation'), ('PR_000027594', 'histone H3', 56, 'histone H3'), ('SO_0000167', 'promoter', 86, 'promoter'), ('PR_000004512', 'ataxin-8', 98, 'AMPK-α1'), ('UBERON_0002107', 'liver', 113, 'liver'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 144, 'rats')]
PMC5519748	7/2017	S136-PMC5519748	['thirty microgram of Liver protein extracts were heated for 7\u2009min at 95\u2009°c and then subjected to 10% Sds-page gels using the bio-rad mini protean ii system, and proteins were electroblotted onto Polyvinylidene Difluoride Membranes (0.2 μm pore size, catalog no.']	N/A	N/A	[('UBERON_0002107', 'liver', 20, 'liver'), ('CHEBI_8984', 'sodium dodecyl sulfate', 100, 'SDS'), ('CHEBI_53245', 'poly(vinylpyridine)', 194, 'polyvinylidene difluoride'), ('GO_0016020', 'membrane', 220, 'membranes')]
PMC5519748	7/2017	S153-PMC5519748	['briefly, a quantity of 40\u2009mg Liver Tissue was incubated with 1% Formaldehyde for 10\u2009min at room temperature to cross link proteins and dna.']	N/A	N/A	[('UBERON_0002107', 'liver', 29, 'liver'), ('UBERON_0000479', 'tissue', 35, 'tissue'), ('CHEBI_16842', 'formaldehyde', 64, 'formaldehyde')]
PMC5519748	7/2017	S155-PMC5519748	['the Liver Tissue was washed twice with cold pbs and placed in 1\u2009ml of Sds Lysis buffer containing 5\u2009ul1x protease inhibitor Cocktail ii.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('UBERON_0000479', 'tissue', 10, 'tissue'), ('CHEBI_8984', 'sodium dodecyl sulfate', 70, 'SDS'), ('GO_0019835', 'cytolysis', 74, 'lysis'), ('CHEBI_60004', 'mixture', 124, 'cocktail')]
PMC5521778	7/2017	S16-PMC5521778	['g ., Liver, Lung, Adipose) [3].']	N/A	N/A	[('UBERON_0002107', 'liver', 5, 'liver'), ('UBERON_0002048', 'lung', 12, 'lung'), ('UBERON_2000251', 'adipose fin', 18, 'adipose')]
PMC5521778	7/2017	S118-PMC5521778	['as shown infig 1a, the ~2.5 kb Bco1 mrna is readily detected in Human Heart, Skeletal muscle, Kidney, Liver, Placenta, and Lung.10.1371/journal.pone.0181466.g001\n\ncaption (fig): fig 1\nExpression of Bco1 in Human Lung Tissues and a variety of Human cell lines.']	N/A	N/A	[('PR_000004693', 'Bcl-2-like protein 10', 31, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 64, 'human'), ('UBERON_0000948', 'heart', 70, 'heart'), ('UBERON_0004288', 'skeleton', 77, 'skeletal'), ('UBERON_0002113', 'kidney', 94, 'kidney'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0001987', 'placenta', 109, 'placenta'), ('UBERON_0002048', 'lung', 123, 'lung'), ('GO_0010467', 'gene expression', 184, 'Expression'), ('PR_000004693', 'Bcl-2-like protein 10', 198, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 206, 'human'), ('UBERON_0002048', 'lung', 212, 'lung'), ('UBERON_0000479', 'tissue', 217, 'tissues'), ('NCBITaxon_9606', 'Homo sapiens', 242, 'human')]
PMC5521778	7/2017	S279-PMC5521778	['dex is known to increase Pparα mrna and protein levels in Liver Cells [45,46], Kidney [47], and Lung Tissue [48,49].']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 25, 'PPARα'), ('CL_0000592', 'large luteal cell', 58, 'liver cells'), ('UBERON_0002107', 'liver', 58, 'liver'), ('UBERON_0002113', 'kidney', 79, 'kidney'), ('UBERON_0002048', 'lung', 96, 'lung'), ('UBERON_0000479', 'tissue', 101, 'tissue')]
PMC5526977	7/2017	S5-PMC5526977	['maternal hfd also increased Plasma leptin, Il-6, and Mcp-1 in wt and increased arcuate Expression of Kiss1 and Esr1 (Erα) and Liver Expression of g6pc and Pepck in wt and kiko.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 28, 'plasma'), ('PR_000001470', 'interleukin-28B', 43, 'IL-6'), ('PR_000010439', 'myeloid leukemia factor 1', 53, 'MCP-1'), ('GO_0010467', 'gene expression', 87, 'expression'), ('PR_000009224', 'junctophilin-3', 101, 'Kiss1'), ('PR_000007164', 'general transcription and DNA repair factor IIH helicase subunit XPD', 111, 'Esr1'), ('PR_000007120', 'ephrin type-A receptor 1', 117, 'ERα'), ('UBERON_0002107', 'liver', 126, 'liver'), ('GO_0010467', 'gene expression', 132, 'expression'), ('PR_000012233', 'P antigen family member 4', 155, 'Pepck')]
PMC5526977	7/2017	S201-PMC5526977	['Glucose-6-phosphatase ( g6pc ) Expression, which Controls Hepatic Glucose Production46, was elevated by maternal hfd in wt (p\u2009<\u20090.0001) and kiko (p\u2009<\u20090.05) females (fig.']	N/A	N/A	[('CHEBI_17234', 'glucose', 0, 'Glucose'), ('GO_0010467', 'gene expression', 31, 'expression'), ('GO_0065007', 'biological regulation', 49, 'controls'), ('GO_0007568', 'aging', 58, 'hepatic'), ('UBERON_0002107', 'liver', 58, 'hepatic'), ('CHEBI_17234', 'glucose', 66, 'glucose'), ('GO_0006094', 'gluconeogenesis', 66, 'glucose production46')]
PMC5526977	7/2017	S210-PMC5526977	['Sterol Regulatory Element-Binding Protein 1 ( Srebp1 ), a regulator of Liver transcription for Glucose, Fatty Acid, and Lipid Production49, was not altered by maternal hfd but was Expressed less in ko than in wt (p\u2009<\u20090.05 for both; fig.']	N/A	N/A	[('CHEBI_15889', 'sterol', 0, 'Sterol'), ('PR_000015890', 'synaptophysin', 0, 'Sterol regulatory element-binding protein 1'), ('GO_0065007', 'biological regulation', 7, 'regulatory'), ('SO_0001678', 'regulatory_promoter_element', 7, 'regulatory element'), ('PR_000015909', 'synaptotagmin-7', 46, 'Srebp1'), ('UBERON_0002107', 'liver', 71, 'liver'), ('CHEBI_17234', 'glucose', 95, 'glucose'), ('GO_0007369', 'gastrulation', 95, 'glucose ...'), ('CHEBI_35366', 'fatty acid', 104, 'fatty acid'), ('GO_0001553', 'luteinization', 104, 'fatty acid ...'), ('CHEBI_18059', 'lipid', 120, 'lipid'), ('GO_0032945', 'negative regulation of mononuclear cell proliferation', 120, 'lipid production49'), ('GO_0010467', 'gene expression', 180, 'expressed')]
PMC5526977	7/2017	S215-PMC5526977	['maternal hfd increased Liver insr Expression in wt (p\u2009<\u20090.05) and kiko (p\u2009<\u20090.01) and was Expressed at lower levels in kiko (p\u2009<\u20090.05) and ko (p\u2009<\u20090.01) from hfd-Fed dams than wt.']	N/A	N/A	[('UBERON_0002107', 'liver', 23, 'liver'), ('GO_0010467', 'gene expression', 34, 'expression'), ('GO_0010467', 'gene expression', 90, 'expressed'), ('GO_0007631', 'feeding behavior', 162, 'fed')]
PMC5526977	7/2017	S217-PMC5526977	['caption (fig): figure 7\n\nLiver Gene Expression in all genotypes after 20 weeks of Adult Chow diet.']	N/A	N/A	[('UBERON_0002107', 'liver', 25, 'Liver'), ('GO_0010467', 'gene expression', 31, 'gene expression'), ('SO_0000704', 'gene', 31, 'gene'), ('UBERON_0007023', 'adult organism', 82, 'adult'), ('CHEBI_33290', 'food', 88, 'chow')]
PMC5526977	7/2017	S328-PMC5526977	['Abdominal Cavity was dissected for Liver Tissue (Secondary Lobe).']	N/A	N/A	[('UBERON_0003684', 'abdominal cavity', 0, 'Abdominal cavity'), ('UBERON_0002107', 'liver', 35, 'liver'), ('UBERON_0000479', 'tissue', 41, 'tissue'), ('UBERON_0001872', 'parietal lobe', 49, 'secondary lobe')]
PMC5526977	7/2017	S329-PMC5526977	['Liver Tissue was fixed in rnalater (life technologies, grand island, ny, usa) and stored at –80\u2009°c.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000479', 'tissue', 6, 'tissue')]
PMC5526977	7/2017	S330-PMC5526977	['Liver rna was extracted using a standard trizol® extraction (life technologies) coupled with macherey-nagel nucleospin® rna extraction and dnase-1 kit (bethlehem, pa, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC5526977	7/2017	S338-PMC5526977	['Liver and Arcuate rna quantity and quality were determined using a nanodrop nd-2000 spectrophotometer (thermofisher, waltham, ma, usa) and an agilent 2100 bioanalyzer and rna nano chips (agilent technologies, santa clara, ca, usa).']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0001876', 'amygdala', 10, 'arcuate')]
PMC5526977	7/2017	S347-PMC5526977	['the relative mrna Expression was calculated using the δδctmethod utilizing a calibrator of diluted (1:20) cdna from Liver or bh of an untreated male.']	N/A	N/A	[('GO_0010467', 'gene expression', 18, 'expression'), ('UBERON_0002107', 'liver', 116, 'liver')]
PMC5562975	8/2017	S50-PMC5562975	['fetal Organs including Heart, Liver, Placenta and Kidney as well as the Cow Uterus were dissected free of Connective Tissue and weighed.']	N/A	N/A	[('UBERON_0000062', 'organ', 6, 'organs'), ('UBERON_0000948', 'heart', 23, 'heart'), ('UBERON_0002107', 'liver', 30, 'liver'), ('UBERON_0001987', 'placenta', 37, 'placenta'), ('UBERON_0002113', 'kidney', 50, 'kidney'), ('NCBITaxon_33208', 'Metazoa', 72, 'cow'), ('UBERON_0000995', 'uterus', 76, 'uterus'), ('UBERON_0002384', 'connective tissue', 106, 'connective tissue')]
PMC5562975	8/2017	S53-PMC5562975	['two samples of approximately 5\xa0g of Heart, Liver, Caruncle, Cotyledon, Ld and St Muscles were collected, rinsed in ice-cold saline, snap frozen in liquid nitrogen and stored at −80\xa0°c.']	N/A	N/A	[('UBERON_0000948', 'heart', 36, 'heart'), ('UBERON_0002107', 'liver', 43, 'liver'), ('UBERON_0001847', 'lobule of pinna', 50, 'caruncle'), ('UBERON_0010232', 'placodal ectoderm', 60, 'cotyledon'), ('UBERON_0004621', 'lumbar vertebra 5', 71, 'LD'), ('UBERON_0001290', 'proximal straight tubule', 78, 'ST'), ('UBERON_0005090', 'muscle structure', 81, 'muscles')]
PMC5562975	8/2017	S56-PMC5562975	['rna extraction and real-time pcr\nHeart, Liver, Caruncle, Cotyledon, and ld and st muscle samples were ground under liquid nitrogen using a mortar and pestle.']	N/A	N/A	[('UBERON_0000948', 'heart', 33, 'Heart'), ('UBERON_0002107', 'liver', 40, 'liver'), ('UBERON_0001847', 'lobule of pinna', 47, 'caruncle'), ('UBERON_0010232', 'placodal ectoderm', 57, 'cotyledon')]
PMC5562975	8/2017	S59-PMC5562975	['total rna from Liver, ld and st muscle was extracted from 30 to 50\xa0mg of Tissue using the mirneasy micro kit (qiagen, germantown, md, usa) according to manufacturer’s instructions.']	N/A	N/A	[('UBERON_0002107', 'liver', 15, 'liver'), ('UBERON_0000479', 'tissue', 73, 'tissue')]
PMC5562975	8/2017	S72-PMC5562975	['therefore, peptidylprolyl isomerase a ( ppia ), Hydroxymethylbilane synthase ( hmbs ), Eukaryotic Translation Elongation Factor 1 Alpha 2, ( Eef1A2 ), tyrosine 3-monooxygenase/tryptophan ( ywhaz ) and the geometric mean of ywhaz/ glyceraldehyde-3-Phosphate dehydrogenase ( gapdh ) were used as the endogenous control to correct for rna extraction and Reverse Transcription efficiency in Liver, Heart, muscle (ld and st), Cotyledon, and Caruncle, respectively.']	N/A	N/A	[('CHEBI_5791', 'hydromorphone hydrochloride', 48, 'Hydroxymethylbilane'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 87, 'Eukaryotic Translation Elongation Factor 1 Alpha 2'), ('PR_000006901', 'early endosome antigen 1', 141, 'EEF1A2'), ('CHEBI_16332', 'D-xylulose 5-phosphate', 245, '3-Phosphate'), ('GO_0001171', 'reverse transcription', 351, 'reverse transcription'), ('UBERON_0002107', 'liver', 387, 'liver'), ('UBERON_0000948', 'heart', 394, 'heart'), ('UBERON_0010232', 'placodal ectoderm', 421, 'cotyledon'), ('UBERON_0001847', 'lobule of pinna', 436, 'caruncle')]
PMC5562975	8/2017	S108-PMC5562975	['1\n\nmrna abundance for Insulin-Like Growth Factors and myogenesis related Genes in Liver ( a ) and Heart ( b, c ) Tissue from fetal calf ( n \xa0=\xa022) exposed to a high or low diet in utero during the 2nd half of Gestation.']	N/A	N/A	[('PR_000008959', 'immunoglobulin heavy constant gamma 1', 22, 'Insulin-like growth factors'), ('SO_0000704', 'gene', 73, 'genes'), ('UBERON_0002107', 'liver', 82, 'liver'), ('UBERON_0000948', 'heart', 98, 'heart'), ('UBERON_0000479', 'tissue', 113, 'tissue'), ('GO_0007565', 'female pregnancy', 209, 'gestation')]
PMC5562975	8/2017	S152-PMC5562975	['indeed, a study in Baboons showed that maternal dietary restriction lead to lower Expression of Igf1 mrna and protein in fetal Liver [30], as well, Igf1 mrna was lower in Livers of Nutrient-restricted fetal Sheep when measured at the end of the restriction period [31].']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 19, 'baboons'), ('GO_0010467', 'gene expression', 82, 'expression'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 96, 'IGF1'), ('UBERON_0002107', 'liver', 127, 'liver'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 148, 'IGF1'), ('UBERON_0002107', 'liver', 171, 'livers'), ('CHEBI_33284', 'nutrient', 181, 'nutrient'), ('NCBITaxon_10088', 'Mus <genus>', 207, 'sheep')]
PMC5594587	9/2017	S140-PMC5594587	['it also increased the number of th receptors and deiodinase mrna Expression in different target Tissues such as Liver, Cardiac Muscle and Longissimus Dorsi Muscle but decreased the number of th receptors and deiodinase mrna Expression in Adipose Tissues [64].']	N/A	N/A	[('GO_0010467', 'gene expression', 65, 'expression'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0002107', 'liver', 112, 'liver'), ('UBERON_0001133', 'cardiac muscle tissue', 119, 'cardiac muscle'), ('UBERON_0001401', 'longissimus thoracis muscle', 138, 'longissimus dorsi muscle'), ('GO_0010467', 'gene expression', 224, 'expression'), ('UBERON_0001013', 'adipose tissue', 238, 'adipose tissues')]
PMC5612564	7/2017	S118-PMC5612564	['the ob/gyn resident assesses the patient in triage, orders initial investigations (complete Blood count (cbc), electrolytes, Liver function tests, Coagulation tests, Urinalysis).']	N/A	N/A	[('UBERON_0000178', 'blood', 92, 'blood'), ('UBERON_0002107', 'liver', 125, 'liver'), ('GO_0050817', 'coagulation', 147, 'coagulation'), ('GO_0006281', 'DNA repair', 166, 'urinalysis')]
PMC5621069	9/2017	S32-PMC5621069	['when it is orally administered, it is Metabolized in the Liver and loses its potency, entailing irregular Blood concentration and more frequent side effects.']	N/A	N/A	[('GO_0008152', 'metabolic process', 38, 'metabolized'), ('UBERON_0002107', 'liver', 57, 'liver'), ('UBERON_0000178', 'blood', 106, 'blood')]
PMC5627472	10/2017	S69-PMC5627472	['however, the saturated fat diet resulted in elevated Liver and Visceral fat accumulations.']	N/A	N/A	[('UBERON_0002107', 'liver', 53, 'liver'), ('UBERON_0002075', 'viscus', 63, 'visceral')]
PMC5634437	10/2017	S52-PMC5634437	['the most common categories were ‘Alimentary Tract and Metabolism’ followed by ‘dermatologicals’ (table\xa0s3).']	N/A	N/A	[('UBERON_0002107', 'liver', 33, 'Alimentary'), ('UBERON_0001018', 'axon tract', 44, 'Tract'), ('GO_0008152', 'metabolic process', 54, 'Metabolism')]
PMC5634602	10/2017	S53-PMC5634602	['exclusion criteria included infants with congenital abnormalities, Gastro-Intestinal, Liver, or Kidney disease, inborn errors of Metabolism, Parathyroid disease, disorders of calcium Metabolism, and infants receiving seizure medication or Steroids.']	N/A	N/A	[('UBERON_0005409', 'alimentary part of gastrointestinal system', 67, 'gastro-intestinal'), ('UBERON_0002107', 'liver', 86, 'liver'), ('UBERON_0002113', 'kidney', 96, 'kidney'), ('GO_0008152', 'metabolic process', 129, 'metabolism'), ('UBERON_0001132', 'parathyroid gland', 141, 'parathyroid'), ('GO_0008152', 'metabolic process', 183, 'metabolism'), ('CHEBI_35341', 'steroid', 239, 'steroids')]
PMC5640793	9/2017	S155-PMC5640793	["caption (table-wrap): table 1\n\ncharacteristics of participantscontrolinterventionall mothers and infants eligible at Birth154114603001District (state)west singhbhum (jharkhand)781 (51%)727 (50%)1508 (50%)kendujhar (odisha)760 (49%)733 (50%)1493 (50%)residencemain village964 (63%)889 (61%)1853 (62%)hamlet577 (37%)571 (39%)1148 (38%))mother's age (years)24·0 (4·6)23·9 (4·7)23·9 (4·6)parity2·4 (1·6)2·4 (1·6)2·4 (1·6)class or caste statusscheduled tribe1199 (78%)1100 (75%)2299 (77%)scheduled caste71 (5%)123 (8%)194 (7%)other backward class269 (18%)234 (16%)503 (17%)other2 (<1%)3 (<1%)5 (<1%)land ownershipless than 2 bighas956 (62%)837 (57%)1793 (60%)between 2 and 4 bighas342 (22%)355 (24%)697 (23%)more than 4 bighas110 (7%)99 (7%)209 (7%)land mortgaged6 (<1%)7 (1%)13 (<1%)no land119 (8%)145 (10%)264 (9%)missing8 (1%)17 (1%)25 (1%)literacycan read easily430 (28%)418 (29%)848 (28%)cannot read or with difficulty907 (59%)874 (60%)1781 (59%)missing204 (13%)168 (11%)372 (12%)educationnone or less than 3 years107 (7%)119 (8%)226 (8%)primary171 (11%)201 (14%)372 (12%)lower secondary283 (18%)284 (19%)567 (19%)higher secondary and above126 (8%)124 (9%)250 (8%)missing854 (55%)732 (50%)1586 (53%)multidimensional poverty quintilesfirst (poorest) quintile217 (14%)221 (15%)438 (15%)second quartile319 (21%)286 (20%)605 (20%)third quartile479 (31%)463 (32%)942 (31%)fourth quartile428 (28%)410 (28%)838 (28%)fifth (richest) quintile98 (6%)80 (6%)178 (6%)access to toiletyes—improved (flush or covered latrine)14 (1%)19 (1%)33 (1%)yes—not improved (open latrine)9 (<1%)10 (1%)19 (1%)no toilet1518 (99%)1431 (98%)2949 (98%)main source of drinking Watertap3 (<1%)19 (1%)22 (1%)hand pump or tubewell1027 (67%)933 (64%)1960 (65%)covered dug well24 (2%)29 (2%)53 (2%)uncovered dug well273 (18%)273 (19%)546 (18%)River, Canal or spring214 (14%)206 (14%)420 (14%)\ndata are n (%) or mean (sd)."]	N/A	N/A	[('GO_1904379', 'protein localization to cytosolic proteasome complex involved in ERAD pathway', 117, 'birth154114603001District'), ('CHEBI_83331', '(S)-orciprenaline', 1646, 'waterTap3'), ('UBERON_0002107', 'liver', 1807, 'River'), ('UBERON_0000025', 'tube', 1814, 'canal')]
PMC5678092	11/2017	S6-PMC5678092	['maternal obesity programmed increased adiposity and Liver Triglycerides, with decreased Glucose tolerance, Liver Nad+levels and citrate synthase activity in offspring.']	N/A	N/A	[('UBERON_0002107', 'liver', 52, 'liver'), ('CHEBI_17855', 'triglyceride', 58, 'triglycerides'), ('CHEBI_17234', 'glucose', 88, 'glucose'), ('UBERON_0002107', 'liver', 107, 'liver'), ('CHEBI_15846', 'NAD(+)', 113, 'NAD+')]
PMC5678092	11/2017	S82-PMC5678092	['after decapitation, white Adipose Tissue (Gonadal, Retroperitoneal, Inguinal), muscle (Quadriceps, Tibialis, Soleus) and Liver were weighed.']	N/A	N/A	[('UBERON_0001013', 'adipose tissue', 26, 'adipose tissue'), ('UBERON_0000991', 'gonad', 42, 'gonadal'), ('UBERON_0003693', 'retroperitoneal space', 51, 'retroperitoneal'), ('UBERON_0008337', 'inguinal part of abdomen', 68, 'inguinal ...'), ('UBERON_0001377', 'quadriceps femoris', 87, 'quadriceps'), ('UBERON_0008230', 'tibialis', 99, 'tibialis'), ('UBERON_0001389', 'soleus muscle', 109, 'soleus'), ('UBERON_0002107', 'liver', 121, 'liver')]
PMC5678092	11/2017	S83-PMC5678092	['Liver was ground using a Tissue pulverizer (bessman) on dry ice and liquid N2.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver'), ('UBERON_0000479', 'tissue', 25, 'tissue'), ('CHEBI_17997', 'dinitrogen', 75, 'N2')]
PMC5678092	11/2017	S84-PMC5678092	['Hepatic Triglyceride, citrate synthase activity and Nad+-nadh assays\nTriglyceride measurement was conducted as described previously26.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Hepatic'), ('CHEBI_17855', 'triglyceride', 8, 'triglyceride'), ('CHEBI_72855', '(4Z,7Z,10Z,13Z,19Z)-16,17-epoxydocosapentaenoic acid', 52, 'NAD+-'), ('CHEBI_17855', 'triglyceride', 69, 'Triglyceride')]
PMC5678092	11/2017	S85-PMC5678092	['briefly, after homogenisation and extraction, Liver Triglyceride content was determined using a commercially available colorimetric assay kit, Tg Reagent Triglyceride Gpo-Pap (cat# 11730711 216) from roche/hitachi.']	N/A	N/A	[('UBERON_0002107', 'liver', 46, 'liver'), ('CHEBI_17855', 'triglyceride', 52, 'triglyceride'), ('CHEBI_17855', 'triglyceride', 143, 'TG'), ('CHEBI_33893', 'reagent', 146, 'reagent'), ('CHEBI_17855', 'triglyceride', 154, 'Triglyceride'), ('PR_000008210', 'glutathione peroxidase 1', 167, 'GPO'), ('PR_000014701', 'heparin cofactor 2', 171, 'PAP')]
PMC5678092	11/2017	S87-PMC5678092	['citrate synthase activity was assayed by homogenizing 35\u2009mg of powdered Liver in tris buffer and subjecting to three freeze-thaw cycles with liquid n226.']	N/A	N/A	[('UBERON_0002107', 'liver', 72, 'liver')]
PMC5678092	11/2017	S92-PMC5678092	['dna was extracted from 25–30\u2009mg of ground Liver.']	N/A	N/A	[('UBERON_0002107', 'liver', 42, 'liver')]
PMC5678092	11/2017	S163-PMC5678092	['no significant changes were induced in muscle or Liver mass by the exercise and nmn interventions.']	N/A	N/A	[('UBERON_0002107', 'liver', 49, 'liver')]
PMC5678092	11/2017	S164-PMC5678092	['a post-weaning hfd increased the mass of all three muscles and Fat Pads (table\xa02), with no effect on Liver weight.']	N/A	N/A	[('UBERON_0003916', 'fat pad', 63, 'fat pads'), ('UBERON_0002107', 'liver', 101, 'liver')]
PMC5678092	11/2017	S191-PMC5678092	['caption (fig): figure 2\n\neffects of maternal diet, post-weaning diet, exercise and nmn on Hepatic Nad+- nadh, citrate synthase activity and Triglyceride content.']	N/A	N/A	[('UBERON_0002107', 'liver', 90, 'Hepatic'), ('CHEBI_72855', '(4Z,7Z,10Z,13Z,19Z)-16,17-epoxydocosapentaenoic acid', 98, 'NAD+-'), ('CHEBI_17855', 'triglyceride', 140, 'triglyceride')]
PMC5678092	11/2017	S198-PMC5678092	['Liver citrate synthase activity\nboth maternal (f (1,34)\u2009=\u20093.9, p\u2009=\u20090.054) and post weaning (f(1,34)\u2009=\u200911.496, p\u2009<\u20090.01) diet reduced citrate synthase activity, but there was no additive effect (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 0, 'Liver')]
PMC5678092	11/2017	S205-PMC5678092	['offspring Consuming hfd showed a significant reduction in Hepatic Triglyceride accumulation in response to both interventions; exercise and nmn (fig.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 10, 'consuming'), ('UBERON_0002107', 'liver', 58, 'hepatic'), ('CHEBI_17855', 'triglyceride', 66, 'triglyceride')]
PMC5678092	11/2017	S210-PMC5678092	['cd36 , a marker for fat Transport Into Liver, showed higher mrna Expression in the Liver in response to both maternal and post-weaning hfd.']	N/A	N/A	[('GO_0006366', 'transcription by RNA polymerase II', 24, 'transport into liver'), ('UBERON_0002107', 'liver', 39, 'liver'), ('GO_0010467', 'gene expression', 65, 'expression'), ('UBERON_0002107', 'liver', 83, 'liver')]
PMC5678092	11/2017	S251-PMC5678092	['caption (fig): figure 3\n\neffect of nmn and exercise on Expression of Genes involved in fat transport, Synthesis and β-oxidation in Liver.']	N/A	N/A	[('GO_0010467', 'gene expression', 55, 'expression'), ('SO_0000704', 'gene', 69, 'genes'), ('GO_0046153', 'ommochrome catabolic process', 102, '... synthesis'), ('UBERON_0002107', 'liver', 131, 'liver')]
PMC5678092	11/2017	S257-PMC5678092	['no changes in Hepatic sirt1 mrna Expression were observed in response to post-weaning diet or either intervention.']	N/A	N/A	[('UBERON_0002107', 'liver', 14, 'hepatic'), ('GO_0010467', 'gene expression', 33, 'expression')]
PMC5678092	11/2017	S270-PMC5678092	['these differences were in final body weight, Organ weights, gtt, Plasma Insulin, Liver Triglyceride and Pparg Transcript levels.']	N/A	N/A	[('UBERON_0000062', 'organ', 45, 'organ'), ('UBERON_0001969', 'blood plasma', 65, 'plasma'), ('PR_000045358', 'insulin family protein', 72, 'insulin'), ('UBERON_0002107', 'liver', 81, 'liver'), ('CHEBI_17855', 'triglyceride', 87, 'triglyceride'), ('PR_000013343', 'PH and SEC7 domain-containing protein 4', 104, 'Pparg'), ('SO_0000673', 'transcript', 110, 'transcript')]
PMC5678092	11/2017	S278-PMC5678092	['nmn injection leads to increased Nad+levels in the Liver.']	N/A	N/A	[('CHEBI_15846', 'NAD(+)', 33, 'NAD+'), ('UBERON_0002107', 'liver', 51, 'liver')]
PMC5678092	11/2017	S300-PMC5678092	['in hhs groups the reduction in Liver Triglyceride was equivalent in the exercise (hhx) or nmn (hhn) groups.']	N/A	N/A	[('UBERON_0002107', 'liver', 31, 'liver'), ('CHEBI_17855', 'triglyceride', 37, 'triglyceride')]
PMC5680205	11/2017	S28-PMC5680205	['results\n\nmoderate dietary Zinc restriction reduces circulating Zinc and Liver metallothionein concentrations\nto confirm that moderate dietary zinc restriction reduced maternal zinc status in c57bl/6\u2009j female Mice Fed a zinc-deficient diet (containing 10\u2009mg/kg zinc) compared to a zinc-replete diet (containing 40\u2009mg/kg Zinc), we analysed maternal Plasma zinc concentrations, Liver metallothionein Expression and Placental and fetal zinc content.']	N/A	N/A	[('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 26, 'Zinc'), ('CHEBI_27377', "Unsym-bis(4'-chlorophenyl)ethylene", 63, 'Zinc'), ('UBERON_0002107', 'liver', 72, 'Liver'), ('NCBITaxon_10088', 'Mus <genus>', 208, 'mice'), ('GO_0007631', 'feeding behavior', 213, 'fed'), ('CHEBI_33340', 'zinc group element atom', 319, 'zinc'), ('UBERON_0001969', 'blood plasma', 347, 'plasma'), ('UBERON_0002107', 'liver', 375, 'liver'), ('GO_0010467', 'gene expression', 397, 'expression'), ('UBERON_0001987', 'placenta', 412, 'placental')]
PMC5680205	11/2017	S30-PMC5680205	['1a; p \u2009=\u20090.005) and long term zinc status, as measured by Liver metallothionein, was also reduced by 19% (fig.']	N/A	N/A	[('UBERON_0002107', 'liver', 58, 'liver')]
PMC5680205	11/2017	S38-PMC5680205	['at gd18.5, a reduction in circulating zinc levels ( a ) as well as Liver metallothionein ( b ) was observed in the zinc-deficient dams.']	N/A	N/A	[('UBERON_0002107', 'liver', 67, 'liver')]
PMC5680205	11/2017	S262-PMC5680205	['disruptions to long term zinc stores were analysed by measuring Liver metallothionein at gd18.5 and 21 days post-Birth using a109cd/Heme affinity assay71.']	N/A	N/A	[('UBERON_0002107', 'liver', 64, 'liver'), ('GO_0007567', 'parturition', 113, 'birth'), ('CHEBI_30413', 'heme', 132, 'heme')]
PMC5682869	11/2017	S80-PMC5682869	['the main dietary sources of Vitamin D are cod Liver oil and fish.']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0002107', 'liver', 46, 'liver')]
PMC5682869	11/2017	S99-PMC5682869	['later in Life, both poor weight gain and accelerated weight gain in the first months of Infancy increase the risk of non-alcoholic fatty Liver disease (nafld) [27].']	N/A	N/A	[('UBERON_0000104', 'life cycle', 9, 'life'), ('UBERON_0000023', 'wing', 88, 'infancy'), ('UBERON_0002107', 'liver', 137, 'liver')]
PMC5685050	10/2014	S4-PMC5685050	["Vitamin D2(Ergocalciferol), from dietary sources or supplements, and Vitamin D3Are Metabolized in the Liver to 25-Hydroxyvitamin D (25(Oh)D), which is the major circulating form of Vitamin D and is used to determine an Individual's Vitamin D status[1]."]	N/A	N/A	[('CHEBI_28934', 'vitamin D2', 0, 'Vitamin D2'), ('PR_000017279', 'testis-specific basic protein Y 1', 0, 'Vitamin D2'), ('CHEBI_4910', 'etomidate', 11, 'ergocalciferol'), ('CHEBI_66036', "(2S)-2'-hydroxy-7,8,3',4',5'-pentamethoxyflavan", 69, 'vitamin D3are'), ('PR_000017209', 'utrophin', 69, 'vitamin D3are'), ('GO_0008152', 'metabolic process', 83, 'metabolized'), ('UBERON_0002107', 'liver', 102, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 111, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('NCBITaxon_1', 'root', 219, 'individual'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
PMC5690443	12/2015	S4-PMC5690443	['the offspring of Pregnant Rats Fed a magensium restricted diet have developed hypermethylation in the Hepatic 11Β-Hydroxysteroid Dehydrogenase-2 Promoter.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 17, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 26, 'rats'), ('GO_0007631', 'feeding behavior', 31, 'fed'), ('UBERON_0002107', 'liver', 102, 'hepatic'), ('CHEBI_36858', '2alpha-hydroxy steroid', 110, '11β-hydroxysteroid'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 110, '11β-hydroxysteroid dehydrogenase-2'), ('SO_0000167', 'promoter', 145, 'promoter')]
PMC5690443	12/2015	S112-PMC5690443	['Animal models\nquantitative real-time pcr-based methylation analysis of three Glucocorticoid related Genes was performed from Liver samples of offspring.']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_24261', 'glucocorticoid', 77, 'glucocorticoid'), ('SO_0000704', 'gene', 100, 'genes'), ('UBERON_0002107', 'liver', 125, 'liver')]
PMC5704156	11/2017	S27-PMC5704156	['Human Dihydrofolate reductase (dhfr), the enzyme that converts it to useable Dihydrofolate and Tetrahydrofolate, has relatively low and variable activity in the Liver, especially when compared to other Mammals [23].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('CHEBI_36263', 'hydrogenmolybdate', 6, 'dihydrofolate'), ('CHEBI_36263', 'hydrogenmolybdate', 77, 'dihydrofolate'), ('CHEBI_67016', 'tetrahydrofolate', 95, 'tetrahydrofolate'), ('UBERON_0002107', 'liver', 161, 'liver'), ('NCBITaxon_40674', 'Mammalia', 202, 'mammals')]
PMC5716389	9/2017	S37-PMC5716389	['dietary sources of Vitamin A include whole Milk, Liver, eggs, dark colored fruits and vegetables [11].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 19, 'vitamin A'), ('UBERON_0001913', 'milk', 43, 'milk'), ('UBERON_0002107', 'liver', 49, 'liver')]
PMC5724074	8/2017	S122-PMC5724074	['the content usually includes the following advices: (a) taking extra Food; (b) consumption of meat, Fish, Liver, egg, Milk/Milk products, lentils, colourful vegetables, fruits and oil; and (c) taking iron-Folic Acid (60\u2009mg iron and 40\u2009mg Folic Acid) and Calcium (500\u2009mg) supplements.']	N/A	N/A	[('CHEBI_33290', 'food', 69, 'food'), ('GO_0007601', 'visual perception', 100, 'fish'), ('UBERON_0002107', 'liver', 106, 'liver'), ('UBERON_0001913', 'milk', 118, 'milk'), ('UBERON_0001913', 'milk', 123, 'milk'), ('CHEBI_30751', 'formic acid', 205, 'folic acid'), ('CHEBI_30751', 'formic acid', 238, 'folic acid'), ('CHEBI_22313', 'alkaline earth metal atom', 254, 'calcium')]
PMC5732382	12/2017	S196-PMC5732382	['other items believed to increase Blood, as mentioned by various respondents, include Liver, fruits, Animal Blood, Milk, red beans, porridge prepared by flour of Finger Millet mixed with sorghum, iron supplements (issued at the anc clinic), herbs and red Soil/stones.']	N/A	N/A	[('UBERON_0000178', 'blood', 33, 'blood'), ('UBERON_0002107', 'liver', 85, 'liver'), ('NCBITaxon_33208', 'Metazoa', 100, 'animal'), ('UBERON_0000178', 'blood', 107, 'blood'), ('UBERON_0001913', 'milk', 114, 'milk'), ('UBERON_0002389', 'manual digit', 161, 'finger'), ('NCBITaxon_10088', 'Mus <genus>', 168, 'millet'), ('UBERON_0001913', 'milk', 254, 'soil')]
PMC5758844	12/2017	S0-PMC5758844	['outcomes following serial Intragastric balloon therapy for obesity and nonalcoholic fatty Liver disease in a single centre\n\nabstract\n\nbackground\nthe incidence of nonalcoholic fatty Liver disease (nafld) continues to parallel the rise in obesity rates.']	N/A	N/A	[('UBERON_0008907', 'dermal bone', 26, 'Intragastric'), ('UBERON_0002107', 'liver', 90, 'Liver'), ('UBERON_0002107', 'liver', 181, 'liver')]
PMC5758844	12/2017	S12-PMC5758844	['it is expected that nafld will become the main indication for Liver transplantation by 2020 [2].']	N/A	N/A	[('UBERON_0002107', 'liver', 62, 'liver')]
PMC5758844	12/2017	S40-PMC5758844	['the presence of nafld was determined on the basis of retrospective Liver biopsies confirming >5% Hepatic steatosis, formal reports of Hepatic steatosis on Liver ultrasound (performed within six months from the time of igb insertion), or a raised controlled attenuation parameter (cap) reading of >268\u2009db/m on fibroscan-cap [25].']	N/A	N/A	[('UBERON_0002107', 'liver', 67, 'liver'), ('UBERON_0002107', 'liver', 97, 'hepatic'), ('UBERON_0002107', 'liver', 134, 'hepatic'), ('UBERON_0002107', 'liver', 155, 'liver')]
PMC5758844	12/2017	S51-PMC5758844	['the primary outcome measure was weight loss, with secondary outcome measures including any significant changes in Liver function, Insulin resistance, and Lipid profiles.']	N/A	N/A	[('UBERON_0002107', 'liver', 114, 'liver'), ('PR_000045358', 'insulin family protein', 130, 'insulin'), ('CHEBI_18059', 'lipid', 154, 'lipid')]
PMC5758844	12/2017	S56-PMC5758844	['the following biochemical assays were performed: full Blood count, Liver function tests, Renal function, total Cholesterol, high-density lipoprotein (hdl), low-density lipoprotein (ldl), Triglycerides, Glucose, Insulin, hba1c, Vitamin D, and crp.']	N/A	N/A	[('UBERON_0000178', 'blood', 54, 'blood'), ('UBERON_0002107', 'liver', 67, 'liver'), ('UBERON_0002113', 'kidney', 89, 'renal'), ('CHEBI_16113', 'cholesterol', 111, 'cholesterol'), ('CHEBI_17855', 'triglyceride', 187, 'triglycerides'), ('CHEBI_17234', 'glucose', 202, 'glucose'), ('PR_000045358', 'insulin family protein', 211, 'insulin'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
PMC5758844	12/2017	S62-PMC5758844	['cap values range from 100 to 400\u2009db/m, with higher values indicating a greater degree of Liver fat.']	N/A	N/A	[('UBERON_0002107', 'liver', 89, 'liver')]
PMC5758844	12/2017	S122-PMC5758844	['we also observed several cases of improved Hepatic nash fibrosis with igb therapy, as measured though serial fibroscan recordings (results not shown) in a few patients and verified with serial Liver biopsy results in one case.']	N/A	N/A	[('UBERON_0002107', 'liver', 43, 'hepatic'), ('UBERON_0002107', 'liver', 193, 'liver')]
PMC5827025	2/2018	S11-PMC5827025	['introduction\nVitamin D, a Secosteroid Hormone, is synthesized primarily in the skin upon exposure to sunlight and is converted to active Vitamin D3 in the Liver and the Kidney.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 13, 'Vitamin D'), ('CHEBI_26661', 'shidasterone', 26, 'secosteroid hormone'), ('CHEBI_33279', 'vitamin D5', 137, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 137, 'vitamin D3'), ('UBERON_0002107', 'liver', 155, 'liver'), ('UBERON_0002113', 'kidney', 169, 'kidney')]
PMC5941617	5/2018	S14-PMC5941617	['Vitamin D2And D3Are transported by Vitamin D binding protein to the Liver, where they are 25-hydroxylated by the Vitamin D-25-hydroxylase (Cyp2R1) to produce 25-Hydroxyvitamin D [25(Oh)D], the major circulating Vitamin D Metabolite which is used to evaluate individual Vitamin D status.']	N/A	N/A	[('CHEBI_67916', '2alpha,3beta,23-trihydroxylup-20(29)-en-28-oic acid', 0, 'Vitamin D2and D3are'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D2and D3are'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002107', 'liver', 68, 'liver'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 139, 'CYP2R1'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 158, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 179, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 221, 'metabolite'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
PMC5941617	5/2018	S19-PMC5941617	['caption (table-wrap): table 1\n\nVitamin D content in some foodsfoodvitamin D average content (iu)milk and dairy productscow’s milk5–40/Lgoat’S Milk5–40/lbutter30/100\xa0gyogurt2.4/100\xa0gcream30/100\xa0gother foodspork40–50/100\xa0gbeef Liver40–50/100\xa0gsnapper (genus dentex dentex ), Cod, gilthead ( sparus auratus ), Dogfish ( mustelus mustelus ), sole, trout, salmon, Herring300–1500/100\xa0gcod Liver oil400/5\xa0mlegg yolk20/100\xa0g\n\nmethods\nthis document represents a consensus opinion of experts derived from current literature revision and it is intended to be mainly directed to hospital or primary care pediatricians.']	N/A	N/A	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 74, 'D'), ('UBERON_0005294', 'gonadal ridge', 134, 'lGoat’s'), ('UBERON_0015143', 'mesenteric fat pad', 142, 'milk5'), ('UBERON_0000104', 'life cycle', 225, 'liver40'), ('NCBITaxon_10088', 'Mus <genus>', 273, 'cod'), ('NCBITaxon_33208', 'Metazoa', 307, 'dogfish'), ('NCBITaxon_1', 'root', 359, 'herring300'), ('UBERON_0002107', 'liver', 384, 'liver')]
PMC5941617	5/2018	S131-PMC5941617	['vegan diet)• chronic Kidney disease• Hepatic failure and/or cholestasis• Malabsorption syndromes (i.e.']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'kidney'), ('UBERON_0002107', 'liver', 37, 'Hepatic'), ('GO_0046661', 'male sex differentiation', 73, 'Malabsorption')]
PMC5941617	5/2018	S193-PMC5941617	['vegan diet)• chronic Kidney disease• Hepatic failure and/or cholestasis• Malabsorption syndromes (i.e.']	N/A	N/A	[('UBERON_0002113', 'kidney', 21, 'kidney'), ('UBERON_0002107', 'liver', 37, 'Hepatic'), ('GO_0046661', 'male sex differentiation', 73, 'Malabsorption')]
PMC5991930	4/2018	S119-PMC5991930	['the team will request Blood work to assess Blood count, Kidney and Liver function, and electrolytes, including magnesium levels.']	N/A	N/A	[('UBERON_0000178', 'blood', 22, 'blood'), ('UBERON_0000178', 'blood', 43, 'blood'), ('UBERON_0002113', 'kidney', 56, 'kidney'), ('UBERON_0002107', 'liver', 67, 'liver')]
PMC6039335	7/2018	S160-PMC6039335	['the Fa De Novo Synthesis occurs mainly in Adipose Tissue in ruminants [84], whereas it occurs in the Liver in Humans and rodents.']	N/A	N/A	[('CHEBI_30751', 'formic acid', 4, 'FA'), ('GO_0006747', 'FAD biosynthetic process', 4, 'FA de novo synthesis'), ('UBERON_0001013', 'adipose tissue', 42, 'adipose tissue'), ('UBERON_0002107', 'liver', 101, 'liver'), ('NCBITaxon_9606', 'Homo sapiens', 110, 'humans')]
PMC6039335	7/2018	S196-PMC6039335	['Feeding medium-chain tgs, such as coconut Oil increased the Lipid content in the Liver and Carcasses of holstein calves under cold stress [104].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 0, 'Feeding'), ('CHEBI_63708', 'isopimara-8(14),15-diene', 42, 'oil'), ('CHEBI_18059', 'lipid', 60, 'lipid'), ('UBERON_0002107', 'liver', 81, 'liver'), ('UBERON_0008979', 'carcass', 91, 'carcasses')]
PMC6039335	7/2018	S221-PMC6039335	['the decreased flake thickness of steam-flaked sorghum increased Starch digestion and Liver Gluconeogenesis [114].']	N/A	N/A	[('CHEBI_28017', 'starch', 64, 'starch'), ('GO_0060174', 'limb bud formation', 85, 'liver gluconeogenesis'), ('UBERON_0002107', 'liver', 85, 'liver')]
PMC6039335	7/2018	S286-PMC6039335	['vitamin c\nvitamin C can be synthesized from Glucose in the Liver of many mammalian species other than guinea pigs, Humans, and other Primates [146].']	N/A	N/A	[('PR_000004900', 'complement C3', 18, 'C'), ('CHEBI_17234', 'glucose', 44, 'glucose'), ('UBERON_0002107', 'liver', 59, 'liver'), ('NCBITaxon_9606', 'Homo sapiens', 115, 'humans'), ('NCBITaxon_33208', 'Metazoa', 133, 'primates')]
